Unnamed: 0,date,top_5_titles
0,2019-11-10,Dreading winter? Check out these 3 simple ways to help keep your kids healthy this season - Johnson & Johnson
1,2019-11-11,Johnson & Johnson's Tremfya backs psoriatic arthritis play with newest data - FiercePharma|FDA Class 1 Recall of J&J/Ethicon Surgical Staplers - Louisville Personal Injury Attorney
2,2019-11-12,Ebola vaccine approved as second jab trialled - BBC
3,2019-11-13,"CIO50 2019: #18 Angela Coble, Johnson & Johnson - CIO|Q&A: How to overhaul community health for improved global outcomes - Devex|Dr Koongoo keessatti talaalliin Iboolaa marsaa lammaffaan kennamuufi - BBC.com"
4,2019-11-14,Oklahoma judge reduces penalty against Johnson & Johnson in opioid crisis lawsuit - Fox News|Oklahoma Judge Shaves $107 Million Off Opioid Decision Against Johnson & Johnson - NPR
5,2019-11-15,"Whoops. Judge Reduces J&J Opioid Fine After Mistaking Thousands for Millions (Published 2019) - The New York Times|AHA: Johnson & Johnson, Bayer still looking for answers in aborted Xarelto study - FiercePharma|Rollout of Johnson & Johnson Ebola vaccine begins in Congo - The Fiji Times"
6,2019-11-16,Lee So-young cruised to two-stroke victory at 2019 LF Hazzys Point Final Championship - 코리아타임스
7,2019-11-17,"Inflammatory Bowel Disease Insight Report: Current Therapies, Drug Pipeline and Outlook - BioSpace"
8,2019-11-18,What Do Working Dads Want? Flexibility and Paid Family Leave to Start - Johnson & Johnson|Top 10 pharma settlements since 2018 - FiercePharma|New York CIO Leadership Association 2019: Larry Jones - Crain's New York Business
9,2019-11-19,Pelvic mesh maker Johnson and Johnson loses class action suit - ABC News|Johnson & Johnson invests EGP 2.3bn in Egypt - Daily News Egypt|Australian women win landmark vaginal mesh class action against Johnson & Johnson - The Guardian|Australian women win mesh implant class action lawsuit against Johnson & Johnson - Feminist Current
10,2019-11-20,Global Cosmetic Skin Care Market 2019-2023|Evolving Opportunities with Beiersdorf and Johnson & Johnson Services|Technavio - Business Wire|Johnson & Johnson loses vaginal mesh class action - BBC|New Cervical Spine System from DePuy Synthes Advances Treatment Options for Patients with Complex Cervical Spine Disorders - PR Newswire
11,2019-11-21,'Treated like guinea pigs': Landmark win for Australian women - The Canberra Times|Pelvic mesh maker Johnson and Johnson loses class action suit - The New Daily|J&J's DePuy Synthes launches surgical fixation system for patients with frailer head and neck bones - Fierce Biotech
12,2019-11-22,"Fight is not over, says winner of vaginal mesh implant court victory - CNN"
13,2019-11-23,nan
14,2019-11-24,
15,2019-11-25,
16,2019-11-26,Epidemiology of Hematologic Malignancies in Real-World Settings: Findings From the Hemato-Oncology Latin America Observational Registry Study - ASCO Journals|Development of PsA Linked to Tenosynovitis in Patients With Arthralgia - AJMC.com Managed Markets Network
17,2019-11-27,
18,2019-11-28,
19,2019-11-29,
20,2019-11-30,
21,2019-12-01,"Have IBD? Read about the next frontier in disease research that taps into the microbiome - Johnson & Johnson|Ski-in, ski-out Vail chalet formerly owned by Johnson & Johnson heiress listed for $26M (Photos) - The Business Journals"
22,2019-12-02,Johnson & Johnson confirms no asbestos in Johnson's Baby Powder - CNBC|The top 15 biopharma M&A mistakes of the last decade - FiercePharma
23,2019-12-03,J&J Stock Gains After Company Says FDA Wrong About Asbestos In Baby Powder - Barron's|Johnson & Johnson Confirms No Asbestos In Johnson's Baby Powder - Checkout|2019 Australian 15 Years and Under Championship - Jack Newton Junior Golf
24,2019-12-04,"Johnson & Johnson Names Hubert Joly, Executive Chairman of Best Buy and Mark A. Weinberger, Former EY Global Chairman and CEO to its Board of Directors - PR Newswire"
25,2019-12-05,Hubert Joly - Johnson & Johnson
26,2019-12-06,"Vindicated. New J&J CAR-T myeloma data confirm strong efficacy, ease doubts raised by Chinese version - STAT"
27,2019-12-07,The Weekly|Johnson & Johnson Lawsuits Raise Fears Over Baby Powder (Published 2019) - The New York Times
28,2019-12-08,ASH: J&J's Darzalex cuts death risk by 40% in new myeloma patients - FiercePharma
29,2019-12-09,
30,2019-12-10,
31,2019-12-11,
32,2019-12-12,
33,2019-12-13,
34,2019-12-14,
35,2019-12-15,"Pfizer, Astellas' Xtandi matches J&J's rival Erleada with new prostate cancer nod - FiercePharma"
36,2019-12-16,This is the decade we made one of the world’s deadliest diseases preventable and curable - Wellcome Trust
37,2019-12-17,
38,2019-12-18,▼ (Esketamine) Nasal Spray Approved in Europe for Adults with Treatment-Resistant Major Depressive Disorder - Business Wire
39,2019-12-19,Johnson & Johnson Announces Agreement to Acquire Remaining Stake in Verb Surgical Inc. - PR Newswire|J&J to acquire remaining stake in Verb Surgical - Mass Device|J&J takes over Verb Surgical as Verily exits robotics partnership - MedTech Dive|Johnson & Johnson Agrees to Acquire Remaining Stake in Verb Surgical Inc. - MPO-mag
40,2019-12-20,Johnson & Johnson Acquires Taris Biomedical - FinSMEs
41,2019-12-21,
42,2019-12-22,J&J taps TARIS Biomedical for novel bladder cancer technology - PMLiVE | Johnson & Johnson Acquires TARIS Biomedical - njbmagazine.com | Johnson & Johnson buys out Verily stake in Verb Surgical - Robot Report | Jury backs Johnson & Johnson in talc cancer case - Fox Business
43,2019-12-23,Carcinogens in Consumer Products - C-SPAN
44,2019-12-24,The 5 best and 5 worst pharma deals of the decade: Leerink - Business Insider
45,2019-12-25,Look for the sign: The unique way Johnson & Johnson helped ring in the New Year in 1915 - Johnson & Johnson
46,2019-12-26,
47,2019-12-27,
48,2019-12-28,
49,2019-12-29,
50,2019-12-30,
51,2019-12-31,
52,2020-01-01,"AG Ferguson sues opioid manufacturer Johnson & Johnson over state’s opioid epidemic - Washington State|Office of the Attorney General|Biosimilars a '21st century revolution that we're helping to lead', says Biogen exec - The Pharma Letter"
53,2020-01-02,
54,2020-01-03,Johnson & Johnson faces criminal charges in faulty hip implants case - The Economic Times
55,2020-01-04,
56,2020-01-05,
57,2020-01-06,"JAMA Study Finds No Significant Link Between Talc Powder, Ovarian Cancer - AJMC.com Managed Markets Network"
58,2020-01-07,"Johnson & Johnson's Ernie Knewitz named Americas comms lead for Janssen - PR Week|US Latino Population With Psoriasis Exposed to Heightened Disease Severity, Worse Quality of Life - AJMC.com Managed Markets Network"
59,2020-01-08,Johnson & Johnson’s Ernie Knewitz named Americas comms lead for Janssen - MM+M Online
60,2020-01-09,Janssen Expands Research & Development Presence with Major Investment in South San Francisco - Business Wire|J&J’s Ethicon defeats all but 4 claims in Kentucky pelvic mesh case - Mass Device
61,2020-01-10,
62,2020-01-11,"Harold Burson, public relations giant often called upon during a crisis, dies at 98 - The Washington Post"
63,2020-01-12,"Johnson & Johnson to pay $6.3M in Infants' Tylenol class-action lawsuit - WTHR|Johnson & Johnson to Pay $6.3 Million in Infant’s Tylenol Settlement - WNEP Scranton/Wilkes-Barre|If you bought Infants’ Tylenol, you may be entitled to cash under class action lawsuit - WECT"
64,2020-01-13,"After Johnson & Johnson Lawyer Scolded By Judge, Talc Trial Resumes With New Defense Team - Law.com|Treatment of human skeletal muscle cells with inhibitors of diacylglycerol acyltransferases 1 and 2 to explore isozyme-specific roles on lipid metabolism - Nature.com"
65,2020-01-14,Healthpeak Signs Johnson & Johnson Subsidiary to The Shore at Sierra Point - Connect CRE
66,2020-01-15,
67,2020-01-16,Judge Slashes $8 billion Risperdal award against Johnson & Johnson to $6.8 million - CBS News
68,2020-01-17,
69,2020-01-18,
70,2020-01-19,Alzheimer’s disease: Why one company refuses to give up the search for a cure - Johnson & Johnson|How the 8 biggest U.S. pharmas enriched their shareholders in 2019 - FiercePharma
71,2020-01-20,JNJ Stock Pattern Suggests Uptrend is Almost Over - EWM Interactive
72,2020-01-21,"Johnson & Johnson beats Wall Street expectations on profit, misses on revenue - CNBC|Johnson & Johnson Is Regaining Its Health - The Wall Street Journal"
73,2020-01-22,Johnson & Johnson to disclose robot-assisted surgery plans in May - Robot Report|Stelara setback in UK reimbursement process - The Pharma Letter|Juniors Star at NSW Amateur - Jack Newton Junior Golf
74,2020-01-23,Rising Trends of Hydrogel Market in Worldwide|Topmost Key - openPR
75,2020-01-24,
76,2020-01-25,
77,2020-01-26,"J&J CEO takes the stand for first time at Baby Powder trial - Al Jazeera English|Theismann, Johnson & Johnson exec kick off SMC3 Jump Start conference - American Journal of Transportation"
78,2020-01-27,What you need to know about the coronavirus—and a potential preventive vaccine - Johnson & Johnson|J&J's ketamine depression drug Spravato spurned by England's influential cost watchdogs - FiercePharma
79,2020-01-28,
80,2020-01-29,"Attorney General Becerra Secures nearly $344 Million Judgment Against Johnson & Johnson for Endangering Patients through Deceptive Marketing of Pelvic Mesh Products - California Department of Justice | Johnson & Johnson Is Told to Pay $344 Million in Pelvic Mesh Suit (Published 2020) - The New York Times | Bayer's Nubeqa scores key prostate cancer win in battle with Pfizer, J&J - FiercePharma"
81,2020-01-30,Johnson & Johnson ordered to pay US$344 million in pelvic mesh case - CTV News|Johnson & Johnson Fined $344M in Pelvic Mesh Case - MPO-mag
82,2020-01-31,Transvaginal mesh: Johnson & Johnson fined $344m for deceptive marketing to women - The Guardian|Johnson & Johnson (JNJ) Fundamental Valuation Report - ValueWalk|Johnson & Johnson Acquires TARIS Biomedical - Contract Pharma
83,2020-02-01,
84,2020-02-02,
85,2020-02-03,Johnson & Johnson ordered to pay $344M in marketing case - Southwest Ledger|FDA to hold public meeting on testing for asbestos in talc - NBC News|Judge Sanctions Simmons Hanly for 'Frivolous' Disclosure of J&J CEO's Deposition - Law.com
86,2020-02-04,"Does baby powder cause cancer? Johnson & Johnson stops selling talc powder after years of scrutiny - USA TODAY|Johnson & Johnson Dr. Paul Janssen Award 2020 for Biomedical Research ($200,000 Cash prize) - Opportunity Desk"
87,2020-02-05,Jury Orders J&J to Pay $750 Million for Talc Case Punishment - Bloomberg
88,2020-02-06,Johnson & Johnson ordered to pay $750 million in New Jersey talc case: Lawyer - Fox Business
89,2020-02-07,nan
90,2020-02-08,
91,2020-02-09,"That's so presidential! 4 of Johnson & Johnson’s most memorable moments with heads of state - Johnson & Johnson | Johnson & Johnson ""most valuable"" pharma brand, says report - European Pharmaceutical Review"
92,2020-02-10,
93,2020-02-11,The charming way Johnson & Johnson showed its love to employees in the 1960s - Johnson & Johnson | Exclusive: Pharma firm exploited patient group to lobby NHS for drug approval - PR Week
94,2020-02-12,GIANT PARTNERSHI­P FROM JANSSEN AND ABDİ İBRAHİM PHARMACEUT­ICAL COMPANY - PressReader|Johnson and Johnson launch investigation after mothers claim children were left with 'burn' marks - Daily Mail
95,2020-02-13,Encouraging data for subcutaneous Stelara in Crohn's disease - The Pharma Letter|Baby wipe range withdrawn by Johnson & Johnson after parents report “burns” to children’s faces - Deadline News
96,2020-02-14,
97,2020-02-15,
98,2020-02-16,J&J Institute rolling out VR headsets to train surgeons - MedCity News|DePuy Synthes Confirms Plans To Move Distribution Center - InkFreeNews.com
99,2020-02-17,Johnson & Johnson to Expand Partnership with U.S. Department of Health & Human Services to Accelerate the Discovery of Potential COVID-19 Treatments - PR Newswire|Sanofi Pasteur to use SARS technology to expedite potential COVID-19 vaccine - The Pharma Letter
100,2020-02-18,J&J offered doctors free services and profit-making advice to boost Remicade scripts: whistleblower suit - FiercePharma|Johnson & Johnson pays $514 million in lump sums in 2019 - Pensions & Investments|GIRLGAMER Esports Festival Announces Partnerships With Multiple Cosmetics Brands – ARCHIVE - archive.esportsobserver.com
101,2020-02-19,
102,2020-02-20,J&J’s Ethicon mostly fends off Intuitive Surgical’s robotic surgery patent challenge - Mass Device
103,2020-02-21,
104,2020-02-22,"For U.S. Media Agency of the Year UM, Making Cannes-Worthy Movies Is Just Part of the Job - Adweek"
105,2020-02-23,Battle of the ’bots: 4 robotic surgery rivalries to watch in the year ahead - MedTech Dive
106,2020-02-24,"Johnson & Johnson Launches Heartline™, the First-of-its-Kind, Virtual Study Designed to Explore if a New iPhone App and Apple Watch Can Help Reduce the Risk of Stroke - PR Newswire|Apple Working With Johnson & Johnson on 'Heartline Study' Aimed at Reducing Risk of Stroke - MacRumors|“I Think They’ll Be Very Generous With You”: Inside a Trump Bedminster/Mar-a-Lago Drug Deal—Literally - Vanity Fair|Apple and Johnson & Johnson team up on new study to see if Apple Watch can reduce risk of stroke - CNBC"
107,2020-02-25,"Apple, J&J open enrollment of Heartline Study to Medicare seniors with iPhones - Mobihealth News|Apple, Johnson & Johnson team up on heart study using Apple Watches - Fierce healthcare|Why Apple and Johnson & Johnson's new heart study is a big deal for digital health - CNBC|Can an Apple Watch reduce the likelihood of suffering a stroke? The innovative study that's tackling the problem of AFib - Johnson & Johnson"
108,2020-02-26,How Johnson & Johnson fills its procurement talent pipeline - Supply Chain Dive|Can your Apple Watch help prevent a stroke? - Fast Company
109,2020-02-27,
110,2020-02-28,
111,2020-02-29,
112,2020-03-01,Johnson & Johnson to pay $2.6m to women with faulty pelvic mesh implants - ABC News | Thirty-One Dividend Aristocrats for Further Review - Dividend Growth Investor
113,2020-03-02,"Citing J&J's legal controversies, investor group calls for split of Gorsky's CEO and chairman roles - FiercePharma"
114,2020-03-03,
115,2020-03-04,J&J chief Alex Gorsky nabbed $25M pay package in year marked by legal controversy - FiercePharma | How a Red Bank lawyer won a $750 million verdict against Johnson & Johnson - Asbury Park Press
116,2020-03-05,Windows on the past: The Johnson & Johnson employees who were forever commemorated in stained glass - Johnson & Johnson|Supira Medical closes $35m Series B for its pVAD tech - Mass Device
117,2020-03-06,
118,2020-03-07,
119,2020-03-08,What it really feels like to have multiple sclerosis - Johnson & Johnson|Here's the Strategy Behind Miami Lawyers' $9 Million Win Against Johnson & Johnson - Law.com
120,2020-03-09,
121,2020-03-10,
122,2020-03-11,Beth Israel is working with Johnson & Johnson on a coronavirus vaccine - The Boston Globe|Thermo Fisher Scientific Signs Agreement with Janssen to Co-Develop Companion Diagnostic for Cancer - PR Newswire
123,2020-03-12,"Professor served cease and desist after publishing journal article - The Brown Daily Herald|J. Seward Johnson, world-renowned sculptor, dies at 89 - My Central Jersey"
124,2020-03-13,"Seward Johnson, Johnson & Johnson heir who sculpted real-life images in bronze, dies at 89 - The Washington Post"
125,2020-03-14,
126,2020-03-15,Covid-19 vaccine in development by J&J and BIDMC. - Pharmaceutical Technology
127,2020-03-16,
128,2020-03-17,Lapierre Aircode aero road & Aerostorm time trial disc brake prototypes teased & raced by FDJ - BikeRumor.com
129,2020-03-18,J&J's Tylenol production at maximum capacity as coronavirus boosts demand - Reuters.com|Former Visiogen Chief Executive Tapped to Lead PROCEPT BioRobotics - MPO-mag
130,2020-03-19,Janssen sends off NDA for new multiple sclerosis drug ponesimod - Fierce Biotech
131,2020-03-20,Wall Street analysts say buy these ‘safe-haven’ stocks amid market volatility - CNBC
132,2020-03-21,
133,2020-03-22,"J&J joins one-stop shop movement, backs Omnicom to lead media, digital ...everything - Mi3"
134,2020-03-23,
135,2020-03-24,
136,2020-03-25,How Johnson & Johnson companies used a ‘super poppy’ to make narcotics for America’s most abused opioid pills - The Washington Post
137,2020-03-26,"Advancing Well-Being and Resilience for Frontline Health Workers in COVID-19 - Johnson & Johnson|""I was on the front lines of the COVID-19 outbreak in Wuhan"": A doctor shares his story - Johnson & Johnson|Swiss operates the longest flight in its history with the Boeing 777 - aeroflap"
138,2020-03-27,"ACC: J&J, Bayer's blood thinner Xarelto scores in artery disease post-surgery - FiercePharma"
139,2020-03-28,Johnson & Johnson Stock Rebounds Below 'Reversion to the Mean' - Investopedia
140,2020-03-29,Johnson & Johnson aims to begin clinical trial of coronavirus vaccine by September - KTLA Los Angeles|US and J&J commit $1b to coronavirus vaccine codeveloped by Beth Israel - The Boston Globe|Drugmakers fight for freight space as coronavirus grounds flights - South China Morning Post
141,2020-03-30,"Johnson & Johnson partners with US Government to co-fund COVID-19 vaccine research - The New Economy|The $1 billion bet: Pharma giant and U.S. government team up in all-out coronavirus vaccine push - Science|J&J says clinical trials for COVID-19 vaccine candidate will begin by September - European Pharmaceutical Review|US stocks close higher but oil is at an 18-year low: March 30, 2020 - CNN"
142,2020-03-31,
143,2020-04-01,
144,2020-04-02,Johnson & Johnson chief looks to the greater good - Financial Times
145,2020-04-03,
146,2020-04-04,
147,2020-04-05,
148,2020-04-06,Everything Must Go Right for Big Pharma’s Bet on a Fast Vaccine - Bloomberg
149,2020-04-07,"Hilarious, heartfelt, the signs of the times - Sippican Week"
150,2020-04-08,6 impactful ways Johnson & Johnson is helping in the fight against COVID-19 - Johnson & Johnson
151,2020-04-09,(PDF) Financial Statement Analysis: A comparative analysis of Johnson and Johnson (JNJ) vs Eli Lilly Company (LLY) - ResearchGate|The Shocking Size Of Johnson & Johnson - Daily Infographic
152,2020-04-10,
153,2020-04-11,
154,2020-04-12,High-profile marketer Richa Goswami leaves J&J - Campaign Asia
155,2020-04-13,"How is COVID-19 affecting drugmakers? J&J execs offer some early clues - FiercePharma|JNJ Shares Up Nearly 4% as Johnson & Johnson Posts Revenue of $20,69B in Q1 2020 - Coinspeaker|Johnson and Johnson Heiress’ Horse Farm Is Relisted With Huge Price Cut - Realtor.com News|JNJ Rallies After First Quarter Earnings Beat - TheStreet"
156,2020-04-14,What you need to know about Johnson & Johnson's 2020 first-quarter earnings - Johnson & Johnson|Selective inhibition of cancer cell self-renewal through a Quisinostat-histone H1.0 axis - Nature.com|Johnson & Johnson Lowers Revenue Forecast on Coronavirus Impact - The Wall Street Journal|P2X7 receptor inhibition ameliorates dendritic spine pathology and social behavioral deficits in Rett syndrome mice - Nature.com
157,2020-04-15,"JLABS @ Washington, DC: The unique innovation hub that's poised to help protect us from future pandemics - Johnson & Johnson|Johnson & Johnson CEO Alex Gorsky on a Potential COVID-19 Vaccine - Johnson & Johnson|2020-2024 Alfentanil Market Worldwide Analysis Report - openPR"
158,2020-04-16,"Johnson & Johnson, Gilead and Roche are the world’s antiviral patent leaders &nbsp - IAM|Johnson & Johnson execs offer upbeat view of second-half recovery from COVID-19 pandemic - MarketWatch"
159,2020-04-17,
160,2020-04-18,
161,2020-04-19,The top 20 pharma companies by 2019 revenue - FiercePharma
162,2020-04-20,"J&J, AbbVie's Imbruvica pads CLL lead with FDA green light in younger patients - FiercePharma"
163,2020-04-21,How Johnson & Johnson IT is managing a global crisis - CIO
164,2020-04-22,
165,2020-04-23,"""I'm racing to screen thousands of molecules"": These scientists are canvassing a vast library in search of a potential COVID-19 treatment - Johnson & Johnson"
166,2020-04-24,
167,2020-04-25,
168,2020-04-26,U.S. judge rules talc lawsuits against Johnson & Johnson can proceed - Fox Business
169,2020-04-27,
170,2020-04-28,"Caring on the COVID-19 front lines: ""I rallied colleagues all over the world to help me make over 2,100 cloth masks"" - Johnson & Johnson"
171,2020-04-29,
172,2020-04-30,
173,2020-05-01,
174,2020-05-02,Meet Two Innovative Nurses Working to Keep Moms and Babies Healthy - Johnson & Johnson
175,2020-05-03,
176,2020-05-04,
177,2020-05-05,
178,2020-05-06,
179,2020-05-07,"Johnson & Johnson’s Stock Tops Out, But There’s More To The Story - The Healthcare Technology Report."
180,2020-05-08,
181,2020-05-09,
182,2020-05-10,Even finding a covid-19 vaccine won’t be enough to end the pandemic - The Washington Post
183,2020-05-11,Adenoviral vectors are the new COVID-19 vaccine front-runners. Can they overcome their checkered past? - Chemical & Engineering News
184,2020-05-12,ASCO: J&J's Erleada extends lives by 14 months in nonmetastatic prostate cancer - FiercePharma
185,2020-05-13,
186,2020-05-14,Lava Therapeutics Announces Collaboration with Janssen to Develop Bi-specific Gamma-Delta T-cell Engager Therapeutics - Business Wire
187,2020-05-15,
188,2020-05-16,Johnson & Johnson looks to acquire Ci:z Holdings Co. Ltd for up to $2.05bn - Healthcare Digital | Made-in-India Coronavirus test swabs to cost only one-tenth of imported ones - The Hindu | Johnson & Johnson are no longer selling metal-on-metal hip implants - Healthcare Digital | TOP 10: Most Promising Drugs Guaranteed to Save Lives in 2015 - Healthcare Digital
189,2020-05-17,Johnson & Johnson Faces Elmiron Lawsuit for Allegedly Concealing Adverse Event Data - MedTruth|Janssen Presents First Data from Phase 1 Study of BCMAxCD3 Bispecific Teclistamab in Patients with Heavily Pre-treated Relapsed or Refractory Multiple Myeloma - Business Wire
190,2020-05-18,"Johnson & Johnson Discontinues Talc Baby Powder in U.S., Canada - Bloomberg|Johnson & Johnson to discontinue talc-based baby powder - Fox Business|Johnson & Johnson stops selling talc-based baby powder - Financial Times|Johnson & Johnson discontinues talc baby powder in U.S. and Canada - Los Angeles Times"
191,2020-05-19,"Johnson & Johnson discontinues talc-based baby powder in U.S., Canada amid lawsuits - NBC News|Johnson & Johnson will stop selling talc-based Johnson's Baby Powder - USA TODAY"
192,2020-05-20,"Johnson & Johnson Finally Shuts Business in US-Canada, Lawsuits Claim Its Baby Talcum Powder Caused Cancer - India.com|Johnson & Johnson Discontinues Talcum Baby Powder in U.S. and Canada - TIME|Johnson & Johnson Discontinues Talc-Based Baby Powder In US And Canada - Forbes|Johnson & Johnson will stop selling talc-based baby powder - CNN|Johnson & Johnson to stop selling talc baby powder in U.S. and Canada - Reuters.com"
193,2020-05-21,"Johnson & Johnson baby talc powder: Should North American market pullout be a concern for Indian... - Moneycontrol|Johnson & Johnson to halt North American sales of talc-based Johnson’s baby powder - Salon|Do UK parents need to be concerned about Johnson & Johnson talc scandal? - The Independent|Johnson & Johnson Stops Selling Baby Powder In America — What Is Talc, And Why It May Be A Concern - NYLON SINGAPORE|Women in vaginal mesh lawsuit settle for £50m - Scottish Legal News"
194,2020-05-22,
195,2020-05-23,
196,2020-05-24,
197,2020-05-25,
198,2020-05-26,"AI at Johnson & Johnson – Current Investments - Emerj|Johnson & Johnson supplies hydration drinks to over 20,000 medical frontliners - Philstar.com"
199,2020-05-27,Feminine Products: Buy Women Hygiene Products @Upto 10% OFF - Netmeds.com
200,2020-05-28,J&J To Discontinue Sales of Talc-Based Baby Powder - ConsumerSafety.org
201,2020-05-29,
202,2020-05-30,Johnson & Johnson’s Angela Coble on averting a virus crisis - CIO
203,2020-05-31,"Janssen, PRA Design First Mobile Virtual Trial - Contract Pharma|This is the time when technology will leap frog: Emrana Sheikh, Johnson & Johnson - People Matters"
204,2020-06-01,
205,2020-06-02,"Pfizer, Merck, AZ, J&J and Moderna selected as 'Warp Speed' finalists: NYT - FiercePharma | Biopharma CEOs call for action on systemic racism—across America and in their own ranks - FiercePharma"
206,2020-06-03,
207,2020-06-04,"Fresh off ASCO myeloma data, Legend Bio gets $424M in biotech’s biggest IPO of 2020 - BioPharma Dive | Free One on One Golf Lessons to Introduce Newbies to Golf - Jack Newton Junior Golf"
208,2020-06-05,
209,2020-06-06,"Johnson & Johnson Partner's Stock Soars As Investors Embrace China Health, Tech - Forbes"
210,2020-06-07,
211,2020-06-08,Johnson & Johnson delivers its first 4K endoscopic imaging system in China - China Daily
212,2020-06-09,"Testing accelerated for coronavirus vaccine developed by Beth Israel, Johnson & Johnson - The Boston Globe"
213,2020-06-10,Band-Aid launching racially diverse bandages - New York Post
214,2020-06-11,Band-Aid will make black and brown flesh-toned bandages - CNN|BIO: Kura Oncology CEO Wilson on the power of biotech in the quest beyond KRAS - Fierce Biotech|Band-Aid Brings Back Bandages for Diverse Skin Tones - NBC Chicago
215,2020-06-12,EHA: Johnson & Johnson's Darzalex branches out beyond myeloma with AL amyloidosis win - FiercePharma
216,2020-06-13,Band-Aid will make black and brown flesh-toned bandages - KWTX
217,2020-06-14,BAND-AID released new bandages in different skin-colors - ABC13 Houston
218,2020-06-15,Four signs of a competitive moat at Johnson & Johnson (NYQ:JNJ) - Stockopedia
219,2020-06-16,Lassen Therapeutics uncloaks with $31M and anti-IL-11 antibody - Fierce Biotech
220,2020-06-17,
221,2020-06-18,
222,2020-06-19,"Johnson & Johnson will stop selling its 'Clean & Clear ' fairness products in India|Company Business News - Mint|Johnson & Johnson discontinues Middle East skin lightening products - The New Arab|Johnson & Johnson will no longer sell skin-lightening products sold mainly in India, Middle East, and other parts of Asia - Business Insider|Johnson & Johnson stops sale of 'Clean & Clear' fairness products in India amid criticism - Republic World"
223,2020-06-20,
224,2020-06-21,"Johnson & Johnson pulls skin whitening creams off shelves in Asia, Middle East - afaqs! | Johnson & Johnson Will Finally Stop Selling Skin-Whitening Creams - The Cut | J&J To Pull Skin-Whitening Creams - Beauty Packaging | Johnson & Johnson To Stop Selling 2 Lines Of Skin-Lightening Products Popular In Asia - NPR | Johnson & Johnson Is Ceasing Production of Skin-Care Products Used for Skin Lightening in Asia and Middle East - Allure"
225,2020-06-22,Why Johnson & Johnson Is Stopping The Sale Of Skin-Whitening Creams - The List|Johnson & Johnson to cease sale of skin whitening products - GlobalCosmeticsNews|Shock in Asia as skincare giant ends skin-whitening cream sales - South China Morning Post
226,2020-06-23,"Virology analysis of chronic hepatitis B virus–infected patients treated for 28 days with JNJ-56136379 monotherapy - Wiley Online Library|The Crossover: A Profitable Intersection of Asset Prices - Towards Data Science|Johnson & Johnson ordered to pay $2.1 billion in baby powder lawsuit - The Hill|Missouri appeals court reduced Johnson & Johnson's compensation verdict by half to US$ 2,12 billion - MercoPress"
227,2020-06-24,"Twitter says 'fare thee well' to skin-whitening creams as HUL knocks off 'Fair' from 'Fair and Lovely' - The Economic Times|Amid calls for racial equality, people question why 'beauty means white skin' - CGTN|Unilever, Johnson & Johnson will pull or rebrand skin-lightening creams in India - CNN|""I'm one of the more than half a million people who can go years undiagnosed"": A woman shares the story of her shocking AFib Diagnosis - Johnson & Johnson|Johnson & Johnson Will Stop Selling Skin-Whitening Lotions (Published 2020) - The New York Times"
228,2020-06-25,J&J's Janssen scraps Stelara study in SLE - The Pharma Letter|Criticism of Skin Lighteners Brings Retreat by Unilever and Johnson & Johnson (Published 2020) - The New York Times
229,2020-06-26,Johnson & Johnson to Pull Down Fairness Cream From India And Other Asia-Middle East Markets Amid Black Lives - India.com
230,2020-06-27,"L'Oréal is the latest beauty company to remove words like 'fair,' 'light,' and 'whitening' from marketing skin-tone products - Business Insider"
231,2020-06-28,Certain Personality Traits in Patients With Psoriasis May Explain Social Anxiety - AJMC.com Managed Markets Network
232,2020-06-29,Companies are pulling skin-lightening items and reckoning with racism - Business Insider
233,2020-06-30,
234,2020-07-01,Access and pricing principles - Johnson & Johnson
235,2020-07-02,
236,2020-07-03,
237,2020-07-04,
238,2020-07-05,"""AIDS won’t stop for COVID-19"": Meet 3 inspiring women who are as committed as ever to making HIV history - Johnson & Johnson | Governments must scale up better TB treatment as J&J drops crucial drug price - Médecins Sans Frontières (MSF) International | Announcing Price Reduction for BDQ for Treatment of DR-TB in Low- And Middle-Income Countries - Stop TB Partnership"
239,2020-07-06,Biomedical engineer Pallavi Tiwari named ‘Women in STEM2D Scholar’ - The Daily|Case Western Reserve University|Johnson & Johnson et al. v. Advanced Inventory Management Inc. et al. - Global Legal Chronicle
240,2020-07-07,Pressure mounts on Johnson & Johnson to halt sales of baby powder globally - Deccan Chronicle
241,2020-07-08,
242,2020-07-09,Campaign to stop Johnson&Johnson selling its talk Baby Powder worldwide - MercoPress
243,2020-07-10,nan
244,2020-07-11,
245,2020-07-12,Perfect Corp. and Johnson & Johnson Launch First-Ever AR Virtual Contact Lens Try-On in Taobao and WeChat Mini Programs - Business Wire | The top 15 pharma companies by 2026 sales - FiercePharma | Bad Breath Offers a Rare Payoff in Listerine-Royalty Stake Sale - Bloomberg
246,2020-07-13,"J&J's Tremfya grabs psoriatic arthritis nod, setting up a battle with Cosentyx, Taltz and more - FiercePharma"
247,2020-07-14,These 3 Healthcare Companies Drive Innovation Through Venture Capital - Built In
248,2020-07-15,
249,2020-07-16,"Johnson & Johnson delays regulatory filing for general surgery robot - Robot Report | J&J drops planned 510(k) for Verb-Auris robot, targets 2022 clinical trial start - MedTech Dive"
250,2020-07-17,
251,2020-07-18,
252,2020-07-19,"""We have a health disparities problem in America"": Meet a woman on a mission to improve healthcare for black women - Johnson & Johnson|The top 10 highest paid biopharma R&D executives in 2019 - Fierce Biotech|6 Robotic Surgery Stocks for Retail Investors - Nanalyze"
253,2020-07-20,
254,2020-07-21,"Some Vaccine Makers Say They Plan to Profit From Coronavirus Vaccine (Published 2020) - The New York Times | Sell Overpriced Novavax Stock While You Still Can - Markets Insider | Trump Administration Has 'Major' Vaccine Investment in Pfizer, Four Others - Newsweek"
255,2020-07-22,
256,2020-07-23,
257,2020-07-24,
258,2020-07-25,
259,2020-07-26,
260,2020-07-27,
261,2020-07-28,
262,2020-07-29,"J&J begins clinical trial of single-dose coronavirus vaccine - Fox Business | Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques - Nature.com | Experimental Johnson & Johnson vaccine protects monkeys in a single dose, study finds - CNBC"
263,2020-07-30,
264,2020-07-31,
265,2020-08-01,
266,2020-08-02,"Genscript chief, the majority shareholder of Legend, becomes China biotech’s new CEO - Fierce Biotech | J&J’s Ethicon wins FDA breakthrough nod for microwave ablation tech - Mass Device | 40 Under 40 2020 | Kim Montagnino, Johnson & Johnson, 33 - PR Week | Coronavirus: FDA approves Johnson & Johnson nasal spray for treatment of acutely suicidal patients - WSOC Charlotte | European lift for Cosentyx - The Pharma Letter"
267,2020-08-03,
268,2020-08-04,"U.S. to pay $1 billion for 100 million doses of Johnson & Johnson's COVID-19 vaccine candidate - Reuters | Johnson & Johnson Announces Agreement with U.S. Government for 100 Million Doses of Investigational COVID-19 Vaccine - Canada NewsWire | Here’s How Much COVID-19 Vaccines Will Cost From The 5 Frontrunners - Observer | Hanmi Pharma off-loads efinopegdutide, as possible NASH treatment, in $870 million deal - The Pharma Letter"
269,2020-08-05,J&J’s Ethicon touts surgical stapler study - Medical Design & Outsourcing|Johnson & Johnson develops first antidepressant nasal spray for actively suicidal people; here is how it works - The Times of India
270,2020-08-06,"Johnson & Johnson, looking to safeguard Darzalex share, eyes subcutaneous label boost - FiercePharma|Call for Global Ban on Johnson & Johnson’s Talcum Powder - Mesothelioma.com"
271,2020-08-07,
272,2020-08-08,
273,2020-08-09,
274,2020-08-10,
275,2020-08-11,4 innovative ways Johnson & Johnson has helped protect the public's health during outbreaks since the late 1800s - Johnson & Johnson|J&J appoints Jyotsna Ghosal as Executive Director- Government Affairs & Public Policy - Exchange4Media
276,2020-08-12,Biosense Webster receives CE mark approval for QDot Micro ablation catheter - Cardiac Rhythm News|J&J ties up with Biological E for manufacturing Covid vaccine in India - Deccan Chronicle
277,2020-08-13,"The U.S. has already invested billions in potential coronavirus vaccines. Here's where the deals stand - CNBC|J&J ties up with Hyderabad company, plans affordable vaccine - The Times of India|UK government secures new COVID-19 vaccines and backs global clinical trial - GOV.UK"
278,2020-08-14,
279,2020-08-15,
280,2020-08-16,Why Johnson & Johnson is investing in this niche telehealth startup - Fierce healthcare
281,2020-08-17,"Johnson & Johnson hunts for agency partner for beauty, skin-care brands - PR Week"
282,2020-08-18,"Johnson & Johnson to Acquire Momenta Pharmaceuticals, Inc., Expanding Janssen's Leadership in Novel Treatments for Autoimmune Diseases - PR Newswire|Johnson & Johnson to buy biotech Momenta in $6.5bn deal - Financial Times|J&J Snaps Up Momenta Pharmaceuticals in $6.5 Billion All-Cash Deal - BioSpace|Momenta Pharmaceuticals' stock rockets after $6.5 billion buyout deal with Johnson & Johnson - MarketWatch"
283,2020-08-19,
284,2020-08-20,"Johnson & Johnson's Darzalex, Amgen's Kyprolis join forces with new myeloma combo approval - FiercePharma | Band-Aid celebrates 100-year milestone in Shanghai - China Daily | China’s Coronavirus Vaccine More Expensive Than Western Vaccines - CodeBlue"
285,2020-08-21,
286,2020-08-22,
287,2020-08-23,More women should look and feel good after surgery - Henley Standard
288,2020-08-24,
289,2020-08-25,Pfizer Got Kicked Off the Dow Jones Industrial Average Just as Things Were Looking Up - Barron's
290,2020-08-26,FDA pulls J&J's Invokana boxed warning after reviewing amputation risks—but the sales damage is done - FiercePharma|BARDA and JLABS Pick 7 Startups to Battle COVID-19 and Future Pandemics - BioSpace
291,2020-08-27,"ILC: Searching for a functional cure while battling rivals, Vir and Alnylam post hep B data peek - Fierce Biotech"
292,2020-08-28,
293,2020-08-29,
294,2020-08-30,Benadryl Makers Beg Parents to Beware TikTok Challenge After Oklahoma Teen Reportedly Dies of Overdose - TooFab
295,2020-08-31,"Hall of Femme 2020: Diane Gomez-Thinnes, Johnson & Johnson - MM+M Online"
296,2020-09-01,Leading the race for a vaccine - Irvine Standard|1507p17 J&J implored to verify powder safety - Vietnam Investment Review
297,2020-09-02,"J&J, free from rival bidders, made Momenta wait on $6.5B deal - Fierce Biotech"
298,2020-09-03,
299,2020-09-04,
300,2020-09-05,
301,2020-09-06,Pollution costs lives and is bad for business. Here are 5 ways companies can clean up the air - World Economic Forum | EU approves Imbruvica plus rituximab in first-line CLL - The Pharma Letter
302,2020-09-07,
303,2020-09-08,The Top 7 Healthcare Stocks You Should Be Watching - InvestorPlace
304,2020-09-09,4 high-tech tools Johnson & Johnson is using to get products to you during the pandemic - Johnson & Johnson|Grail Stock IPO: What to Know About the Cancer-Test Company That Filed to Go Public - Barron's
305,2020-09-10,
306,2020-09-11,
307,2020-09-12,
308,2020-09-13,Hair cell α9α10 nicotinic acetylcholine receptor functional expression regulated by ligand binding and deafness gene products - pnas.org
309,2020-09-14,"Cancer scientist Lewis Cantley, Ph.D., wins the 2020 Dr. Paul Janssen Award for biomedical research - Johnson & Johnson"
310,2020-09-15,"‘Accelerating action’: Johnson & Johnson outlines 2030 goals on plastic packaging, ingredients transparency and preventive health - CosmeticsDesign-Europe.com"
311,2020-09-16,Johnson’s launches campaign for Cottontouch with a virtual baby shower - ETBrandEquity
312,2020-09-17,New evidence reaffirms the role of mouthwash in gum health - Dentistry.co.uk|Johnson & Johnson charged by New York with civil insurance fraud over opioid claims - The Fiji Times
313,2020-09-18,
314,2020-09-19,"Janssen Presents Findings from Global, Multi-Centre Trial Examining Amivantamab in Combination with Lazertinib in Patients with EGFR-Mutated Non-Small Cell Lung Cancer - Business Wire"
315,2020-09-20,Johnson & Johnson urges patients not to delay healthcare due to COVID-19 - MM+M Online
316,2020-09-21,J&J wants everyone to know that taking care of their health can't wait—even during a pandemic - FiercePharma|Johnson & Johnsons to invest in Black-owned hair care line Sunday II Sunday - GlobalCosmeticsNews
317,2020-09-22,"JOHNSON & JOHNSON EXPECTS 7-9% GROWTH OF PHARMA MARKET IN UKRAINE - Ukraine open for business|Major study to start for COVID-19 vaccine developed by Johnson & Johnson, Beth Israel - The Boston Globe|Johnson & Johnson's COVID-19 vaccine goes into final human trials - NewsBytes|The 5 stages of COVID-19 vaccine development: What you need to know about how a clinical trial works - Johnson & Johnson"
318,2020-09-23,J&J's next-gen Darzalex sparks drug delivery royalties battle - FiercePharma|Johnson & Johnson Consumer Health Commits $800 Million Throu - 3BL Media
319,2020-09-24,"Patent Database Exposes Pharma’s Pricey “Evergreen” Strategy - UC Law San Francisco|TikTok ""Benadryl Challenge"" prompts FDA warning on overdoses - CBS News|Company to pay $60 million for deceptive marketing with pelvic mesh - CBS News"
320,2020-09-25,Johnson & Johnson's single-dose COVID-19 vaccine induces strong immunity - NewsBytes
321,2020-09-26,
322,2020-09-27,"Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses | npj Vaccines - Nature.com | Johnson & Johnson picks Golin to handle North America Skin Health PR - PR Week | J&J kicks off final study of single-shot COVID-19 vaccine in 60,000 volunteers - Turks and Caicos Sun"
323,2020-09-28,Interview: Johnson & Johnson to build Dr.Ci:Labo future on digitalisation and internationalisation - The Moodie Davitt Report
324,2020-09-29,"Early Data Shows Promise for Johnson & Johnson’s COVID-19 Vaccine - TechTarget|Xian Janssen Blazes Way to Digitization in China With Johnson & Johnson's Pioneer Public E-Hospital Strategic Partnership - Yicai Global|Eager for a Covid vaccine, Trump now trusts drug companies he previously vilified - STAT"
325,2020-09-30,"How Russia Shortened the Covid Vaccine Race to Declare Victory - Bloomberg|Johnson & Johnson Completes Acquisition of Momenta Pharmaceuticals, Inc. - PR Newswire"
326,2020-10-01,Johnson & Johnson completes $6.5B takeover of Momenta - Fox Business|6 Bizarre Halloween-Related Lawsuits - Mentalfloss
327,2020-10-02,Lessons for skin lightener industry - The Herald
328,2020-10-03,Kareena Kapoor Khan and Saif Ali Khan are new brand ambassadors of Johnson & Johnson - Bollywood Hungama
329,2020-10-04,"GSK's ViiV, armed with long-term Dovato data, eyes 'tipping point' for 2-drug HIV regimen - FiercePharma"
330,2020-10-05,Quiz: 10 Fun Facts About BAND-AID® Brand Adhesive Bandages - Johnson & Johnson|Johnson & Johnson Will Pay $100M in Baby Powder Lawsuits - Asbestos.com|Johnson & Johnson To Pay Over $100 Million Settlement Over Talc Baby Powder Claims - LatinTimes
331,2020-10-06,Kathryn Wengel: Executive VP and CGSCO Johnson & Johnson - Supply Chain Digital|Smart People: Dr Neil Davie - PharmaTimes
332,2020-10-07,Johnson & Johnson Announces European Commission Approval of Agreement to Supply 200 Million Doses of Janssen's COVID-19 Vaccine Candidate - PR Newswire
333,2020-10-08,"Dynamic science duo: 4 things to know about the inspiring women who just won the 2020 Nobel Prize in Chemistry - Johnson & Johnson|EU seals Covid-19 vaccine deal with Johnson & Johnson, securing 1,1 billion doses for its 450 million population - MercoPress"
334,2020-10-09,
335,2020-10-10,
336,2020-10-11,Johnson & Johnson Covid-19 vaccine study paused due to unexplained illness in participant - STAT
337,2020-10-12,"Johnson & Johnson pauses Covid vaccine trial as participant becomes ill - ETHealthWorld|Coronavirus updates: Johnson & Johnson pauses vaccine trial - ABC News|Johnson & Johnson's immunology, cancer blockbusters deliver Q3 growth—and fuel hopes for 2021 - FiercePharma|Johnson & Johnson pauses Covid-19 vaccine trial over patient illness|The New Times - New Times Publication"
338,2020-10-13,Wilkinsons launch JNJ Tree Service - Aurora News Register|Johnson & Johnson pauses Covid vaccine trial as participant becomes ill - Ahmedabad Mirror
339,2020-10-14,"2nd COVID-19 vaccine trial paused over unexplained illness - Loop News Cayman|J&J's immunology meds Stelara, Tremfya posted big revenue gains, but pricing is slipping: analyst - FiercePharma|BREAKING NEWS: One Dead, One Hospitalized in North Paso Robles Shooting - The Atascadero News|A Dental Robot That Helps With Dental Surgeries - Nanalyze|Chris Hourigan steps in as Company Group Chairman for Janssen APAC - BSA bureau"
340,2020-10-15,"4 ways Johnson & Johnson is cultivating outside-the-box innovations for COVID-19 - Johnson & Johnson|Covid Vaccine Trials Are Halted, US Cases Rise, and More - WIRED|10 of the Largest Pharmaceutical Companies by Revenue - TechTarget"
341,2020-10-16,Paso Robles PD Seek Information on Two Persons of Interest Connected to Fatal Shooting - The Atascadero News
342,2020-10-17,"The effects of inhibition of fatty acid amide hydrolase (FAAH) by JNJ-42165279 in social anxiety disorder: a double-blind, randomized, placebo-controlled proof-of-concept study - Nature.com"
343,2020-10-18,
344,2020-10-19,
345,2020-10-20,"How Johnson & Johnson is helping over 40,000 employees exercise their ability to vote in a pandemic - Johnson & Johnson|Why Johnson & Johnson is a world leader worth owning - Interactive Investor"
346,2020-10-21,
347,2020-10-22,"AstraZeneca, Oxford Coronavirus Vaccine Trial Can Continue in the US - Business Insider"
348,2020-10-23,"Johnson & Johnson, AstraZeneca coronavirus vaccine trials set to resume - The Washington Post"
349,2020-10-24,
350,2020-10-25,
351,2020-10-26,
352,2020-10-27,Healthcare Industry Is Addicted to Tobacco - As You Sow
353,2020-10-28,Watch The David Rubenstein Show: Johnson & Johnson CEO Alex Gorsky - Bloomberg|A COVID-19 Vaccine Test Will Resume in the Heart of West Hollywood - WEHOville
354,2020-10-29,9 Johnson & Johnson (2020) - Beauty Packaging
355,2020-10-30,
356,2020-10-31,42 new COVID-19 cases - Trinidad Guardian
357,2020-11-01,The future of STEM is female: Meet 5 university scientists working on breakthrough healthcare ideas - Johnson & Johnson
358,2020-11-02,"S African firm, Johnson & Johnson strike vaccine deal - BusinessLine"
359,2020-11-03,"Johnson & Johnson resumes clinical trials of the Covid-19 vaccine in Brazil - MercoPress|Johnson & Johnson fails to overturn $2.12 billion baby powder verdict, plans Supreme Court appeal - The Fiji Times"
360,2020-11-04,"Johnson & Johnson, three other companies close in on $26 billion deal on opioid litigation - The Washington Post"
361,2020-11-05,
362,2020-11-06,
363,2020-11-07,
364,2020-11-08,
365,2020-11-09,
366,2020-11-10,
367,2020-11-11,"Johnson & Johnson confident in 1B dose goal for COVID-19 vaccine next year, looking ahead to 2022 - FiercePharma|adidas appoints Sanchita Johri as Director Digital Activation - afaqs!"
368,2020-11-12,J&J Joins Century Club in the S&P 500 With Longstanding Auditors - Bloomberg
369,2020-11-13,Johnson & Johnson and U.S. Department of Health & Human Services Expand Agreement to Support Next Phase of COVID-19 Vaccine Candidate Research and Development - PR Newswire|St. Jude and the University of Tennessee Health Science Center begin recruiting adult participants for phase 3 COVID-19 vaccine clinical trial - St. Jude Children's Research Hospital
370,2020-11-14,
371,2020-11-15,"Heart doctors more likely to implant devices from manufacturers that pay them, new study finds - ICIJ.org"
372,2020-11-16,Johnson & Johnson to Address Racial and Social Injustice Through Platform that Aims to Eliminate Health Inequities for People of Color - PR Newswire|How to sign up for COVID-19 vaccine trials at UChicago Medicine - UChicago News|3 ETFs For Tesla's S&P 500 Addition - Benzinga
373,2020-11-17,Johnson & Johnson vows to add 50% more Black managers in five years. Here's how. - Asbury Park Press
374,2020-11-18,She oversees one of the world's largest healthcare businesses: 7 questions for Ashley McEvoy in the time of COVID-19 - Johnson & Johnson|BREAKING: Johnson & Johnson finally unveils its new robot-assisted surgery system - Mass Device|Ottava surgical assistant robot finally unveiled by Johnson & Johnson - Robot Report
375,2020-11-19,"Robotic Surgery Around The Corner For $JNJ - Hedgeye|J&J readies rivals to da Vinci and Mako, eyeing new markets for robots - MedTech Dive|Johnson & Johnson Unveils Details On Ottava Soft-Tissue Robot, Chasing Intuitive, Medtronic - Citeline News & Insights"
376,2020-11-20,How a Medical Innovation Is Helping Treat Intestinal Parasites - Johnson & Johnson|J&J sees ‘tremendous opportunity’ in robotics as it unveils Ottava details - BioWorld Online|Johnson & Johnson ordered to pay $120 million damages in New York baby powder case - Reuters
377,2020-11-21,nan
378,2020-11-22,"Building a diverse talent pipeline: A Johnson & Johnson case study - People Matters|Genscript, Legend Biotech founder arrested in China for suspected smuggling - FiercePharma|Why Phyllis Ellis Is One Of Chatelaine’s 2020 Women Of The Year - Chatelaine"
379,2020-11-23,Here's a look at how the different coronavirus vaccines work - CNN
380,2020-11-24,"The Organic Skincare Products Market 2020-2024- Featuring Beiersdorf AG, Johnson & Johnson, LOreal SA, Among Others|Industry Analysis, Market Trends, Opportunities and Forecast 2024|Technavio - Business Wire"
381,2020-11-25,
382,2020-11-26,
383,2020-11-27,
384,2020-11-28,
385,2020-11-29,
386,2020-11-30,
387,2020-12-01,Janssen buys up eye disorder gene therapy asset from Hemera Biosciences - Fierce Biotech
388,2020-12-02,"Army veteran finds new career opportunities with Penn State Smeal EMBA - Penn State University|3 vaccine executives say that after approval, distribution will be the main challenge - NBC News|Not just AstraZeneca: Hackers targeted 5 other COVID-19 drug developers, vaccine cold chain suppliers - FiercePharma|'Major catastrophe': Sydney surgeon calls for hernia mesh ban - 9News"
389,2020-12-03,
390,2020-12-04,Impact during a pandemic: 5 ways Johnson & Johnson was recognized for its COVID-19 work in 2020 - Johnson & Johnson
391,2020-12-05,nan
392,2020-12-06,ASH: Johnson & Johnson shores up Darzalex's myeloma lead with another subcutaneous win - FiercePharma
393,2020-12-07,"“What it’s like to be in a clinical trial"": 3 people share their personal stories - Johnson & Johnson"
394,2020-12-08,Inclusive capitalism: Lauder and Johnson & Johnson execs among global business leaders to join forces with the Vatican on new initiative - GlobalCosmeticsNews|COVID-19: What local vaccine production actually means - Spotlight
395,2020-12-09,Neutrogena Oil-Free Skincare Class Action Lawsuit Claims False Advertising - Top Class Actions
396,2020-12-10,Analysis: More Black people need to be part of Covid-19 vaccine trials. Here's why I participated - CNN
397,2020-12-11,
398,2020-12-12,
399,2020-12-13,"The latest science behind caring for your skin while on chemotherapy - Johnson & Johnson|An integrated approach combining prevention, interception and treatment to tackle lung cancer - Nature.com|The ultimate work-at-home assignment: Create a vaccine to stop the COVID-19 pandemic - ABC News"
400,2020-12-14,
401,2020-12-15,Winter skin know-how: Why do psoriasis and eczema flare up in winter? - Johnson & Johnson | Neutrogena Oil-Free Moisturizer Class Action Lawsuit Moves Forward - Top Class Actions
402,2020-12-16,"Former J&J exec sues for sexual discrimination and harassment, alleging 'ruthless pattern of retaliation' - STAT|Former Johnson & Johnson exec alleges gender, sex discrimination, retaliation in lawsuit - My Central Jersey|Black Journalist Documents Journey in COVID Vaccine Trial to 'Demystify' Process for Skeptics - PEOPLE"
403,2020-12-17,Is There a Recall on Johnson & Johnson Baby Products? - Lawyer Monthly Magazine|8 brands called out for greenwashing in 2020 - Eco-Business
404,2020-12-18,"Former exec sues Johnson & Johnson for gender discrimination, harassment and retaliation - NJ.com"
405,2020-12-19,nan
406,2020-12-20,"Tuscaloosa businesses honored for work, efforts made during pandemic - Tuscaloosa Magazine"
407,2020-12-21,"""My heart and mind feel lighter"": Meet a health worker who leaned on support from a unique psychological training program during the pandemic - Johnson & Johnson|THIS ‘SILENT KILLER’ HAS NO CURE, BUT CAN BE CONTROLLED - PressReader"
408,2020-12-22,
409,2020-12-23,
410,2020-12-24,
411,2020-12-25,
412,2020-12-26,
413,2020-12-27,"You asked, we answered: Do the COVID-19 vaccines contain aborted fetal cells? - Nebraska Medicine"
414,2020-12-28,ESG resources - Johnson & Johnson
415,2020-12-29,"Video: The Standing 7-Minute Workout - The New York Times|Global Face Cream Market to Grow by $ 6.82 Billion During 2020-2024|Featuring Beiersdorf AG, Coty Inc., and Johnson & Johnson Among Others|Technavio - Business Wire"
416,2020-12-30,The top companies sued over discrimination and harassment in 2020 - Business Insider
417,2020-12-31,
418,2021-01-01,
419,2021-01-02,
420,2021-01-03,"Former Johnson & Johnson exec sues for discrimination, harassment - HR Dive | For an Exercise ‘Snack,’ Try the New Standing 7-Minute Workout (Published 2021) - The New York Times"
421,2021-01-04,Revitope Oncology Announces Strategic Collaboration with Janssen to Leverage its Unique T Cell Engager Platform - PR Newswire|Johnson & Johnson India sees revenue increase and net profit decrease in 2020 fiscal year - FashionNetwork.com
422,2021-01-05,
423,2021-01-06,
424,2021-01-07,
425,2021-01-08,
426,2021-01-09,Vaccine makers prepare for game of Covid cat and mouse - Financial Times
427,2021-01-10,4 ways Johnson & Johnson advanced much-needed healthcare innovations amid the pandemic - Johnson & Johnson|Wall Street analysts are cautiously optimistic on J&J's 'one-dose' Covid vaccine - CNBC|Johnson & Johnson’s formula for meeting healthcare needs in Asia Pacific - Singapore Economic Development Board
428,2021-01-11,
429,2021-01-12,Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine - nejm.org | Inside Johnson & Johnson’s Nonstop Hunt for a Coronavirus Vaccine (Published 2020) - The New York Times | Delays overshadow Johnson & Johnson vaccine's long-lasting potential - Axios | COVID-19 in the ER? Level Ex uses J&J grant to simulate infections in medical education video games - FiercePharma
430,2021-01-13,Paige Announces Series C Funding Round of $100 Million to Accelerate Transformation of Digital Pathology - Business Wire
431,2021-01-14,Don't ignore this headline: The pandemic is getting worse. What happens next is up to you - CNN
432,2021-01-15,
433,2021-01-16,
434,2021-01-17,
435,2021-01-18,DePuy Synthes Receives 510(k) FDA Clearance for VELYS™ Robotic-Assisted Solution Designed for Use with the ATTUNE® Total Knee System - PR Newswire | Depuy Synthes gets FDA nod for Velys for use with the Attune total knee system - BioWorld Online | The top 10 largest biopharma M&A deals in 2020 - FiercePharma | Luye’s schizophrenia drug approval in China challenges J&J’s Risperdal Consta - BioWorld Online
436,2021-01-19,J&J Sprucing Up New Brunswick Campus in Hopes to Make It a Little Like Silicon Valley - TAPinto.net|Johnson & Johnson’s COVID-19 vaccine safely elicits an immune response - European Pharmaceutical Review|The marathon of covid-19 vaccination - The Economist
437,2021-01-20,DePuy Synthes lands FDA clearance for Velys robotic knee system - Mass Device|Fake Johnson and Johnson sutures racket busted in Mumbai - ETHealthWorld
438,2021-01-21,The Standing 7-Minute Workout (Published 2021) - The New York Times
439,2021-01-22,
440,2021-01-23,We could know soon whether vaccines work against a scary new coronavirus variant - MIT Technology Review
441,2021-01-24,nan
442,2021-01-25,"General Electric, Johnson & Johnson, American Express - Tuesday's Premarket Movers - TheStreet|J&J beats fourth-quarter earnings expectations, will release Covid vaccine data 'soon' - CNBC|Biden Inherits a Vaccine Supply Unlikely to Grow Before April (Published 2021) - The New York Times|Cantor Fitzgerald: The trial results from J&J's COVID vaccine are very important to public perception - CNBC|Johnson & Johnson Reports 2020 Fourth-Quarter and Full Year Results - Johnson & Johnson"
443,2021-01-26,What you need to know about Johnson & Johnson's 2020 fourth-quarter and full-year earnings report - Johnson & Johnson|4 ways Johnson & Johnson has worked to make access to medicines around the world more equitable - Johnson & Johnson|Johnson & Johnson's Debt Overview - Yahoo Finance
444,2021-01-27,EXPLAINER: Why it’s hard to make vaccines and boost supplies - The Associated Press|DePuy Receives Clearance for Ortho Robotic System - https://ryortho.com/
445,2021-01-28,"Janssen Investigational COVID-19 Vaccine: Interim Analysis of Phase 3 Clinical Data Released - National Institutes of Health (NIH) (.gov)|Johnson & Johnson’ single-shot vaccine is 66 percent effective against COVID-19 - PBS NewsHour|FDA advisers unanimously recommend Johnson & Johnson’s Covid-19 vaccine - Vox.com|Single-shot Johnson & Johnson vaccine prevents illness but shows the threat of variants - The Washington Post|J&J one-dose Covid vaccine is 66% effective, a weapon but not a knockout punch - STAT"
446,2021-01-29,The best Covid vaccine is the one you can get — here's how they compare - CNBC|J&J one-dose COVID vaccine 66% effective in late-stage trial - Business Insider
447,2021-01-30,"Moderna scientist says Johnson & Johnson's shot is 'darn good' too - Business Insider|J&J single-shot vaccine found 66% effective in phase 3 clinical trials; what this means - The Indian Express|J&J 1-dose shot prevents COVID-19, but less than some others - Loop News Cayman"
448,2021-01-31,"Johnson & Johnson’s COVID-19 Vaccine Is 66% Effective Overall, Over 50 Percent on Emerging Variants - The Herald"
449,2021-02-01,"Comparing the Covid-19 vaccines developed by Pfizer, Moderna, and Johnson & Johnson - STAT|Structural basis for ligand recognition of the neuropeptide Y Y2 receptor - Nature.com|How Effective Are The Covid-19 Vaccines? - Statista|DePuy Synthes Announces Exclusive Expandable Cage Distribution Agreement with Expanding Innovations Inc. - OrthoSpineNews"
450,2021-02-02,Mocospace Apk : How to download on your phone ? - DigiStatement|Development of new coronavirus vaccines may be hitting critical mass. Here's how they work - CNN
451,2021-02-03,"COVID-19: How do the Pfizer, Oxford, Moderna, Novavax and Johnson & Johnson coronavirus vaccines compare? - Sky News|Johnson & Johnson requests emergency authorization from FDA for Covid vaccine - CNBC|Johnson & Johnson Seeks US Vaccine Approval for Emergency Use - VOA Asia|Johnson & Johnson Announces Submission of Application to the U.S. FDA for Emergency Use Authorization of its Investigational Single-Shot Janssen COVID-19 Vaccine Candidate - PR Newswire|Johnson & Johnson asks US to approve single-dose COVID jab - Al Jazeera English"
452,2021-02-04,"When your chance for a COVID-19 shot comes, experts say don’t worry about the numbers - The Philadelphia Inquirer|Johnson & Johnson files COVID-19 vaccine application with U.S. FDA - The Hindu"
453,2021-02-05,"Advanced Analytics to Accelerate Development of Genetic Vaccines - BioProcess Insider|Rock Hill man shares experience with Johnson & Johnson vaccine trial ahead of three-week FDA review - WBTV|FDA now reviewing a third COVID vaccine, this one made by Johnson & Johnson - Ars Technica"
454,2021-02-06,nan
455,2021-02-07,"""COVID-19 inspired me to improve patient care"": How two nurses devised new ways to help kids and fellow nurses during the pandemic - Johnson & Johnson|SPRAVATO®▼ (Esketamine Nasal Spray) Authorised in Europe for the Rapid Reduction of Depressive Symptoms in a Psychiatric Emergency for Patients with Major Depressive Disorder - Business Wire|Discover why Johnson & Johnson picked Singapore as its RHQ and innovation hub - Singapore Economic Development Board|WORLD: South Africa halts AstraZeneca vaccine rollout over new variant - Barbados Today"
456,2021-02-08,J&J reaches $6m settlement over counterfeit surgical tools - Life Sciences Intellectual Property Review|South Africa switches to Johnson & Johnson COVID-19 vaccine - P.M. News|Synthesis and Pharmacological Evaluation of Novel Non-nucleotide Purine Derivatives as P2X7 Antagonists for the Treatment of Neuroinflammation - ACS Publications
457,2021-02-09,One pathway to health equity: Increasing racial and ethnic diversity in nursing education - Johnson & Johnson|Molecular mechanism and structural basis of small-molecule modulation of the gating of acid-sensing ion channel 1 - Nature.com|India's Biological E aims to produce 60 crore doses of Johnson & Johnson covid vaccine a year|Mint - Mint
458,2021-02-10,Biden administration continues vaccination push with five new mass vaccination sites in Texas and New York - CNN|We’re not looking at the most important vaccine statistic - Vox.com
459,2021-02-11,Could the U.S. Buying More COVID Vaccines Hurt Johnson & Johnson and Novavax? - The Motley Fool
460,2021-02-12,
461,2021-02-13,
462,2021-02-14,
463,2021-02-15,"The path to leadership: Four nurse leaders share their stories - Johnson & Johnson | Johnson & Johnson seeks vaccine approval from EU - WJAC Johnstown | Erleada-ADT Combo Found to Prolong Survival, Delay Cancer Worsening - Prostate Cancer News Today"
464,2021-02-16,"Anthony Fauci Speaks To Meharry About Vaccine Hesitancy, Health Equity And The Latest Vaccine - WPLN|Rolling out the vaccine: Provincial plans compared - Spotlight"
465,2021-02-17,"Paths to the Top: Nefertiti Greene, U.S. Ethicon - AdvaMed"
466,2021-02-18,Johnson & Johnson Announces Submission to World Health Organization for Emergency Use Listing of Investigational Single-Shot Janssen COVID-19 Vaccine Candidate - PR Newswire|Glimmer of hope as Covid-19 vaccine roll-out begins in KZN - PressReader
467,2021-02-19,Topamax Lawsuit Focuses On Drug’s Side Effects - Newsome Law
468,2021-02-20,nan
469,2021-02-21,Meet a Woman Committed to Creating Inclusive Skincare Products - Johnson & Johnson
470,2021-02-22,"J&J Faces 25,000 Baby Powder Lawsuits, Assigns $4B Litigation Expenses - Business Insider|Johnson & Johnson fortifies pension plans with $870 million in 2020 - Pensions & Investments|12 surgical robotics companies you need to know - Mass Device|Pfizer, Moderna and J&J tout supercharged COVID-19 vaccine output, eyeing nearly 140M doses by March - FiercePharma"
471,2021-02-23,"GR company producing J&J vaccine ready for FDA approval - WOODTV.com|Johnson & Johnson vaccine deemed safe and effective in documents released by FDA - NBC News|Johnson & Johnson's one-shot Covid vaccine effective, FDA review says - The Guardian"
472,2021-02-24,"Top Five Questions About the Johnson & Johnson COVID-19 Vaccine Answered - LVHN News|Johnson and Johnson vaccine: FDA finds the single-shot jab safe - BBC.com|How does the Johnson & Johnson vaccine compare to other coronavirus vaccines? 4 questions answered - The Conversation|Johnson & Johnson covid vaccine is safe and effective, FDA finds - The Washington Post"
473,2021-02-25,"FDA panel endorses Johnson & Johnson vaccine in 22-0 vote - POLITICO|Is J&J’s COVID-19 vaccine linked to tinnitus? - Drug Discovery & Development|What You Need to Know About the Johnson & Johnson COVID-19 Vaccine - University of Missouri Health Care|Pfizer, Moderna or J&J? Right now, the best vaccine for you is the one you can get. - The Washington Post"
474,2021-02-26,Johnson & Johnson's Covid-19 vaccine gets emergency use authorization from FDA - CNN|FDA grants emergency authorization to Johnson & Johnson vaccine - NBC News|FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine - FDA.gov|A Guide to Johnson & Johnson’s COVID-19 Vaccine - FactCheck.org|The US is getting a third coronavirus vaccine. Here's how it's different from the others - CNN
475,2021-02-27,FDA Authorizes Johnson & Johnson's One-Shot COVID-19 Vaccine - NPR|FDA authorizes Johnson & Johnson coronavirus vaccine - POLITICO
476,2021-02-28,Johnson & Johnson Covid vaccine: FDA approves single-shot jab - BBC.com|CDC Panel Endorses Johnson & Johnson's One-Dose COVID-19 Vaccine - NPR|Here is what we know about the rollout of the Johnson & Johnson vaccine. (Published 2021) - The New York Times|4 things we now know about the rare disease AL amyloidosis - Johnson & Johnson|Here is how Johnson & Johnson’s vaccine differs from Pfizer’s and Moderna’s. (Published 2021) - The New York Times
477,2021-03-01,"Explaining Johnson & Johnson’s, AstraZeneca’s new COVID-19 vaccines - Wexner Medical Center - The Ohio State University|This is how the Johnson & Johnson vaccine is different from Pfizer and Moderna’s shots - Fast Company"
478,2021-03-02,Merck will help make Johnson & Johnson coronavirus vaccine as rivals team up to help Biden accelerate shots - The Washington Post|Johnson & Johnson COVID-19 vaccine approved for use in California - CBS News 8|North Texas vaccination sites to receive Johnson & Johnson COVID-19 vaccine - FOX 4 News Dallas-Fort Worth|Some U.S. Faith Leaders Express Moral Concerns About Johnson & Johnson Vaccine - NPR
479,2021-03-03,How effective is the Johnson & Johnson vaccine? Here's what to know - NBC News|JNJ Stock: Avoid Johnson & Johnson Shares Like the Plague - InvestorPlace|Johnson & Johnson loses pelvic mesh court appeal - ABC News|Comparing the Johnson & Johnson COVID-19 Vaccine to the Others - Spectrum News
480,2021-03-04,"J&J vaccine at your door? New shot spurs fresh outreach - NBC News|Johnson & Johnson COVID Vaccine Efficacy, Side Effects and Availability - Newsweek|Canada approves the Johnson & Johnson vaccine, giving it a fourth option. (Published 2021) - The New York Times"
481,2021-03-05,1 Shot Or 2 Shots? 'The Vaccine That's Available To You — Get That' - NPR|Michigan won't receive Johnson & Johnson COVID-19 vaccine doses for next 2 weeks - Detroit Free Press|How approval of Johnson & Johnson's 'one and done' COVID-19 vaccine could change Canada's vaccination game - CBC News|Health Canada approves 4th COVID-19 vaccine as Pfizer agrees to accelerate deliveries - CBC News
482,2021-03-06,First batch Johnson & Johnson's vaccine to arrive in Oman in June - Times Of Oman|New York City's Javits Center offering COVID-19 vaccinations 24/7 - ABC News|From Pfizer to Moderna: who's making billions from Covid-19 vaccines? - The Guardian|Covid-free 2022 - Chronicle|The One Vaccine Efficacy Number That Truly Matters - Bloomberg
483,2021-03-07,"Here's how much money Pfizer, Moderna and Johnson & Johnson could make from COVID vaccines - Fox Business|Roscommon woman jailed after luxury spending sprees with company credit card - BreakingNews.ie|From humble beginnings to vaccinating the president, Sister Bennett’s journey of hope - News24|IQVIA Collaborating with Janssen Research & Development on Their Investigational COVID-19 Vaccine Trials - IQVIA"
484,2021-03-08,"3-Pillar strategy to promote diversity, equity and inclusion - ETHRWorld.com|Detroit to open Johnson & Johnson vaccination site, Mayor Duggan announces in State of the City - Crain's Detroit Business|The facts on what the Catholic Church has said about the Johnson & Johnson vaccine - PolitiFact|Johnson & Johnson has been using a virtual trial approach from IQVIA for its phase 3 COVID-19 vaccine - Fierce Biotech|GlaxoSmithKline CEO Walmsley's pay falls to $9.7M as pandemic drags on profits - FiercePharma"
485,2021-03-09,"J&J Covid vaccine distribution in poor, Black communities raises race questions - CNBC|Habenula GPR139 is associated with fear learning in the zebrafish - Nature.com|Biden orders 100 million more vaccine shots from Johnson & Johnson - The Washington Post|Cabrera: Johnson & Johnson vaccine effective at preventing hospitalization, death - KUAM.com|Johnson & Johnson's Talc Lawsuits Are Fueling Skepticism of Its Vaccine - Newsweek"
486,2021-03-10,"European Medicines Agency recommends Johnson & Johnson vaccine to EU - Business Insider|Archbishop: don't pick Johnson & Johnson vaccine if you have a choice - KUAM.com|With Johnson & Johnson in the mix, here's how each U.S. state is doing with COVID vaccine distribution - Fortune|Europe OKs Johnson & Johnson's COVID-19 vaccine, but deliveries won't start till April - FiercePharma"
487,2021-03-11,"Africa's Aspen Pharmacare to Deliver J&J Covid Vaccines in Next Three Months - Bloomberg|WHO adds Janssen vaccine to list of safe and effective emergency tools against COVID-19 - World Health Organization (WHO)|Head of Johnson & Johnson China on Lessons Learned from COVID-19 - Johnson & Johnson|DeSantis rolls out Johnson & Johnson vaccine in Barefoot Bay, claps back at Biden - Florida Today"
488,2021-03-12,"Here's what pregnant women should know about the J&J COVID-19 vaccine - ABC News|Cardinal Health sells troubled Cordis unit to private equity firm for $1B - MedTech Dive|Erie-region teachers receive Johnson & Johnson, Pfizer COVID vaccine at multiple county clinics - GoErie.com"
489,2021-03-13,WHO backs AstraZeneca COVID vaccine amid clotting concerns; green lights Johnson & Johnson shots - One Papua New Guinea
490,2021-03-14,"Archbishop Byrnes advises Catholics to not choose Johnson & Johnson COVID-19 vaccine - Pacific Daily News|Big Pharma Battled the Pandemic. The Stocks Are Cheap. - Barron's|Johnson & Johnson picks German site for coronavirus vaccine production - POLITICO Europe|Church now says taking Johnson & Johnson vaccine is ""morally acceptable"" - KUAM.com|Archbishop: don't pick Johnson & Johnson vaccine if you have a choice - KUAM.com"
491,2021-03-15,"Cardinal Health to sell off its Cordis device division in $1B deal - Fierce Biotech|What is J&J Covid vaccine that India’s Bio E will make with US help, the challenges it faces - ThePrint|How Effective Is the Johnson & Johnson COVID-19 Vaccine? Here’s What You Should Know - UC San Francisco"
492,2021-03-16,"Why is the Johnson & Johnson vaccine only one shot? Here’s what to know. - The Washington Post|Expand your enhanced CPD horizons online with Johnson & Johnson - Dentistry.co.uk|Challenging AbbVie and Lilly in psoriatic arthritis, J&J touts 2-year data for Tremfya - FiercePharma"
493,2021-03-17,Cuomo gets J&J vaccine - WCAX|Bishops say COVID-19 vaccine can be used in good conscience - Chicago Catholic|Catholic opinions on Johnson & Johnson vaccine highlight debate between hardliners on abortion and others in the church - The Conversation|9 Ways to Prepare for Your COVID-19 Vaccine Appointment - Self
494,2021-03-18,"J&J nabs FDA nod for Ponvory, joining Novartis, Bristol Myers in crowded MS market - FiercePharma|COVID Help Desk: Where can I get a Johnson & Johnson vaccine? Can I drink after the vaccination? - Houston Chronicle|The supply and demand conundrum of Oregon’s COVID-19 vaccines - Oregon Public Broadcasting|Covid vaccine side-effects: what to know and why you shouldn't worry - The Guardian|Ford Field to distribute more than 300K doses of Pfizer, Johnson & Johnson vaccines - Detroit News"
495,2021-03-19,"Johnson & Johnson vs. Pfizer vs. Moderna Vaccines - Nurse.org|Covid vaccines: Why some Americans are choosy about their jab - BBC.com|Vaccine studies are expanding. That’s good news for children, pregnant women and those over 65. - The Washington Post"
496,2021-03-20,Covid vaccines: Why some Americans are choosy about their jab - BBC
497,2021-03-21,"One shot, that's all: What you need to know about Johnson & Johnson vaccine clinic in Hattiesburg - Hattiesburg American"
498,2021-03-22,Investing in Psychedelics with MindMed Stock - Nanalyze|4 things scientists now know about autoimmune diseases in kids - Johnson & Johnson|Kenya launches new community health strategy - Johnson & Johnson|Johnson & Johnson vaccine manufacturing partner Catalent scores approval for Indiana plant: reports - FiercePharma
499,2021-03-23,"Johnson & Johnson-owned medical robotics company has signed a lease for 76,000 square feet in San Jose - The Business Journals|AstraZeneca, Pfizer, Moderna, Johnson & Johnson: Breaking down the differences between coronavirus vaccines - KFSN-TV|Why can teens aged 16, 17 get the Pfizer vaccine but not Moderna or Johnson & Johnson? - WGHP FOX8 Greensboro"
500,2021-03-24,"J&J's allergy-fighting contact lens nets first approval in Japan, allowing wearers to skip eye drops - Fierce Biotech|Johnson & Johnson vaccinations administered to the public at Eva's Kitchen in Paterson - NorthJersey.com|5 people share their Johnson & Johnson vaccine side effects, from sore arms to chills - Business Insider"
501,2021-03-25,"Comparing the COVID-19 vaccines: If you have a choice, which one should you get? - Salt Lake Tribune|Elliott Waves on Johnson & Johnson (JNJ Stock) suggest ending diagonal pattern [Video] - FXStreet|Company with Trump administration tie may be COVID-19 vaccine bottleneck - Roll Call|Jewel-Osco Giving Customers Choice of COVID Vaccines - NBC Chicago|Vanderburgh County Jail vaccinates first round of inmates against COVID-19 - Courier & Press"
502,2021-03-26,Comparing the COVID-19 vaccines. Which vaccine will I get? What about side effects and efficacy comparison? - USA TODAY
503,2021-03-27,President and Deputy President undertake Eastern Cape visit - The Presidency
504,2021-03-28,Johnson & Johnson to Supply 400 Million COVID-19 Vaccine Doses to African Union - VOA Asia|Goochland County man suffers ‘rare’ severe reaction to COVID-19 vaccine - WRIC ABC 8News|Africa Signs Historic Agreement with Johnson & Johnson for 400 Million Doses of COVID-19 Vaccines - African Export-Import Bank|Johnson & Johnson Announces Advance Purchase Agreement with the African Vaccine Acquisition Trust for the Company's COVID-19 Vaccine Candidate - PR Newswire
505,2021-03-29,"Man, 74, gets ‘rare’ severe rash all over body and says his ‘skin peeled off’ after Johnson & Johnson vacci... - The US Sun|Target, Amazon selling J&J's newest racially diverse bandages - Fox Business"
506,2021-03-30,Virginia man developed severe rash after Johnson & Johnson vaccine - Business Insider|Man’s skin ‘peeled off’ in rare reaction to Johnson & Johnson COVID vaccine - New York Post|Man’s skin ‘peeled off’ after vaccine - news.com.au|Johnson & Johnson COVID-19 vaccine causes man's skin to peel off - The Jerusalem Post|Oregon hedges COVID-19 vaccination timeline in response to concerns over Johnson & Johnson shipments - OregonLive
507,2021-03-31,"Emergent plant that ruined Johnson & Johnson vaccine doses had prior FDA violations - The Washington Post|Johnson & Johnson Says Contractor Botched Part Of Vaccine Production : Coronavirus Updates - NPR|Opinion|I got the placebo in the Johnson & Johnson vaccine trial. Here’s my full journey. - The Washington Post|Roughly 15 million doses of the Johnson & Johnson vaccine were ruined because of a factory mixup, report says - Business Insider"
508,2021-04-01,Johnson & Johnson COVID-19 vaccine batch fails quality check - KCCI Des Moines|Quality control issues force Johnson & Johnson to scrap doses of COVID-19 vaccine - CBS News|Johnson & Johnson confirms vaccine production problems at Emergent plant in Baltimore - The Washington Post
509,2021-04-02,"Barbados Considering COVID-19 Vaccines in Addition to AstraZeneca - caribbeannationalweekly.com|’Incredible investment in health equity’: Local clinics get vaccine boost from feds - The Santa Rosa Press Democrat|Whistleblower raises hygiene concerns from 2018 FDA inspection of Merck’s Durham plant - Raleigh News & Observer|J&J opts for bolder, darker tone in new Tremfya ads to reflect real-life patient struggles - FiercePharma|I got the COVID-19 Johnson & Johnson vaccine. Here's what happened. - Clarion Ledger"
510,2021-04-03,US government moves AstraZeneca out of vaccine plant that suffered contamination - CNN
511,2021-04-04,"Legend Biotech, J&J finish off rolling submission for CAR-T hopeful, approach finish line - Fierce Biotech"
512,2021-04-05,"How procurement could've helped the J&J vaccine contamination issue - Spend Matters|FBI warning people of COVID-19 vaccination scams - WSIL TV|The top 10 pharma R&D budgets in 2020 - Fierce Biotech|Inmates in Aransas County receive the Johnson & Johnson vaccine - KIIITV.com|Richard Serbin, Former Johnson & Johnson's VP and a Leading Global Strategy Advisor in the Healthcare Industry, to Join Innocan Pharma's Scientific Advisory Committee - Yahoo Finance"
513,2021-04-06,"Coldwater CVS now giving Johnson & Johnson vaccine - Coldwater Daily Reporter|South Korea Grants Conditional Approval to Johnson & Johnson Coronavirus Vaccine - U.S. News & World Report|Komodo Health charts out $220M round, Janssen real-world data deal - Fierce Biotech"
514,2021-04-07,"Grandview Yard Giant Eagle to administer 10,000 doses of Johnson & Johnson vaccine - ABC6OnYourSide.com|With millions vaccinated, rare side-effects of jabs are emerging - The Economist|Theater receives generous gift from Johnson & Johnson matriarch - Press Pubs"
515,2021-04-08,Hepatitis B Virus Infection - Global Drug Forecast and Market Analysis to 2029 - GlobeNewswire|Johnson & Johnson set to begin India trial of its single-shot vaccine soon - The Indian Express|Colorado Department Of Public Health Clears Use Of Johnson & Johnson Vaccine After Some Experience Adverse Side Effects - CBS Colardo|The latest on the coronavirus pandemic and vaccines: Live updates - CNN|Blow to US vaccination campaign as J&J ‘one-shot’ vaccine deliveries plummet - The Guardian
516,2021-04-09,Sierra Leone receives Ebola vaccine from Johnson & Johnson pharmaceuticals - Sierra Leone Telegraph|CEO at troubled vaccine plant received 51 percent compensation boost in 2020 - The Washington Post|European regulators are watching J&J's vaccine for unusual blood clots - Business Insider
517,2021-04-10,Why There Will Be Fewer Johnson & Johnson COVID-19 Vaccines Next Week - WBEZ Chicago|Scientists say blood clots caused by the Johnson & Johnson vaccine are 'extraordinarily rare' - Daily Mail|Haiti - Health : The Minister of Health wants another vaccine than AstraZeneca - HaitiLibre.com|Georgia pauses Johnson & Johnson vaccine site after adverse reactions - WJHG
518,2021-04-11,Oregon’s shipment of Johnson & Johnson COVID vaccine doses slashed by 88% this week - OregonLive|Ionis taps Progenity to create oral antisense therapies - FiercePharma|Johnson & Johnson's one-dose COVID-19 vaccine won't be coming to Australia due to AstraZeneca similarities - ABC News|Australia shelves plans to buy Johnson & Johnson's one-dose Covid-19 vaccine - CNBC
519,2021-04-12,"Trump criticizes FDA on Johnson & Johnson vaccine pause - The Hill|Colleges cancel, postpone Johnson & Johnson vaccine appointments - The Washington Post|Australia won’t buy Johnson & Johnson’s one-dose Covid vaccine due to AstraZeneca similarities - The Guardian|CDC, FDA Recommend Pause of Johnson & Johnson Coronavirus Vaccine Over Blood Clot Concerns - U.S. News & World Report|The US is pausing the Johnson & Johnson coronavirus vaccine rollout, citing concerns over rare blood clots - Business Insider"
520,2021-04-13,"Johnson & Johnson delays Covid-19 vaccine rollout in Europe - FRANCE 24 English|I got the Johnson & Johnson vaccine on Monday and took a selfie. Things got weird after that. - NBC News|Is it the adenovirus vaccine technology, used by AstraZeneca and Johnson & Johnson, causing blood clots? There’s no evidence yet - The Conversation|News|FDA and CDC “Pause” Johnson & Johnson Vaccine - GoLocalProv|Why the Johnson & Johnson news feels so bad - USA TODAY"
521,2021-04-14,"Trump’s Conspiracy About the Johnson & Johnson Vaccine Is Straight Off 4chan - VICE|South Africa Pauses J&J Vaccination Campaign After US Expresses Concerns - VOA Asia|Fauci defends J&J vaccine pause, says vaccinated shouldn't worry - Business Insider"
522,2021-04-15,"What you should do if you’ve received the Johnson & Johnson coronavirus vaccine - The Washington Post|What’s different about Johnson & Johnson’s vaccine that might explain its blood clot risk? - Los Angeles Times|Fauci expects Johnson & Johnson COVID-19 vaccine will 'get back on track' soon - Fox News|With the Johnson & Johnson COVID-19 vaccine pause, getting the message right is critical - Northeastern University|Prisons postpone vaccinations with Johnson & Johnson shots paused - ABC News"
523,2021-04-16,"What Have I Preserved: A Conversation with J. Nicole Jones - Literary Hub|Higher risk of brain clots from COVID-19 than from vaccines - UK study - The Jerusalem Post|J&J Asked Rivals to Help Study Blood Clots, Moderna, Pfizer Said No: WSJ - Business Insider|Why You Shouldn't Compare Blood Clots After Johnson & Johnson Vaccine to Birth Control - Verywell Health"
524,2021-04-17,"Scientists exploring possible link between Johnson & Johnson, AstraZeneca vaccine blood clot issues - ABC News|Fauci on upcoming Johnson & Johnson vaccine decision: 'We will get it back' - Business Insider"
525,2021-04-18,I got the COVID vaccine. Are my side effects normal? - WHYY|Johnson & Johnson said blood clots have been reported with all Covid-19 vaccines. The author of the study they cited says they're wrong. - CNN|The Johnson & Johnson pause has dented Americans’ confidence in the jab - The Economist|Athens community reacts to Johnson & Johnson vaccine pause - Red and Black
526,2021-04-19,"Johnson & Johnson Q1 profit, sales jump - Loop News Cayman|Fear that Johnson & Johnson pause could heighten vaccine hesitancy in US - The Guardian|EU Regulator: 'Possible Link' Between Johnson & Johnson Vaccine And Rare Blood Clots : Coronavirus Updates - NPR"
527,2021-04-20,Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19 - nejm.org|Johnson & Johnson CFO pushes back against Biden's proposed corporate tax hike - Fox Business|Federal Inspectors Fear More Vaccines Were Exposed to Contamination (Published 2021) - The New York Times
528,2021-04-21,"Collaboration with Johnson & Johnson Innovation to jump-start search for new malaria drugs - Walter and Eliza Hall Institute of Medical Research|Experts will vote on J&J COVID vaccine: end pause, warning for women? - Business Insider|FDA inspectors find ""brown residue"" and other violations in plant making Johnson & Johnson vaccine - CBS News|F.D.A. Clears Johnson & Johnson’s Shot, the Third Vaccine for U.S. (Published 2021) - The New York Times|White House writes off Johnson & Johnson vaccine after string of production failures - POLITICO"
529,2021-04-22,"Blood Clots and the Johnson & Johnson Vaccine: What We Know So Far - Scientific American|Pause on Johnson & Johnson COVID vaccine in US lifted by FDA, use to resume - USA TODAY|FDA ends Johnson & Johnson vaccine pause - POLITICO|Johnson & Johnson COVID-19 shots can resume in Arizona after US lifts pause, state says - The Arizona Republic"
530,2021-04-23,"Johnson & Johnson coronavirus vaccine rollout resumes - Business Insider|Federal agencies lift pause on use of Johnson & Johnson vaccine, saying benefits outweigh risks - The Washington Post|U.S. Lifts Pause In Use Of J&J Vaccine After Vote By Expert Panel - NPR"
531,2021-04-24,"Amid blood clot concerns, US to resume use of Johnson & Johnson's single-dose COVID-19 vaccine - Jagran English|The Lessons of the Johnson & Johnson Vaccine Saga - The New Yorker|Opinion|It’s good to resume the J&J vaccine. But younger women should be warned against it. - The Washington Post|US health officials lift suspension of Johnson & Johnson Covid jab - Guernsey Press|Kennedy-King College resumes use of Johnson & Johnson vaccine in Englewood - FOX 32 Chicago"
532,2021-04-25,"The Renewed, Curious Case Study of Johnson & Johnson - Adweek|CEO of vaccine maker Emergent sold $10 million in stock before company ruined Johnson & Johnson doses - The Washington Post|The public’s concerns over the Johnson & Johnson coronavirus vaccine are widespread, Post-ABC poll finds - The Washington Post|Johnson & Johnson Looks To Offload Breast Implant Business, Once Again: Bloomberg - Yahoo Finance"
533,2021-04-26,"Health Officials End Pause on Johnson & Johnson Vaccine - AARP|COVID-19: Johnson & Johnson vaccine to arrive in B.C. next week - Vancouver Sun|Trust in Johnson & Johnson's coronavirus vaccine is low, yet overall intent to get inoculated rises: POLL - ABC News"
534,2021-04-27,55% of U.S. adults have gotten a COVID vaccine. See how your state is doing - Fortune|Ed Helms confused by 'baby shampoo company' Johnson & Johnson offering COVID vaccine - Yardbarker|The CDC is investigating 2 new reports of clotting tied to the Johnson & Johnson COVID-19 vaccine - Business Insider|UOG clinic resumes Johnson & Johnson vaccine distribution - KUAM.com|What women should know about the Johnson & Johnson coronavirus vaccine - CNN
535,2021-04-28,Tracking the impact of the J&J pause across social media - Brookings Institution|Johnson & Johnson Vision to power global HQ with 100% solar electricity - edie.net|Opioids - National Association of Attorneys General
536,2021-04-29,"Anxiety led dozens to faint or get dizzy after Johnson & Johnson COVID vaccine, CDC says - Miami Herald|Meet Teresa Harrison, who is changing how mental healthcare is being delivered in Grimsby, UK - Johnson & Johnson|CDC finds some COVID-19 vaccine reactions actually due to anxiety - ABC News|Factory Owners Around the World Stand Ready to Manufacture Covid-19 Vaccines - The Intercept|Ford Field offering Johnson & Johnson COVID-19 vaccine starting Tuesday - Detroit News"
537,2021-04-30,Covid vaccines available with no appointment through Southcoast Health - Wareham Week
538,2021-05-01,Anxiety seems to be the culprit in J&J vaccine fainting spells - Vox.com
539,2021-05-02,Johnson & Johnson vaccine recommended for Canadians 30 and older despite risk of rare blood clots - CBC.ca|CDC investigating Ionia Co. woman’s death after getting J&J vaccine - WOODTV.com|Denmark to stop using J&J vaccinate over clot fear - Republic World|Denmark stops use of Johnson & Johnson Covid-19 vaccine - The Irish Times|How Johnson & Johnson changed its review process during the pandemic - Business Insider
540,2021-05-03,"Why Tarana Burke thinks vulnerability is actually the key to success - Johnson & Johnson|Woman died from complications after receiving Johnson & Johnson vaccine, family says - MLive.com|CDC investigating Ionia County woman's death after receiving Johnson & Johnson vaccine - HollandSentinel.com"
541,2021-05-04,"Family says Ionia woman died of complications after Johnson & Johnson vaccine - WILX|Miami Beach suspends COVID orders, announces return of in-person commission meetings - Miami Herald|Less than half of NYPD cops have received at least one COVID-19 vaccine - New York Post|Johnson & Johnson vaccine resumes in FSM - Pacific Daily News"
542,2021-05-05,Vicarious Surgical Stock – Surgical Robots With VR - Nanalyze|Wolstein Center clinic now offering Johnson & Johnson vaccine - Crain's Cleveland Business|U.S. Bet Big on Covid Vaccine Manufacturer Even as Problems Mounted (Published 2021) - The New York Times|Doctors first to treat rare blood clotting side-effect of Johnson & Johnson COVID vaccine with Heparin alternative - Study Finds
543,2021-05-06,"New York City proposes vaccinating tourists in popular spots - The Guardian|Countries are sitting on millions of J&J vaccine doses, report says - Business Insider"
544,2021-05-07,Armenia has proposal for Novavax and Johnson & Johnson vaccines - Armenpress|Anti-vaxxer records himself stealing a vial of Johnson & Johnson COVID-19 vaccine to 'investigate' in a laboratory - Business Insider
545,2021-05-08,
546,2021-05-09,"Good Question: Which vaccine is more effective - Johnson & Johnson or AstraZeneca? - WBTV | Norway urged to exclude AstraZeneca, J&J from vaccine scheme by country experts - Cyprus Mail"
547,2021-05-10,"More than five million doses of ""Johnson & Johnson"" vaccine arrive in Libya within days - The Libya Observer|Bolivia signs J&J vaccine deal with a twist - it needs WTO patent waiver - Reuters.com|3 Explanations for the Vaccine Slowdown - The Atlantic|Questions about the Johnson & Johnson COVID-19 vaccines? UF Health experts have answers - UF Health News"
548,2021-05-11,"J&J Vision sets sights on childhood myopia with new FDA contact lens clearance - Fierce Biotech|Johnson & Johnson vaccine linked to 28 cases of blood clots, CDC reports - NBC News|NYC subway stations begin to offer COVID-19 vaccinations - New York Post"
549,2021-05-12,How Doctors Successfully Treated a Johnson & Johnson Vaccine-Related Blood Clot - Verywell Health|J&J develops reshaping contact lenses for childhood myopia - Mobihealth News|World’s Largest Healthcare Companies 2021: Big Pharma And Insurers Profit Through The Pandemic - Forbes
550,2021-05-13,"J&J to donate 200,000 vaccine regimens to curb Ebola outbreak - European Pharmaceutical Review|Crohn's and colitis group encourages patients to 'Spill Your Guts' to ditch stigma in pharma-backed campaign - FiercePharma|Zero Johnson & Johnson COVID-19 vaccine doses set to ship next week as production holdup lingers - FiercePharma"
551,2021-05-14,"What To Make Of The Yankees Outbreak? Scientists Say: Don't Panic, We Expected This - NPR|New York Yankees say 8 vaccinated members tested positive for Covid-19. Here's how that could happen - CNN|5 pressing questions about the New York Yankees’ breakthrough Covid-19 infections - STAT"
552,2021-05-15,nan
553,2021-05-16,Prioritizing health worker mental health and well-being is critical to achieving healthcare goals - Johnson & Johnson
554,2021-05-17,"J&J aims to create community for PAH patients and their doctors with new Uptravi campaign - FiercePharma|Johnson & Johnson recalls Acuvue contact lenses sold by Walmart, Sam’s Club and others - Miami Herald"
555,2021-05-18,"ASCO: AbbVie, J&J pad Imbruvica's CLL case with Venclexta fixed-duration combo data - FiercePharma|If you use these contact lenses, throw them out and get your money back - BGR|ASCO: Johnson & Johnson's bispecific lung cancer combo shows promise as Tagrisso backup, but the Big Pharma wants more - Fierce Biotech|Johnson & Johnson documented contamination risks at Baltimore plant months before vaccine was ruined - The Washington Post|India's Biological E. to produce Johnson & Johnson COVID-19 vaccine - Moneycontrol"
556,2021-05-19,"J&J working with Telangana-based company to manufacture Covid vaccine - Business Standard|Emergent was unequipped to produce both J&J and AstraZeneca COVID-19 vaccines, execs tell lawmakers - FiercePharma|Maddox Memorial will host Johnson & Johnson clinic Thursday - Richland Source"
557,2021-05-20,What the 'Choosing Your COVID-19 Vaccine' Meme Gets Wrong - Snopes.com
558,2021-05-21,
559,2021-05-22,Johnson & Johnson spotlights safety edge after Stelara's near miss against Humira in Crohn's - FiercePharma
560,2021-05-23,J&J’s new cancer drug leads a growing pipeline of dual-targeting antibodies - BioPharma Dive|ASCO: J&J's subcutaneous bispecifics tackle multiple myeloma in phase 1 - Fierce Biotech|Centene Appoints Suzy DePrizio as Chief Marketing Officer - Centene Corporation
561,2021-05-24,"Belmont Girls Shine at US College - Jack Newton Junior Golf|Cherry Huang named new CEO of Janssen Korea - KBR|What to know about HDFN, a serious blood disorder in babies, including a possible new treatment - Johnson & Johnson|European Commission approves Ponvory for RMS - The Pharma Letter"
562,2021-05-25,Preclinical and clinical characterization of the RORγt inhibitor JNJ-61803534 - Nature.com|J&J appoints new Area Managing Director for Consumer Health Northern Europe - Pf Media|Belgium suspends J&J vaccine for under 41s after death - ETHealthWorld
563,2021-05-26,"Belgium halts J&J COVID vaccine for under 41s after first EU death - Reuters.com|UCSC reopens COVID-19 vaccination clinics for students, faculty and staff - KSBW Monterey|J&J-backed Pulmocide fills its lungs with $92M series C to fund phase 3 ahead of possible IPO - Fierce Biotech"
564,2021-05-27,Johnson & Johnson stock outperforms market on strong trading day - MarketWatch|Janssen single-dose Covid vaccine approved by UK - BBC.com|What are the side effects of the Johnson & Johnson vaccine? - Open Access Government|Johnson & Johnson Single-Dose Vaccine Approved For Use in the UK - winnFm|Johnson & Johnson’s Vaccine Offers Strong Protection but Fuels Concern About Variants (Published 2021) - The New York Times
565,2021-05-28,How does the Johnson & Johnson vaccine work? - Guernsey Press|COVID-19: Johnson & Johnson single-dose vaccine approved for use in the UK - Sky News|COVID-19: How does the newly-approved Johnson & Johnson vaccine work - and how does it compare? - Sky News
566,2021-05-29,
567,2021-05-30,"Johnson & Johnson asks Supreme Court to void $2B talc verdict - NBC News | Qu&Co, Janssen Pharmaceuticals to Develop and Test Quantum Computational Methods Pharma R&D - The Quantum Insider | Johnson & Johnson Asks High Court to Void $2B Talc Verdict - winnFm | Johnson & Johnson: Carrie takes Boris's surname after wearing 'borrowed' £2,870 wedding dress - Daily Mail"
568,2021-05-31,U.S. Supreme Court rebuffs J&J appeal over $2 billion baby powder judgment - Reuters.com|Supreme Court Says A $2 Billion Verdict In A Baby Powder Cancer Case Should Remain - NPR|How Johnson & Johnson has pioneered in the battle against HIV/AIDS - Johnson & Johnson
569,2021-06-01,Johnson & Johnson's last-ditch appeal of $2B talc verdict falls short at Supreme Court - FiercePharma|Johnson & Johnson Faces Another Crisis After Supreme Court Decision - Forbes|Johnson & Johnson to pay $2.1bn in talc cancer case after Supreme Court rejection - Financial Times
570,2021-06-02,"Thirty Madison Reaches $1B Valuation with $140M Series C Funding - HIT Consultant|J&J touts Tremfya win in Humira-resistant psoriatic arthritis patients amid showdown with AbbVie's Skyrizi - FiercePharma|Jamaica Secures Over 1 Million Doses of Johnson & Johnson Vaccine - caribbeannationalweekly.com|Johnson & Johnson vaccines could cost millions annually - Windhoek Observer|Agency News|⚡Govt Holding Discussions With Pfizer, Johnson & Johnson: G Kishan Reddy - LatestLY"
571,2021-06-03,Holistic strategy to drive eye health excellence - BSA bureau|Greece rolls out ‘long-awaited’ mass vaccine campaign to refugees - Al Jazeera English|Government sourcing more doses of COVID-19 vaccines including Johnson & Johnson to further vaccination efforts - SKNVibes.com|Mexico to Use US-Donated Vaccines Along Border - NBC San Diego
572,2021-06-04,"Carcinogen found in some popular sunscreens and after-sun products including Neutrogena, tests show - CBS News"
573,2021-06-05,
574,2021-06-06,Johnson & Johnson culls $1.6B argenx blood cancer drug collab - Fierce Biotech | Argenx Regains Rights to Blood Cancer Drug Following Dropped $1.6 Billion Deal - BioSpace | Updated: 5 things to know about the Johnson & Johnson vaccine - Loop News Trinidad & Tobago
575,2021-06-07,"Kuwait approves Johnson & Johnson Covid vaccine - Reuters.com|Class Action Lawsuit Claims OGX Shampoos, Conditioners May Cause Scalp Irritation, Hair Loss - ClassAction.org"
576,2021-06-08,"Brazil to receive 3 million doses of J&J COVID vaccine - minister - Reuters.com|France opens its doors to Albanians who have been vaccinated with Pfizer, Moderna, AstraZeneca and Johnson & Johnson - Telegrafi|Johnson & Johnson OGX Shampoo Makes Your Hair Fall Out, Class Action Lawsuit Alleges - Top Class Actions|DePuy Synthes Launches 2.7 mm Variable Angle Locking Compression Plate Clavicle System Designed to Accommodate Different Shapes and Sizes of the Collarbone - OrthoSpineNews"
577,2021-06-09,US extends expiration dates for J&J COVID vaccine by 6 weeks - The Associated Press|FDA extends shelf life of Johnson & Johnson COVID-19 vaccine - Reuters.com
578,2021-06-10,FDA tells Johnson & Johnson to toss 60 million Covid vaccine doses - NBC News|Astellas' Xtandi nabs leg up over Johnson & Johnson's Erleada with NICE prostate cancer win in U.K. - FiercePharma|EU rejects contaminated J&J COVID shots - DW (English)
579,2021-06-11,"COVID-19 Vaccine Drug Substance Manufactured by Emergent BioSolutions Authorized as Part of Johnson & Johnson’s Emergency Use Authorization - BioBuzz|EU won't use J&J COVID shots from time of U.S. contamination issue - Reuters.com|EHA: Johnson & Johnson, nearing Sanofi showdown, bolsters Darzalex's myeloma lead with 'unprecedented' survival data - FiercePharma|FDA tells J&J to scrap 60 million vaccine doses made at troubled plant - POLITICO"
580,2021-06-12,"South Africa to Dispose of 2 Million Contaminated J&J Vaccines - Bloomberg|South African health inspectors will not release unsuitable J&J vaccines - ETHealthWorld|EHA: A shorter leukemia therapy? AbbVie, J&J tee up FDA filing for Imbruvica, Venclexta fixed-duration combo - FiercePharma"
581,2021-06-13,The top 10 highest paid biopharma R&D executives in 2020 - Fierce Biotech|Mattapoisett Land Trust scholarship winners - Sippican Week|South Africa pulls 2 million doses of JJ vaccine after contamination concerns - 코리아타임스
582,2021-06-14,The Story Behind BAND-AID® Brand OURTONE™ Adhesive Bandages - Johnson & Johnson|U.S. authorizes another 14 mln doses of Johnson & Johnson's COVID-19 vaccine -sources - Reuters.com|Health Departments Across Wisconsin Have More J&J Vaccine Than They Can Use - WPR
583,2021-06-15,"BIO 2021: After COVID-19 showcased the power of science, J&J exec urges industry to start thinking 'cure' in cancer - FiercePharma|PYC Therapeutics Establishing New U.S. Headquarters in San Diego, Announces Residency at Johnson & Johnson Innovation, JLABS - InvisionMag|SA ramp up Covid-19 vaccine rollout - DPSA"
584,2021-06-16,Webinar: Introduction of South Korea's Digital Market & Key Strategies to Run A Successful Campaign - AnyMind Group|Family is key to locksmith firm’s success - Southwest Ledger
585,2021-06-17,"Full Court dismisses Johnson & Johnson’s appeal against findings in pelvic mesh class action - Maddocks|The Phillie Phanatic Will Get Vaccinated Next Week - That Balls Outta Here|Moderna, Johnson & Johnson approved for use locally - Trinidad Guardian"
586,2021-06-18,"""How Johnson & Johnson helped us adopt 11 children"" - Johnson & Johnson|Johnson & Johnson companies play vital role in global health - Irish Examiner|Johnson & Johnson, caring for health for more than 130 years - Irish Examiner"
587,2021-06-19,
588,2021-06-20,Ethicon Expands Advanced Biopolar Energy Portfolio With Launch Of ENSEAL X1 Curved Jaw Tissue Sealer - News-Herald | Active Amplify ETF Reaches Big AUM Milestone - ETFdb.com
589,2021-06-21,COVID-19: Which vaccines are effective against the delta variant? - Medical News Today|J&J cell therapy partner Legend carves out production foothold in Belgium as myeloma drug nears finish line - FiercePharma
590,2021-06-22,From game-changer to back-up: J&J's COVID vaccine struggles in Europe - Reuters.com|Darzalex scores a first with new EC approval in AL - The Pharma Letter
591,2021-06-23,A Comeback for Dividends - Kiplinger's Personal Finance|Tijuana has become a popular destination for Mexicans looking for COVID-19 vaccine - Border Report|Lynparza approval cements value of China for AstraZeneca - The Pharma Letter
592,2021-06-24,
593,2021-06-25,Johnson & Johnson confirms opioid business has ended in $230 million settlement with New York - CNBC | Johnson & Johnson to pay $230m in New York opioids case - Al Jazeera English | Johnson & Johnson pays $230m to settle New York opioids case - The Guardian | J&J Agrees To Pay $230M In New York Opioid Settlement - NPR
594,2021-06-26,"J&J Vision Care’s Limerick plant is key to global mission - Business Post|J&J to pay $263 mln in New York opioid settlements, avoids trial - The Fiji Times|Johnson & Johnson to pay $230m to settle opioid claim - BBC.com"
595,2021-06-27,"ESPERION Appoints JoAnne Micale Foody, MD, FACC, FAHA as Chief Medical Officer - GlobeNewswire|Johnson & Johnson Stock: A Compounder With Better Credit Than The US Government (NYSE:JNJ) - Seeking Alpha|Booster may be needed for J&J shot as Delta variant spreads, some experts already taking them - Reuters.com"
596,2021-06-28,Johnson & Johnson ranks #4 on Fortune’s Return on Leadership list - Johnson & Johnson|Johnson & Johnson's Tremfya eyes bigger psoriatic arthritis share with promising analysis in large subset of patients - FiercePharma
597,2021-06-29,3 cutting-edge eye lenses designed to help improve how you see - Johnson & Johnson
598,2021-06-30,"Reports of Some Getting Pfizer, Moderna ‘Boosters’ After J&J Vaccine Prompts Calls for More Guidance - U.S. News & World Report|Pfizer, Moderna, J&J Vaccines: Efficacy as Delta Variant Concerns Rise - NBC Boston|Covid-19 vaccines in India: Prices and doses to availability, your complete guide - India Today"
599,2021-07-01,"Johnson & Johnson vaccine seems to stand up against delta variant, preliminary research suggests - ABC News|Medical Robotics: A Profit Machine?|Healthcare Stocks - Sick Economics"
600,2021-07-02,
601,2021-07-03,South Africa Hits New Record With 26 000 Daily COVID-19 Cases - pindula.co.zw
602,2021-07-04,Zimbabwe: Govt Rejects Johnson & Johnson Vaccine Donation - AllAfrica - Top Africa News|Children's singer Jaber Othman dies of COVID-19 - The Libya Observer
603,2021-07-05,"New research finds J&J vaccine has muscle against COVID’s delta variant - PolitiFact|'Broken promise': Lawsuit claims ingredient in some J&J shampoos causes hair loss - WZTV|Suit Alleges J&J's OGX Shampoo, Conditioners Cause Hair Loss - Cosmetics & Toiletries"
604,2021-07-06,"CSU, Chico to Host a Free Drop-in COVID-19 Vaccine Clinic for the Community on July 13 - Chico State|From Junior Ranks to Tour Champs - Jack Newton Junior Golf"
605,2021-07-07,
606,2021-07-08,"Johnson & Johnson's Stelara posts positive 3-year data in ulcerative colitis as competition heats up - FiercePharma | COVID-19: Armenia to acquire Johnson & Johnson’s and Novavax vaccines in autumn - Armenpress | Armenia To Buy American COVID-19 Vaccines - Ազատություն Ռադիոկայան | UNICEF to ship up to 220M doses of Johnson & Johnson vaccine to Africa - Anadolu Agency | English | BlueTriton, producer of Poland Spring water, names new CEO - The Advocate"
607,2021-07-09,"Johnson & Johnson, L’Oréal USA & More Named As Best Companies By Seramount - Beauty Packaging"
608,2021-07-10,"Lawsuit: Johnson & Johnson’s “OGX” Shampoos Cause Hair Loss - Legal Reader|Bayer kidney disease drug gets FDA nod, pitting it against AstraZeneca, J&J meds - MedCity News|Egypt to receive 2 M dozes of Pfizer COVID-19 vaccine in few days: Minister - Egypt Today"
609,2021-07-11,"FDA adds new warning on Johnson & Johnson vaccine related to rare autoimmune disorder - The Washington Post|FDA adds warning to J&J vaccine for possible link to rare neurological disorder - NBC News|One and Done: Why People Are Eager for Johnson & Johnson’s Vaccine (Published 2021) - The New York Times|Pfizer to discuss COVID-19 vaccine booster with U.S. officials - PBS NewsHour|J&J COVID vaccine may pose 'small possible risk' of rare neurological syndrome, CDC says - CBC.ca"
610,2021-07-12,Johnson & Johnson in discussion with FDA regarding COVID-19 vaccine side effects - The Fiji Times|Johnson & Johnson makes significant progress towards 100% renewable electricity goal with new wind and solar power purchase agreements - Johnson & Johnson|Johnson & Johnson Achieves 100% Renewable Electricity Across European Operations - Environment+Energy Leader
611,2021-07-13,"FDA warns of potential rare neurological complication with Johnson & Johnson coronavirus vaccine - CNN|Update: Suspect in liquor store shooting believed to have fled to Mexico - Paso Robles Daily News|Johnson & Johnson recalling Neutrogena, Aveeno sunscreens because of benzene traces - NBC News|Lawsuit Alleges Johnson & Johnson OGX Shampoo Products Cause Hair Loss - AboutLawsuits.com"
612,2021-07-14,Where Will Johnson & Johnson Stock Be In 5 Years? - Seeking Alpha|CVS stops selling two of its own sunscreen products after Johnson & Johnson recall - CBS News|Johnson & Johnson Recalls 5 Aerosol Sunscreens After Finding Carcinogen Traces - NPR
613,2021-07-15,"Johnson and Johnson recalls some Neutrogena and Aveeno sunscreens after it detects benzene in them - CNN|Johnson & Johnson recalls five Neutrogena, Aveeno sunscreen products containing traces of benzene - The Washington Post|Johnson & Johnson Recalls Tons of Neutrogena Sunscreens Over Contamination Concerns - Prevention Magazine|Johnson & Johnson Issues Recall on Sunscreens - AARP"
614,2021-07-16,How to Know if Your Aveeno or Neutrogena Sunscreen Was Recalled for Containing the Carcinogen Benzene - Green Matters|6 Sunscreens to Buy Instead of Johnson & Johnson’s Neutrogena and Aveeno - Popdust|FDA investigating how a known carcinogen wound up in J&J sunscreen - Reuters.com|J&J recalls 5 sunscreen sprays found to contain carcinogen benzene - Livescience.com
615,2021-07-17,"Sunscreen recall: What the finding of a cancer-causing chemical means for you - CNN|Neutrogena spray-on sunscreens recalled after 'elevated' levels of benzene detected - CBC.ca|Bargains aplenty, COVID vaccine clinic found at flea market, but few get shots - San Antonio Express-News|Philippines receives 1.6-M doses of Johnson & Johnson vaccines - Philstar.com"
616,2021-07-18,"How Johnson & Johnson transformed its corporate business-technology operating model - McKinsey|""1.5 million children are living with HIV in sub-Saharan Africa. I'm one of the doctors treating these young patients every day"" - Johnson & Johnson|The United States Announces Donation of 453,600 Doses of the Johnson & Johnson COVID-19 Vaccine to Ethiopia - U.S. Embassy in Ethiopia|Nepal’s disabled get a shot at Covid - Nepali times"
617,2021-07-19,Johnson & Johnson takes to Twitter to expand its network of storytelling patients - FiercePharma|2 Neutrogena spray-on sunscreens recalled due to elevated levels of benzene - The Northern View
618,2021-07-20,"If you got the Johnson & Johnson vaccine, do you need another dose? - NBC News|Johnson & Johnson Taps Jones Day to Explore Talc Bankruptcy - The Wall Street Journal|Johnson & Johnson pencils in €2.1bn in Covid-19 vaccine sales - The Irish Times|'Light at the end of the COVID-19 tunnel' as J&J's medtech companies rebound to $7B in Q2 sales - Fierce Biotech"
619,2021-07-21,"Johnson & Johnson Posts Higher Profit as Healthcare Demand Returns - The Wall Street Journal|Johnson & Johnson to pay $5bn in landmark $26bn US opioid settlement - The Guardian|Big 3 U.S. drug distributors, Johnson & Johnson reach landmark $26 billion opioid settlement - CNBC"
620,2021-07-22,"Pfizer, Johnson & Johnson Settle Antitrust Suit Over Remicade - Bloomberg Law|Woman says Johnson & Johnson OGX shampoo can cause hair loss - TODAY|Influence of frosted haptics on rotational stability of toric intraocular lenses - Nature.com|How bankruptcy could help Johnson & Johnson corral vast talc litigation|Company Business News - Mint|Lawsuit Claims Johnson & Johnson’s OGX Shampoos and Conditioners Lead to Hair Loss - Prevention Magazine"
621,2021-07-23,The delta variant is now dominant in Washington. How well is the J&J vaccine working against it? - The Seattle Times|The United States Donates Over One Million Doses of Johnson & Johnson Vaccine to Tanzania - USEmbassy.gov
622,2021-07-24,Ghana aims to receive 18 million COVID shots by October - Reuters.com
623,2021-07-25,"Pfizer, Johnson & Johnson settle high-profile Remicade biosim lawsuit on undisclosed terms - FiercePharma"
624,2021-07-26,"Ben Crump files lawsuit against Johnson & Johnson on behalf of Black women - ABC News|Purdue points to creditor support for bankruptcy plan to escape opioid litigation, but will Congress follow? - FiercePharma|Black women's organization sues Johnson & Johnson over talcum-based powder - CBS News|Johnson & Johnson to End Talc-Based Baby Powder Sales in North America (Published 2020) - The New York Times"
625,2021-07-27,"Zimbabwe approves J&J COVID-19 vaccine for emergency use - Reuters.com|Crump, National Council of Negro Women File Lawsuit Against J&J - Business Insider|The FDA Extends The Expiration Date On Johnson & Johnson's COVID Vaccine To 6 Months - NPR|Advocacy group sues Johnson & Johnson over products marketed to Black women, alleging cancer link - CNN|Women With Cancer Awarded Billions in Baby Powder Suit (Published 2020) - The New York Times"
626,2021-07-28,"J&J faces new lawsuit over marketing talc baby powder to Black women - Business Insider|Johnson & Johnson Targeted Black Women With Products Linked To Cancer, Lawsuit Says - NPR|FDA OK's Emergent BioSolutions plant to resume manufacturing J&J's Covid-19 vaccine - CNN"
627,2021-07-29,Johnson & Johnson COVID-19 Vaccine Help Boost COVID-19 Vaccination Rollout in Champasak Province - UNICEF|US Says COVID-19 Vaccines “Don’t Come with Strings Attached” - VOA Cambodia News|One jab of J& J per person - PressReader
628,2021-07-30,Covid-19: Johnson & Johnson Vaccine Pause Is Another Hurdle For Europe (Published 2021) - The New York Times|Black women’s group sues J &J over baby powder - The Citizen
629,2021-07-31,"Letters to the Editor for Aug. 1, 2021 - Bucks County Courier Times|Adiri hospital urges oxygen supplies as patients continue to stream in - The Libya Observer"
630,2021-08-01,"Johnson & Johnson Not Responsible For Death Of Illinois Woman In Talc Case - Lawyer Monthly Magazine|The power of prioritizing your vision - Johnson & Johnson|​More US-made Johnson & Johnson Covid jabs arrive​ - The Phnom Penh Post|Kenya Approves J&J, Pfizer Covid-19 Vaccines as Cases Surge - Bloomberg"
631,2021-08-02,Johnson & Johnson Gets Burned by Benzene - Happi|Second tranche of U.S.-donated vaccines Arrive in Gambia - The Point
632,2021-08-03,"This nurse leader in Liberia is making sure mothers and babies get the healthcare they need - Johnson & Johnson|Pulmonologist On Making Lung Cancer A Disease Of The Past - Health Professional Radio|J&J, Google back inflammatory disease startup Mestag with $45M seed - Fierce Biotech|CVS stops giving J&J Covid vaccines in pharmacies, still offers shots at some MinuteClinics - CNBC|Saudi Arabia updates COVID-19 entry requirements - ASIA-Plus"
633,2021-08-04,Urgent recall of popular Johnson & Johnson Neutrogena Ultra Sheer Sunscreen Spray over cancer scare - Daily Mail|Malawi to receive Johnson & Johnson vaccine on Saturday Malawi 24|Latest News from Malawi - Malawi24
634,2021-08-05,Rollout of 400m Johnson & Johnson doses in Africa kicks off - Mmegi Online||Ferguson statement on court order against Johnson & Johnson - Washington State Wire|CVS stops offering Johnson & Johnson shots at its pharmacies - WWLP.com
635,2021-08-06,"India approves Johnson & Johnson Covid vaccine for emergency use - The Guardian|Jim Gabriele named president and CEO of M2GEN - The Cancer Letter|African Vaccine Acquisition Trust (AVAT) announces 108,000 doses of vaccines arriving in Mauritius as part of the first monthly shipment of Johnson & Johnson vaccines - africacdc.org|Johnson and Johnson’s single-dose COVID-19 vaccine approved for emergency use in India - The Hindu"
636,2021-08-07,Malawi Receives First Doses of Johnson & Johnson Vaccine - VOA Asia|PNG Receives More COVID-19 Vaccines Johnson & Johnson From The United States - Papua New Guinea Today
637,2021-08-08,"Scott O’Brien’s life was filled with family, friends and love - The Anna Maria Island Sun Newspaper|Covid-19 Cases Are Still Rising, but the Vaccine News Is Promising - Barron's|ECA, Afreximbank, Africa CDC procure 158,400 Johnson & Johnson vaccines for Cameroon, millions more to come - United Nations Economic Commission for Africa"
638,2021-08-09,Minimally invasive quantification of cerebral P2X7R occupancy using dynamic [ - Nature.com|Instagram Testing Photo Ads Within Its ‘Shop’ Tab - Tubefilter|What To Do If You Used Johnson & Johnson Recalled Sunscreen Products? - The Legal Examiner
639,2021-08-10,"Togo, the first country in Africa to receive made-in-Africa Johnson & Johnson vaccine - Togo First|Why the Recent Sunscreen Recalls Are So Alarming, According to Skincare Experts - Good Housekeeping|J&J matches Stelara's 'Bold' message to the Olympic spirit in TV media buy during Tokyo games - FiercePharma"
640,2021-08-11,"Researchers ask FDA to pull more sunscreens over possible carcinogen - New York Post|BD finds new global finance chief in 20-year Johnson & Johnson vet - Fierce Biotech|Ethicon's Echelon Circular Powered Stapler Associated With Major Reduction In Serious Complications Following Colorectal Surgery - PR Newswire|J&J, Amgen and Roche face growing biosimilar competition that is driving down prices: report - FiercePharma"
641,2021-08-12,
642,2021-08-13,
643,2021-08-14,Johnson & Johnson vaccines on way to T&T - Trinidad Guardian
644,2021-08-15,"UPDATED: Pfizer, Eli Lilly and J&J roll out COVID-19 vaccination rules as delta makes case for mandates - FiercePharma|As Delta spreads, some travelers double up on COVID-19 vaccine in U.S. - Reuters|The world is making billions of Covid vaccine doses, so why is Africa not getting them? - The Guardian"
645,2021-08-16,"South African activists slam J&J for exporting vaccines - Loop News Cayman|Listerine Naturals Mouthwash Made with ‘Non-Natural, Synthetic Process,’ Says Class Action Lawsuit - Top Class Actions|Johnson & Johnson Vision to pioneer integrated eye health ecosystem in Singapore - Singapore Economic Development Board"
646,2021-08-17,"Johnson & Johnson Vision unveils 3-year plan to develop eye health ecosystem in Singapore - Mobihealth News|Optellum Announces Strategic Collaboration With The Lung Cancer Initiative At Johnson & Johnson, Applying AI To Transform Early Lung Cancer Treatment - PR Newswire|DePuy Synthes Introduces the INHANCE™ Shoulder System, a First-to-Market, Fully Integrated Shoulder Arthroplasty System - OrthoSpineNews"
647,2021-08-18,"J&J names Joaquin Duato as CEO effective Jan 3, replacing Alex Gorsky - CNBC|DePuy Synthes launches Inhance shoulder system - Mass Device|Will Johnson & Johnson COVID-19 vaccine recipients need booster too? - Fox News|J&J’s New Insider CEO Brings Expertise From Crucial Pharma Post - Bloomberg"
648,2021-08-19,"Johnson & Johnson names Joaquin Duato as its next CEO - ABC17News.com|J&J CEO Gorsky to step down, company veteran to lead in 2022 - The Associated Press|Alex Gorsky to Serve as Executive Chairman and Transition Role of Chief Executive Officer of Johnson & Johnson to Joaquin Duato, Effective January 3, 2022 - PR Newswire|Johnson & Johnson CEO Alex Gorsky to step down, company veteran Joaquin Duato to take over in 2022 - The Globe and Mail|J&J's CEO Plans to Step Down. Analysts Expect a Smooth Transition. - Barron's"
649,2021-08-20,"Joaquin Duato to take over as J&J chief executive - Jersey Evening Post|J&J CEO Gorsky to step aside, handing reins of world's largest pharma to COVID-19 navigator Duato - FiercePharma|Johnson & Johnson taps Duato as new CEO, replacing Gorsky - Fortune|J&J Names New CEO - Morningstar"
650,2021-08-21,"Deyalsingh: Johnson & Johnson vaccines for coastal, remote areas - Loop News Trinidad & Tobago|108,000 one-shot Johnson & Johnson vaccines arrive - Trinidad Guardian|Johnson and Johnson COVID vaccines delayed - Trinidad Guardian|Trinidad and Tobago received 108,700 doses of single dose Johnson & Johnson vaccine - WIC News"
651,2021-08-22,"Joaquin Duato to Take Over as Chief Executive Officer of Johnson & Johnson - njbmagazine.com|UPDATE: Theravance drops one of 2 in J&J collab after JAK inhibitor's midstage ulcerative colitis failure - Fierce Biotech|What biotech, pharma firms pay their workers in 2021: Moderna, Pfizer, Novartis - Business Insider|Big business pledged nearly $50 billion for racial justice after George Floyd’s death. Where did the money go? - The Washington Post|34,000 single-dose Johnson & Johnson vaccines expected today - News Room Guyana"
652,2021-08-23,"J&J CEO Alex Gorsky To Step Aside - Contract Pharma|Tobago East MP: One-shot Johnson & Johnson vaccine safe too - TT Newsday|Watch: J&J vaccine to be given to Guyanese in rural communities - Loop News Caribbean|Another 5,000 Sputnik V vaccines here; single-dose Johnson & Johnson vaccines arrive - News Room Guyana"
653,2021-08-24,“I’ve learned I don’t have to apologize for my psoriasis” - Johnson & Johnson|Singapore Association of Pharmaceutical Industries (SAPI) elect new President and Vice President - BSA bureau|J&J's new CEO Joaquin Duato: What to know - Fox Business|Moderna probes reports of COVID-19 vaccine contamination in Japan - FiercePharma
654,2021-08-25,"DKSH to distribute CanSino vaccine in Malaysia - The Malaysian Reserve|J&J, finally! - Jamaica Gleaner|Belize to receive over 100,000 Johnson & Johnson vaccine doses - Loop News Caribbean"
655,2021-08-26,J&J Talc Spinoff Strategy Survives Legal Proceeding - BioSpace|NICE rebuffs J&J's Darzalex price for newly diagnosed myeloma but leaves negotiation door open - FiercePharma|Johnson & Johnson is recognized with the Best Places to Work Certification in Romania for 2021 - Business Review
656,2021-08-27,"Do I need a booster shot if I got the Johnson & Johnson vaccine? A virologist answers 5 questions - The Conversation|J&J Vaccine and Blood Clots: The Risks, if Any, Are Very Low (Published 2021) - The New York Times|Health Ministry receives Johnson & Johnson vaccines as variant activity increases - Antigua Observer"
657,2021-08-28,"Hikma gains US rights to BAT2206, a proposed biosimilar to Stelara - The Pharma Letter"
658,2021-08-29,COVID vaccine manufacturer taking 'go forward' approach to shots - Fox Business
659,2021-08-30,"Joaquin Duato To Succeed Alex Gorsky As CEO Of Johnson & Johnson - Beauty Packaging|OGX Shampoo, TRESemmé, WEN: Johnson & Johnson not the only brand to be accused of putting dangerous chemicals in shampoo - Top Class Actions"
660,2021-08-31,How the telehealth trend is revolutionizing medical care as we know it - Johnson & Johnson|Johnson & Johnson scores an FDA first with nod for twice-yearly schizophrenia drug Invega Hafyera - FiercePharma|Johnson & Johnson pulls HIV vaccine trial in Africa; but pledges to continue with Phase 3 Mosaico study - BioPharma-Reporter.com
661,2021-09-01,"Sierra Leone receives 52,800 doses of Johnson & Johnson Covid-19 Vaccine - Swit Salone|200 Johnson & Johnson vaccines distributed to prisons - Loop News Trinidad & Tobago|Johnson & Johnson COVID-19 vaccines shipped from South Africa to Europe to be returned - FiercePharma"
662,2021-09-02,"Down to a Science: How Johnson & Johnson Boosts Its Business With MLOps - NVIDIA Blog|Birthright trips to resume, no need for quarantine for those jabbed - The Jerusalem Post|Pfizer, Johnson & Johnson and Sinopharm vaccines at SATT's Mass Vaccination Site - Trinidad Guardian"
663,2021-09-03,
664,2021-09-04,"Shop and vaccinate with J&J doses at Long Circular, Westmall, Starlite - TT Newsday"
665,2021-09-05,"Vaccine advocate: Veronica Smith-Creer - El Dorado News-Times|129,600 doses of Johnson & Johnson COVID-19 vaccines delivered to Zambia - United Nations Economic Commission for Africa|Imbruvica: new safety signal for use with rituximab and ACE inhibitors - The Pharma Letter|One shot-Johnson & Johnson COVID-19 vaccine now available - Breaking Belize News"
666,2021-09-06,"Organ-on-a-chip maker Emulate secures $82M to expand scientific, commercial efforts - Fierce Biotech|Emulate Inc. closes $82M Series E to fund expansion of ‘organ-on-a-chip’ products - TechCrunch"
667,2021-09-07,"GSK, Pfizer and Johnson & Johnson race toward $10B-plus RSV vaccine market: analyst - FiercePharma|Another discount does the trick: Johnson & Johnson wins NICE backing for prostate cancer drug Erleada - FiercePharma|DePuy Synthes Product, Inc. Leases Palm Beach Gardens Office Space Expanding South Florida Footprint - PROFILE Miami"
668,2021-09-08,"FDA Approves Johnson & Johnson’s Schizophrenia Injectable - TechTarget|Best Places to Work Asia 2021: Diversity, Equity & Inclusion - PR Week"
669,2021-09-09,Vaccines effective against Delta variant - Regenstrief Institute|J&J jab comes to City Gate - Trinidad & Tobago Express Newspapers
670,2021-09-10,
671,2021-09-11,"COVID-19 Vaccines Effective Against Delta Variant – How Pfizer, Moderna and J&J Compare - SciTechDaily | Vaccine recipients happy with ‘one shot and done’ - Trinidad Guardian"
672,2021-09-12,"Johnson & Johnson Digs Deeper Into Data to Unlock Product Innovation - Consumer Goods Technology|On heels of one expansion, J&J will pour $176M into another boost for its manufacturing site in Ireland - FiercePharma|What Women Need to Know About the Covid Vaccine (Published 2021) - The New York Times|J&J Recalls Neutrogena, Aveeno Sunscreens over Potential Cancer Concerns - DrugWatch.com"
673,2021-09-13,Vaccines and blood clots? COVID clots are a greater concern - Novant Health
674,2021-09-14,"Cingulate, gunning for pharma majors, seeks $58M to develop extended-release ADHD drugs - FiercePharma|US donates 152,950 doses of Johnson & Johnson Covid-19 vaccine to South Sudan - Radio Tamazuj"
675,2021-09-15,Iran approves U.S. firm J&J's shot as it fights fifth COVID wave - Reuters.com
676,2021-09-16,Johnson & Johnson gears up for showdown over reorg votes with ex-talc supplier - Reuters.com
677,2021-09-17,
678,2021-09-18,
679,2021-09-19,"Johnson & Johnson, Mauna Kea launch study of lung cancer biopsy guidance tool - Fierce Biotech|Will 600 million India-made doses of J&J vaccine be exported to rich Western countries? - The Caravan"
680,2021-09-20,"J&J’s Ebola Vaccine Generates Robust Antibody Responses - TechTarget|Second dose of Johnson & Johnson vaccine increases protection against covid-19, maker says - The Washington Post|Johnson & Johnson trots out two-dose COVID vaccine data as it builds case for boosters - FiercePharma"
681,2021-09-21,J&J Says Second Shot of COVID Vaccine Adds Protection - Voice of America English News|Pfizer Versus Moderna Versus Johnson & Johnson - 3BL Media|J&J says second shot boosts protection for moderate-severe COVID-19 to 94% - Reuters
682,2021-09-22,"HealthVerity partners with J&J's Janssen to provide real-world data for clinical trial, R&D work - Fierce Biotech|New report shows leading Covid-19 vaccine pharma companies fuelling unprecedented human rights crisis - Amnesty International"
683,2021-09-23,What to know about booster shots if you received Johnson & Johnson’s COVID-19 vaccine - PBS NewsHour|Johnson & Johnson: This Mega-Ship Is Slowing Down (NYSE:JNJ) - Seeking Alpha
684,2021-09-24,New Johnson & Johnson data shows second shot boosts antibodies and protection against COVID-19 – but one dose is still strong against delta variant - The Conversation
685,2021-09-25,Are there medical exemptions from getting a COVID vaccine? Here’s what to know - NJ.com
686,2021-09-26,Activists Shame Johnson & Johnson over Pharma Greed - AIDS Healthcare Foundation|Johnson & Johnson Scores Cosmetic Talc Trial Victory in Missouri - CVN News|The ‘Dividend Aristocrats’ With the Safest Payouts - Barron's
687,2021-09-27,Two pioneering RNA scientists win the 2021 Dr. Paul Janssen Award for biomedical research - Johnson & Johnson|Deloitte Digital Dialogue powered by J&J|Life Sciences & Healthcare|Deloitte South Africa - Deloitte
688,2021-09-28,"Swiss buy 150,000 doses of J&J COVID-19 vaccine - Reuters.com|Slovenia suspends Johnson vaccine over death of 20-year-old - Al Jazeera English|How does the COVID-19 vaccine affect type 2 diabetes - Medical News Today|Slovenia police use water cannons at anti-COVID pass protest - The Associated Press"
689,2021-09-29,"MDL Watch: Panel to weigh CPAP, sunscreen actions - Reuters.com"
690,2021-09-30,"Building a future-ready workforce with data and AI - IBM|FDA won't extend shelf life of J&J Covid vaccine doses, may extend life of millions of Moderna shots - NBC News|EU finds J&J COVID shot possibly linked to another rare clotting condition - Reuters.com"
691,2021-10-01,Why some unvaccinated Albertans are looking for the Johnson & Johnson shot - CBC.ca
692,2021-10-02,WTF is Happening to Spire Stock – SPIR? - Nanalyze
693,2021-10-03,"Extra Shots from J. & J. and Pfizer Give Immune Boost, Companies Report (Published 2021) - The New York Times"
694,2021-10-04,"RSV shot prevents pneumonia with 80 percent efficacy in older adults, J&J says - McKnight's Long-Term Care News|J&J is asking the FDA to authorize its COVID-19 booster shots - NPR|Jacksonville worker sues Johnson & Johnson Vision Care over COVID vaccination requirement - The Florida Times-Union|Seattle mother who died from blood clots got J&J vaccine to be child's 'room mom' - KOMO News"
695,2021-10-05,"The top 10 jokes from Dave Chappelle’s Netflix comedy special, The Closer - Chattr|Johnson & Johnson Submits Booster Shot Data To FDA For Authorization - Forbes|Washington woman died from rare blood clotting syndrome after receiving Johnson & Johnson Covid-19 vaccine, local health agency says - CNN"
696,2021-10-06,A pan-serotype dengue virus inhibitor targeting the NS3–NS4B interaction - Nature.com|An Experimental H.I.V. Vaccine Fails in Africa (Published 2021) - The New York Times|Penn State Smeal graduate Wanda Hope receives Alumni Fellow Award - Penn State University
697,2021-10-07,"J&J asks for booster go-ahead, says second vaccine dose provides 100 percent COVID protection - McKnight's Long-Term Care News|Potent Dengue Antiviral Effective against All Known Variants - Genetic Engineering & Biotechnology News"
698,2021-10-08,Effects of the selective orexin-2 receptor antagonist JNJ-48816274 on sleep initiated in the circadian wake maintenance zone: a randomised trial - Nature.com
699,2021-10-09,
700,2021-10-10,"How your own DNA could someday save your vision - Johnson & Johnson | The next frontier of prostate cancer care - Johnson & Johnson | Curing cancer from within: The promise of cell therapy - Johnson & Johnson | Judicial panel consolidates Philips CPAP, J&J sunscreen litigation - Reuters.com"
701,2021-10-11,Johnson & Johnson Announces Jessica Moore as Vice President of Investor Relations - PR Newswire
702,2021-10-12,"J&J science chief Stoffels to retire after decade at the top, adding to C-suite changes - Fierce Biotech|NWRHA administers 1,224 J&J covid vaccines - TT Newsday|Johnson & Johnson's Top Scientist, Stoffels, to Retire at Year-End - TheStreet|A study of COVID vaccine boosters suggests Moderna or Pfizer works best - NPR"
703,2021-10-13,"Biden Promotes Vaccine Donation in Meeting With Kenya’s President (Published 2021) - The New York Times|US to donate more than 17 million Johnson & Johnson Covid-19 vaccines to African Union - CNN|Johnson & Johnson Subsidiary Seeks Bankruptcy Protection to Handle Talc Product Claims (Published 2021) - The New York Times|J&J Covid-19 shot gets better boost from Moderna or Pfizer, US study shows - South China Morning Post"
704,2021-10-14,"Paul Stoffels, Johnson & Johnson’s CSO, to retire - Chemical & Engineering News|Johnson & Johnson vaccine available for shut-ins - Loop News Barbados|Johnson & Johnson vaccine for Shut-Ins - Barbados Today"
705,2021-10-15,Booster Shot of Johnson & Johnson COVID-19 Vaccine Recommended by FDA Panel - Maryland Matters|FDA J&J booster vote updates: Panel unanimously endorses extra shots; FDA pressed on speed of review - CNBC
706,2021-10-16,Small molecule fights dengue in mice - Chemical & Engineering News
707,2021-10-17,"FDA to allow ‘mix-and-match’ approach on coronavirus booster vaccines - The Washington Post|Bio-Thera partners with Pharmapark in Russia/CIS on BAT2206, a Stelara biosimilar - The Pharma Letter|McNeil Lactaid Supplements are Drugs, Not Supplements, Class Action Lawsuit Claims - Top Class Actions"
708,2021-10-18,J&J’s Talcum Two-Step; Albemarle’s Stock Flies While Apple Slowly Dies - Banyan Hill Publishing|Johnson & Johnson’s Sales Climb Across Divisions - The Wall Street Journal|J&J foresees end to not-for-profit sales of coronavirus vaccine - BioPharma Dive
709,2021-10-19,The FDA authorizes Moderna and J&J COVID vaccine boosters - NPR|F.D.A. Panel Unanimously Recommends Johnson & Johnson Booster Shots (Published 2021) - The New York Times|F-star Therapeutics Announces License Agreement with - GlobeNewswire|Johnson & Johnson discloses two-year delay for Ottava robot - Mass Device
710,2021-10-20,"J&J Institute, DePuy Synthes launch mobile training lab for Velys robotic surgery platform - Mass Device|CDC signs off on Moderna and Johnson & Johnson boosters and says people can get a shot different from their original one - The Washington Post|CDC endorses booster doses of Moderna and Johnson & Johnson vaccines, says mix and match is fine - CNN|FDA authorizes Moderna, Johnson & Johnson Covid vaccine booster shots - NBC News|Michigan woman’s death caused by rare Johnson & Johnson COVID vaccine side effect, autopsy report says - MLive.com"
711,2021-10-21,J&J is using a bankruptcy maneuver to block lawsuits over baby powder cancer claims - NPR|Walgreens Now Offering Moderna and Johnson & Johnson COVID-19 Vaccine Booster Shots Nationwide - Walgreens Boots Alliance
712,2021-10-22,Mix-and-match Covid vaccine boosters are here — How to choose the best one for you - CNBC|‘I was the first’: Recipients of Johnson & Johnson shot rush to get boosters - The Washington Post|J&J accused of shielding assets amid baby powder cancer lawsuits Malawi 24|Latest News from Malawi - Malawi24|US regulator approves expansion of COVID vaccine boosters - Al Jazeera English
713,2021-10-23,Health Ministry continues COVID vaccination at select sites this weekend - Trinidad Guardian
714,2021-10-24,"Johnson & Johnson : Top 20 Companies in 2021 - Beauty Packaging|U.S. Gives 100,260 Covid-19 Pfizer Vaccines to Nepal, Adding to 1.5M Johnson & Johnson Doses Donated - Pacific Command|C.D.C. Recommends Covid Booster Shots for Millions of Americans (Published 2021) - The New York Times|Fresh Start: Professor Melissa Jacoby - The Deal Pipeline|The F.D.A. is likely to make its long-awaited decision on Pfizer boosters this week. (Published 2021) - The New York Times"
715,2021-10-25,Texas reaches $290 million settlement with Johnson & Johnson in nationwide opioid case - The Texas Tribune|Boosters for Moderna and Johnson & Johnson - City and Borough of Juneau|California Jury Orders J&J to Pay $26.5M in Talcum Powder Lawsuit - Consumernotice.org
716,2021-10-26,"Marquette County Health Department to offer Moderna booster clinics - WLUC|CDC Approves Moderna, J&J and Pfizer COVID-19 Boosters; Appointments Available at PWHC - University of Arkansas Newswire|Moderna and Johnson & Johnson Covid-19 vaccine booster shots now available - Marianas Variety News & Views"
717,2021-10-27,FDA sets stronger safety warnings for breast implants - Loop News Cayman|The case for cloud in life sciences - McKinsey|Johnson & Johnson’s ‘Texas-two-step’ sparks outcry over US bankruptcy regime - Financial Times|What does J&J’s Ottava delay mean for Intuitive and Medtronic? It’s complicated. - MedTech Dive
718,2021-10-28,"Villgro Africa, Johnson & Johnson seek startups empowering frontline healthcare workers - - Disrupt Africa"
719,2021-10-29,"J&J settles most Risperdal lawsuits, with $800 million in expenses - Reuters|Talk to the doctors, Deyalsingh urges - Trinidad & Tobago Express Newspapers"
720,2021-10-30,
721,2021-10-31,"Mobilizing the community to eliminate preventable blindness in children - Johnson & Johnson | Johnson and Johnson, Costco settle lawsuits over recalled sunscreen products with cancer-causing chemical - Fox Business | Americans who received the one-dose J&J Covid vaccine were 3.5 times likely to develop blood clots - Daily Mail | J&J, Costco agree to settle lawsuit with consumers over recalled sunscreen - FOX 29 Philadelphia | J&J, Costco settle lawsuits over recalled sunscreen - Reuters.com"
722,2021-11-01,"UVA doctor: Johnson & Johnson vaccine has no Myocarditis-associated risk - 29 News|California judge delivers drugmakers 1st trial win in opioid litigation - Reuters.com|Can Johnson & Johnson Just Dump Its Racist, Cancer-Causing Baby Powder Biz? - The Daily Beast"
723,2021-11-02,"The COVID-19 vaccine for kids under 12: What parents should know - CHOC Health|Johnson & Johnson advances global health and avoids supply chain disruptions - Source - Microsoft|Covid Vaccines for Kids Are Coming, but Not for Many Months (Published 2021) - The New York Times|High-Throughput Experimentation Enabling Rapid Process Optimization of an RSV Drug Candidate - ACS Publications"
724,2021-11-03,"Federal Government Cuts Ties With Troubled Vaccine Maker (Published 2021) - The New York Times|ASH: Chasing AbbVie and J&J's Imbruvica, BeiGene's Brukinsa fleshes out competitive leukemia data again - FiercePharma|Johnson & Johnson loses bid to take pelvic mesh appeal to High Court - ABC News"
725,2021-11-04,U.S. cancels multimillion-dollar deal with coronavirus vaccine maker whose plant ruined Johnson & Johnson doses - The Washington Post|Johnson & Johnson launches e-Pharmacy for easy access - The Manila Times
726,2021-11-05,Canada obtaining Johnson & Johnson doses as it works to vaccinate the holdouts - CBC.ca|COVID-19 booster shots now available through the Wellness Center - Sandspur|US cancels vaccine maker’s multimillion dollar deal - Trinidad Guardian
727,2021-11-06,
728,2021-11-07,Unsealed Emails Show How J&J Shaped Report on Talc's Links to Cancer - Bloomberg | Do COVID vaccines affect male fertility? What to know after Aaron Rodgers’ comments - Miami Herald | U.S. administers 429.4 million doses of COVID-19 vaccines –CDC - The Fiji Times
729,2021-11-08,Johnson & Johnson's $465 million opioid penalty overturned by Oklahoma court - NBC News|Johnson & Johnson CEO Alex Gorsky joins Apple's board of directors - AppleInsider|Oklahoma court overturns $465m opioid ruling against Johnson & Johnson - The Guardian|Johnson & Johnson’s Brand Falters Over Its Role in the Opioid Crisis (Published 2019) - The New York Times
730,2021-11-09,Apple Adds Johnson & Johnson CEO to Board in Health Push - Bloomberg|Oklahoma's Supreme Court tossed out a landmark $465 million opioid ruling - NPR|Johnson & Johnson Chairman Alex Gorsky Joins Apple's Board of Directors - MacRumors
731,2021-11-10,Drug Distributors and J.&J. Reach $26 Billion Deal to End Opioid Lawsuits (Published 2021) - The New York Times|Taking a bite out of Big Tech: Outgoing J&J CEO Gorsky takes health tech talents to Apple - Fierce Biotech|Johnson & Johnson CEO joins Apple’s board of directors - TechCrunch|Johnson & Johnson CEO to Join Apple's Board - The Hans India|Alex Gorsky Joins Apple’s Board of Directors - Mactrast
732,2021-11-11,Johnson & Johnson follows GSK with plan to split into two standalone firms - Evening Standard|Johnson & Johnson to spin off consumer business - Financial Times|Some of the world’s biggest companies are breaking apart. Here’s why. - The Washington Post|Johnson & Johnson to spin off consumer health business - BioPharma-Reporter.com|Johnson & Johnson to split into two companies - News24
733,2021-11-12,"Johnson & Johnson stock rises on split news: Here's why and when the company is separating - Fast Company|Johnson & Johnson to Split Consumer From Pharmaceutical, Medical-Device Businesses, Creating Two Companies - The Wall Street Journal|Johnson & Johnson plans to split into two companies - The Straits Times|Johnson & Johnson’s Breakup: What to Know - The Wall Street Journal"
734,2021-11-13,Breakups Usher In a New Era of Corporate Conglomerates - Bloomberg|The Week in Business: Conglomerates Break Up (Published 2021) - The New York Times|The Young Hungarians Who Got Vaccinated With Sputnik And Sinopharm And Now Wish They Hadn't - Radio Free Europe / Radio Liberty|How Johnson & Johnson became the sprawling healthcare giant it is today - ETHealthWorld|Johnson & Johnson to split into two companies - ETLegalworld
735,2021-11-14,"Johnson & Johnson Stock: Split, An Excellent Decision (NYSE:JNJ) - Seeking Alpha|Death To Conglomerates: GE, J&J And Toshiba All Reveal Plans To Break Themselves Up - Forbes|Johnson & Johnson to spin off consumer healthcare division - Cosmetics Business|2021's Fiercest Women in Life Sciences - FiercePharma|Supporting the Health for Humanity 2025 Goals through the Buy Social Corporate Challenge - Johnson & Johnson"
736,2021-11-15,"AHA: Bristol Myers, Janssen look to phase 3 as anticoagulant med aces proof-of-concept study - Fierce Biotech|Johnson & Johnson wants to pitch its bandages and mouthwash products through social media - Fortune|What does J&J’s split mean for the medical device business? - MedTech Dive"
737,2021-11-16,Cala Health scores $77M to expand its tremor-fighting wearable to new conditions - Fierce Biotech|J&J spin-off: pharma continues to cut the cord on consumer healthcare - Pharmaceutical Technology|How to Advocate for Yourself at the Dermatologist - Johnson & Johnson
738,2021-11-17,"What You Need to Know About Covid-19 Vaccine Booster Shots - The Wall Street Journal|Your questions about the GE and Johnson & Johnson company breakups, answered - CNBC|Bucs’ Antonio Brown accused of obtaining fake vaccine card - Tampa Bay Times|How Johnson & Johnson's innovative supply chain technology is helping transform how we work—and live - Johnson & Johnson|J&J's Heaton becomes face of COVID-19 booster debate in first months as Janssen vaccine chief - Fierce Biotech"
739,2021-11-18,"Johnson & Johnson is proud to lead efforts to outpace antimicrobial resistance - Johnson & Johnson|Johnson & Johnson touts ‘golden moment’ to pursue pharma-led future - Financial Times|Johnson & Johnson talc claimant group says spinoff will create 'barriers' - Reuters.com|Antonio Brown accused of obtaining fake Covid vaccination card, prompting NFL review - NBC News"
740,2021-11-19,"Antonio Brown Fake-Vax-Card Claim Draws NFL Scrutiny - Vanity Fair|The 30 Best Stocks of the Past 30 Years - Kiplinger's Personal Finance|Despite Alberta's pleas for single-dose Johnson & Johnson vaccine, uptake is slow - CBC.ca"
741,2021-11-20,
742,2021-11-21,Rapid-fire interview with Katrina Symons of Johnson & Johnson - People Matters | J&J to carve out premium position with 'added-value' personal care following split: Analyst - CosmeticsDesign-Europe.com | 26 Best US Dividend Stocks - DGI Roundup - Tawcan
743,2021-11-22,"Perspective|Giants like GE and IBM are splitting up. The picture for shareholders is complicated. - The Washington Post|The United States donates additional 840,000 Johnson & Johnson vaccines to Mozambique - Club of Mozambique"
744,2021-11-23,"Canada becomes first country to fully approve Johnson & Johnson's COVID-19 vaccine - CBS News|Covid-19: Togo gets 150,000 more doses of Johnson & Johnson vaccines - Togo First|CITF Expands Covid-19 Booster Shots To All Adults - CodeBlue|Mauritania Receives Batch of Johnson & Johnson’s Vaccines from Spain – Mauritanian News Agency - الوكالة الموريتانية للأنباء"
745,2021-11-24,
746,2021-11-25,Scientists Race to Test Vaccines Against Omicron COVID Strain - Newsweek
747,2021-11-26,
748,2021-11-27,
749,2021-11-28,Lung Center Philippines opens smoking cessation clinic to help more smokers quit for good - Punto Central Luzon
750,2021-11-29,How Johnson & Johnson is working to create a healthier planet - Johnson & Johnson|South African Company Nears License to Sell J. & J. Covid Shot Across Africa (Published 2021) - The New York Times|Impact investing to support health equity - ImpactAlpha
751,2021-11-30,Enterprise Explains: Conglomerate breakups - enterprise.news|EXPLAINER|How Aspen aims to make enough Covid-19 vaccines for every single person in Africa - News24|DePuy Synthes buys OrthoSpin and its robotic external fixation system - Mass Device|This ring may just help protect women against HIV - Johnson & Johnson
752,2021-12-01,Janssen taps Tempus' AI and real-world data library for cancer drug discovery - Fierce Biotech|11 steady-rising stocks to own for 2022 - Fortune
753,2021-12-02,Johnson & Johnson Settles Most Risperdal Lawsuits - MedTruth|Big conglomerates split apart to make way for small companies - The Ticker
754,2021-12-03,Can Johnson & Johnson put the taint of scandal behind it? - The Economist
755,2021-12-04,
756,2021-12-05,"Johnson & Johnson Prepares to Untangle Finances Ahead of Planned Split - The Wall Street Journal | The conglomerate paradox : The Indicator from Planet Money - NPR | Covid-19: South Sudan to receive 168,000 doses of Johnson & Johnson vaccine on Tuesday - Radio Tamazuj"
757,2021-12-06,2021 JNJG 12 Years & Under State Age Championships - Jack Newton Junior Golf
758,2021-12-07,Biopharma digital transformation: Gain an edge with leapfrog digital innovation - Deloitte|Tralee student receives Johnson & Johnson STEM scholarship - Radio Kerry|J&J celebrates nurses with a new campaign in wake of burnout plaguing the profession - FiercePharma|Janssen Pharmaceuticals – Immunology Therapeutic Area Pivots - Health Professional Radio
759,2021-12-08,"4 Things to Know About RSV in the Time of COVID-19 - Johnson & Johnson|Pfizer-BioNTech Covid-19 shot loses power against Omicron variant, but booster restores protection - STAT"
760,2021-12-09,"Johnson & Johnson Appoints Senior Leaders to Executive Committee - PR Newswire|DePuy Synthes acquires OrthoSpin - Today's Medical Developments|Johnson & Johnson comms chief Michael Sneed to retire in April - PR Week|There’s no basis to claim thousands have died from COVID-19 vaccines - PolitiFact|Janssen EMEA Receives Conditional Marketing Authorisation for RYBREVANT® ▼ (amivantamab), the First Treatment Approved for Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations... - Business Wire"
761,2021-12-10,"ASH: Sanofi, Johnson & Johnson on collision course with Sarclisa, Darzalex 4-drug regimens in myeloma - FiercePharma"
762,2021-12-11,
763,2021-12-12,"J&J Turned Away by U.S. Supreme Court Over Talc Cancer Suits - Bloomberg | As the pandemic raged, at least 75 lawmakers bought and sold stock in companies that make COVID-19 vaccines, treatments, and tests - Business Insider"
764,2021-12-13,Chief Executive Leadership Institute Honors Dr. Albert Bourla of Pfizer and Alex Gorsky of Johnson & Johnson with Legend in Leadership Award - Yale School of Management|Vaccine Makers Funneled Undisclosed Campaign Cash to Democrats and Republicans in 2020 - The Intercept
765,2021-12-14,"A C.D.C. panel will meet on a blood clot risk linked to J.&J.’s vaccine. (Published 2021) - The New York Times|Vaccine Makers Promote Use of Artificial Intelligence for Development - BroadbandBreakfast.com|414 days at work, zero days off: Dan Barouch and the race to develop the Johnson & Johnson vaccine - The Boston Globe"
766,2021-12-15,US panel recommends J&J shots be sidelined after clot deaths - BBC.com|How To Be A White Label Partner To An Established Agency - ValueWalk|CDC committee recommends saying mRNA COVID vaccines 'preferred' over J&J shots - Axios
767,2021-12-16,"Johnson & Johnson COVID Shot Has Little Effect Against Omicron Variant, According to New Study - PEOPLE|J&J, Sinopharm, Sputnik V COVID-19 shots less effective against Omicron -study - Reuters|Johnson & Johnson Faces Yet Another Crisis Situation This Year - Inkl|CDC narrows use of J&J vaccine due to concerns about rare blood clots - NPR"
768,2021-12-17,"The C.D.C. recommends that other vaccines be preferred over J.&J. (Published 2021) - The New York Times|Barron’s 10 Stock Picks for 2022 - Barron's|CDC recommends Pfizer, Moderna COVID-19 shots over J&J’s - Trinidad Guardian"
769,2021-12-18,2021 Most Influential in Healthcare Alex Gorsky - Modern Healthcare
770,2021-12-19,"Natus Medical appoints new president and CEO - Mass Device|CDC Recommends people not get J&J vaccine if Pfizer, Moderna are available - THE STAR - St. Lucia|P&G recalls dry shampoos and other hair products because of benzene, chemical linked to cancer - NBC News|Haiti - FLASH : Donation of 165,000 doses of Johnson & Johnson vaccines but... - HaitiLibre.com|J&J unit must face novel whistleblower patent lawsuit - Reuters"
771,2021-12-20,"Sierra Leone receives 168,000 doses of Johnson & Johnson covid vaccine from the USA - Sierra Leone Telegraph|Apple’s long-term credit rating upgraded to AAA by Moody’s - Al Jazeera English"
772,2021-12-21,Ortoma Signs Agreement for Exclusive Distribution Rights in Japan - OrthoSpineNews|JANSSEN GETS THUMBS UP: Govt says Johnson & Johnson vax remains effective and safe despite rare blood clots - EyeWitness News|Johnson & Johnson ropes in Ex-Marico Media Head Anagha Bhojane as Head Consumer Experience - afaqs!|State Court Docket Watch: Oklahoma ex rel. Hunter v. Johnson & Johnson - The Federalist Society|Which COVID vaccine and booster are right for me? - LabRoots
773,2021-12-22,"Marjorie Taylor Greene, who has boasted about being unvaccinated, owns stock in 3 major vaccine makers - Business Insider"
774,2021-12-23,Johnson & Johnson: Another 2022 Safety Bet (NYSE:JNJ) - Seeking Alpha|Another oral option for people with multiple sclerosis in the UK - The Pharma Letter
775,2021-12-24,Moody’s gives Apple top ‘AAA’ credit rating on growth promise - PressReader
776,2021-12-25,
777,2021-12-26,
778,2021-12-27,
779,2021-12-28,
780,2021-12-29,"New COVID studies show promise for the Johnson & Johnson vaccine booster - NPR|Johnson & Johnson ships another bispecific off to FDA, this time in multiple myeloma - Fierce Biotech|J&J’s booster shown effective against Covid hospitalization - POLITICO"
781,2021-12-30,Mental health takes the centre stage at The ET Panache Talk Your Heart Out campaign - The Economic Times|Johnson and Johnson - Windhoek Observer
782,2021-12-31,
783,2022-01-01,
784,2022-01-02,Oh Jin-yong named new GM of J&J Medical Korea - KBR
785,2022-01-03,
786,2022-01-04,"Merck, Pfizer, Lilly and J&J restored funding to legislators who stoked Jan. 6 Capitol attack, watchdog says - FiercePharma | FDA Approves Two Pediatric Indications For J&J’s Xarelto - TechTarget"
787,2022-01-05,"Tie pharma CEO pay to fair global COVID-19 vaccine access, investors say - Reuters.com|i2O Therapeutics Announces Research Collaboration and Option Agreement with Janssen to Investigate the Oral Delivery of Macromolecules - Business Wire|Johnson & Johnson launches Aveeno Soothing Bath Soak for itchy skin - Chemist+Druggist"
788,2022-01-06,Capitol Insider: Lawmaker and doctor returns contributions from COVID-19 vaccine makers - The Columbus Dispatch
789,2022-01-07,
790,2022-01-08,
791,2022-01-09,"Johnson & Johnson Medical Devices Companies: Reimagining the patient journey in a digital era - Microsoft|JPM 2022: New Johnson & Johnson CEO Duato points out 5 pipeline meds that can generate $5B-plus - FiercePharma|JPM 2022: Johnson & Johnson links up with Microsoft to cloud-connect its digital surgery programs - Fierce Biotech|Johnson & Johnson is spinning off its consumer division, which could come with risks - CNBC|Johnson & Johnson stock falls Monday, underperforms market - MarketWatch"
792,2022-01-10,
793,2022-01-11,"Microsoft, Johnson & Johnson Medical Device Companies team up on digital surgery ecosystem - Mobihealth News | JPM 2022: J&J, Legend hope to avoid supply challenges that have ailed Bristol Myers' Abecma as cita-cel nears FDA nod - FiercePharma | Philips Stock Plunged. Supply-Chain Issues Persist for the Sonicare Maker. - Barron's"
794,2022-01-12,"M&A Ruling Illustrates Limits of Disclaiming Fraud in Del. - Troutman Pepper|Janssen takes a multifaceted approach to ensuring diversity, equity, and inclusion in its COVID-19 vaccine trial - Johnson & Johnson"
795,2022-01-13,"EMA lists rare spinal condition as side effect of AstraZeneca's COVID-19 shot - Reuters.com|Thousands of suspected injuries tied to breast implants revealed in manufacturer data dump, CBC analysis finds - CBC News"
796,2022-01-14,"8 companies, trade groups that donated to 'Sedition Caucus' members - Business Insider"
797,2022-01-15,"Guyana receives donation of 28,800 Johnson & Johnson vaccine doses from Spain govt - writeups24"
798,2022-01-16,
799,2022-01-17,4 Things to Know About the Flu in the Time of COVID-19 - Johnson & Johnson | Getting Vaccinated or Boosted? CDC Recommends Pfizer-BioNTech or Moderna COVID-19 Vaccines - Riverside Health System | mRNA vaccines offer lasting protection against severe COVID-19 - Medical News Today | CorVista Health Appoints Charles R. Bridges as Chief Scientific Officer - Business Wire | Overland Pharmaceuticals Appoints Ed Zhang as Chief Executive Officer and Welcomes Industry Leaders John Maraganore and Peter Ho as Strategic Advisors - Business Wire
800,2022-01-18,"Fierce JPM Week: Johnson & Johnson's JLABS—Taming the beast, while letting it roam the world - Fierce Biotech"
801,2022-01-19,"Bringing healthcare to remote villages in India and serving as a role model for girls - Johnson & Johnson|Here's what Taunton, Raynham will get from $26B national opioid settlement - Taunton Daily Gazette|Educating the ‘leaders of tomorrow’: Johnson & Johnson to support UL’s Immersive Software Engineering course - University of Limerick|COVID vaccines help Pfizer, Moderna reign supreme reputation-wise, but they're a double-edged sword for J&J and AZ - FiercePharma"
802,2022-01-20,"Battling Cancer, Evan Plotkin Continues His Revitalization Efforts - Business West|‘BPA-free means nothing’: TikToker who worked for ‘Rohnson & Rohnson’ exec says plastics are full of ‘toxic’ chemical that ‘hasn’t been banned yet’ - The Daily Dot|Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine ... - CDC"
803,2022-01-21,Long Island high school teacher who administered at-home COVID vaccine to teen faces felony charge - ABC7 New York
804,2022-01-22,nan
805,2022-01-23,"New finance chief, board changes highlight latest exec moves - Washington Technology|Perineologic Appoints Jim Fortune as President and Promotes Matthew Allaway, DO, to Chief Executive Officer - BioBuzz"
806,2022-01-24,"Prescription drugs, medical devices boost J&J in Q4 - WesternSlopeNow|J&J expects more than $3 billion in Covid vaccine sales this year in mixed quarterly report - CNBC|J&J ‘constantly looking’ at biotech M&A, but focused on small, mid-sized deals - BioPharma Dive"
807,2022-01-25,"Drugmaker Galapagos names former J&J exec Paul Stoffels as CEO - Reuters|Herophilus Appoints Brad Savall, Ph.D. as Vice President and Head of Chemistry as it Advances Pipeline of Novel Drugs for Complex Brain Diseases - Business Wire|Johnson & Johnson Reports Q4 and Full-Year 2021 Results - PR Newswire|Prescription drugs, medical devices boost J&J in Q4 - ETHealthWorld"
808,2022-01-26,Johnson & Johnson Reports Fourth-Quarter Sales of $24.8 Billion in 2021 - Happi|5 things to know about how Johnson & Johnson is helping kids with intestinal worms - Johnson & Johnson|Mayo students at NUI Galway awarded STEM scholarships - Connaught Telegraph
809,2022-01-27,"Johnson & Johnson partners with Microsoft to further digital surgery solutions - Today's Medical Developments|Johnson and Johnson vaccine booster questions, answered by a doctor - Colorado Public Radio|Johnson and Johnson stock forecast: a positive outlook? - Capital.com|Former J&J CSO to Lead New Chapter at Galapagos - BioSpace"
810,2022-01-28,
811,2022-01-29,
812,2022-01-30,Meet Some of the New 2022 Dividend Aristocrats - ETF Trends|Key opinion leaders reach an evidence-based consensus on mouthwash use - Dentistry.co.uk
813,2022-01-31,Tribes Reach $590 Million Opioid Settlement With J. & J. and Distributors (Published 2022) - The New York Times|Native American tribes reach a tentative opioid settlement with J&J and distributors - NPR|Market cap rises widespread among industry's biggest players in 2021 - The Pharma Letter
814,2022-02-01,"Here’s How the AstraZeneca COVID-19 Vaccine Compares to Those Available in the U.S. - Prevention Magazine|J&J discontinues work on eczema drug, leading to $610M in impairment charges for ex-XBiotech asset - Fierce Biotech|3 ways Johnson & Johnson is working to boost the number of diverse doctors - Johnson & Johnson|Native American tribes reach $590 million opioid settlement - NBC News"
815,2022-02-02,"J&J to record $610 mln charge related to skin disease drug - Reuters.com|Mersana, Janssen Come Together in Potential $1B ADC Deal - BioSpace"
816,2022-02-03,Inside J&J's secret plan to cap litigation payouts to cancer victims - Reuters|J&J's Janssen inks $1B biobucks pact for Mersana's ADC tech in 3 targets - Fierce Biotech
817,2022-02-04,
818,2022-02-05,Johnson & Johnson faces push to force global ban on talc baby powder sales - The Guardian | ‘Texas two-step’ outcry risks ending fee bonanza for law firm Jones Day - Financial Times
819,2022-02-06,"Imagining the future of cloud-connected medical devices with Johnson & Johnson leaders - Medical Design & Outsourcing|Johnson & Johnson stock falls Monday, still outperforms market - MarketWatch|Cancer scare pushes Johnson & Johnson toward global talcum powder ban - The Drum"
820,2022-02-07,"J.&J. Pauses Production of Its Covid Vaccine Despite Persistent Need (Published 2022) - The New York Times|Johnson & Johnson pauses production of its Covid-19 vaccine - The Irish Times|J&J pauses production of anti-COVID vaccine - KOHA.net|Nigeria receives two million doses of Johnson & Johnson COVID vaccine from EU countries - Tribune Online|Johnson & Johnson's talc-based baby powder may get banned globally, here’s why - DNA India"
821,2022-02-08,"J&J pauses COVID-19 vaccine production at Dutch plant in temporary pivot to RSV shot: NYT - FiercePharma|Johnson & Johnson plant pauses Covid vaccine production, report says - CNBC|Johnson & Johnson’s Baby Powder Is Facing More Than 30,000 Lawsuits Globally - The Swaddle"
822,2022-02-09,"Johnson & Johnson halts production of COVID-19 vaccine, report says - CBS News|Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S - nejm.org|P&G and J&J dominate most trusted brands - Strategy Online"
823,2022-02-10,Suppression of tumor metastasis by a RECK -activating small molecule - Nature.com|DePuy Synthes acquires CrossRoads Extremity Systems - Mass Device
824,2022-02-11,
825,2022-02-12,
826,2022-02-13,ASCO GU: J&J plays up precision therapy approach for Zejula's prostate cancer bid after mixed results - FiercePharma|J&J's Cerenovus allots €50M to stroke device development at Ireland research site - Fierce Biotech|At the CrossRoads: J&J's DePuy Synthes acquires foot and ankle implant system maker - Fierce Biotech
827,2022-02-14,"Johnson & Johnson stock rises Tuesday, still underperforms market - MarketWatch|Johnson & Johnson talc bankruptcy attacked by cancer plaintiffs as ‘rotten’ - The Fiji Times|AC Immune's Janssen-partnered Alzheimer's vaccine spurs tau-attacking antibodies in early-stage trial - Fierce Biotech"
828,2022-02-15,Johnson & Johnson stop production of Covid-19 vaccine; what it may signal - Magnetic Media|Johnson & Johnson adds Honeywell CEO to its board - Mass Device
829,2022-02-16,J&J to explore RNA reprogramming with Remix research deal - BioPharma Dive|Leading stroke care company CERENOVUS announces €50 million investment in Ballybrit site - Galway Advertiser|4 questions for a data science innovator - Johnson & Johnson
830,2022-02-17,Remix Therapeutics signs Janssen licensing deal that could top $1B - Fierce Biotech
831,2022-02-18,nan
832,2022-02-19,2022 Women Leaders Melinda Richter - Modern Healthcare
833,2022-02-20,DePuy (a JNJ company) Buys CrossRoads Extremity Systems - https://ryortho.com/|COVID-19 Vaccine Booster Shot: Frequently Asked Questions - National Institute for Communicable Diseases
834,2022-02-21,"What does a more aggressive M&A approach mean for J&J’s devices unit? - MedTech Dive|Janssen Pharmaceuticals Case Study|Machine Learning|Life Sciences - AWS Blog|J&J to shutter Pennsylvania OTC manufacturing plant by 2023, report - FiercePharma"
835,2022-02-22,FG begins Johnson & Johnson single dose COVID-19 vaccination - Royal News
836,2022-02-23,
837,2022-02-24,"Drug distributors, J&J agree to finalize $26 bln opioid settlement - Reuters | UPDATED: Pfizer to join J&J, Moderna in shareholder vote showdown on vaccine pricing strategy, manufacturing tech sharing - FiercePharma | Kinova signs 5-year extension to support Auris Health’s surgical robots - Robot Report | 4 U.S. companies will pay $26 billion to settle claims they fueled the opioid crisis - NPR | Johnson & Johnson wins a key court battle in baby powder case - NPR"
838,2022-02-25,Attorney General Bonta: Drug Distributors and Johnson & Johnson Commit to $26 Billion Opioid Agreement - California Department of Justice|3 smart tech tools that help diagnose pulmonary arterial hypertension - Johnson & Johnson
839,2022-02-26,"Johnson & Johnson’s idea of DE&I at the workplace - ETHRWorld.com|Johnson & Johnson: How Deron and Sean Rose Up the Ranks in the Twins' Front Office - Twins Daily|J&J, distributo­rs finalise US$26b landmark opioid settlement - PressReader"
840,2022-02-27,"Johnson & Johnson, Legend's CAR-T Carvykti enters myeloma ring with FDA nod - FiercePharma|J&J, Legend cell therapy approved by FDA for multiple myeloma - BioPharma Dive|Dental hygiene and therapy panel advises on mouthwash use - Dentistry.co.uk"
841,2022-02-28,"Johnson & Johnson goes early on myasthenia gravis awareness push, eyeing argenx, AstraZeneca battle ahead - FiercePharma|2021's top 10 clinical trial flops - Fierce Biotech|Cloud, IoT usher in new era for healthcare - CIO"
842,2022-03-01,"Complications from Johnson & Johnson Covid vaccine caused Oregon woman's death - NBC News|Russia-Ukraine war: Siemens, J&J vow to continue serving all patients while Conformis freezes Russian sales - Fierce Biotech|J&J $26 Billion Opioid Settlement Finalized - Addiction Center"
843,2022-03-02,"FDA approves J&J's allergy-fighting contact lens infused with an antihistamine - Fierce Biotech|40 Under 40: Beerju Patel, The Janssen Pharmaceutical Companies of Johnson & Johnson - MM+M Online|Mitigation of total body irradiation-induced mortality and hematopoietic injury of mice by a thrombopoietin mimetic (JNJ-26366821) - Nature.com"
844,2022-03-03,"The Multi-Ocean Distribution of the Hadal Amphipod, Hirondellea dubiaDahl, 1959 (Crustacea, Amphipoda) - Frontiers|Johnson & Johnson India: Handling crises with care - Forbes India"
845,2022-03-04,
846,2022-03-05,"Drug companies are investing big in psychedelics, but can they engineer out the trip? - Chemical & Engineering News | J&J targets Chinese biotech deals as western pharma groups look east - Financial Times | Tobago hotelier worries about borderline vaccinations - TT Newsday"
847,2022-03-06,Terry Smith jettisons Johnson & Johnson from £25bn fund - Portfolio Adviser|Johnson and Johnson cancer lawsuits exposes history of human experimentation on Black prisoners - The Independent|J&J’s Controversial Prison Testing Resurfaces in Baby Powder Lawsuits - Bloomberg
848,2022-03-07,"With J&J-partnered CAR-T nod in hand, Legend CEO eyes earlier myeloma use, cheaper cell therapy manufacturing - FiercePharma|Bankruptcy Court Approves J&J Talc Case - MedTruth|Johnson & Johnson MedTech earns a spot on Fast Company's 2022 Most Innovative Companies list - Johnson & Johnson"
849,2022-03-08,"South Africa's Aspen signs deal to package and sell J&J COVID vaccine - Reuters|9 ways Johnson & Johnson has supported women since 1886 - Johnson & Johnson|200 jobs from Johnson & Johnson’s €35 million Limerick investment - Limerick Post|Johnson & Johnson Vision to begin producing Intraocular Lenses in Limerick, Ireland - IDA Ireland"
850,2022-03-09,"Uganda Receives 2.9m Doses of Johnson & Johnson COVID-19 Vaccines - softpower.ug|Top 10 Pfizer Competitors & Alternatives - Business Strategy Hub|J&J inks vaccine licensing deal with Aspen, paving the way for Africa's first local COVID-19 shot - FiercePharma"
851,2022-03-10,"Coincidence of cholinergic pauses, dopaminergic activation and depolarisation of spiny projection neurons drives synaptic plasticity in the striatum - Nature.com|Nigeria lobbies US to help identify looted assets - The Africa Report"
852,2022-03-11,
853,2022-03-12,
854,2022-03-13,4 things to know about seeing the doctor in the time of COVID-19 - Johnson & Johnson
855,2022-03-14,"Johnson & Johnson Medical Devices drops ‘medical devices’ in rebranding - Medical Design & Outsourcing|J&J Spin-Off Company Allowed to Proceed with Bankruptcy Affecting Baby Powder Lawsuits - The Legal Examiner|Playing catch-up with J&J, Sanofi taps Blackstone for $300M to fund pivotal trial of subcutaneous Sarclisa - FiercePharma"
856,2022-03-15,Past Asbestos Testing on Inmates Could Affect J&J Talc Lawsuits - Asbestos.com|DePuy Synthes adds two knee systems to Attune Knee portfolio - Mass Device
857,2022-03-16,Former J&J CEO Alex Gorsky saw total pay fall last year but remains among pharma's best-paid - FiercePharma|J&J's DePuy Synthes found guilty of infringing orthopedic device patent in $20M verdict - Fierce Biotech
858,2022-03-17,"President Biden signs into law bipartisan landmark bill supporting mental health of U.S. health workers - Johnson & Johnson|Janssen Pharmaceuticals - Products, Recalls & Lawsuits - DrugWatch.com|A look at the most interesting innovations at SXSW 2022: From holograms to the future of psychedelics - Fierce healthcare|Neurological problems no higher after vaccination; depression, anxiety risk tied to COVID severity - Reuters"
859,2022-03-18,J&J's Covid vaccine shows promising long-term durability - NBC News
860,2022-03-19,'Reassuring' data suggests Johnson & Johnson vaccine may still have a role to play against Covid-19 - CNN|Is tinnitus a rare side effect of Covid vaccines? - NBC News
861,2022-03-20,"5 things to know about Johnson & Johnson’s new CEO, Joaquin Duato - Johnson & Johnson"
862,2022-03-21,J&J to cut off 340B discounts to contract pharmacies starting in May despite lingering legal fight - Fierce healthcare|Quick guide: Most widely used COVID-19 vaccines and how they work - Livescience.com
863,2022-03-22,
864,2022-03-23,
865,2022-03-24,"Could changes in your microbiome increase your risk of colorectal cancer? - Johnson & Johnson|Omicron deaths of Johnson & Johnson recipients were double the rate of other vaccinated Americans, new data show - CBS News|J&J Unveils Latest Skincare & Suncare Research - Happi|J&J India launches ‘Be The Change For TB’ initiative - ETHealthWorld|Johnson & Johnson India launches youth initiative for tuberculosis eradication - The Financial Express"
866,2022-03-25,Johnson & Johnson India's â€˜Be The Change For TBâ€™ Initiative on World TB Day - Adgully
867,2022-03-26,Johnson & Johnson dose arrive - Solomon Star
868,2022-03-27,How the Different Types of COVID-19 Vaccines Work - Healthline
869,2022-03-28,"Johnson & Johnson Halts Supply of Personal-Care Products in Russia - Bloomberg|J&J to Stop Selling Personal Care Products in Russia - The Business of Fashion|J&J Suspends Personal-Care Product Sales in Russia - The Wall Street Journal|Give Pease a chance: Charles River Laboratories names new CFO - Fierce Biotech|CDC: If you got J&J’s vaccine and booster, consider an mRNA shot now - The Washington Post"
870,2022-03-29,"CNBC Transcript: Johnson & Johnson CEO Joaquin Duato Speaks with CNBC’s Meg Tirrell Live During CNBC’s Healthy Returns Summit Today - CNBC|""Even on my worst days with multiple sclerosis, I believe in finding joy where I can"" - Johnson & Johnson|Next decade will transform health care more than past century: Johnson & Johnson CEO - CNBC|InnovHeart nabs J&J, Haemonetics alum to lead mitral system maker as CEO - Fierce Biotech"
871,2022-03-30,"Women to Watch 2022 - PR Week|AG’s office sues J&J, Janssen for marketing and selling opioids in NMI - Marianas Variety News & Views"
872,2022-03-31,"Feds probe ring of counterfeit HIV meds targeting Gilead, GlaxoSmithKline and Johnson & Johnson: report - FiercePharma|Legend Biotech CSO abruptly leaves Johnson & Johnson's CAR-T partner he co-founded - Fierce Biotech|Sun taps travel for its new 'long haul' psoriasis campaign - FiercePharma|Effectiveness of Homologous and Heterologous COVID-19 Booster Doses .. - CDC|Nancy Lane, Spirit Behind Studio Museum in Harlem, Dies at 88 (Published 2022) - The New York Times"
873,2022-04-01,"Rich companies are using a quiet tactic to block lawsuits: bankruptcy - NPR|Johnson and Johnson COVID vaccine: Safety, protection and booster - TODAY"
874,2022-04-02,
875,2022-04-03,"Trial begins in West Virginia lawsuit against opioid manufacturers - PBS NewsHour | West Virginia says J&J, drugmakers caused ‘tsunami’ of addiction - Al Jazeera English | Investors Say The Time for High-Dividend Stocks Is Now - ETFdb.com"
876,2022-04-04,Workers sanctioned over safety breach that ‘could have led to explosion’ - The Irish Times
877,2022-04-05,COVID-19 Vaccine: What Women Need to Know - Cedars-Sinai
878,2022-04-06,"The trailblazer who became J&J's first Black female vice president - Johnson & Johnson|J&J Funded Asbestos and Talc Testing on Inmates in the 1970s - Mesothelioma.com|Eli Lilly, AbbVie positioned for long-term growth, while Bristol Myers Squibb may struggle: analysts - FiercePharma"
879,2022-04-07,Multilanguage advertising in the early 1900s - Johnson & Johnson
880,2022-04-08,
881,2022-04-09,
882,2022-04-10,"J&J aims to 'save legs, change lives' with new peripheral artery disease awareness effort - FiercePharma"
883,2022-04-11,Appeals court: Johnson & Johnson must pay $302 million in pelvic mesh case - Cleveland 19 News|The top 20 pharma companies by 2021 revenue - FiercePharma
884,2022-04-12,"Johnson & Johnson ordered to pay $302m over pelvic mesh implant ads - The Guardian|Ngee Ann Poly, J&J S'pore tie up to open training centre for data analysis, marketing - The Straits Times"
885,2022-04-13,Johnson & Johnson ordered to pay USD 302M in pelvic mesh case - The Times of India|‘Not So Pretty’ Is Changing the Investigative Documentary Game - Decider
886,2022-04-14,
887,2022-04-15,
888,2022-04-16,
889,2022-04-17,"Johnson & Johnson subsidiary settles West Virginia opioid lawsuit for $99 million - PBS NewsHour | Johnson & Johnson stock falls Monday, underperforms market - MarketWatch | Johnson & Johnson welcomes new Vision Experience Center to Beijing - China Daily | Johnson & Johnson Vision India launches Bubble Pop Colored Contact lenses Inbox - Adgully"
890,2022-04-18,"Stock Market Today: Stocks Rise Despite Rate Concerns, Mixed Earnings - Kiplinger's Personal Finance|J&J taps tiny Bioasis for tech to cross blood-brain barrier - FiercePharma|Johnson & Johnson, after weak quarter of vaccine sales, will no longer include it in guidance - FiercePharma|J&J pulls COVID vaccine sales forecast due to low demand, supply glut - Reuters|Johnson & Johnson suspends COVID-19 vaccine sales forecast - 코리아타임스"
891,2022-04-19,Dividend Stock Analysis of Johnson & Johnson (JNJ) - Dividend Growth Investor|Johnson & Johnson receives USD457M from Covid vaccine sales - MENAFN.COM
892,2022-04-20,"Listerine Mouthwash Royalties for Sale at $2.1 Million - TMZ|Bell Media Announces New Virtual In-Content Advertising Products - Bell Media|Alabama settles opioid claims with J&J, McKesson, Endo for $276 mln -attorney general - Reuters"
893,2022-04-21,J&J Vision settles contact lens antitrust litigation for $55 million - Reuters|J&J brand Neutrogena unveils new skin care products in India - BSI bureau
894,2022-04-22,Annual meetings are the new frontline in the battle over corporate purpose - The Economist
895,2022-04-23,
896,2022-04-24,
897,2022-04-25,Rider students take first place in national J&J case competition - News at Rider|Johnson & Johnson Files Suit Against Alleged HIV-Drug Counterfeiters - The Wall Street Journal|Ontario Strengthens Domestic Pharmaceutical Manufacturing Capacity - Government of Ontario News
898,2022-04-26,Johnson & Johnson shareholders called on to end talc baby powder sales - The Guardian|Johnson & Johnson follows Gilead with lawsuit targeting alleged HIV drug counterfeiters - FiercePharma|Working to increase the number of midwives—especially “melanated” midwives—across all communities in the U.S. - Johnson & Johnson
899,2022-04-27,Johnson & Johnson investors reject proposal to end global talc sales. (Published 2022) - The New York Times|Empowering Johnson & Johnson to build meaningful customer relationships with the power of first-party data - Marketing Interactive
900,2022-04-28,The Architect of J&J's Breakup Bets on Tech for the Future of Drugs - Bloomberg
901,2022-04-29,
902,2022-04-30,
903,2022-05-01,FDA clears J&J’s Ethicon’s Monarch surgical robot for urology procedures - Mass Device
904,2022-05-02,Self-medicating contact lenses can stop allergic reactions before they start - Fast Company|Louth student Ciara Duffy honoured with prestigious Johnson & Johnson scholarship - Irish Independent
905,2022-05-03,South Africa Urges Africa’s First COVID-19 Vaccine Plant to Keep Its Doors Open - Voice of America English News|Johnson & Johnson Vision Named a Winner of Fast Company's 2022 World Changing Ideas Awards for ACUVUE® Theravision™ with Ketotifen - PR Newswire|Alcon and Kirkland invalidate two AMO eye surgery patents - JUVE Patent|Why Monarch's New Clearance Is Big for J&J’s Surgical Robot - MD+DI
906,2022-05-04,"J&J Sues Drug-Benefit Middleman Over Use of Drug-Cost Assistance Program - The Wall Street Journal|FDA sharply limits use of Johnson & Johnson shot due to rare blood clots - The Washington Post|FDA limits use of Johnson & Johnson’s Covid-19 vaccine, citing clotting risk - STAT|US restricts use of Johnson & Johnson Covid vaccine over rare blood clot risk - The Guardian|Johnson & Johnson vaccine launching today - Solomon Star"
907,2022-05-05,"FDA Limits Use Of Johnson & Johnson Vaccine Due To Blood Clot Risk - Forbes|Citing Safety Concerns, F.D.A. Further Limits J.&J. Covid Vaccine (Published 2022) - The New York Times|FDA restricts Johnson & Johnson’s COVID-19 vaccine due to blood clot risk - PBS NewsHour|FDA PLACES NEW RESTRICTIONS ON JOHNSON & JOHNSON’S COVID-19 VACCINE - National Blood Clot Alliance"
908,2022-05-06,"Pharmaceutical brands save millions of lives and trillions of dollars, brand values surge as result - Brand Finance|FDA restricts JJ's COVID-19 vaccine due to blood clot risk - 코리아타임스|Nicole Audia says Johnson & Johnson vaccine sent her health into a tailspin - CBS New York|Back where it started: FDA restricts use of J&J's COVID-19 shot because of blood clot threat - FiercePharma"
909,2022-05-07,nan
910,2022-05-08,"Johnson & Johnson to Continue Global Sale of Talc-Based Baby Powder - Asbestos.com|J&J axes Bavarian Nordic pact for HPV and hep B vax, keeps 2 other programs - Fierce Biotech|Africa’s only COVID-19 vaccine production plant Aspen Pharmacare may have to shut down as no one wants to buy their Johnson & Johnson vaccine too risky to be used in the U.S. because of a dangerous clotting condition called 'thrombosis' - Today News Africa|Global pharma brands ranked for strength and value in 2022|Pharmaceutical|The Pharmaletter - The Pharma Letter|Which COVID Booster Should I Get? What to Know About Mixing Vaccines - CNET"
911,2022-05-09,"Bayer's pharma business feels the pain from Xarelto generics in China - FiercePharma|The top 10 highest paid biopharma R&D executives in 2021 - Fierce Biotech|Emergent destroyed up to 400M COVID-19 vaccines, far more than previously known: report - FiercePharma|How data science is ushering in a new era of modern medicine - Johnson & Johnson"
912,2022-05-10,Can these nurses’ inventions revolutionize patient care? - Johnson & Johnson|Pharma50Talks: Janssen’s company group chairman dishes on growth strategy - Drug Discovery & Development
913,2022-05-11,"Not so fast on Johnson & Johnson's Texas Two-Step strategy as appeals court says it'll take another look - FiercePharma|Johnson & Johnson taps insiders to lead consumer health group after 2023 separation - FiercePharma|Africa’s First Covid-19 Vaccine Factory Hasn’t Received a Single Order (Published 2022) - The New York Times|J&J names Thibaut Mongon, current consumer health leader, as CEO of new spin-off company - CNBC"
914,2022-05-12,"""I tell them they can do anything"": Meet a mom whose kids are living with a disease that causes blindness - Johnson & Johnson"
915,2022-05-13,nan
916,2022-05-14,How J&J exceeds Singles Day expectations - The Supply Chain Xchange
917,2022-05-15,"In the Hamptons, a $48 Million Home Sells Before It Hits the Market - The Wall Street Journal|J&J program adds Ena's infectious disease nasal spray to roster - FiercePharma|Fixed-income diversification helpful in rising-rate environment - Investment Executive|A new mouthwash consensus – presenting the science and evidence – part one - Dentistry.co.uk"
918,2022-05-16,FDA clears DePuy Synthes’ Inhance for total shoulder arthroplasty - Mass Device|Johnson & Johnson names CEO and CFO Designate for New Consumer Health Company - GlobalCosmeticsNews
919,2022-05-17,J&J-backed Locus closes $35M financing to push CRISPR-based antibacterial drug into phase 2/3 - Fierce Biotech|J&J debuts 'Depression Looks Like Me' campaign by and for the LGBTQ+ community - FiercePharma|Johnson & Johnson Names CEO & CFO Of Planned Consumer Health Company - Beauty Packaging
920,2022-05-18,5 Things We Now Know About Crohn’s Disease - Johnson & Johnson|Janssen (Johnson & Johnson’s pharmaceutical segment) - Drug Discovery & Development
921,2022-05-19,Johnson & Johnson gets pulmonary hypertension nurses talking with live online educational campaign - FiercePharma|COVID-19 Vaccine Authorized For Kids Ages 5 to 11: What Parents Need to Know - Yale Medicine
922,2022-05-20,
923,2022-05-21,Palm oil firms depriving tribes of millions of dollars - BBC.com
924,2022-05-22,"Innovating to improve mental health across the globe - Johnson & Johnson|New Global Surgery Initiative Aims to Improve Access to Quality Surgical Care in Resource-Limited Settings - Johnson & Johnson|Building a learning culture with AI - The Enterprisers Project|J&J's $230M blood pressure bet hits phase 3 endpoint, but questions linger about blockbuster potential - Fierce Biotech"
925,2022-05-23,"In bankruptcy case, US wants court to block J&J's use of high-powered, highly paid lawyer Neal Katyal - FiercePharma|This home health nurse supporting high-risk moms is empowering her clients to trust their gut and use their voice - Johnson & Johnson|Here's What to Know About Getting a COVID Booster Shot - Verywell Health"
926,2022-05-24,"The Stocks You Will Wish You Had 5 Years From Now - The Stock Dork|BigLaw partner's hourly billing rate of nearly $2,500 draws objection from bankruptcy trustee - ABA Journal|Lawyer's $2,465 hourly rate draws objection in J&J talc bankruptcy case - Reuters"
927,2022-05-25,"Lawsuits Galore: J&J, BMS, GSK, Mylan and Others - BioSpace"
928,2022-05-26,"Mayo Clinic, Janssen AI to detect pulmonary hypertension scores FDA breakthrough nod - Fierce Biotech"
929,2022-05-27,
930,2022-05-28,Mumbai Greens: Johnson & Johnson Garden is small but packs a punch - The Indian Express
931,2022-05-29,
932,2022-05-30,The top 20 drugs by worldwide sales in 2021 - FiercePharma
933,2022-05-31,
934,2022-06-01,Johnson & Johnson aims to transform the experience of clinical research with new ClinApp platform - diginomica
935,2022-06-02,Johnson & Johnson Attempts To Side-Step $100 Million Baby Powder Settlement - Our Time Press|Cambridge start-up Enhanc3D Genomics wins Johnson & Johnson support for human 3D genome technology - Cambridge Independent
936,2022-06-03,
937,2022-06-04,
938,2022-06-05,"The Janssen Ad26.COV2.S COVID-19 vaccine: What you need to know - World Health Organization (WHO)|Nurturing the next great healthcare breakthroughs - Johnson & Johnson|Serotiny Announces a Research Collaboration With Janssen to Optimize Designs for Chimeric Antigen Receptors Signaling Domains - Business Wire|ASCO: ‘Any way you slice’ it, Arcellx's CAR-T is matching J&J-Legend’s Carvykti, analyst says - Fierce Biotech|Emergent says J&J owes up to $420M for breach of contract. J&J: You want to talk breaches? - FiercePharma"
939,2022-06-06,"Ethicon launches next-gen surgical stapler - Mass Device|ETHICON LAUNCHES NEXT GENERATION ECHELON™ 3000 STAPLER DESIGNED FOR EXCEPTIONAL - MultiVu|J&J, Emergent Accuse Each Other Of Violating COVID-19 Vaccine Deal - BioSpace"
940,2022-06-07,"Johnson & Johnson Releases 2021 Health for Humanity Report Highlighting Performance on ESG Priorities and Progress Against Public Commitments - PR Newswire|COVID-19 booster shots: Your questions answered - PeaceHealth|Tackling the world’s most urgent healthcare needs - Johnson & Johnson|Willem Appelo to succeed Sophie Bechu as Philips’ Chief Operations Officer - Philips|Dupixent leads TV ad spending for 2nd month in a row, but top 10 total still down compared to February high - FiercePharma"
941,2022-06-08,Exclusive look at stunning architecture at 800-acre farm donated by late philanthropist (PHOTOS) - NJ.com|PROTACs: great opportunities for academia and industry (an update from 2020 to 2021) - Nature.com|Missouri legal aid agencies receive $126M windfall from Johnson & Johnson talc liability judgment - Missouri Independent
942,2022-06-09,6 Women Developed This Rare Blood Clot After Receiving the Johnson & Johnson Vaccine—Here's What to Know - Health.com|Why Johnson & Johnson can outperform in a economic slowdown — and is a buy - CNBC
943,2022-06-10,
944,2022-06-11,
945,2022-06-12,
946,2022-06-13,Mike Kuhn and Greg Stremlaw join the MBS Advisory Board - Maine Business School - UMaine - University of Maine | Johnson & Johnson Names Health Equity Innovation Challenge Awardees - Happi | The top 10 most profitable pharma companies in 2021 - FiercePharma
947,2022-06-14,
948,2022-06-15,"Screen addicts, rejoice: J&J Vision to roll out contact lenses designed for digital device fatigue - Fierce Biotech | The Department of Health – Abu Dhabi collaborates with a leading healthcare company to boost health technology and clinical research | Department of Health - Abu Dhabi - DoH | Johnson & Johnson - Windhoek Observer"
949,2022-06-16,"Paige, Janssen team up to launch AI-powered bladder cancer test - Fierce Biotech"
950,2022-06-17,
951,2022-06-18,
952,2022-06-19,Johnson & Johnson Opens First Satellite Center for Global Health Discovery in Asia Pacific at Duke-NUS to Advance Dengue Research - PR Newswire
953,2022-06-20,Kellogg to focus on snacks with surprise three-way split - Reuters|NEJM publishes results on adding Lynparza to Zytiga - The Pharma Letter
954,2022-06-21,"An ETF With Strong Balance Sheet Stocks, Opportunities - ETFdb.com|Cork unit of J&J records €296m loss after provisions for claims over anti-psychotic drug - BreakingNews.ie|WHO approves Biological E Limited as additional manufacturing site for Johnson & Johnson COVID-19 vaccine - ThePrint"
955,2022-06-22,5 things we now know about the tropical disease dengue - Johnson & Johnson
956,2022-06-23,NMRC updates on Janssen COVID-19 vaccine - Namibia Fact Check
957,2022-06-24,
958,2022-06-25,VIDEO: J&J Vision using digital technology to drive outcomes - Healio
959,2022-06-26,Here are the companies that will cover travel expenses for employee abortions. (Published 2022) - The New York Times|Disposable contact lens antitrust $75M class action settlement - Top Class Actions|The 15 highest paid pharma CEOs of 2021 - FiercePharma
960,2022-06-27,"""Why I decided to undergo facial feminization surgery"" - Johnson & Johnson|Planning all-oral, once-daily regimen, J&J gets EMA backing for Imbruvica-venetoclax combination - FiercePharma"
961,2022-06-28,"Johnson & Johnson refreshes 'Positively Fearless' HIV campaign with a new digital presence and LGBTQ+ ambassador - FiercePharma|Behind the Scenes, McKinsey Guided Companies at the Center of the Opioid Crisis (Published 2022) - The New York Times|What it really feels like to have aphasia - Johnson & Johnson|New recommendations from ADA for Bayer’s Kerendia - The Pharma Letter"
962,2022-06-29,"Gilead, Sanofi, GSK and more to pay for employees' abortion-related travel costs after Roe ruling - FiercePharma"
963,2022-06-30,nan
964,2022-07-01,
965,2022-07-02,
966,2022-07-03,
967,2022-07-04,
968,2022-07-05,Johnson & Johnson Wins Third Ethicon Pelvic Mesh Trial This Year - Law.com|(07/06/22) Stick With What’s Working Until It Doesn’t - Moneyshow.com
969,2022-07-06,The science of sustainability: Orthopaedics lab receives global recognition - Johnson & Johnson|Launch of the Satellite Center for Global Health Discovery at Duke-NUS - Johnson & Johnson
970,2022-07-07,
971,2022-07-08,
972,2022-07-09,
973,2022-07-10,Johnson & Johnson Galvanizes Efforts to Achieve an Even More Inclusive Supplier Network - Johnson & Johnson | Procurement’s Training Program Prepares Suppliers to Advance Sustainability Priorities - Johnson & Johnson | 'J&J Medtech Korea to transform into digital healthcare company' - KBR
974,2022-07-11,"Johnson & Johnson Vision, Singapore's A*STAR forge partnership to set up digital eye health consortium - Healthcare IT News|A*STAR and Johnson & Johnson Vision ink MoU for eye health digital innovation consortium - Agency for Science, Technology and Research (A*STAR)"
975,2022-07-12,
976,2022-07-13,J&J lambasts Sanofi for Zantac marketing claims just as its Icy Hot pain patch campaign faces scrutiny - FiercePharma | Bruised investors seek shelter in US healthcare stocks - Marianas Variety News & Views
977,2022-07-14,
978,2022-07-15,
979,2022-07-16,
980,2022-07-17,
981,2022-07-18,"J&J Sees Sales, Profit Growth Diluted by Dollar’s Strength - Bloomberg|J&J’s cancer drug sales help weather hit from stronger dollar - PharmaLive|Johnson & Johnson's cancer drug sales help weather hit from stronger dollar - CNBC|7 Best Stocks for College Graduates - InvestorPlace|J&J lowers full-year sales forecast amid rising inflation, currency pressures - MedTech Dive"
982,2022-07-19,Johnson & Johnson names successor to veteran general counsel -|Governance Intelligence|Johnson & Johnson blames US dollar strength for second cut in profit outlook - Financial Times
983,2022-07-20,"Johnson & Johnson leans on beauty trends to create Vivvi & Bloom baby care brand - Glossy|Cover crops and carbon stocks: How under-vine management influences SOC inputs and turnover in two vineyards - ScienceDirect.com|With big changes ahead for J&J and Novartis, here's what the companies' execs are talking about - PharmaVoice|Fresh Start: Professor David Skeel Talks Bankruptcy Backlash - The Deal Pipeline"
984,2022-07-21,"Announcing Vivvi & Bloom™: Simple, Proven and Positive Skin & Hair Care Products Developed for Little Ones - PR Newswire|The biggest medtech personnel moves so far in 2022 - Mass Device|Johnson & Johnson Launches Baby Care Brand Co-Created By Parents And Caregivers - Essence"
985,2022-07-22,
986,2022-07-23,
987,2022-07-24,Johnson & Johnson Unveils New Skin & Hair Care Brand For Babies & Toddlers - Beauty Packaging|Zoetis Appoints Vanessa Broadhurst to its Board of Directors - Business Wire|J&J Unveils New Baby Skin and Haircare Brand Vivvi & Bloom - Happi|Follow Nancy Pelosi and Watch These 8 Stocks That Lawmakers Are Buying - InvestorPlace
988,2022-07-25,Tech Developed to Align JWST’s Mirrors Used to Improve Human Vision - PetaPixel|New Therapeutics Options in Rheumatoid Arthritis Pipeline as 120+ Key Companies are Working on Drug Profiles|DelveInsight - PR Newswire UK
989,2022-07-26,Transforming the Trajectory of Lung Cancer [Sponsored] - Scientific American|The American Cancer Society Awards $4.2 Million in Grants for Patient Navigation to Hospitals Across the Country - American Cancer Society Press Room|Maria Walsh lands promotion at Janssen UK - The Pharma Letter
990,2022-07-27,Barbilicious once a big deal! - SNL24|Meet 3 men who’ve been on the front lines of HIV treatments for decades - Johnson & Johnson
991,2022-07-28,Job Corps partnership with Johnson & Johnson Vision promotes manufacturing - The Florida Times-Union|PolyNovo soars after snaring J&J veteran as new CEO - The Australian Financial Review|Is Johnson & Johnson Baby Powder Safe to Use Now? - Mesothelioma Guide|Takeda pulls Exkivity lung cancer app in EU as Velcade generics cost oncology franchise dearly - FiercePharma
992,2022-07-29,
993,2022-07-30,
994,2022-07-31,"J&J is not the first name in Alzheimer's these days, but Janssen is charting the 'sweet spot' behind the scenes - Fierce Biotech|Johnson & Johnson isn't finished with Emergent dispute, files arbitration demand - FiercePharma|FDA green light for Stelara in children with active PsA - The Pharma Letter|The top 10 Big Pharmas for their diversity, equity and inclusion efforts in 2022 - FiercePharma"
995,2022-08-01,
996,2022-08-02,"What it takes to truly diversify clinical trials - Johnson & Johnson | Powering implantable medical devices: Meet Dr. Feifei Shi, WiSTEM - Johnson & Johnson | Johnson & Johnson spotlights 'HIV Heroes' at international AIDS conference - FiercePharma | 8 Facts You Need to Know About the COVID-19 Vaccine & Pregnancy - Healthline | 'Price controls,' not negotiations, are in pricing bill: AbbVie CEO - FiercePharma"
997,2022-08-03,South Africa reports first death causally linked to COVID vaccine - Reuters
998,2022-08-04,Restoring quality of life for patients with facial bone defects: Get to know WiSTEM - Johnson & Johnson|Looking at malaria from a mathematical perspective: Meet WiSTEM - Johnson & Johnson|Gilead pays out $405M for a chance to compete with Eli Lilly's BTLA program - Fierce Biotech|Structure of human spermine oxidase in complex with a highly selective allosteric inhibitor - Nature.com
999,2022-08-05,
1000,2022-08-06,
1001,2022-08-07,"Johnson & Johnson supports creation of the Africa Frontline First Catalytic Fund - Johnson & Johnson|Peter Hoehn, Accomplished Pharmaceutical Executive, Joins Cohen Veterans Bioscience (CVB) in Newly Created Executive Leadership Role - PR Newswire"
1002,2022-08-08,HCA Healthcare announces collaboration with Johnson & Johnson to address key healthcare clinical and industry issues - HCA Healthcare Today|J&J’s Mathai Mammen Abruptly Departs in Latest Leadership Jolt - BioSpace
1003,2022-08-09,"The quest to make neurodegenerative disease a thing of the past - Johnson & Johnson|Pursuing AbbVie and J&J, Innovent hits primary endpoint in phase 2 psoriasis trial - Fierce Biotech|The 10 largest orthopedic device companies in the world - Mass Device"
1004,2022-08-10,Johnson & Johnson Drops Talcum Powder Globally as Lawsuits Mount - Bloomberg|Johnson & Johnson to replace talc-based powder with cornstarch - BBC.com|Johnson & Johnson to stop sale of talc-based baby powder in 2023 - The Hill|J&J to stop selling talc-based baby powder globally in 2023 - CNBC
1005,2022-08-11,Johnson & Johnson to stop selling talc-based baby powder after cancer claims - The Independent|Johnson & Johnson Will Discontinue Talc-Based Baby Powder in 2023 - NewBeauty Magazine|Johnson & Johnson to stop making talc-based baby powder globally - The Guardian
1006,2022-08-12,"J&J to end sales of baby powder with talc globally next year - The Associated Press|Johnson & Johnson to stop selling talc-based baby powder in 2023 - Al Jazeera English|After billions in legal costs, Johnson & Johnson plans to halt talc sales worldwide - FiercePharma|Johnson & Johnson to replace talc-based powder with cornstarch - BBC"
1007,2022-08-13,"Whether talcum powder is safe, and why Johnson & Johnson is replacing talc-based baby powder - inews|Johnson & Johnson to discontinue baby powder globally amid cancer concerns - Doha News|Johnson & Johnson to stop all sales of talc baby powder - The Times|J&J to end sales of baby powder with talc worldwide next year - KGW.com|J&J talc powder sold in Saudi Arabia does not contain asbestos: SFDA - Saudi Gazette"
1008,2022-08-14,J&J talc powder sold in Saudi Arabia is safe: SFDA - The Siasat Daily|Johnson & Johnson Ends Worldwide Sale of Talc-Based Baby Powder - Asbestos.com
1009,2022-08-15,TEVA: 1 Stock Warren Buffett Might Have Sold Too Soon - StockNews.com|Johnson & Johnson To Discontinue Global Sales Of Talc-Based Baby Powder - Beauty Packaging|USFDA issues warning letter to Emergent BioSolutions Baltimore facility - Medical Dialogues|WuXi Advanced Therapies Enters Licensing Agreement With Janssen - Contract Pharma
1010,2022-08-16,What You Need to Know About the Novavax Vaccine - University of Missouri Health Care|Still buying Johnson & Johnson powder for your child? Read how the company sold cancer in a bottle over the years - The Kashmir Monitor|Johnson & Johnson to stop selling talc-based baby powder worldwide - Top Class Actions
1011,2022-08-17,Willem Appelo - Philips|Irritability and Novel Treatments for Core Symptoms are Most Unmet for Autism - Autism Parenting Magazine
1012,2022-08-18,These Companies Will Cover Travel Expenses for Employee Abortions - The New York Times
1013,2022-08-19,
1014,2022-08-20,Johnson & Johnson Ends Production and Sale of Talc Baby Powder Worldwide - Mesothelioma Guide
1015,2022-08-21,Johnson & Johnson won’t take controversial baby powder off shelves in India - Moneycontrol|Axsome soars on FDA approval of oral depression drug Auvelity - The Pharma Letter|Johnson & Johnson to Stop Worldwide Sales of Talc-Based Baby Powder - Supermarket News
1016,2022-08-22,"Learn How Leading Companies Are Building AI Centers of Excellence, at NVIDIA GTC - NVIDIA Blog|Johnson & Johnson WiSTEM2D Scholars Award 2023 for Early to Mid-career women (up to $150,000) - Opportunity Desk|Josephine Pang has a new role at Johnson & Johnson MedTech - Telum Media"
1017,2022-08-23,"You've heard of greenwashing, now meet 'social washing' - Morningstar.com.au|Under Pressure, McDonald’s Shakes Up Its Board (Published 2022) - The New York Times|Johnson & Johnson lost to Pfizer in bidding war for Global Blood Therapeutics: Bloomberg - FiercePharma"
1018,2022-08-24,"A global company stops selling baby powder containing talc amid fears that it may cause cancer..and this is a safe alternative - طقس العرب|AbbVie, J&J's Imbruvica wins first pediatric nod, this one for chronic graft-versus-host disease - FiercePharma|JNJ Appoints Merlo as Non-Executive Chair Designate - njbmagazine.com|J&J bags first nod for multiple myeloma bispecific to complement its own CAR-T offering - FiercePharma"
1019,2022-08-25,Johnson & Johnson to End Talcum Powder Sales Amid Global Momentum for Clean Beauty - Euromonitor International
1020,2022-08-26,
1021,2022-08-27,
1022,2022-08-28,"Bristol Myers, Bayer study results seed doubt about an emerging group of blood thinners - BioPharma Dive"
1023,2022-08-29,Johnson & Johnson Unit Faces Suit Over Color Additive in Tylenol - Bloomberg Law|J&J to stop production of baby talc in India by Q1 of 2023 - The Economic Times|Explained: What is the controversy around J&J's talc-based baby powder? - Business Standard
1024,2022-08-30,9 best US dividend stocks across 9 sectors to buy and hold - Dr Wealth
1025,2022-08-31,Johnson & Johnson – Company Profile - GlobalCosmeticsNews|Pfizer poaches Verily's Panayiotou for new chief marketing role - FiercePharma|Johnson & Johnson and aCommerce Launch Sustainable Packaging Solution in the Philippines - ESG News|Johnson & Johnson to pay $40.5 million to settle opioid epidemic lawsuit - The Financial Express
1026,2022-09-01,Warren Buffett Stocks: Johnson & Johnson - Kenyan Wallstreet|PP KRIT CROWNED ‘FRIEND OF DEFINE’ - PressReader
1027,2022-09-02,
1028,2022-09-03,
1029,2022-09-04,(BPRW) Advocacy Groups Celebrate Victory Against Johnson & Johnson - Black PR Wire
1030,2022-09-05,Health Matters|Stop Wasting Money on Multivitamins. Science Around Their Health Benefits is Still Fuzzy - News18
1031,2022-09-06,
1032,2022-09-07,Former J&J executive settles with company in workplace discrimination lawsuit - FiercePharma | What are the largest medical device companies? - Mass Device | Did NICE play fair? J&J wins appeal—in part—to glean rationale behind cost watchdog's Spravato snub - FiercePharma
1033,2022-09-08,
1034,2022-09-09,
1035,2022-09-10,
1036,2022-09-11,Johnson & Johnson and a New War on Consumer Protection - The New Yorker | High Hopes for Johnson & Johnson’s Covid Vaccine Have Fizzled in the U.S. (Published 2021) - The New York Times | J&J reaches $205 million settlement in Australian pelvic mesh class action - Reuters.com | Australian pelvic mesh implant victims win record $300m payout from Johnson & Johnson - 9News
1037,2022-09-12,"J&J agrees to settle class action pelvic mesh suits in Australia for more than $200M - MedTech Dive|University of North Florida unveils new facilities, announces Johnson & Johnson partnership - The Capitolist"
1038,2022-09-13,"A Sensational Murder Trial in the Newly Founded New Yorker - The New Yorker|You've Heard Of Blue Light Glasses, But What About Blue Light Contacts? - mindbodygreen|Johnson & Johnson reaches $300m settlement over pelvic mesh implants - The Guardian"
1039,2022-09-14,“I’m working to develop better treatments for children with devastating diseases” - Johnson & Johnson
1040,2022-09-15,"JNJ-1245, a novel and potent Mcl-1 inhibitor for hematologic malignancies - BioWorld Online|Johnson & Johnson to invest €100m in Munster operations creating 80 jobs in Limerick - Cork Beo|Johnson & Johnson Vision sees 80 new jobs for Limerick with €100m investment - SiliconRepublic.com|Jobs boost in mid-west - Nenagh Guardian"
1041,2022-09-16,Johnson & Johnson Plans To Expand Limerick Facility - Checkout|Johnson & Johnson Vision announces €100m Limerick investment - Irish Building Magazine|Maharashtra FDA axe Johnson & Johnson's baby powder manufacturing license - Business Standard|Maha: FDA cancels Johnson & Johnson’s licence to make baby powder - The Siasat Daily
1042,2022-09-17,Johnson & Johnson barred from making talcum powder in Maharashtra - The Times of India|Maharashtra FDA cancels Johnson & Johnson baby powder licence in state - CNBCTV18|Harmful to babies: License of Johnson & Johnson baby powder revoked in Maharashtra - Janam TV English
1043,2022-09-18,"Johnson & Johnson pours €100M into contact lens plant in Ireland - Fierce Biotech|Why Johnson & Johnson Is In Trouble, This Time In Maharashtra|BOOM - BOOM|Eastman Collaborates with Ethicon on Sterile-barrier Packaging - Eastman|Johnson & Johnson debuts a groundbreaking R&D facility in the San Francisco Bay Area - Johnson & Johnson|J&J tried to block lawsuits from 40,000 cancer patients. A court wants answers - NPR"
1044,2022-09-19,Johnson & Johnson opens 400-person R&D facility to strengthen Bay Area presence - Fierce Biotech|Report: J&J Vision spending €100 million to expand Irish facility - Mass Device|Cancer victims suing Johnson & Johnson over talc products urge court to end bankruptcy roadblock - The Financial Express
1045,2022-09-20,J&J kicks off prostate cancer health disparities campaign with pro football Hall-of-Famer Shannon Sharpe - FiercePharma|J&J revenues down 49% in 2021-22; net profit up 9%: Tofler - The Economic Times|Why giant drug maker J&J's Janssen unit is plotting its future on the Peninsula - The Business Journals|J&J opens new research hub near San Francisco - BioPharma Dive
1046,2022-09-21,Could these 3 researchers transform the fates of patients with multiple myeloma? - Johnson & Johnson|UL WiSTEM2D Programme Applications Open for Academic Year - I Love Limerick|Johnson & Johnson WiSTEM2D programme for new academic year launches at UL - University of Limerick|Movement in the Tylenol murders: Law enforcement seeks to persuade prosecutors to act on ‘chargeable’ case - Chicago Tribune
1047,2022-09-22,"Alex Gorsky, Johnson & Johnson Executive Chairman, Joins Cleveland Clinic Speaker Series - Cleveland Clinic Newsroom"
1048,2022-09-23,
1049,2022-09-24,Kenya makes history with new initiative to formally support community health workers and advance health equity - Johnson & Johnson
1050,2022-09-25,Johnson & Johnson Vision Care Ireland expands Limerick facility - Med-Tech Innovation|Johnson & Johnson vision announces €100M investment - Medical Plastics News
1051,2022-09-26,"5 top ophthalmic device innovations you need to know - Mass Device|MHRA raises concerns with switching between long-acting J&J, Novartis and Takeda drugs - FiercePharma"
1052,2022-09-27,"Johnson & Johnson Names New Consumer Health Company: Kenvue - Happi|Raghu Krishnan Named Johnson & Johnson’s New Consumer Health Area Managing Director for Africa, Middle East, and Turkey - Business Wire|Johnson & Johnson Announces Kenvue as the Name for Planned New Consumer Health Company - Johnson & Johnson|J&J names consumer health business Kenvue ahead of spin-off - Reuters"
1053,2022-09-28,Johnson & Johnson taps Scottish inspiration in branding its consumer spinoff - FiercePharma|STEM programme expands into MTU - Cork Independent|J&J’s Planned New Consumer Health Company Named Kenvue - njbmagazine.com
1054,2022-09-29,"Band-Aids and Tylenol will have a new name on their packages - CNN|Johnson & Johnson announces Kenvue as new consumer health company - TheIndustry.beauty|Johnson and Johnson names Consumer Health Business ""Kenvue"" - Medical Dialogues|The Surprising Reasons These Companies Changed Their Brand Names - Cheapism"
1055,2022-09-30,Robert Johnson & family - Forbes
1056,2022-10-01,Johnson & Johnson’s Introduces Kenvue Portfolio of Consumer Brands and Shiseido Buys Gallinée - Happi
1057,2022-10-02,"After $100M deal, J&J links gene therapy to improved vision in early-phase trial - Fierce Biotech|Johnson & Johnson names new Consumer Health Company Kenvue - GlobalCosmeticsNews"
1058,2022-10-03,Jennifer Taubert Makes Fortune 2022 Most Powerful Women List - Johnson & Johnson|Forging deeper learning pathways to boost vital knowledge and skills for those at the front lines of care in Africa - Johnson & Johnson|J&J takes trial diversity push into communities with hematology doctor tie-up and mobile clinic - FiercePharma
1059,2022-10-04,How Johnson & Johnson is supporting mental healthcare in the Hispanic and Latino communities - Johnson & Johnson
1060,2022-10-05,"J&J, Legend double CAR-T manufacturing investment to $500M as Carvykti eyes wider myeloma use - FiercePharma|Johnson & Johnson Offers Stability In Uncertain Times (NYSE:JNJ) - Seeking Alpha|Amgen unveils its 2nd-largest R&D site, opening 245,000-square-foot facility in San Francisco - Fierce Biotech"
1061,2022-10-06,Children’s pain medication to continue to be ‘intermittently available’: Health Canada - Global News
1062,2022-10-07,Press release – Start registration for the 6th edition of Hackathon4Health – UMPCD - UMFCD
1063,2022-10-08,
1064,2022-10-09,
1065,2022-10-10,"""I had a condition that threatened my chances of having healthy children"" - Johnson & Johnson|Johnson & Johnson 2022: Driving change, collaboration, and innovation - PharmaLive"
1066,2022-10-11,"BeiGene heaps more pressure on AbbVie, J&J with new Brukinsa head-to-head win over Imbruvica - FiercePharma|An update on the efficacy of mouthwash use - Dentistry.co.uk"
1067,2022-10-12,These 6 women in STEM are on a mission to change the world - Johnson & Johnson|Total recall: How the Tylenol murders of 1982 ushered in tamper-resistant packaging - Retail Brew|Conduct better performance reviews by following J&J's playbook - Business Insider
1068,2022-10-13,Inside J&J's 4-Month Process of Developing the Kenvue Brand - Adweek|J&J Ulcerative Colitis Clinical Trial Produces High Rate of Remission - TechTarget|Cancer-linked Johnson & Johnson’s Baby Powder being sold in Lahore with 50% discount - Dispatch news Desk
1069,2022-10-14,"Alcon, J&J Vision settle for $75M in contact lens price-fixing case - Fierce Biotech"
1070,2022-10-15,nan
1071,2022-10-16,Johnson & Johnson sells Telangana plant as demand slumps: Report - Deccan Herald|‘The Magic of J&J’: Announcing HRE’s HR Executive of the Year - Human Resource Executive®|Johnson & Johnson Kenvue spinoff: JNJ consumer health division business separation date and details - Capital.com|Hetero acquires Johnson & Johnson's manufacturing plant in Telangana - The Economic Times|Johnson & Johnson sells baby powder plant it never opened to Hetero - FiercePharma
1072,2022-10-17,Hetero acquires Johnson & Johnson plant in Telangana - The Hindu|Jim Cramer gives Johnson & Johnson his stamp of approval - CNBC|JnJ sells Telangana plant to Hetero for Rs 130 crore - Medical Dialogues
1073,2022-10-18,"Johnson & Johnson Overhauls Pharma’s B2B ‘Ecosystem’ with Embedded Payments - PYMNTS.com|Johnson & Johnson Stock Can Fly if It Clears This Level - TheStreet|J&J sets sights on $60B in pharma sales by 2025, targets 8 brands to deliver growth - FiercePharma|Johnson & Johnson sells its largest India plant as demand weakens - The Economic Times|J&J, flush with blood cancer assets, cuts one from the pipeline - Fierce Biotech"
1074,2022-10-19,"J&J reveals just how much economic turbulence is affecting Big Pharma - PharmaVoice|Johnson & Johnson signals job cuts amid consumer health separation, inflation pressure - FiercePharma|J&J, Legend's Carvykti delivers encouraging early growth ahead of key myeloma readout - FiercePharma|Johnson & Johnson names new marketing lead for Vision Care - Marketing Interactive"
1075,2022-10-20,"J&J and Corning put more than 100 New York jobs on the chopping block in latest pharma layoff round - FiercePharma|10 Dividend Kings That May Last Centuries - sharewise|Fierce Pharma Asia—Carvykti's growth; Sanofi, J&J sell plants; LG Chem's Aveo buy - FiercePharma"
1076,2022-10-21,News|CDC Director Walensky Cancels Trip to RI After Testing Positive for COVID - GoLocalProv
1077,2022-10-22,
1078,2022-10-23,What J&J’s CHRO learned from two CEO successions - Human Resource Executive® | Johnson & Johnson Is #7 On Our Top Global Beauty Companies 2022 Report - Beauty Packaging | Guam receives more than $1.6M in Johnson & Johnson opioid settlement - KUAM.com
1079,2022-10-24,Humankind Investments Ranks Top 100 U.S. Companies Creating Most Value for Society - Business Wire|J&J's BCMA bispecific Tecvayli wins FDA approval in multiple myeloma—but as a late-line therapy - FiercePharma|How Johnson & Johnson is looking to lead the way in ablation - Mass Device
1080,2022-10-25,Is baby powder harmful? - Top Class Actions|5 top trends shaping the medtech industry - Mass Device
1081,2022-10-26,"XtalPi Announces Research Collaboration with Janssen - PR Newswire|Baby powder case: HC asks Maharashtra to hand over lab report to Johnson & Johnson - The Economic Times|Johnson & Johnson moves Bombay High Court against cancellation of license in Maharashtra - Bar & Bench - Indian Legal News|Tragedy, then triumph: How Johnson & Johnson made sure Tylenol survived the Tylenol murders - Chicago Tribune"
1082,2022-10-27,"Study confirms AstraZeneca jab’s higher risk of very rare clot - The Hindu|Johnson & Johnson Run To High Court, Demand For Suspension Of Cancellation Of Children's Cosmetics Manufacturing License - Punekar News"
1083,2022-10-28,Delivering Equitable Lung Cancer Care [Sponsored] - Scientific American
1084,2022-10-29,nan
1085,2022-10-30,
1086,2022-10-31,Johnson & Johnson to Acquire Abiomed - Diagnostic and Interventional Cardiology | Johnson & Johnson to acquire Abiomed for $16.6B - Mass Device | J&J's $16.6B Deal for Abiomed Signals a New Focus on Medtech - Barron's | Johnson & Johnson doles out $16.6B to snatch up miniaturized heart pump maker Abiomed - Fierce Biotech | Johnson & Johnson bucks global M&A slowdown with $16.6bn Abiomed deal - Financial Times
1087,2022-11-01,Johnson & Johnson to Acquire Cardiovascular Technology Company Abiomed in USD 16.6 Billion Deal - HospiMedica|J&J to buy heart pump maker Abiomed for $16.6 bln ahead of consumer health spinoff - Reuters|Johnson & Johnson to buy heart pump maker Abiomed in $16.6B deal - The Business Journals
1088,2022-11-02,J&J to buy Danvers-based cardio technology company Abiomed for $16.6B - Boston.com|Magic mushroom compound shows promise as depression treatment in key study - Reuters|Lions Clubs International Foundation and Johnson & Johnson Vision's complete 20 years of partnership on Sight for Kids initiative - Business Standard
1089,2022-11-03,nan
1090,2022-11-04,"MIGHTY 25: From the Army to Johnson & Johnson, John Perez still serves - We Are The Mighty"
1091,2022-11-05,
1092,2022-11-06,"What is real-world evidence and how does it help patients? - Johnson & Johnson | J&J MedTech names new innovation and R&D head - Medical Design & Outsourcing | Johnson & Johnson Vision and Lions Clubs International Foundation celebrate 20 years of Sight for Kids, conduct vision screening for over 500 children - ANI News | J&J, Coloplast face class action lawsuit in SA for devices allegedly causing vaginal injuries - The Citizen | J&J promoted Susheel Shukla - Medical Buyer"
1093,2022-11-07,Johnson & Johnson to acquire Abiomed - Healthcare IT News|5 things we now know about multiple myeloma - Johnson & Johnson
1094,2022-11-08,Cancer-stricken Britons sue Johnson & Johnson over claims talc was to blame in landmark lawsuit - Daily Mail
1095,2022-11-09,Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial - Nature.com|Who killed the COVID vaccine waiver? - POLITICO Europe|Woman claims Neutrogena sunscreen caused her skin cancer - Top Class Actions
1096,2022-11-10,Johnson & Johnson’s big bet on intelligent automation - CIO|Johnson & Johnson Wins Bid to Dismiss Lactaid Labeling Lawsuit - Bloomberg Law
1097,2022-11-11,"J&J, SciBase team up to build out skin-screening AI to predict eczema in newborns - Fierce Biotech|A Top Goldman Tech Banker Speaks to Global Risks - Bloomberg"
1098,2022-11-12,nan
1099,2022-11-13,16 surgical robotics companies you need to know - Mass Device|Johnson & Johnson Will Soon Face Talcum Powder Cancer Lawsuits in the U.K. As Well as In U.S. - AboutLawsuits.com|2022's Fiercest Women in Life Sciences - FiercePharma|[Johnson & Johnson license cancellation] Bombay High Court calls for re-examination of baby powder samples in government lab - Bar & Bench - Indian Legal News
1100,2022-11-14,Improving access to medicine around the world - Johnson & Johnson|Johnson & Johnson rises to #2 in ranking of companies’ efforts to expand access to medicines worldwide - Johnson & Johnson
1101,2022-11-15,"GSK, J&J and AZ top global drug access index, but foundation says plenty more work needs to be done - FiercePharma|Practicing in Medical Devices and Digital Health Today: What You Must Know - Food and Drug Law Institute|HIV patients report Eviplera shortage - GxP News"
1102,2022-11-16,J&J Vision Sets Sights on Sustainability - Packaging Digest
1103,2022-11-17,What happens when antibiotics stop working? - Johnson & Johnson
1104,2022-11-18,
1105,2022-11-19,
1106,2022-11-20,Digital deployment: J&J brand Dr.Ci:Labo taps tech at new China store amid three-year expansion push - CosmeticsDesign-Asia.com|Top Dividend ETFs in 2022 - Nasdaq
1107,2022-11-21,Litigator of the Year: Skadden's Allison Brown Achieves Success Against All Odds - Law.com|FDA fines J&J ₹16 lakh for misleading advertisement - Hindustan Times|Johnson & Johnson supports Philippine Mental Health Association (PMHA) in Mental Health Care - LionhearTV
1108,2022-11-22,J&J's nasal spray Spravato bests former AZ drug Seroquel XR in treatment-resistant depression trial - FiercePharma|Coimbatore hospital brings in robotic total knee replacement technology - The Hindu
1109,2022-11-23,
1110,2022-11-24,
1111,2022-11-25,10 Best Roth IRA Stocks To Buy According To Hedge Funds - Yahoo Finance
1112,2022-11-26,Women Of The C-Suite: Joana McKenna on The Five Things You Need To Succeed As A Senior Executive - Medium
1113,2022-11-27,CMR Surgical signs collaboration agreement with Ethicon in select markets - CMR Surgical
1114,2022-11-28,CMR Surgical and J&J are partnering on surgical robotics - Mass Device|Profits jump at Johnson & Johnson’s Irish unit - The Irish Times|Janssen reports sharp increase in profits - Irish Examiner
1115,2022-11-29,"J&J’s Ethicon, CMR Surgical pair up on minimally invasive robotic surgery - Fierce Biotech|Amgen, J&J and Sanofi size up Horizon as Big Pharma renews interest in rare disease M&A - FiercePharma|J&J CEO Joaquin Duato to take additional role of Chairman - Reuters"
1116,2022-11-30,"Johnson & Johnson Names CEO Duato Chairman of the Board - njbmagazine.com|J&J unit, happy with AC Immune Alzheimer's work, moves 1 of 2 shots to next step - Fierce Biotech|Johnson & Johnson CEO Joaquin Duato to take additional role of chairman - CNBC|How advances in HIV treatment could help young people living with HIV - Johnson & Johnson"
1117,2022-12-01,"Johnson & Johnson CEO Joaquin Duato elected as new Chairman of Board - Medical Dialogues|With J&J's Gorsky departing, Duato adopts dual role as chairman and CEO - FiercePharma|Johnson & Johnson baby powder: HC prima facie says its Mulund facility adheres to legal requirements on - Free Press Journal"
1118,2022-12-02,J&J’s Duato to replace departing Gorsky as board chair - BioPharma Dive|Pelvic mesh victims left unsure of futures as legal fees threaten to slash class action payout - ABC News
1119,2022-12-03,
1120,2022-12-04,Pharmalittle: J&J drops out of bidding for Horizon; FDA takes a harder line on fast-track approvals - STAT | Johnson & Johnson names Joaquin Duato Chairman of the board - Cosmetics Business | Biggest biopharma firms see market cap decline | Biotechnology | The Pharmaletter - The Pharma Letter
1121,2022-12-05,HIV Vaccine: Study Shows It May Induce Key Antibody Precursors - Healthline|What to watch for as J&J gets ready to split into two separate companies next year - CNBC
1122,2022-12-06,"Careful modulation of T-cell response will transform treatment - Nature.com|Giving the gift of sight - Johnson & Johnson|J&J re-ups nurse campaign, lauding the 'innovators, lifesavers, and fierce patient advocates' - FiercePharma|J&J Hit With Child Sunscreen Class Action - MedTruth"
1123,2022-12-07,"UL students receive scholarships through Johnson & Johnson WiSTEM2D awards - University of Limerick|On its annual list of price hike offenders, ICER calls out Bausch's Xifaxan, J&J's Invega - FiercePharma"
1124,2022-12-08,"Gilead lands new cell therapy for Kite in $225M Arcellx deal, providing global scale for future J&J-Legend showdown - Fierce Biotech|Employers use patient assistance programs to offset their own costs - Fierce healthcare|Agility critical for start-ups to pivot expertise to healthcare needs: JLABS APAC head - KBR|Mayo students receive scholarships at University of Limerick - Connaught Telegraph"
1125,2022-12-09,
1126,2022-12-10,
1127,2022-12-11,4 things we now know about hip replacement surgery - Johnson & Johnson|The highest paid medtech CEOs - Fierce Biotech|Buyout on Horizon: Amgen floats $28B offer for rare disease drug maker as Sanofi exits bidding war - FiercePharma|Building recession-ready portfolios for wealthy clients - Investment Executive|South Africa’s Aspen gets $30 mln grant to make vaccines - CNBCAfrica.com
1128,2022-12-12,ABM Industries Inc (ABM-N) Quote - Press Release - The Globe and Mail
1129,2022-12-13,"J&J leads $85M funding for HistoSonics' tumor-blasting ultrasound amid FDA review - Fierce Biotech|Johnson & Johnson Raises Price Of Band-Aids To $100,000 Apiece - The Onion|Biotech giant Amgen announced it’s buying Horizon Therapeutics - Finimize|Janssen presents preclinical data on JNJ-80948543 - BioWorld Online|Johnson & Johnson agrees $16.6bn deal to acquire Abiomed - Financier Worldwide"
1130,2022-12-14,Ebola vaccines produced lasting antibodies during trial: Studies - Al Jazeera English|J&J and Merck Ebola vaccines produce lasting antibodies in children and adults - Fox Business|ITR Global Tax 50 2022: Katherine Amos - International Tax Review|5 Best Dividend Stocks That Outperformed in 2022 - Insider Monkey|Johnson & Johnson extends tender offer for Abiomed acquisition - Mass Device
1131,2022-12-15,J&J-partnered Sonnet halts work on bispecific while hunting for fresh collaborators - Fierce Biotech|J&J’s Auris alleges former employees brought trade secrets to new company Noah Medical - Mass Device|Troutman Pepper Files Amicus Brief with U.S. Supreme Court on Behalf of the Washington Legal Foundation - Troutman Pepper
1132,2022-12-16,Is Pfizer Stock A Better Pick Over This Pharmaceuticals Bellwether? - Forbes|META Stock Gets Another Wall Street Upgrade - Kiplinger's Personal Finance
1133,2022-12-17,nan
1134,2022-12-18,11 innovative ways Johnson & Johnson packaged its earliest products - Johnson & Johnson|J&J subsidiaries accuse former Auris employees of stealing robotic surgery trade secrets - MedTech Dive|Barron's 10 Top Stock Picks for 2023 - Barron's
1135,2022-12-19,Cadila Pharma appoints Ashraf Allam global COO - ETHealthWorld|A Deep Dive Into Johnson & Johnson’s Asbestos and Talc Controversy - Mesothelioma Guide
1136,2022-12-20,5 tips from medtech leaders for the next generation - Medical Design & Outsourcing|Meet 7 people who inspired us in 2022 - Johnson & Johnson|Abiomed wins FDA nod for Impella ECP pivotal heart pump trial - Mass Device|J&J CIO Jim Swanson: Current IT Projects and Best Career Advice - InformationWeek|Cancer center leaders lay bare CAR-T makers' struggles—and an unexpected laggard - FiercePharma
1137,2022-12-21,J&J closes acquisition of heart pump maker Abiomed - MedTech Dive|Janssen gets help from Hero in reaching the Black community - FiercePharma
1138,2022-12-22,"Johnson & Johnson completes $16.6B Abiomed acquisition - Mass Device|6 Defensive Healthcare Stocks for 2023 - Barron's|Effects of rifampin on the pharmacokinetics and pharmacodynamics of milvexian, a potent, selective, oral small molecule factor XIa inhibitor|Scientific Reports - Nature.com"
1139,2022-12-23,
1140,2022-12-24,
1141,2022-12-25,7 Best Warren Buffett Stocks to Buy Now in July 2022 - InvestorPlace
1142,2022-12-26,FAA Clears One-shot Covid Vaccine - Aviation International News|Johnson & Johnson Vision launches new lens for astigmatism patients in India - Express Healthcare
1143,2022-12-27,Johnson & Johnson Vision launches lens for astigmatism patients - Healthcare Radius
1144,2022-12-28,
1145,2022-12-29,
1146,2022-12-30,
1147,2022-12-31,
1148,2023-01-01,
1149,2023-01-02,"Texas Jury Clears Johnson & Johnson in $28M+ Pelvic Mesh Product Liability Trial - CVN News | Janssen, American Cancer Society team up to help patients on their oncology journeys - FiercePharma | Does the J&J COVID-19 Vaccine Need a Booster? - Health.com | Jim Cramer predicts these 10 Dow stocks will perform well in 2023 - CNBC"
1150,2023-01-03,J&J Files to Spin Off Consumer-Health Business as Kenvue - Bloomberg|Taking a holistic approach to navigating mental health needs - Financial Times
1151,2023-01-04,"KVUE IPO News - Johnson & Johnson's consumer health unit Kenvue files for an estimated $5 billion IPO - Renaissance Capital|J&J's new consumer health biz Kenvue files to become independent firm - Marketing Interactive|Oklahoma reaches 4 new opioid settlements totaling more than $226 million - CBS News|Neutrogena, Nourished use AI to craft customizable 3D printed gummies - Marketing Dive"
1152,2023-01-05,"J&J's consumer health unit Kenvue prepares to leave the nest with IPO filing - FiercePharma|Novo Nordisk, AstraZeneca and Lilly will top pharma's revenue growth in 2023: report - FiercePharma|CRISPR Layoffs 2023: Job Cuts Hit Gene-Editing Stocks FATE, TCRR, IPSC - InvestorPlace"
1153,2023-01-06,"Fate hits reset as J&J cell therapy deal collapses, slashing pipeline and head count to stretch cash - Fierce Biotech"
1154,2023-01-07,nan
1155,2023-01-08,"Securing the future of surgery, one staple at a time - Johnson & Johnson|2 Warren Buffett Stocks That Are No-Brainer Buys and 1 to Avoid Like the Plague - The Motley Fool|Lilly rides TRex into regulatory T-cell space, paying $55M upfront for 3 immune-mediated disease drugs - Fierce Biotech|5 Biggest Non-Tech Companies in the World by Market Cap - Insider Monkey|With growing health concerns, baby talc market sees shift towards organic, corn-starch-based powder - ETRetail"
1156,2023-01-09,"Bombay High Court Quashes Orders Cancelling Johnson & Johnson's License For Baby Powder Production, Says... - Live Law - Indian Legal News|J&J may eye deals that boost eye care, surgical robots businesses - CEO - ETHealthWorld|Celltrion signs up to support Rani's oral biosimilar copy of J&J's Stelara, lands right of first negotiation - FiercePharma"
1157,2023-01-10,"Bombay HC permits Johnson & Johnson to manufacture, sell baby powder - Business Standard|Johnson & Johnson Recalls Clean & Clear Morning Burst Facial Cleanser - Beauty Packaging|Big relief for Johnson & Johnson, Bombay HC allows firm to manufacture and sell baby powder - The Economic Times"
1158,2023-01-11,"Bombay HC quashes Johnson & Johnson baby powder manufacturing ban over FDA test delay - The Times of India|Sanofi tops off venture arm, bringing fund to $750M - BioPharma Dive|How Doug Godshall Ignited The Spark At Shockwave - Investor's Business Daily|Explained: Why Maharashtra Stopped Johnson & Johnson Baby Powder's Sale, HC Ruling And Other Controversies - Outlook India"
1159,2023-01-12,"J&J Slashes Production of Its Unpopular Covid-19 Shot - The Wall Street Journal|Geron hires a host of commercial, marketing execs - FiercePharma"
1160,2023-01-13,Meet the American who invented Band-Aids: cotton buyer and devoted husband Earle Dickson - Fox News|Riding the wave - The New Indian Express
1161,2023-01-14,‘Dangerous’ baby powder still sold in South Africa - TimesLIVE
1162,2023-01-15,
1163,2023-01-16,"Johnson & Johnson UK class action - Signature Litigation | Johnson & Johnson cuts production of underperforming COVID vaccine: WSJ - FiercePharma | Entering J&J's fiefdom, Luye wins FDA approval of long-acting schizophrenia drug - FiercePharma | Pick Either Johnson & Johnson Stock Or Its Peer – Both May Offer Similar Returns - Forbes | Following in our footprints: The importance of the healthcare industry demonstrating new standards of medical care, sustainably - Johnson & Johnson"
1164,2023-01-17,J&J Ends Large HIV Vaccine Trial in Latest Setback for Field - Bloomberg|First McDonald’s restaurant for Tilbury - The Chatham Daily News
1165,2023-01-18,7 Dividend Growth Stocks For January 2023 - TheStreet|One of the greatest cancer drugs lost its edge. This is why it was vulnerable. - MarketWatch|Johnson & Johnson Says the Only HIV Vaccine in Advanced Trials Has Failed - Them|Warren Buffett Says 90% of People Who Buy Stocks Make This Mistake - The Motley Fool
1166,2023-01-19,U.S. fines J&J $9.75 mln over kickbacks to surgeon for overseas surgeries - Reuters.com|IAVI statement on results from Mosaico HIV vaccine trial - IAVI|VHT: 3 Top Health Care ETFs to Buy and Hold for the Long Haul - StockNews.com|Johnson & Johnson Korea to raise supply price of Tylenol lineup by 18% from March - KBR
1167,2023-01-20,
1168,2023-01-21,
1169,2023-01-22,2 big ideas to help lower the risk of maternal-fetal complications in BIPOC women - Johnson & Johnson|Walmart and Johnson & Johnson Consumer Health Team Up with CareSource to Expand Community Resources for Black Mothers in Georgia - Walmart Corporate|Morphic loses another Big Pharma partner as J&J follows AbbVie out of the door - Fierce Biotech|Bayer chairman under fire for lack of spinoff activity amid renewed investor activism - FiercePharma
1170,2023-01-23,"J&J expects inflation, China COVID hit to carry into 2023 - Reuters.com|Johnson & Johnson's WISTEM2D Scholarships - News|University College Cork|J&J's Duato keeps $60B sales target in sight even as Imbruvica slides and Stelara nears patent cliff - FiercePharma|J&J trims the edges of its pipeline with the company mum on timing of looming readouts - Fierce Biotech"
1171,2023-01-24,Economic crisis? J&J execs say that won’t stop them from hitting $60B target - PharmaVoice|J&J Earnings Forecast Beats Street Citing Second-Half Surge - Bloomberg|J&J’s Nicorette Becomes World’s First Licensed Vaping And Smoking Cessation Therapy - hbw.citeline.com|An mTOR feedback loop mediates the ‘flare’ (‘rebound’) response to MET tyrosine kinase inhibition - Nature.com
1172,2023-01-25,Gordon receives Dr. Paul Janssen Award for Biomedical Research – WashU Medicine - WashU Medicine|AC Immune's ACI-24.060 anti-amyloid beta vaccine shows promise for Alzheimer's - The Pharma Letter|Aaron Rodgers calls out Big Pharma over 2021 COVID-19 vaccine controversy - MM+M Online
1173,2023-01-26,"J&J says blood cancer drug improves progression-free survival in patients - Reuters.com|J&J, Legend's Carvykti hits goal in earlier myeloma, escalates CAR-T showdown with Bristol Myers' Abecma - FiercePharma|Chutes & Ladders—Johnson & Johnson CMO Joanne Waldstreicher announces retirement - Fierce Biotech"
1174,2023-01-27,
1175,2023-01-28,
1176,2023-01-29,"Court rejects Johnson & Johnson's Texas two-step bankruptcy ploy for talc claims - FiercePharma|Johnson & Johnson’s Attempt to Contain Talc-Related Liabilities Is Rebuffed (Published 2023) - The New York Times|Johnson & Johnson blocked from using bankruptcy to resolve talcum powder lawsuits - Financial Times|J&J’s Talc Bankruptcy Case Thrown Out by Appeals Court - The Wall Street Journal|DJIA Closes Down 260 pts, Nasdaq Sheds 2% - AASTOCKS.com"
1177,2023-01-30,U.S. court rejects J&J bankruptcy strategy for thousands of talc lawsuits - Reuters.com
1178,2023-01-31,"How Do Lawsuits Affect Johnson & Johnson's Stock Price? - Nasdaq|Matt Levine: Johnson & Johnson's (JNJ) Bankruptcy Didn't Work - Bloomberg|Johnson & Johnson named a 2023 Fortune World's Most Admired Company and ranked #1 on the Pharmaceutical Industry list. - Johnson & Johnson|What is Benzene, and why does it keep causing beauty product recalls? - The Washington Post"
1179,2023-02-01,"Big Pharma companies trimming pipelines in 2023 - Drug Discovery & Development|Insight: Corporate lawsuit dodge imperiled after court rejects J&J bankruptcy tactic - Reuters.com|Post misleads on J&J COVID vaccine, DNA - The Associated Press"
1180,2023-02-02,"Fierce Pharma Asia—J&J, Legend's CAR-T win; Sanofi's India job cuts; BeiGene, Novartis' PD-1 delay - FiercePharma|Johnson & Johnson unit plots job cuts; James Merson to depart - The Business Journals|Pharma giant Johnson & Johnson, subsidiary Janssen are cutting jobs, sources say - WRAL TechWire|J&J's pharma group quietly works through global overhaul, with layoffs expected to reach multiple countries - FiercePharma"
1181,2023-02-03,Women suing J&J speak out after company's failed legal maneuver - NBC News
1182,2023-02-04,"Talc ruling a blow to J&J and the ‘Texas two-step’ bankruptcy jig - Financial Times|2 Reasons to Buy Johnson & Johnson, and 2 Reasons to Sell - The Motley Fool|NOBL: The Best Dividend Growth Stocks In A Single ETF - TheStreet"
1183,2023-02-05,J&J's latest data for nipocalimab in fetal disorder suggest Momenta acquisition may still pay off - Fierce Biotech|J&J says drug it acquired from Momenta succeeds in study of ultra-rare condition - BioPharma Dive|The top 10 medtech M&A deals of 2022 - Fierce Biotech
1184,2023-02-06,How Does Johnson & Johnson Stock Compare With This Large Beverage Company? - Forbes|J&J’s Ethicon completes first robot-assisted kidney stone removal with Monarch platform - Mass Device|Pensacola woman joins thousands in lawsuit against Johnson & Johnson - WEAR|J&J once again breaks out the blue jacket for prostate cancer awareness fashion show - FiercePharma
1185,2023-02-07,"As J&J quietly overhauls R&D, Arrowhead waits for news on RNAi hepatitis B therapy - Fierce Biotech|Arrowhead confirms J&J’s plan to dial back hepatitis B drug research - BioPharma Dive"
1186,2023-02-08,"Microbiome researcher Jeffrey Gordon receives the 2022 Dr. Paul Janssen Award for biomedical research - Johnson & Johnson|J&J, Medtronic, Boston Scientific gird for battle over US cardiac ablation market with new trials - MedTech Dive|It Takes a System - George W. Bush Presidential Center|J&J, Sanofi back SG pharma platform’s $10m round - Tech in Asia"
1187,2023-02-09,New indications drive SGLT2 sales - BioCentury|Johnson & Johnson MedTech India partners with Karkinos to upskill cancer care workforce - BSI bureau
1188,2023-02-10,
1189,2023-02-11,
1190,2023-02-12,JNJ Bought Up Biotech Stock MeiraGTx. It Sold Procept BioRobotics. - Barron's|Alcon to pay Johnson & Johnson $199 mln to settle eye-laser cases - Reuters.com|Alcon reaches $199M settlement with J&J Vision over cataract surgery lasers - Fierce Biotech|Johnson & Johnson poaches Sanofi’s top R&D executive - STAT|UPDATED: Reed relinquishes R&D reins at Sanofi for J&J role - Fierce Biotech
1191,2023-02-13,John Reed Jumps Ship at Sanofi to Helm J&J’s R&D - BioSpace|Better Buy: Johnson & Johnson or AbbVie? - The Motley Fool|Sanofi R&D chief John Reed decamps for Johnson & Johnson - MM+M Online
1192,2023-02-14,"Johnson & Johnson, Retailer Defendants Argue Tylenol Autism, ADHD Lawsuits Are Preempted - AboutLawsuits.com|Efficacy and Safety of an Ad26.RSV.preF–RSV preF Protein Vaccine in Older Adults - nejm.org|Janssen Returns Phase I NASH Candidate to Arrowhead - BioSpace"
1193,2023-02-15,"Arrowhead’s $3.7B J&J deal is done, CEO says, after ‘out of the blue’ NASH decision - Fierce Biotech|J&J returns NASH med back to Arrowhead's quiver with hep B still in limbo - Fierce Biotech|'Damaged' women left reeling by proposed mesh settlement payout - Nine Shows"
1194,2023-02-16,"“I’m supporting my husband through cancer treatment” - Johnson & Johnson|Chutes & Ladders—John Reed jumps Sanofi ship, boards J&J team - Fierce Biotech|With FDA approval for Filspari, Travere turns Bristol Myers castoff into unique drug for rare kidney disease - FiercePharma|Applied Medical suit against Medtronic alleges surgical-device bundling practice curbs competition - MedTech Dive"
1195,2023-02-17,
1196,2023-02-18,
1197,2023-02-19,
1198,2023-02-20,Attorney General Bonta Welcomes Supreme Court Decision Refusing to Review $302 Million Judgment Against Johnson & Johnson Over Pelvic Mesh Products - California Department of Justice | J&J loses challenge to $302 million judgment over pelvic mesh marketing - Reuters.com | Local business JNJ Apparel creates unique Tuscaloosa gear - wvua23.com | She blames her cancer on baby powder. Now she's suing and urges other women to 'get checked' - CBC.ca | J&J loses bid for Supreme Court review of $302M vaginal-mesh verdict - MedTech Dive
1199,2023-02-21,"J&J Is Rejected by Supreme Court Over $302 Million Vaginal-Mesh Award - Bloomberg|Exclusive: Caligan urges Anika Therapeutics to conduct review, plans board challenge - Reuters.com|Johnson & Johnson Vision launches Acuvue Oasys Max 1-DAY and Acuvue Oasys Max 1-Day Multifocal - AOP"
1200,2023-02-22,
1201,2023-02-23,Advancing diversity: 3 healthcare experts share their career stories - Johnson & Johnson | 5 things we now know about peripheral artery disease - Johnson & Johnson | J&J wins EU backing for PARP combo Akeega in prostate cancer—but only in some patients - FiercePharma | Johnson & Johnson India’s Stayfree signs actor Kiara Advani for new ad campaign | Company Business News - Mint
1202,2023-02-24,
1203,2023-02-25,
1204,2023-02-26,"""My job is to educate about the need for new treatments for rare diseases"" - Johnson & Johnson|After spending $6.5B for Momenta, J&J readies 'pipeline in a product' for pivotal year - Fierce Biotech|Investing in digital public goods to help achieve health for all - Johnson & Johnson|Aqemia making waves in computational drug discovery - BioWorld Online"
1205,2023-02-27,What is a rare disease? - Johnson & Johnson
1206,2023-02-28,Johnson & Johnson logs 57 layoffs in Pennsylvania as Kenvue spinoff nears - FiercePharma|STEM students at Trinity College Dublin celebrated with scholarships - Dublin Gazette
1207,2023-03-01,"Johnson & Johnson Consumer Health to close central Pa. facility - PennLive|Bristol Myers, J&J plan tests of new blood thinner in nearly 50,000 patients - BioPharma Dive|J&J partners with Holobiome for next-gen probiotics and prebiotics for infant & maternal immune health - NutraIngredients-usa.com|Zakharova: Russia is deeply concerned about allegations of Serbia's involvement in arms sales to Ukraine - Vijesti.me"
1208,2023-03-02,"FDA clears surgical robot from Noah Medical - Mass Device|Unilever, J&J, Olaplex and L'Oreal Still Treading Legal Waters Over Lilial, Benzene - Cosmetics & Toiletries"
1209,2023-03-03,
1210,2023-03-04,
1211,2023-03-05,"ACC23: J&J's combo pill of Opsumit plus tadalafil improves blood flow in PAH patients - FiercePharma|Harbour ships phase 3 data to take lead over argenx, J&J and UCB in Chinese autoimmune race - Fierce Biotech"
1212,2023-03-06,JNJ: 3 Extremely Safe Stocks to Pick up in 2023 - StockNews.com|J&J-backed startup launches with $100M to build better brain drugs - BioPharma Dive|Protagonist's story turns for the better as J&J-partnered psoriasis med clears lesions in midphase trial - Fierce Biotech|- The Business Journals - The Business Journals
1213,2023-03-07,"Venaig Solinhac joins Johnson & Johnson Consumer Health - Marketing Interactive|Third Rock, J&J spinout Rapport arrives with $100M and ambition to transform precision neuroscience - Fierce Biotech|Johnson & Johnson layoffs hit medtech business, with more than 350 cuts in California - Fierce Biotech|Nearly 350 Bay Area workers laid off by major health care company - SFGATE|Johnson & Johnson cuts nearly 350 surgical robotics jobs - Mass Device"
1214,2023-03-08,Biosense Webster’s First Dual Energy Catheter to Treat Atrial Fibrillation Begins Evaluation in SmartfIRE Clinical Trial - Diagnostic and Interventional Cardiology|Johnson & Johnson’s ablation catheter garners approval in China for atrial fibrillation - BioWorld Online|BMC’s head of spine surgery identified as recipient of alleged kickbacks - The Boston Globe|The story behind Johnson & Johnson's most beloved ad slogans - Johnson & Johnson
1215,2023-03-09,"J&J lays off 350 people at robotics units, says ‘we have to get better’ with Ottava - MedTech Dive|Serbia is unable to control the re-export of its ammunition to Ukraine - Militarnyi|Boston surgeon who famously ducked out of a surgery for a NAP received free medical devices from J&J - Daily Mail|Who are the leading innovators in monoclonal antibody drugs for cancer for the pharmaceutical industry? - Pharmaceutical Technology|Johnson & Johnson, Kellogg, and 2 Other Spinoffs to Watch in 2023 - Barron's"
1216,2023-03-10,Why I'm Convinced That Schwab US Dividend Equity ETF Will Outperform (NYSEARCA:SCHD) - Seeking Alpha|Johnson & Johnson Layoffs 2023: What to Know About the Latest JNJ Job Cuts - InvestorPlace|Johnson & Johnson: Severance Packages - Samfiru Tumarkin LLP
1217,2023-03-11,
1218,2023-03-12,Advancing unconscious bias training for healthcare professionals - Johnson & Johnson | The top 10 drugs losing US exclusivity in 2023 - FiercePharma | StockWatch: Moderna Looks to Accelerate Cancer Vaccine - Genetic Engineering & Biotechnology News
1219,2023-03-13,Sequential Skin x Johnson & Johnson Collab to Quantify Skin Health - Cosmetics & Toiletries
1220,2023-03-14,"IMB spin-out announces successful clinical trial for psoriasis drug - Institute for Molecular Bioscience|In his first year as Johnson & Johnson CEO, Joaquin Duato scored $13.1M payout - FiercePharma|Clinical trial success for psoriasis drug - UQ News - The University of Queensland|The menin inhibitor revumenib in KMT2A -rearranged or NPM1 -mutant leukaemia - Nature.com|Opinion|A Second Chance for Johnson & Johnson in Court - The Wall Street Journal"
1221,2023-03-15,"Vaxart cans oral COVID-19 vaccine plans, lays off 27% of staff to go all in on norovirus program - Fierce Biotech|Johnson & Johnson shelves Carvykti's UK launch amid manufacturing shortfalls - FiercePharma|J&J CEO Joaquin Duato’s compensation dips to $13.1M in 2022 - MM+M Online|Blocking NS3–NS4B interaction inhibits dengue virus in non-human primates - Nature.com"
1222,2023-03-16,"West Point Celebrates Its 221st Birthday During Founders Day - United States Army|Index Providers Disagree on Growth and Value - Morningstar|Janssen No Longer Seeking Approval for Carvykti in the UK - CGTLive™|J&J’s experimental dengue pill prevents infection in mice, monkeys - The Fiji Times"
1223,2023-03-17,
1224,2023-03-18,
1225,2023-03-19,VIDEO: Johnson & Johnson presents ‘wide breadth and depth’ of research at AAD 2023 - Healio|Pretax profits at Irish subsidiary of Johnson & Johnson almost double - The Irish Times
1226,2023-03-20,Johnson & Johnson EVP and Worldwide Chairman of Medtech Ashley McEvoy Named Chairman of AdvaMed Board of Directors - AdvaMed|Generative AI Makes Headway in Healthcare - The Wall Street Journal
1227,2023-03-21,"After appeals loss, Johnson & Johnson will take Texas two-step case to the US Supreme Court - FiercePharma|Drugmakers push back on a clever tactic employers use to avoid paying for specialty medicines - STAT|How To Apply For The New Nurse Innovation Fellowship By J&J, Penn Nursing & Wharton School - Nurse.org"
1228,2023-03-22,JNJ-26366821 repairs acetaminophen-induced liver injury in mice - BioWorld Online|India rejects Johnson & Johnson’s attempt to extend monopoly on lifesaving TB drug - The Hindu
1229,2023-03-23,"Johnson & Johnson bid to extend TB drug Bedaquiline patent rejected in India, paves way for generics - South First|Study Shows 186 Banks Are On The Brink Of Failure - ValueWalk|BL Explainer: What happens to bedaquiline after the expiry of Johnson & Johnson’s patent in July - BusinessLine"
1230,2023-03-24,"Johnson & Johnson’s set to lose patent on key TB drug in July - The Times of India|‘Exceptional redevelopment potential’: Auckland’s Skyworld complex is up for sale - The Spinoff|Modulatory mechanisms of TARP γ8-selective AMPA receptor therapeutics - Nature.com|From glitz to ghost-town: Ex-Planet Hollywood building that once hosted Robin Williams is for sale - OneRoof|Winnipeg woman 'traumatized' by decade of pain after surgical mesh splits apart, lawsuit alleges - CBC.ca"
1231,2023-03-25,"Palm Beach Pride: LGBTQ+ parade draws diverse support, families, ‘mom hugs’ - Palm Beach Post"
1232,2023-03-26,"Top 10 pharma R&D budgets in 2022 - Fierce Biotech|(27 Mar, 2023) - Drishti IAS"
1233,2023-03-27,Communicating effectively with potential contact lens wearers - AOP|J&J adds medtech head Ashley McEvoy to list of highest-paid execs with $7.4M payout in 2022 - Fierce Biotech|Ashley McEvoy joins J&J’s top-paid executives - Medical Design & Outsourcing
1234,2023-03-28,Johnson & Johnson halts development of RSV vaccine in midst of late-stage clinical trials - CNN|MPC Energy Solutions installing LNG-fired CHP plant to energize Optics Manufacturing in Puerto Rico - Energy Tech
1235,2023-03-29,"J&J scraps late-stage RSV vaccine in R&D overhaul, dropping out of race with GSK, Pfizer - Fierce Biotech|Stayfree will engage with a wider segment of women with Kiara Advani’s association: Manoj Gadgil - afaqs!|J&J abandons RSV vaccine in major strategy shift - BioPharma Dive|Former J&J R&D chief Mathai Mammen lands at burgeoning biotech FogPharma, with first trial nearing - Fierce Biotech|Johnson & Johnson stock rises Thursday, still underperforms market - MarketWatch"
1236,2023-03-30,"Pfizer, BMS' Eliquis tops list of drugs destined for Medicare price negotiations in 2026: Moody's - FiercePharma|Mathai Mammen Finds New Home at FogPharma - BioSpace|Mother-daughter promotoras on a mission to empower their community and improve health outcomes one person at a time - Johnson & Johnson"
1237,2023-03-31,Johnson & Johnson Consumer Health Supports TNC - The Nature Conservancy|Hyderabad hospital introduces robotic technology for knee replacement surgeries - The Hindu|Secondary patent for Johnson & Johnson TB drug rejected: How this will help in India’s fight against tuberculosis - The Indian Express|Johnson & Johnson unit loses bid to stay in bankruptcy during Supreme Court appeal - Reuters
1238,2023-04-01,Dividend Aristocrats Raises in 2023 - Dividend Growth Investor|Johnson & Johnson unit loses bid to stay in bankruptcy during Supreme Court appeal - The Fiji Times|Vaccination schedule for April 3 to 6 - Barbados Today
1239,2023-04-02,"CSL's new CEO Paul McKenzie charts course for growth amid expansions in gene therapy, kidney diseases - FiercePharma"
1240,2023-04-03,Johnson & Johnson is again trying to use bankruptcy to settle talc cases for $8.9 billion - CNN|Johnson & Johnson subsidiary LTL Management files for bankruptcy for a second time after company agrees to pay $13.1 billion to settle lawsuits - ABC News|Johnson & Johnson offers $9bn to settle talc claims - BBC.com|Johnson & Johnson to pay $8.9 billion to settle talc cancer claims - CNBC|Johnson & Johnson offers $8.9B to settle talc baby powder claims - The Washington Post
1241,2023-04-04,"Johnson & Johnson offers $8.9 billion settlement to roughly 60,000 people who claim its talc products gave them cancer - Fortune|Johnson & Johnson to pay $8.9 billion to settle claims baby powder, other talc products caused cancer - ABC News|J&J unit files for second bankruptcy to pursue $8.9 billion talc settlement - Reuters|Johnson & Johnson proposes to pay nearly $9 billion to settle talc powder lawsuits - USA TODAY"
1242,2023-04-05,Johnson & Johnson Seeks $9 Billion Settlement of Talc Lawsuits - The Wall Street Journal|Johnson & Johnson offers nearly $9 billion to settle talc lawsuits - CBS News|Johnson & Johnson proposes paying $8.9 billion to settle talcum powder lawsuits - NPR
1243,2023-04-06,"Front Page News: Johnson & Johnson Offers Nearly $9 Billion Settlement For Talcum Powder Lawsuit - The Rickey Smiley Morning Show|AbbVie, J&J pull 2 Imbruvica accelerated approvals in lymphoma, giving way to AZ and BeiGene - FiercePharma|J&J to pay US$8.9B in baby powder suits - Trinidad Guardian|Tanzania probes ‘tainted’ talc as firm offers $9 billion settlement - The Citizen|J&J to pay R162bn to settle baby powder-cancer lawsuits - News24"
1244,2023-04-07,"""People are dying every day"": Alleged victims of J&J's talc case speak out - Axios"
1245,2023-04-08,Mark Cuban Has Good News for People with Diabetes - TheStreet
1246,2023-04-09,"Everything You Need to Know About Johnson & Johnson's Baby-Powder Lawsuits - POPSUGAR|J&J Talc Suits' Outside Funders Unveiled Via Little-Used NJ Rule - Bloomberg Law|Johnson & Johnson’s talc settlement: Why the company is offering $8.9 billion to thousands - The Indian Express|Johnson & Johnson's $8.9B bankruptcy settlement is 'unworkable,' talc plaintiff lawyer says - FiercePharma"
1247,2023-04-10,More than 200 pharmaceutical executives sign open letter calling for reversal of Texas abortion pill ruling - CNBC|Johnson & Johnson launches US creative reviews for Neutrogena and Aveeno - Ad Age|DelveInsight Evaluates a Robust Epilepsy Pipeline as 70+ Influential Pharma Players to Set Foot in the Domain - PR Newswire
1248,2023-04-11,"Inside the decade-long effort to add digital tags to thousands of Johnson & Johnson MedTech products - Johnson & Johnson|J&J talc unit 2nd bankruptcy must be dismissed, cancer victims' lawyers say - Marianas Variety News & Views|Serbia provides military aid to Ukraine – Pentagon documents - Militarnyi"
1249,2023-04-12,What’s on the horizon in surgical robotics? - Mass Device|Purell hand sanitizer looks for a buyer amid falling demand - New York Post
1250,2023-04-13,"J&J, Legend tap Novartis to help make CAR-T drug Carvykti as they work through supply constraints - FiercePharma|Johnson & Johnson Expected to Post a Q1 Earnings Decline - Investopedia|FDA rejects Eli Lilly's ulcerative colitis prospect mirikizumab, citing manufacturing shortfalls - FiercePharma"
1251,2023-04-14,
1252,2023-04-15,Pelvic Mesh Class Action: How to Join - DStv
1253,2023-04-16,"J&J opens the valve on $50M MS partnership with Pipeline - Fierce Biotech|DelveInsight Highlights Major Advances, Transformative - GlobeNewswire"
1254,2023-04-17,"Johnson & Johnson (JNJ) Dividend Stock Analysis 2023 - Dividend Growth Investor|JNJ Earnings: All you need to know about Johnson & Johnson’s Q1 2023 earnings results - AlphaStreet|Johnson & Johnson reports loss after taking $6.9bn charge over talc claims - Financial Times|Johnson & Johnson shares fall after company beats on earnings and revenue, but lowers pharmaceutical sales guidance - CNBC|Johnson & Johnson swings to loss as it books multibillion-dollar charge to settle talc claims - MarketWatch"
1255,2023-04-18,"J&J, Legend's Carvykti cut risk of progression or death by whopping 74% in earlier myeloma, leaked abstract shows - FiercePharma|J&J issues cautious 2023 forecast, shares fall - Reuters.com"
1256,2023-04-19,"US stock market news: Dow Jones, Nasdaq end in red; S&P 500 ekes out gain as tech supports - Zee Business|US judge halts most talc lawsuits against J&J, stops trials - Reuters|J&J ups CAR-T capacity amid high Carvykti demand - BioProcess Insider|U.S. bankruptcy judge halts 40,000 Johnson & Johnson talc and cancer lawsuits - CNBC|Money for Baby Powder cancer lawsuits wipes out Johnson & Johnson profits - The Times"
1257,2023-04-20,"Tylenol's Prenatal Health Risks Lawsuits Against J&J Move Forward - Law.com|11 Best Diversified Stocks to Buy Now - Insider Monkey|AbbVie, J&J get win in UK for Imbruvica combo as BeiGene, AZ surge with single agents - FiercePharma|Lawsuit accuses J&J subsidiary of selling faulty knee replacements - MedTech Dive|Tanzania bans Johnson & Johnson powder - The Citizen"
1258,2023-04-21,Pharma M&A trends: Analyzing the surge in biopharma deals - Drug Discovery & Development|Talc-Cancer Lawsuits on Hold; Diet & Prostate Cancer; Active Surveillance Deep Dive - Medpage Today
1259,2023-04-22,The Top Companies to Work for in Corporate Wellness: A Comprehensive List - Corporate Wellness Magazine
1260,2023-04-23,"Johnson & Johnson Proposes New Settlement Amount for Talc Baby Powder Lawsuits - The Legal Examiner|Johnson & Johnson consumer health unit valued at $40 billion ahead of IPO, report says - CNBC|Johnson & Johnson's PARP combo nabs first global nod but faces tough fight against AZ, Merck's Lynparza - FiercePharma|Breakingviews - J&J carves itself up at a discount - Reuters.com|NICE recommends AbbVie’s/J&J’s Imbruvica for combo use in untreated CLL - Pharmaceutical Technology"
1261,2023-04-24,"Johnson & Johnson eyes $40B valuation for consumer health group Kenvue: WSJ - FiercePharma|J&J's Spinoff Kenvue Valued at $40 Billion. What's Ahead for Consumer Health. - Barron's|Listerine, Neutrogena, and Tylenol Form New Publicly Traded Company - Dr Wealth"
1262,2023-04-25,J&J must stop blocking generic versions of lifesaving TB drug - Doctors Without Borders (MSF-USA)|J&J’s consumer health spinoff seeking $3B stock offering in test of IPO market - BioPharma Dive
1263,2023-04-26,"J&J to retain all talc-related liabilities from litigation in US, Canada - Reuters|Talc Supplier to J&J, Avon, Estée Lauder Files For Bankruptcy After Lawsuits - The Business of Fashion|Kenvue IPO: Everything you need to know about the JNJ spin off - FOREX.com US|""My family and I volunteer on a floating hospital that delivers medical care"" - Johnson & Johnson"
1264,2023-04-27,J&J’s Kenvue Spinoff: A Rare IPO Winner in a Moribund Market - Barron's|Johnson & Johnson to list its consumer health care products on the stock exchange - Fashion Network|Talcum powder cancer claims target J&J’s new consumer carve-out - Financial Times
1265,2023-04-28,
1266,2023-04-29,"Kenvue, multibillion-dollar spinoff of J&J’s consumer health brands, putting its HQ in Summit - ROI-NJ.com"
1267,2023-04-30,"J&J Spinoff Kenvue Locating HQ in Summit - njbmagazine.com|The Whole Story with Anderson Cooper Investigates Claims Brought Against Johnson & Johnson in “Shaken: Baby Powder on Trial” with CNN’s Pamela Brown - CNN Press Room|Murphy, N.J. officials thrilled to have J&J’s billion-dollar spinoff put its HQ in Summit - ROI-NJ.com|Attorney General Ken Paxton to investigate COVID-19 vaccine makers - The Texas Tribune"
1268,2023-05-01,"J&J refuels CAR-T ambitions with $245M upfront to Cellular Biomedicine for pair of therapies - Fierce Biotech|J&J Makes $245M Play to Develop Next-Gen CAR-T Therapies - BioSpace|Kenvue IPO: A Dividend-Paying, ‘High-Caliber’ Company - Morningstar"
1269,2023-05-02,"J&J, building on CAR-T success, strikes another cell therapy deal - BioPharma Dive|Healthium Medtech hires Prashant Krishnan as a global business head - Healthcare Radius|Artificial Intelligence Engine Predicts LYTS Stock to Gain 9% by May 30 - InvestorPlace"
1270,2023-05-03,"J&J spinoff Kenvue prices IPO at $22, toward the top end of expected range - CNBC|Kenvue Stock Jumps in IPO of Former J&J Consumer-Health Business - Barron's|Kenvue IPO: Everything you need to know about the JNJ spin off - FOREX.com|Kenvue IPO: Stock priced as Johnson & Johnson spinoff set to trade today on NYSE - Fast Company|Johnson & Johnson Spins Off Kenvue in Biggest IPO Haul Since 2021 - Kiplinger's Personal Finance"
1271,2023-05-04,"Johnson & Johnson consumer arm’s shares jump in biggest US IPO since 2021 - Financial Times|Kenvue, formerly Johnson & Johnson Consumer Health, debuts on NYSE with IPO - BusinessLine|J&J consumer brand spinoff Kenvue debuts on NYSE - Yahoo Finance"
1272,2023-05-05,"Thousands of Australian women are taking part in medical class actions - but at what cost? - 9News|Let’s Review Vintage Mother’s Day Ads ‘Cause the Aussie Ones Hit Different - The Latch|Florida Food Products Names Kevin Neat Chief Financial Officer - Business Wire|J&J faces 40,000 lawsuits over its talc powder - CNN|J&J says years of testing confirm its talc is safe - CNN"
1273,2023-05-06,11 Best Canadian Dividend Stocks For Income Investors - Yahoo Finance
1274,2023-05-07,"Kenvue Announces Closing of Initial Public Offering - Business Wire|Pfizer, AstraZeneca run it back in IDEA Pharma's annual innovation rankings - FiercePharma"
1275,2023-05-08,Antibody response varies for Big Pharma COVID vaccines - European Pharmaceutical Review|J&J Hip Implant Allegedly Caused Heavy Metal Poisoning - MedTruth|7 Stocks AI Predicts Will Gain in 30 Days - InvestorPlace
1276,2023-05-09,Co-op experiences pave way for career head start|RIT - Rochester Institute of Technology
1277,2023-05-10,"Video: The Johnson & Johnson Baby Powder Controversy May Be Near an End - Bloomberg|Johnson & Johnson MedTech: ‘Stay tuned’ for Ottava next-gen surgical robot - Mass Device|Fulfilling a calling—finding joy and growth in a career in nursing - Johnson & Johnson|Report: Medtronic, Johnson & Johnson consider Shockwave Medical acquisition after Boston Scientific talks stall - Cardiovascular Business"
1278,2023-05-11,India's billionth baby turns 23 today: Here's how life has been for her - Business Standard|Medtronic and Johnson & Johnson reportedly consider Shockwave acquisition - Mass Device|The AdvaMed Code of Ethics: Protecting and Driving Innovation for 30 Years - AdvaMed
1279,2023-05-12,“I helped create the lens that treated my mom’s cataracts” - Johnson & Johnson|The big spenders: The top 25 pharma companies in R&D investments - Drug Discovery & Development
1280,2023-05-13,nan
1281,2023-05-14,"J&J Covid-19 vaccine no longer available in the US - CNN|P&G, Ulta Beauty and Johnson & Johnson Among Top-Ranked Beauty Companies for Diversity - Beauty Packaging|UVA doctor weighs in on Johnson & Johnson COVID-19 vaccine no longer being available in U.S. - WHSV|CDC: Johnson & Johnson COVID-19 vaccine no longer available in U.S. - Spectrum News NY1|Biosense Webster Highlights New Research and Technology to Advance AFib Treatment at Heart Rhythm 2023 - Diagnostic and Interventional Cardiology"
1282,2023-05-15,"It's the end of the line for J&J's COVID shot in the US, CDC says - FiercePharma|Identifying 'gems' before others do: J&J exec gives insider's look at dealmaking spree - Fierce Biotech|Johnson & Johnson encourages Gen Z to put down their screens and envision the future - FiercePharma|Biosense Webster QDot Micro catheter found to improve ablation efficiency for AF - Cardiac Rhythm News"
1283,2023-05-16,Jasmina Brooks Named President of Biosense Webster - Diagnostic and Interventional Cardiology|Opinion|Why is a curable disease still allowed to kill millions? - The Washington Post|Should You Get an Additional COVID-19 Bivalent Booster? - Yale Medicine
1284,2023-05-17,"J&J Vaccine and Guillain-Barré Syndrome: Information on the FDA Warning - Yale Medicine|J&J’s Biosense Webster gets a new president - Mass Device|Moon Surgical raises $55.4M to support surgical robot platform, names Fred Moll board chair - Mass Device|The Link Between J&J’s COVID Vaccine and Blood Clots: What You Need to Know - Yale Medicine"
1285,2023-05-18,"""My battle with IBD has fueled my passion for helping patients like me"" - Johnson & Johnson|By the numbers: Understanding the toll of inflammatory bowel disease - Johnson & Johnson|INHANCE™ Shoulder System: A new option for reverse shoulder replacement surgery - Johnson & Johnson|AbbVie, Genmab's lymphoma drug Epkinly snags FDA approval in heated blood cancer race - FiercePharma"
1286,2023-05-19,
1287,2023-05-20,Moon Surgical Snags $55.5M for Its Robotic Laparoscopy Assistant - MedCity News
1288,2023-05-21,
1289,2023-05-22,"Amgen settles patent lawsuit over biosimilar of J&J's big-selling Stelara - Reuters | The clock's ticking on Stelara: Amgen, J&J ink patent settlement - FiercePharma | Settlement approval for pelvic mesh class action against Johnson & Johnson and Ethicon - Maddocks"
1290,2023-05-23,These Are the Best Supply Chains of 2023 - Gartner|Two WVU Medicine nursing executives selected to prestigious Johnson & Johnson fellowship program - WV News
1291,2023-05-24,
1292,2023-05-25,"Better Bet Than IBM Stock: Pay Less Than International Business Machines To Get More From S&P 500 Stocks WMT, GOOG, JNJ, UNH, JPM - Trefis | Fierce Pharma Asia—Carvykti's EU filing; Thermo Fisher's Singapore expansion; Celltrion's Humira biosim nod - FiercePharma | My great-grandad founded a first aid staple and $401billion pharmaceutical empire – now I’m worth $4.... - The US Sun"
1293,2023-05-26,
1294,2023-05-27,
1295,2023-05-28,
1296,2023-05-29,Top 5 highest paid biopharma R&D executives in 2022 - Fierce Biotech | 23-y-o Jamaican cops finance job at Johnson & Johnson - PressReader
1297,2023-05-30,"A day in the life of a nurse innovator - Johnson & Johnson|Obesity Shot Frenzy Makes Eli Lilly World’s Most Valuable Drugmaker - Bloomberg|Interview With Janssen Doctor Explores Potential Bladder Cancer Treatment Options - Johnson & Johnson|Former chief judge called in to help victims of Johnson & Johnson pelvic mesh bungle - 9News|Yuhan makes $325M cancer bet to challenge Boehringer, Takeda - Fierce Biotech"
1298,2023-05-31,'Chilling Effect'? Johnson & Johnson Sues Expert Witness Over Talc Claims - Law.com|Women of Distinction 2023: How to be a great leader and mentor - PR Week|Evaluation of P2x7 PET tracer [18F]JNJ-64413739 on postmortem Alzheimer's disease human brain tissue - Journal of Nuclear Medicine
1299,2023-06-01,J&J secures dismissal of whistleblower case over misuse of confidential info - Reuters.com|AdvaMed Code of Ethics - AdvaMed|These 5 Dividend ETFs Are a Retiree's Best Friend - The Motley Fool
1300,2023-06-02,Zimbabwe Bans Imports of J&J Baby Powder on Concerns Over Talc - Bloomberg
1301,2023-06-03,
1302,2023-06-04,"Stelara patent deal puts J&J back on path to $57 billion 2025 revenue forecast - Reuters.com | ASCO: J&J's multiple myeloma combo produces déjà vu with 96% Carvykti-like response - Fierce Biotech | ASCO: J&J, Legend's Carvykti stages stellar show in earlier myeloma. But has the CAR-T reached a ceiling? - FiercePharma | FDA Revokes Authorization of J&J’s Covid Vaccine as Demand Wanes - Bloomberg | ASCO: Johnson & Johnson's Balversa tops chemotherapy in bladder cancer trial - FiercePharma"
1303,2023-06-05,Turning our supplier spend into societal good - Johnson & Johnson
1304,2023-06-06,"J&J’s COVID vaccine is dead in the US; FDA revokes authorization - Ars Technica|Zim bans sale of J&J baby powder - The Herald|Tylenol Maker Kenvue Goes From Sure Bet to Question Mark After Year’s Biggest IPO - Bloomberg|Alkermes, after arbitration win over J&J, jacks up revenue forecast by $425M - FiercePharma|10 Top Companies Using AI - The Motley Fool"
1305,2023-06-07,"Johnson & Johnson releases its 2022 Health for Humanity Report and ""We All Belong: 2022 DEI Impact Review"" - Johnson & Johnson|Johnson & Johnson COVID-19 Vaccine: What You Need to Know - Verywell Health|Johnson & Johnson, Legend file for expanded use of Carvykti after key trial win - FiercePharma|Legend and J&J seek earlier Carvykti approval in multiple myeloma indication - The Pharma Letter|Pfizer taps Samsung Biologics in long-term biosimilar production deal worth $411M - FiercePharma"
1306,2023-06-08,"J&J's COVID vaccine taken by 19 MILLION Americans is pulled by FDA due to plummeting demand - Daily Mail|""So many people were there for me when I had cancer. Now I get to pay it forward"" - Johnson & Johnson|US judge rejects 3M effort to resolve earplug lawsuits in bankruptcy - Reuters|Industry reacts to ‘forever chemicals’ report - Optician Online"
1307,2023-06-09,"Man shot at Omaha grocery store, 4 teens arrested after pursuit - WOWT"
1308,2023-06-10,"Weekly Recap: Hello Bello Acquisition, J&J Recall & More - Beauty Packaging"
1309,2023-06-11,"Johnson & Johnson inks another Stelara patent settlement, this time with Alvotech and Teva - FiercePharma|This South African nurse-entrepreneur is helping her patients and uplifting nursing in her community - Johnson & Johnson|Janssen’s approach to business development and strategic partnerships - Fierce Biotech|Propulsion of RNA Interference Therapy Clinical Trial - GlobeNewswire"
1310,2023-06-12,"Kenvue Now Trading on the New York Stock Exchange - Tech Briefs|The Weight-Loss Battle Has A New Contender; Why Novo, Lilly Still Dominate - Investor's Business Daily|Kenya sues Johnson & Johnson over ‘cancerous’ baby powder|The New Times - New Times Publication|Do Benadryl Capsules Contain Xylitol? - Snopes.com"
1311,2023-06-13,Top 10 pharma companies have over $120 billion in cash for mergers and acquisitions - EL PAÍS USA
1312,2023-06-14,Quiz: How much do you know about giving blood? - Johnson & Johnson
1313,2023-06-15,nan
1314,2023-06-16,"Insight: For groups fighting U.S. opioid crisis, settlement money can be hard to come by - Reuters.com"
1315,2023-06-17,Johnson's says the end of its talc baby powder line has 'nothing to do with safety' - TimesLIVE|Why You Should Consider Avoiding Skincare Products Containing Talc - The List
1316,2023-06-18,Driving diversity in medical illustration - Johnson & Johnson|Eli Lilly's Mounjaro is primed to overtake Novo Nordisk's popular diabetes and obesity duo: report - FiercePharma
1317,2023-06-19,Eli Lilly to Buy DICE Therapeutics in $2.4 Billion Autoimmune Disease Push - Barron's|Lilly to buy oral immune drug developer Dice Therapeutics for $2.4B - BioPharma Dive
1318,2023-06-20,By the numbers: Providing mental health support to the LGBTQIA+ community - Johnson & Johnson|GE HealthCare and DePuy Synthes are partnering in spine surgery - Mass Device
1319,2023-06-21,"GE HealthCare, J&J's DePuy Synthes join forces around 3D imaging tech - Fierce Biotech|Dow Jones Today: Index Flat as Investors Mull Global Rate Decisions - Investopedia|KPJ Healthcare names Chin Keat Chyuan as new president/managing director - New Straits Times"
1320,2023-06-22,Intuitive’s Ion platform may provide ‘most exciting advancements in robotic technology’: analysts - MedTech Dive
1321,2023-06-23,
1322,2023-06-24,
1323,2023-06-25,
1324,2023-06-26,"J&J's $8.9 billion talc settlement faces US bankruptcy test - Reuters.com | VIDEO: Smooth flaps, rapid spot creation possible with Elita femtosecond laser - Healio"
1325,2023-06-27,Former J&J sales rep indicted on charges of defrauding Boston hospital - MedTech Dive
1326,2023-06-28,Where Will Johnson & Johnson Be in 5 Years? - The Motley Fool|5 things we now know about myasthenia gravis - Johnson & Johnson
1327,2023-06-29,
1328,2023-06-30,
1329,2023-07-01,
1330,2023-07-02,9 Johnson & Johnson innovations that helped drive medicine forward - Johnson & Johnson
1331,2023-07-03,"Protagonist, J&J oral psoriasis drug falls short of injectables but gets close enough to spur phase 3 - Fierce Biotech|Novel oral therapy shows potential in plaque psoriasis - European Pharmaceutical Review|Cruising for candy at the Marion Fourth of July Parade - Sippican Week"
1332,2023-07-04,"Kenvue Stock: Put This Wide-Moat Name on Your Watchlist - Morningstar|Pepsico, Johnson & Johnson Detail Process Mining Wins Leveraging Celonis - Acceleration Economy|Healthium Medtech appoints Dr. Vivek S. Iyer as GM for Professional Education & Market Growth Strategy - Indian Pharma Post"
1333,2023-07-05,"Maree can return to her green-fingered hobbies following life-changing knee replacement surgery - Johnson & Johnson|Bausch + Lomb Expands OTC Product Line with Acquisition of Blink® Eye Drops - Business Wire|With new data, J&J steps forward in growing race for oral autoimmune drugs - BioPharma Dive"
1334,2023-07-06,"3 Super-Safe Dividend Stocks to Buy for the Rest of 2023 - Yahoo Finance|Lifetime achievement award: Paulette Frank - Sustainability Magazine|Is Walgreens Boots Alliance (WBA) a Buy, Sell, or Hold This Month? - StockNews.com|Johnson & Johnson unloads eye drops line to acquisitive Bausch + Lomb as Brent Saunders' deal streak rolls on - FiercePharma"
1335,2023-07-07,
1336,2023-07-08,
1337,2023-07-09,"James W. Lewis, Suspect in the 1982 Tylenol Murders, Dies at 76 (Published 2023) - The New York Times|Janssen reveals new Spravato data - PharmaTimes|How the weapons of ""friends of Russia"" are fighting against itself - Militarnyi|J&J Extends Lifeline to Nanobiotix in Potential $1.8B Licensing Deal - BioSpace|Nanobiotix ADRs Jump Over 50% After Agreement With J&J's Janssen Pharmaceutical - Investopedia"
1338,2023-07-10,"NANOBIOTIX Announces License Agreement for Worldwide - GlobeNewswire|Jurors urged to impose heavy punitive damages in J&J talc trial - Reuters.com|Nanobiotix SA licences NBTXR3 to J&J - European Biotechnology News|Johnson and Johnson bankruptcy claim is a ruse to limit liability, cancer victims say - New Jersey Monitor"
1339,2023-07-11,"J&J's Ethicon has a serious Megadyne electrode recall due to potential burns in electrosurgery - Mass Device|Biogen, tarnished by Aduhelm, is the big loser in bad year for pharma brand values - FiercePharma|Why you should never powder your perineum - The Telegraph|Johnson Controls launches tech centre in Bengaluru, will step up hiring - Business Standard|Australian Catholic University launches inquiry into its security contractor, Asset Group Solutions - ABC News"
1340,2023-07-12,"Artificial Pancreas Devices System Market Expected to Witness a Sustainable Growth Over 2031|Medtronic, Inc., JDRF, Johnson & Johnson, Beta Bionics, Inc. - Industry Today|Global Drug Facility Update on Access to Bedaquiline - Stop TB Partnership|Johnson & Johnson Letting Nonprofit Distribute Life-Saving Generic Tuberculosis Drug—Greatly Expanding Access In Poorer Countries - Forbes|Daftar Game Mirip Summertime Saga 2023 - VCGamers|Johnson & Johnson sues researchers who linked talc to cancer - Reuters.com"
1341,2023-07-13,"J&J expands global access to TB drug as popular novelist joins advocacy campaign - STAT|In talc defense, Johnson & Johnson sues 4 doctors over their 'junk litigation opinions' - FiercePharma|Johnson & Johnson shares tuberculosis drug after novelist’s campaign - The Independent"
1342,2023-07-14,People - Nature.com|Major drug company bends in battle over access to key TB treatment - Science|John Green May Have Just Helped Save Millions of Lives - The Mary Sue
1343,2023-07-15,nan
1344,2023-07-16,"J&J touts Rybrevant win in newly diagnosed lung cancer, with key Tagrisso head-to-head readout up next - FiercePharma|Johnson & Johnson sues researchers who linked talc to cancer - The Hindu|A Steak Dinner Keeps Ethics Questions Sizzling in J&J's Talc Bankruptcy - Law.com|The Top 25 Healthcare Technology Leaders of New Jersey for 2023 - The Healthcare Technology Report."
1345,2023-07-17,Johnson & Johnson must pay $27.6 million to California man who says he got cancer from baby powder - ABC News|Cheaper TB drugs for millions after global deal on patent rights agreed - The Guardian|A California cancer patient wins $18.8 million from Johnson & Johnson in baby powder trial - Los Angeles Times|Johnson & Johnson sues to stop Medicare negotiation - STAT
1346,2023-07-18,Johnson & Johnson sues Biden administration over Medicare drug price negotiations - CNBC|J&J joins pharma allies in challenging US drug pricing law - BioPharma Dive|Johnson & Johnson becomes 4th drugmaker to file suit against IRA's drug price negotiations - FiercePharma|Johnson & Johnson ordered to pay $18.8 million in California Talc-Cancer trial. Details here|Company Business News - Mint|Johnson & Johnson must pay $18.8m to cancer patient in baby powder lawsuit - The Guardian
1347,2023-07-19,"J&J upbeat on 2023 as devices rebound post-COVID, shares jump - Reuters.com|Janssen's newly merged infectious disease and vaccine unit sees significant pipeline cuts - Fierce Biotech|Johnson & Johnson (JNJ): A Fairly Valued Giant in the Health - GuruFocus.com"
1348,2023-07-20,Johnson & Johnson investors can soon swap their shares for Kenvue stock — here's what you need to know - CNBC|Sales Of Johnson & Johnson Esketamine Drug Spravato Rise Nearly 100% Year Over Year - Benzinga|Kenvue debuts from Johnson and Johnson with strong 2Q results - Proactive Investors Australia|Johnson & Johnson Rips Off the Kenvue Band-Aid - The Wall Street Journal|J&J professes 'voracious' appetite for medtech M&A following Abiomed megadeal - Fierce Biotech
1349,2023-07-21,Roundup: Malaysia-based healthcare generative AI startup launching soon and more briefs - Mobihealth News|Johnson & Johnson sues US government over Medicare drug price negotiation programme - PMLiVE|Albert Edwards Asks What on Earth is Going On? - Real Investment Advice|Man wins $18.8 million from Johnson & Johnson after claiming he got cancer from baby powder - UNILAD
1350,2023-07-22,
1351,2023-07-23,J&J’s Biosense Webster launches AFib mapping catheter - Mass Device | Teva and Alvotech expand biosimilars collaboration - The Pharma Letter | Johnson & Johnson to reduce its Kenvue stake by at least 80% through exchange offer - CNBC | Johnson & Johnson's Kenvue Stock Swap Is a Good Deal for Investors - Barron's | Johnson & Johnson: Split Off of Consumer Unit Kenvue Likely Final Step in Unit’s Divestment - Morningstar
1352,2023-07-24,Johnson & Johnson Medtech India appoints Anuj Virmani as Managing Director - BSI bureau|Johnson & Johnson Offers Exchange for Shares of Spinoff Kenvue - Investopedia|Characterization of the central nervous system penetrant and selective purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder|Translational Psychiatry - Nature.com|Dividend Investors in This Unique Stock-Split Stock Have a Decision to Make - The Motley Fool|Johnson & Johnson Medtech India appoints Anuj Virmani as MD - People Matters
1353,2023-07-25,"Johnson & Johnson Medtech India appoints Anuj Virmani as MD - ETHRWorld.com|Alkermes, nearing oncology split, posts big Q2 sales gain after winning J&J arbitration case - FiercePharma|J&J, GSK's ViiV tout switching study showing patients prefer their long-acting HIV med Cabenuva over Gilead rival - FiercePharma|J&J Subsidiary Wins $18 Million Judgment Against Surgical Tool Counterfeiter - IPWatchdog.com"
1354,2023-07-26,Better Medtech Buy: J&J vs. Medtronic - The Motley Fool
1355,2023-07-27,"J&J effort to resolve talc lawsuits in bankruptcy fails a second time - Reuters.com|Johnson & Johnson’s Second Talc Bankruptcy Case Thrown Out - The Wall Street Journal|J&J's attempt to file its talc liabilities in bankruptcy was rejected for a second time - Axios|Focus: Drugmakers go under the skin, skirting early US Medicare price negotiations - Reuters.com"
1356,2023-07-28,Administration of justice alumnus promotes internships with new enrichment fund - Penn State University
1357,2023-07-29,Judge Rejects Johnson & Johnson’s Effort to Limit Talc-Related Suits (Published 2023) - The New York Times
1358,2023-07-30,"How Johnson & Johnson is helping build a sense of belonging by investing in student nurses of color - Johnson & Johnson|J&J shares on track for biggest daily drop in 3 years on talc setback - Reuters.com|Meet Eni Gesinde: This is a company where I can ‘make my family proud’ and make a difference at the same time. - Johnson & Johnson|Takeda's Exkivity sputters in lung cancer trial, with accelerated approval on the line - FiercePharma|Johnson & Johnson's $8.9B talc deal in jeopardy as judge shoots down 2nd bankruptcy attempt - FiercePharma"
1359,2023-07-31,"The 7 Best 7-Minute Workout Apps for Exercising When You’re Short on Time - The Tech Edvocate|Trial evaluates purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder - News-Medical.Net|""No one would believe me when I suspected I had lung cancer"" - Johnson & Johnson"
1360,2023-08-01,J&J Is Left Weighing Options After Second Talc Bankruptcy Tossed - Bloomberg Law|EXCLUSIVE: Three Firms To Bring Cheaper Key TB Drug To India Soon As J&J Patent Expires - ABP Live|How the Tylenol Murders forever changed product packaging - Packaging Gateway|Why J&J's 'Texas-two step' setback could make it harder for companies to shed lawsuits - Yahoo Finance
1361,2023-08-02,"JNJ-3989 reduces HBsAg, may improve immune control in patients with chronic HBV infection - Healio|Bridge to Employment Overview - FHI 360|Lawyers denied extra $32m for pelvic mesh class action - 9News"
1362,2023-08-03,Ozempic Is the Rage. Why That May Explain a Mysterious Medtech Stock Selloff. - Barron's|J&J Unit Loses Quick Appeal Bid in Tylenol-Autism Warning Suit - Bloomberg Law|Better Buy: Johnson & Johnson vs. Procter & Gamble - The Motley Fool
1363,2023-08-04,J&J taps influencers to push parents to plan back-to-school eye checks - FiercePharma
1364,2023-08-05,nan
1365,2023-08-06,"J&J's Stelara settlement streak rolls on with Fresenius Kabi, Formycon deal - FiercePharma|Dow Jones Today: Index Rebounds with 400-Point Gain - Investopedia"
1366,2023-08-07,J&J's $40 Billion Kenvue Stock Swap: What You Need to Know - Barron's|Is Johnson & Johnson Stock a Buy Now? - The Motley Fool|Fresenius Kabi and Formycon latest to reach Stelara biosimilar deal with J&J - The Pharma Letter
1367,2023-08-08,"Intuitive, Auris Settle Robotic Surgery Patent Case - Law360|3 No-Brainer Stocks to Buy With $200 Right Now - The Motley Fool"
1368,2023-08-09,"Want to Make $1,000 in 2 Weeks? Buy 99 Shares of J&J Stock. - Barron's|Community health centers hold the key to advancing health equity - Johnson & Johnson|Intuitive resolves robotic surgery dispute with J&J unit - Life Sciences Intellectual Property Review|“My Health Can’t Wait”: Johnson & Johnson Has A New Initiative To Bring Free Health Screenings To Communities Across The Country - Essence|J&J grows cancer drug portfolio with newly approved bispecific - BioPharma Dive"
1369,2023-08-10,J&J expands multiple myeloma arsenal with FDA approval for first-in-class Talvey - FiercePharma|US FDA approves Johnson & Johnson's blood cancer therapy - Reuters.com
1370,2023-08-11,"J&J used RWE for an expanded indication— and you can, too - Medical Design & Outsourcing|Supreme Court blocks Purdue Pharma's bankruptcy settlement, threatening immunity to Sackler family - FiercePharma"
1371,2023-08-12,nan
1372,2023-08-13,"With FDA approval for Elrexfio, Pfizer brings multiple myeloma battle to Johnson & Johnson - FiercePharma|Chasing AstraZeneca and Pfizer, Johnson & Johnson snags FDA nod for prostate cancer combo Akeega - FiercePharma|FDA approves bispecific drug from Pfizer for multiple myeloma - BioPharma Dive|Embark on Excellence: Fully-Funded AACR Research Fellowships 2024 in the USA - iHarare News|J&J joins PARP rivals with narrow FDA clearance in prostate cancer - BioPharma Dive"
1373,2023-08-14,Medical illustrations have a representation problem—it can be fatal - Fast Company|J&J's Kenvue Deal Could Be Too Popular. What Happens if It Is. - Barron's|Johnson & Johnson extends their care to the open internet — reaching audiences with CTV and OTT - The Trade Desk
1374,2023-08-15,Founders Factory Africa receives $114 million for investment model - Philanthropy News Digest|J&J MedTech Korea to co-promote Huinno’s ECG monitoring patch with Yuhan Corp - KBR|10 nurses were chosen for a national leadership program. 3 are from UC Davis Health - UC Davis Health|JNJ Kenvue Exchange Offer Is Almost Here. What to Do Now. - Barron's|Gas City opens splash pad but questions linger about contractor who did work - WRTV Indianapolis
1375,2023-08-16,J&J Holders to Get 8 Kenvue Shares for Each J&J Share in Exchange Offer - Barron's|Johnson & Johnson Vs. Kenvue: The Better Dividend Aristocrat Might Shock You (NYSE:JNJ) - Seeking Alpha|The 10 largest orthopedic device companies in the world - Mass Device
1376,2023-08-17,Tylenol Lawsuits Could Be a Headache for Kenvue - Barron's|J&J's Abiomed updates labeling for certain Impella heart pumps in Class I safety event - Fierce Biotech|Johnson & Johnson Subsidiary’s Talc Bankruptcy Denied Again - Asbestos.com
1377,2023-08-18,U.S eyes battle with drug giants over 10 costly medications for seniors - The Washington Post|Kenvue Is a Timely Stock - GuruFocus.com|FDA deems latest Abiomed Impella recall Class I - Mass Device|Johnson & Johnson MedTech|Medtech Big 100 - Medical Design & Outsourcing
1378,2023-08-19,nan
1379,2023-08-20,"Roche, Exelixis' Tecentriq-Cabometyx combo rebounds with partial win in previously treated prostate cancer - FiercePharma|Lilly tops pharma in market cap after 36% growth|Pharmaceutical|The Pharmaletter - The Pharma Letter|J&J's Kenvue Exchange Offer Is Substantially Oversubscribed. What Happens Now. - Barron's|J&J to hold 9.5% stake in Kenvue after share exchange offer - Reuters.com|KVUE Stock Alert: Johnson & Johnson Reveals Results of Kenvue Exchange Offer - InvestorPlace"
1380,2023-08-21,"How J&J Is Pushing the Envelope Using Real-World Evidence - MD+DI|J&J’s Jim Swanson brings mission-driven leadership to the CIO role - CIO|Johnson & Johnson’s Exchange for Kenvue Is Tricky From Tax Standpoint - Barron's|2023 MBA To Watch: Robert “Bob” Reed, Cornell University (Johnson) - Poets&Quants"
1381,2023-08-22,Johnson & Johnson to hold 9.5 percent stake in Kenvue - GlobalCosmeticsNews|J&J Kenvue Stock Swap Offer Was a Huge Hit With Shareholders - Barron's|Kenvue Will Join the S&P 500 Friday. It Could Boost the Stock. - Barron's
1382,2023-08-23,"J&J Cuts R&D at Netherlands Infectious Disease, Vaccine Unit - BioSpace|J&J takes axe to Netherlands vaccines R&D unit - BioProcess Insider|J&J ends R&D at Janssen's infectious disease and vaccine unit - Fierce Biotech|J&J-backed startup raises another $150M for brain drug development - BioPharma Dive"
1383,2023-08-24,"Celltrion completes U.S. patent settlement with J&J, eyeing Stelara biosimilar launch in March 2025 - KBR|Meet New Jersey’s newest Fortune 100 company: Kenvue - ROI-NJ.com|JNJ Kenvue Exchange Offer Was a Big Win for the Little Guy - Barron's"
1384,2023-08-25,Meet the marathoner who is blazing a trail in the male-dominated STEM field - Johnson & Johnson
1385,2023-08-26,nan
1386,2023-08-27,"YoungGuns Class Of 2023: McCann Worldgroup India’s Utsav Khare and Rathish Subramaniam - Storyboard18|Billion-Dollar Drugs’ Makers Set to Face Their First US Price Negotiations - Bloomberg|3 Widely Owned Dow Stocks Prominent Billionaires Are Selling - The Motley Fool|Health equity champion spotlight: For Heather McLaughlin and London Wills, advocacy is personal - Johnson & Johnson|Johnson & Johnson (JNJ): A Modestly Undervalued Gem in the Healt - GuruFocus.com"
1387,2023-08-28,"Eli Lilly and Other Pharma Stocks Are Ignoring Medicare's 10 Drug List - Barron's|Blood thinners, diabetes meds among first 10 drugs for US price negotiations - Reuters.com|First 10 drugs for Medicare price negotiations chosen - POLITICO|Viridian Chart Of The Week: How Capital Intensive Is Cannabis? - Benzinga"
1388,2023-08-29,"Johnson & Johnson's spinoff of Kenvue provides $13.2B in potential M&A firepower - FiercePharma|J&J, India's Lupin cut prices for tuberculosis drug in lower-income countries - Reuters.com|Johnson & Johnson Spinout Kenvue Is the New Dividend Aristocrat - Barron's|J&J’s Akeega FDA approval to heat up PARP battle - BioPharma-Reporter.com"
1389,2023-08-30,"J&J Revises Guidance After Kenvue Spinout. There's Good News on the Dividend. - Barron's|Blood thinners, diabetes meds among first 10 drugs for US price negotiations - Reuters.com|Johnson & Johnson: Updated Guidance Following Kenvue Divestment Consistent With Our Expectations - Morningstar"
1390,2023-08-31,Chutes & Ladders—Sanofi finds John Reed replacement to lead R&D - Fierce Biotech|J&J Dividend Decision Shows Power of Free Cash Flow - Barron's|Lifetime of Achievement Award: Joaquin Duato - Healthcare Digital|Johnson & Johnson slashes price of tuberculosis drug Sirturo after relinquishing patent protections - FiercePharma
1391,2023-09-01,
1392,2023-09-02,
1393,2023-09-03,"J&J’s $40 Billion Split-Off Sets Stage for Pharma, Medical Tech Expansion ﻿ - The Wall Street Journal|Johnson & Johnson Shifts Focus Away from Infectious Disease R&D - The Healthcare Technology Report.|Janssen recruits AI startup to develop blood cancer treatments - OutSourcing-Pharma.com|Intelligent OMICS Ltd in AI-driven Research Collaboration with Janssen - European Pharmaceutical Manufacturer"
1394,2023-09-04,"10 Best Healthcare Stocks to Buy Now - The Tech Edvocate|Amgen tipped to keep Otezla market share in fight with BMS' Sotyktu, leaving opportunity for J&J - FiercePharma"
1395,2023-09-05,"J&J hands back $230M blood pressure drug to Idorsia with approval in sight - Fierce Biotech|J&J says drug combo contains lung cancer from spreading for longer duration - Reuters.com|J&J's patient assistance program suffers data breach, IBM says - FiercePharma|Before key Tagrisso showdown, J&J notches Rybrevant trial win in large lung cancer area - FiercePharma|UPDATED: Janssen sticks with Cidara's flu med but intends to hand over the rights to someone else - Fierce Biotech"
1396,2023-09-06,7 Retirement Stocks That Every Long-Term Investor Should Own Now - InvestorPlace|Johnson & Johnson (JNJ): A Modestly Undervalued Gem? - Yahoo Finance|Johnson & Johnson discloses IBM data breach impacting patients - BleepingComputer|Health Equity Champion spotlight: How Dr. Yolanda Lawson fosters inclusion through clinical trial diversity - Johnson & Johnson
1397,2023-09-07,J&J dumps high-dose Opsumit trial upon failure in rare type of pulmonary hypertension - FiercePharma|Kenvue Stock Falls 6% on Apparent Fears on Tylenol Lawsuits - Barron's|IAPB Announces that Johnson & Johnson Vision Will Join Efforts to Advocate for Better Eye Health - InvisionMag
1398,2023-09-08,7 Best Blue Chip Stocks to Buy Now - Nasdaq
1399,2023-09-09,Kenvue shares may gain after FDA comments in Tylenol-Autism warning label lawsuit - Seeking Alpha
1400,2023-09-10,J&J Illustrate Change - NationSwell
1401,2023-09-11,"Employing a holistic approach to support a diverse and fulfilled health workforce - Johnson & Johnson|AbbVie's Skyrizi deals heavy blow to J&J's Stelara in head-to-head Crohn's disease study - FiercePharma|Sandoz to Commercialize Samsung Bioepis’ Biosimilar to J&J’s Stelara - BioSpace|Rome adds columns to investor support with J&J, BMS joining $72M extension - Fierce Biotech|Johnson & Johnson and Cepheid must pledge access to lifesaving TB medicines and tests - Médecins Sans Frontières (MSF) International"
1402,2023-09-12,CDC Approves Updated COVID-19 Booster Shots to Target New Variants - Healthline|House Democrat Steamrolls Big Pharma Lawyer in Heated Hearing On Lowering Drug Prices - Mediaite|Behind the relentless pursuit of multiple myeloma cures - Johnson & Johnson
1403,2023-09-13,"Johnson & Johnson pharma rebrand highlights innovation as a pillar to reinforce trust - Drug Discovery & Development|PEGylated thrombopoietin mimetic, JNJ‑26366821 a novel prophylactic radiation countermeasure for acute radiation injury - Nature.com|Johnson & Johnson Updates Brand & Visual Identity - njbmagazine.com|After Kenvue spinoff, J&J says it's 'uniting' Janssen and medtech segments under one brand - FiercePharma"
1404,2023-09-14,"Johnson & Johnson Marks New Era as Global Healthcare Company with Updated Visual Identity - Johnson & Johnson|Johnson & Johnson is getting rid of its script logo after more than 130 years - The Associated Press|At Johnson & Johnson, a New Look but Old Hurdles - The Wall Street Journal|Updated branding gives J&J 2 segments sharing 1 name - HealthExec"
1405,2023-09-15,"Johnson & Johnson makes major change after 130 years and customers may be confused the next time they shop... - The US Sun|Pharma company Johnson & Johnson to drop Janssen brand name - Belga News Agency|Janssen rebrands its identity - European Pharmaceutical Review|Johnson & Johnson unleashes power of the ampersand as it follows Sanofi, GSK in major rebrand - FiercePharma|J&J unit, P&G, Walgreens misled consumers about decongestants, lawsuits say - Reuters.com"
1406,2023-09-16,Johnson & Johnson: AAA-Rated & Potentially 20% Undervalued (NYSE:JNJ) - Seeking Alpha|Johnson & Johnson replaces signature logo in brand revamp - The National|J&J unveils new logo after 135 years - Free Malaysia Today|Britons who believe Johnson’s Baby Powder gave them cancer could sue - The Times|Band-Aid SWOT Analysis - MBA Skool
1407,2023-09-17,Johnson & Johnson unveils new logo and visual identity - Creative Review|Johnson & Johnson Updates Visual Identity - Beauty Packaging
1408,2023-09-18,AHF Slams Johnson & Johnson for Immoral Profiteering on TB Treatment - AIDS Healthcare Foundation|Johnson & Johnson Rebrands Logo for First Time in 135 Years - Brand Innovators|J&J starts trial of pulsed field ablation catheter with mapping feedback - MedTech Dive
1409,2023-09-19,Navigating Turbulence: The 7 Safe Dividend Stocks for Today's Market - InvestorPlace|3 No-Brainer Stocks to Buy With $500 Right Now - The Motley Fool|Could we be on the cusp of catching Alzheimer’s before it starts? - Johnson & Johnson
1410,2023-09-20,"Johnson & Johnson Vision unveils SILK laser vision correction procedure in India - The Hindu|This Cancer Therapy is Lifesaving, but There Isn’t Enough of It - The Wall Street Journal|Sudafed PE class action claims medication ineffective following FDA analysis - Top Class Actions"
1411,2023-09-21,"Talc Researcher Asks Court to Dismiss J&J Lawsuit Against Her - Asbestos.com|Adam Taliaferro joins J&J as director, state and community engagement - ROI-NJ.com|South Africa launches ‘unprecedented’ investigation of Johnson & Johnson over TB drug prices - The Guardian|Ukraine: Open Letter: Urgent action by Johnson & Johnson needed to improve equitable access to bedaquiline-based regimens in all countries with a high burden of tuberculosis - MSF Access Campaign"
1412,2023-09-22,Laser Vision Correction: New SILK Procedure For Myopic Patients Launched In India - TheHealthSite|Johnson & Johnson Vision launches SILK procedure performed with next generation laser vision correction... - Medical Dialogues
1413,2023-09-23,"Findings show community-based, person-centered care can ease pressure on mental health services in the UK - Johnson & Johnson"
1414,2023-09-24,"Johnson & Johnson MedTech plans manufacturing facility in Costa Rica - Medical Design & Outsourcing|Johnson & Johnson Unveils Modernized Logo - The Healthcare Technology Report.|Weekly Recap: J&J Updates Visual Identity, L’Oréal Makes Executive Changes & More - Beauty Packaging"
1415,2023-09-25,"J&J, IBM face class-action lawsuit over patient data breach - FiercePharma|Immunovant shares surge as early antibody treatment data beats expectations - Reuters.com|J&J inks 'first of its kind' pact with Singapore government to boost regional life sciences innovation - Fierce Biotech"
1416,2023-09-26,"Our Credo - Johnson & Johnson|Johnson & Johnson Innovation announces collaboration with Singapore Economic Development Board to help transform Singapore’s life science innovation ecosystem - Singapore Economic Development Board|An eye for innovation: helping surgeons see more during spinal operations - Johnson & Johnson|Johnson & Johnson International, EDB to Foster Innovation within Singapore's Life Sciences Sector - CEO Insights Asia"
1417,2023-09-27,"What if bariatric surgery were easier to perform—and recover from? - Johnson & Johnson|J&J cancer drug combo beats Tagrisso in closely watched trial - BioPharma Dive|J&J's lung cancer therapy succeeds in head-to-head study with AstraZeneca's drug - Reuters.com|Johnson & Johnson Vision introduces Silk procedure for Myopia correction in India - The Times of India|J&J hit by 11,000 more lawsuits linking Baby Powder to cancer after judge throws $9B settlement case - Fortune"
1418,2023-09-28,US judge refuses to block Medicare from negotiating drug prices - Reuters.com|J&J's Rybrevant combo bests AstraZeneca's established Tagrisso in key lung cancer study - FiercePharma
1419,2023-09-29,"Top Colgate competitors (Updated in 2023) - Marketing91|Anzu Special Acquisition Corp I (ANZU) Closes Envoy Medical Deal - SPACInsider|MSF responds to groundbreaking news that Johnson & Johnson will not enforce patents on key TB drug bedaquiline in low- and middle-income countries - MSF Access Campaign|These 7 Dividend Stocks Pay $98 Billion Annually, Combined, to Their Shareholders - The Motley Fool"
1420,2023-09-30,Johnson & Johnson not to enforce patents on TB drug - The Hindu|PIH Applauds Breakthrough in Access to Key MDR-TB Drug - Partners in Health
1421,2023-10-01,"Johnson & Johnson says it won't enforce secondary patents on tuberculosis med Sirturo - FiercePharma|IBM, Johnson & Johnson class action claims companies failed to safeguard protected health information - Top Class Actions|Novo Nordisk challenges CMS drug price negotiations, then signs on to the program - FiercePharma"
1422,2023-10-02,"Johnson & Johnson Vision's Acuvue, Ranveer Singh Team Up To Advocate Eye Health Among Indian Youth - Marketing Strategy, Brands ...|Medicare drug costs: Drugmakers agree to price negotiations with Biden administration - NBC News|Takeda to pull lung cancer med Exkivity around the world after confirmatory trial flop - FiercePharma|Sanofi in agreement with Janssen to develop E. coli the vaccine candidate - Reuters.com|Sanofi Clinches Vaccine Deal With J&J to Battle E. Coli - Bloomberg"
1423,2023-10-03,"Johnson & Johnson gets a talc win as New Jersey court erases $223M jury award - FiercePharma|Johnson & Johnson Vision’s ACUVUE onboards Ranveer Singh - Exchange4Media|Sanofi pays J&J $175M for late-phase E. coli shot, pushing deeper into vaccines as partner retreats - Fierce Biotech"
1424,2023-10-04,Shasqi deepens CAPAC pact with Johnson & Johnson - Drug Discovery & Development|Johnson & Johnson Loses Again in Bankruptcy Court - Mesothelioma.com|Johnson & Johnson Unveils Revolutionary “SILK Procedure” in Vision Correction - ThePrint|Here's How Johnson & Johnson's CEO Is Using AI To End Cancer - Fortune|This First-Generation Nurse Graduate is Helping to Improve Health Outcomes in Her Immigrant Community - Johnson & Johnson
1425,2023-10-05,History-making NY Lottery mystery as winning $12M ticket goes unclaimed on Staten Island in 1992 - SILive.com|New partnership offers support to health tech innovators in Singapore - Health Tech World|This Filipino public health nurse is shifting his community’s attitudes towards health - Johnson & Johnson|Travis Kelce laughs at ‘Mr. Pfizer’ nickname from Aaron Rodgers - Washington Examiner
1426,2023-10-06,Jennifer Taubert|2023 Most Powerful Women - Fortune
1427,2023-10-07,nan
1428,2023-10-08,J&J’s DePuy Synthes wins FDA clearance for TriAltis tech - Mass Device|Vale John Kinghorn - Jack Newton Junior Golf|Here's Why Mirati Stock Tumbled On A $5.8 Billion Takeover Bid - Investor's Business Daily|9 Stocks to buy for the long run - True Scoop|J&J could reach market-leading medtech growth after consumer spinoff: analysts - MedTech Dive
1429,2023-10-09,"Johnson & Johnson 2023: A new era: achievement, evolution, and rebranding - PharmaLive|COVID vaccine 'black hole' for injury claims is unconstitutional, lawsuit says - Reuters.com"
1430,2023-10-10,"A deep dive on Shasqi and J&J click chemistry alliance - Drug Discovery & Development|Aaron Rodgers responds to fans calling him ""Mr. JohnsonandJohnson"" - Marca English|ECNP 2023: new esketamine NS safety data for depression - European Pharmaceutical Review|Aaron Rodgers challenges Travis Kelce to Covid vaccine debate - NBC News|Johnson & Johnson Vision eyes more innovations, investments in nation - China Daily"
1431,2023-10-11,"Rheumatoid, psoriatic and osteoarthritis—what you need to know about the 3 main types of arthritis - Johnson & Johnson|FDA warns Abiomed about ‘significant violations’ related to its Impella heart pumps - Cardiovascular Business|Jets’ Aaron Rodgers challenges Chiefs’ Travis Kelce to vaccine debate - FOX 59 Indianapolis"
1432,2023-10-12,FDA issues warning letter to J&J’s Abiomed over Impella heart pump problems - Mass Device|FDA declines to approve Alvotech’s Stelara biosimilar - The Pharma Letter|The top 4IR takeaways from the Lighthouses Live 2023 event - World Economic Forum
1433,2023-10-13,"J&J's Abiomed lands FDA warning letter over Impella heart pumps, software - Fierce Biotech|How big companies from EY to Johnson & Johnson are learning to master AI prompts - Fortune|FDA clears DePuy Synthes TriLeap plating system for foot and ankle surgeries - Mass Device|Addressing the social and racial barriers to health care equity - Fortune"
1434,2023-10-14,Opinion|Johnson & Johnson’s Latest Talc Lawsuit Victory - The Wall Street Journal
1435,2023-10-15,"How surgical robotics could take healthcare to the next level - Mass Device|Wall Street ends up on earnings optimism; eyes remain on Middle East - Reuters.com|Markets News, Oct. 16, 2023: Indexes Finish Higher, Bond Yields Rise To Start Big Earnings Week - Investopedia|DePuy Synthes receives FDA 510(k) clearance for TriALTIS Spine System - Med-Tech Innovation|Israel’s Corporate Defenders Grow Louder (Published 2023) - The New York Times"
1436,2023-10-16,"Johnson & Johnson beats on earnings and hikes outlook as medtech, pharmaceutical sales surge - CNBC|Markets News, Oct. 17, 2023: Indexes Finish Little Changed as Treasury Yields Climb - Investopedia|J&J reports 7% sales growth, one-time $21B cash gain from Kenvue spinoff - MM+M Online|Johnson & Johnson Earnings: Solid Results Lifted by Immunology and Oncology Drug Sales - Morningstar|J&J (JNJ) Raises 2023 Sales View On Strength in Pharma Business - Bloomberg"
1437,2023-10-17,J&J to ditch 'less-profitable' orthopedics markets in 2-year restructuring - Fierce Biotech|JNJ Earnings: All you need to know about Johnson & Johnson’s Q3 2023 earnings results - AlphaStreet
1438,2023-10-18,"Is the ""New"" Johnson & Johnson Stock a Buy With Its Improved Profit Outlook? - The Motley Fool|Big-Name Stock Spinoffs Are Going Mainstream. Here’s Why. - Barron's|J&J to restructure orthopedic business after medical device sales miss - Reuters.com|Johnson & Johnson Looks to Texas for Unit's Third Bankruptcy Bid - Bloomberg Law|Angus Cloud's mother sues Johnson & Johnson over claims baby powder led to her late husband's cancer... two mo - Daily Mail"
1439,2023-10-19,What Are the Common Side Effects of the Updated COVID-19 Vaccine? - Health Matters|Pretrial Schedule for Six Talcum Powder Bellwether Trial Cases Updated By MDL Judge - AboutLawsuits.com|How Johnson & Johnson is Accelerating a Health Equity Mindset: the Business Match Fund - NationSwell|First pill for dengue shows promise in human challenge trial - Reuters.com
1440,2023-10-20,"Johnson & Johnson Considers Ditching Texas Two-Step for Third Talc Bankruptcy - The Wall Street Journal|J&J bites back against dengue, linking antiviral to protection from infection in challenge trial - Fierce Biotech|Johnson & Johnson to slim down DePuy Synthes orthopedic portfolio - DOTmed HealthCare Business News|What is the Dengue Prevention Pill by Johnson & Johnson? Understanding how the drug operates - The Economic Times"
1441,2023-10-21,Structural and mechanistic insights into the inhibition of respiratory syncytial virus polymerase by a non-nucleoside inhibitor|Communications Biology - Nature.com|Business in a bind over messaging on Israel-Hamas war - Financial Times|Dengue Detected in Southern California - Precision Vaccinations|BREAKTHROUGH: Johnson & Johnson Reports Promising Results from First-ever Dengue Fever Pill - WE News English
1442,2023-10-22,"Johnson & Johnson antiviral pill for dengue shows early efficacy - STAT|ESMO: J&J's Rybrevant combo beats Tagrisso on lung cancer progression. Should AZ worry? - FiercePharma|Who is Tim Schmid, Johnson & Johnson MedTech’s new leader? - Mass Device|JLABS @ NYC Celebrates Its 5th Year in the Big Apple - BioSpace|Listerine Faces Boycott Calls Over LGBTQ+ Packaging - Newsweek"
1443,2023-10-23,"Market Leaders Johnson & Johnson Vision, CooperVision, and Alcon Inc Drive Growth in Global Contact Lenses Market - GlobeNewswire|Ashley McEvoy exits Johnson & Johnson after 27 years - Medical Device Network|Johnson & Johnson MedTech head Ashley McEvoy to leave company after nearly 30 years - Fierce Biotech|Ashley McEvoy’s J&J exit means new leadership for AdvaMed board - Mass Device"
1444,2023-10-24,"Ashley McEvoy to depart J&J’s medtech unit after nearly 3-decade stint - MM+M Online|Johnson & Johnson Stock Hits a Low. What’s Ailing Healthcare. - Barron's|TPC Jasna Polana, a Gary Player design in New Jersey built on the former estate of a Johnson & Johnson heir, is for sale - GolfDigest.com"
1445,2023-10-25,"Infecting volunteers with dengue virus shows experimental drug’s promise - Science|Time to call it a day after these two huge companies disappoint? - Interactive Investor|'Euphoria' Actor's Family Suing J&J for Father's Mesothelioma Death - Mesothelioma Guide|J&J faces 18 talc cancer trials, prompting it again to weigh bankruptcy - The Economic Times|Markets News, Oct. 26, 2023: Stocks Tumble; S&P 500 on Cusp of Correction After Strong Q3 GDP Report - Investopedia"
1446,2023-10-26,Companies and consumer lawsuits — a look at recent consumer product litigations in the US - CNBCTV18|Sanofi to Spin Out Consumer Health Division and 2024 Guidance Disappoints - Barron's|Why Is Sanofi Stock Trading Lower Today? - Sanofi (NASDAQ:SNY) - Benzinga
1447,2023-10-27,"Life-saving TB drug is now cheaper in South Africa, but not as cheap as it can be - GroundUp news|As Imbruvica loses steam, AbbVie takes $2.1B charge and points to CMS price negotiations - FiercePharma"
1448,2023-10-28,Redefining the battle against Alzheimer's with tau-focused treatments - News-Medical.Net
1449,2023-10-29,"Vir Biotechnology Appoints Jennifer Towne, Ph.D., as Executive Vice President and Chief Scientific Officer - Business Wire|Western Digital Shares Soar as Company Splits Off Flash Memory Business - Investopedia|Amgen, Regeneron and AbbVie join Lilly and Novo Nordisk in posting largest Q3 market-cap gains: report - FiercePharma"
1450,2023-10-30,"New EDB-J&J initiative to boost support for biotech start-ups in S’pore - The Straits Times|J&J Recalls 8,300 Bottles of Clean & Clear Cleanser for Micro Contamination - Happi"
1451,2023-10-31,"Johnson & Johnson Innovation launches Singapore QuickFire Challenge with the Singapore Economic Development Board - Singapore Economic Development Board|After J&J limbo, Arrowhead finds a new (old) partner for hep B program: GSK - Fierce Biotech|How big companies from EY to Johnson & Johnson are learning to master AI prompts - The Weekly Journal|FDA approves Wezlana, interchangeable biosimilar of Stelara - The Pharma Letter|After patent settlement, Amgen scores FDA nod for its biosimilar version of J&J's Stelara - FiercePharma"
1452,2023-11-01,Johnson & Johnson Stock (NYSE:JNJ): Time to Buy the Dip? - TipRanks|Biosense Webster has positive data for QDOT Micro ablation catheter - Mass Device|What it’s like when your baby has a rare blood disorder - Johnson & Johnson
1453,2023-11-02,Singapore to be an ‘end-to-end’ manufacturing hub for healthcare solutions – EDB - GovInsider|Morgan State University: Supporting the next generation of diverse researchers - Johnson & Johnson|Smith+Nephew plays down concerns about weight-loss drugs - Reuters.com|Amgen Contests J&J’s Stelara with FDA Approval for Interchangeable Biosimilar - BioSpace
1454,2023-11-03,Chutes & Ladders—Longtime BioMarin CEO hands baton off to Genentech chief - Fierce Biotech
1455,2023-11-04,nan
1456,2023-11-05,J&J unit laying off dozens in Colorado Springs area as part of restructuring - Colorado Springs Gazette|Big Pharma Wants to Use AI to Increase Diversity in Clinical Trials - Bloomberg|J&J’s Ethicon unveils AI-powered laparoscopic training tech - Mass Device|This Medtech Company Had 'Good People with Bad Habits' - MD+DI|J&J’s Ethicon Debuts AI-Powered Surgical Simulation Tool - MPO-mag
1457,2023-11-06,"Johnson & Johnson, IBM targeted in class action over health care data breach - BenefitsPro|With Amgen's biosim on the scene, J&J's Stelara looks poised to sidestep Medicare negotiations: HHS - FiercePharma|Viatris US court win reopens path to generic of J&J hypertension drug - Reuters.com|A tireless advocate for integrating community health workers into Kenya’s primary care system - Johnson & Johnson"
1458,2023-11-07,"J&J MedTech aims to put Ottava surgical robot up for US clinical trials in late 2024 - Fierce Biotech|Johnson & Johnson MedTech Provides Details and Timeline for General Surgery Robot - PR Newswire|Dengue is spreading. Can new vaccines and antivirals halt its rise? - Nature.com|Activists Declare Victory After Pushing J&J, Danaher to Lower Price of Tuberculosis Care - BioSpace|Johnson & Johnson Heiress Sells Wellington Equestrian Estate - The Real Deal"
1459,2023-11-08,Nilesh Shah is now the Vice President and General Manager of Emerging Markets at West Pharmaceutical Service.. - ETHealthWorld|J&J books manufacturing space at Fujifilm Diosynth's upcoming mega-plant in North Carolina - FiercePharma|J&J’s Ottava robot arriving too late to threaten Intuitive: analysts - MedTech Dive|Johnson & Johnson plan clinical trial for surgical robot - Medical Device Network|3 Brilliant Artificial Intelligence Stocks to Buy and Hold Forever - The Motley Fool
1460,2023-11-09,"The Continued 'Blanding' Trend That Goes Against Industry Research - Adweek|DePuy Synthes collab aids in whole-eye, partial-face transplant - Mass Device|NYU Langone completes first whole-eye transplant with support from J&J's DePuy Synthes - Fierce Biotech|Fierce Pharma Asia—AstraZeneca's GLP-1 play; Takeda's cancer drug approval; BioNTech's bispecific deal - FiercePharma"
1461,2023-11-10,"J&J orthopedics subsidiary undergoes layoffs at Colorado facility - MedTech Dive|Warren Buffett's Personal Portfolio: New Report Hints at Size, Stocks - Markets Insider|Improving community-based primary medical services to protect the health of China’s aging population - Johnson & Johnson"
1462,2023-11-11,
1463,2023-11-12,How Johnson & Johnson is helping people displaced by war and conflict restart their lives - Johnson & Johnson | JnJ Surgery Robot Moves Closer to FDA Clinical Trials - Healthcare Packaging | Turner Awarded $65 Million in Contracts to Expand Johnson & Johnson Vision Manufacturing Plant - Turner Construction Company | J&J Sheds Light on Plans for Surgical Robot - MD+DI | MONARCH Platform for Bronchoscopy Receives Regulatory License for China - PR Newswire
1464,2023-11-13,Former Top J&J Scientist Bets on China For Biotech Turnaround - Bloomberg|Johnson & Johnson Monarch surgical robot earns regulatory nod for bronchoscopy in China - Mass Device|Woody Johnson Net Worth: How rich is the owner of the New York Jets? - Marca English
1465,2023-11-14,"Ethicon Introduces ETHIZIA™ Hemostatic Sealing Patch, Clinically Proven to Stop Disruptive Bleeding - PR Newswire|Ethicon unveils hemostatic sealing patch in Europe - Mass Device|Warren Buffett's Berkshire Hathaway reveals it sold a bunch of long-held stocks - and made at least one secret bet - Markets Insider|Berkshire sheds GM, Johnson & Johnson, Procter & Gamble as it amasses cash - Reuters.com"
1466,2023-11-15,"Berkshire Hathaway exits GM, Johnson & Johnson positions - Yahoo Finance|Warren Buffett’s Berkshire Hathaway sheds investments in GM, J&J and P&G|Stock Market News - Mint|Grace receives STEM scholarship award - Offaly Independent|Berkshire sheds GM, Johnson & Johnson, Procter & Gamble as it amasses cash - Fox Business"
1467,2023-11-16,"Astellas to acquire Propella Therapeutics - The Pharma Letter|Warren Buffett's Berkshire Hathaway Sells Out of Longtime Holdings - Morningstar|Johnson & Johnson Is Eyeing Intuitive Surgical's Market, But Can It Win? - The Motley Fool|Pharma Is Out of Favor. 5 Drug Stocks With Room to Grow. - Barron's|J&J settles first talc cases to go to trial after failed bankruptcies - Reuters.com"
1468,2023-11-17,
1469,2023-11-18,VIDEO: J&J Vision chief medical officer discusses developments in IOLs - Healio
1470,2023-11-19,Kenvue may be activist target amid recent 13-F filing - Seeking Alpha|Brands keep dumping their script logos. Which brand will be next? - Fast Company|Exploring the potential of nipocalimab in rheumatoid arthritis - Drug Discovery & Development|Two Killarney STEM students receive Johnson & Johnson’s University scholarship - Killarney Advertiser
1471,2023-11-20,"Democrats summon CEOs of J&J, Merck and BMS for Senate hearing on drug prices - FiercePharma|Top 20 Stryker Competitors and Alternatives - Business Strategy Hub|Bayer's blood thinner fails Eliquis test, sinking phase 3 trial and denting $5B sales forecast - Fierce Biotech|4 Best High Yield Dividend Stocks For Retirement Portfolios - Forbes"
1472,2023-11-21,"Talc Lawsuit Filed Against J&J by LA County - MedTruth|Breakthrough in quickly stopping bleeding - Innovation in Textiles|IBM, Johnson & Johnson Hit With Second Health Data Breach Suit - Bloomberg Law"
1473,2023-11-22,"5 Longtime Holdings Warren Buffett Completely Sold During the Third Quarter - The Motley Fool|Johnson & Johnson Vision unveils new lens, cataract surgery device in Korea - KBR"
1474,2023-11-23,Goldman Sachs Value Stocks: Top 12 Stock Picks - Yahoo Finance
1475,2023-11-24,
1476,2023-11-25,"Got $1,500? You Can Confidently Add These 3 Stocks to Your Portfolio - The Motley Fool"
1477,2023-11-26,Protagonist Announces Two New Phase 3 ICONIC Studies in Psoriasis Evaluating JNJ-2113 in Head-to-Head Comparisons with Deucravacitinib - Yahoo Finance|Leeds NHS and Johnson & Johnson MedTech develop new partnership - Med-Tech Innovation|Roundup: Top medtech companies cut jobs in 2023 - MedTech Dive|Lawsuit: Woman says she received full vial of COVID vaccine; CVS subsidiary claims immunity - KSL.com
1478,2023-11-27,FDA investigates 'serious risk' of secondary cancer following CAR-T treatment - FiercePharma|What drives a healthcare champion - PR Week|13 inflation-proof stocks to buy for 2024 - Fortune|Congress of Peru begins analysis of accusation against president - Prensa Latina
1479,2023-11-28,"Medical Supplies Market is Booming Worldwide|Medtronic, Cardinal Health, Johnson & Johnson - Industry Today|US FDA investigating safety risk of CAR-T cancer therapies - Reuters.com|Johnson & Johnson Vision continues to promote eye health awareness through its latest campaign featuring Ran.. - ETBrandEquity|By the numbers: Who gets lung cancer? - Johnson & Johnson|The 7 Biggest Dividend Stocks in Warren Buffett’s Portfolio - InvestorPlace"
1480,2023-11-29,Johnson & Johnson MedTech enters LAA device space with acquisition of Laminar - Mass Device|Johnson & Johnson acquires medical device company behind new LAA technology for $400M - Cardiovascular Business|J&J heats up LAA closure competition with $400M Laminar buy - MedTech Dive|The Human Genome Is the Future of Healthcare - Johnson & Johnson
1481,2023-11-30,"J&J drops $400M to acquire new type of stroke-reducing heart implant - Fierce Biotech|Johnson & Johnson bets heavy on AI-driven drug discovery - STAT|GSK, AstraZeneca, Johnson & Johnson and others raided in Turkish labour market probe - Global Competition Review"
1482,2023-12-01,"Johnson & Johnson MedTech acquires heart implant company Laminar for $400m - Medical Device Network|Johnson & Johnson Stock Gains a Bull Ahead of Analyst Day - Barron's|Markets News, Dec. 1, 2023: Stocks Post Fifth Straight Winning Week as Treasury Yields Retreat - Investopedia"
1483,2023-12-02,"Second-Largest U.S. Pension Sold AMC, NIO, Spotify, and JNJ Stock - Barron's|National Board of Justice begins disciplinary proceedings against Peru’s Attorney General Patricia Benavides - Peru Reports"
1484,2023-12-03,"MYCN and SNRPD3 cooperate to maintain a balance of alternative splicing events that drives neuroblastoma progression|Oncogene - Nature.com|A J&J Executive’s Son Died. That Prompted a Policy Change at the Top - Bloomberg|Johnson & Johnson Manufacturing Plant HVAC Solutions - ACR Latinoamérica|The 7 Best Ways to Invest $1,000 in the Stock Market Now - InvestorPlace"
1485,2023-12-04,"Johnson & Johnson Moves to Disqualify Beasley Allen From Talc Leadership - Law.com|J&J says it has settled some talc claims, will continue bankruptcy strategy - Reuters.com|3 ways Johnson & Johnson is helping make healthcare more sustainable - Johnson & Johnson|Johnson & Johnson MedTech says new products will fuel growth - Mass Device"
1486,2023-12-05,"UPDATED: As Stelara cliff looms, J&J expects 25 blockbuster drugs to drive future sales growth - FiercePharma|Johnson & Johnson’s Ethicon settles more Physiomesh suits - Mass Device|Johnson & Johnson says it's finally making 'progress' on disturbing cancer lawsuits - TheStreet|Johnson & Johnson forecasts as much as 6% sales growth in 2024 - CNBC"
1487,2023-12-06,5 takeaways from J&J’s investor day - MedTech Dive|Vanda expands commercial presence with $100M deal for US rights to J&J multiple sclerosis drug - FiercePharma|A CEO contender left Johnson & Johnson. Was she penalized for saying she wanted to be a CEO? - Fortune|Johnson & Johnson's prescription for growth - Entrepreneur|Peru’s National Board of Justice suspends the Attorney General from her duties - Peru Reports
1488,2023-12-07,"Vanda Buys US, Canadian Rights to J&J’s MS Drug Ponvory in $100M Deal - BioSpace|Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet - Benzinga|Johnson & Johnson raises ADHD awareness through 'All Minds Matter' campaign - Exchange4Media"
1489,2023-12-08,"Rare clotting effect of early COVID shots finally explained — what could that mean for future vaccines? - Livescience.com|ASH: Novel menin inhibitors show promise for patients with advanced acute myeloid leukemias - MD Anderson Cancer Center|Edwards to spin off its critical care business - MedTech Dive|As careers delay parenthood, companies offer fertility benefits - The Times of India"
1490,2023-12-09,
1491,2023-12-10,"December, a cursed month for Peru - EL PAÍS USA | Meet the moment: Don’t set back the clock on patients - POLITICO Europe | As FDA puts CAR-T safety under microscope, researchers dig into adverse events record of BCMA therapies - FiercePharma | As ICER places a spotlight on pharma's price hikes, J&J, Roche and more hit back - FiercePharma | MedTech Innovator Crowns Medipixel Top 2023 Innovator in Grand Finals Competition of Asia Pacific Accelerator - Business Wire"
1492,2023-12-11,"ASH: J&J, Sanofi square off in newly diagnosed multiple myeloma, with one med showing 'unprecedented' efficacy - FiercePharma|BillionToOne Announces Global Collaboration to Provide its UNITY Fetal Antigen™ Clinical Trial Assay in Johnson & Johnson Phase 3 Clinical Trial of Nipocalimab in Hemolytic Disease of the Fetus and Newborn - PR Newswire|Everyday item being investigated over death - news.com.au|The biggest medtech personnel moves of 2023 - Mass Device"
1493,2023-12-12,"Johnson & Johnson Earnings to Be Hit by Loss of Stelara Exclusivity, Wells Fargo Says - Barron's|P&G Appoints Ashley McEvoy to Board of Directors - Procter & Gamble|Integra LifeSciences to buy Johnson & Johnson’s Acclarent and its ENT tech - Mass Device|J&J marks 80th anniversary of celebrated ‘Our Credo’ - NJBIZ|Kenvue: A High-Quality Consumer Health Company on Sale - GuruFocus.com"
1494,2023-12-13,"AbelZeta, Janssen Amend CAR-T Deal - Contract Pharma|Former J&J MedTech head Ashley McEvoy takes board role at consumer goods giant - Mass Device|J&J to sell Acclarent ENT surgery division to Integra in $280M deal - Fierce Biotech"
1495,2023-12-14,"Former medical device execs at J&J unit lose appeal of convictions - Reuters.com|J&J’s Biosense Webster treats first patients in dual-energy AFib ablation trial - Mass Device|Cerenovus President Mark Dickinson on the future of stroke care - Medical Design & Outsourcing|MU Students Attend Johnson & Johnson STEMFest 2023 - Maynooth University|Obituaries in Langhorne, PA - phillyBurbs.com"
1496,2023-12-15,"12 Best Slow Growth Stocks To Buy According To Hedge Funds - Yahoo Finance|Markets News, Dec. 15, 2023: Stocks Post Seventh Weekly Gain as Dow Closes at Fresh Record - Investopedia|Boycotts and protests – how are people around the world defying Israel? - Al Jazeera English"
1497,2023-12-16,
1498,2023-12-17,Integra LifeSciences to Acquire Acclarent from Johnson & Johnson for $275 Million - The Healthcare Technology Report.
1499,2023-12-18,"J&J Spinoff Kenvue Defeats Suits Alleging Tylenol Causes Autism - Bloomberg|Lawsuits claiming Tylenol causes autism lack scientific support, judge finds - Reuters|Behind the Buyouts: Goldman's David Dubner on Rise in Spinoffs - The Deal Pipeline|Dr. Richard Browne joins Johnson & Johnson to combat PAD - Rolling Out"
1500,2023-12-19,13 innovations that inspired us in 2023 - Johnson & Johnson|10 Biggest Biotechnology Companies - Investopedia
1501,2023-12-20,7 Stocks That Might Win on Election Year Uncertainty - InvestorPlace|J&J's Abouzahr aims to advance autoantibody drug development - Drug Discovery & Development|Johnson & Johnson Stock (NYSE:JNJ): A Smart Dividend Pick for 2024 - Nasdaq|J&J bets bigger on MeiraGTx’s eye gene therapy - BioPharma Dive
1502,2023-12-21,"J&J, Legend’s Carvykti slapped with FDA black-box warning over secondary cancer risk - FiercePharma|Yuhan’s lung cancer drug Leclaza takes first step into global market - KBR"
1503,2023-12-22,"J&J seeks US, European approval for drug developed with Yuhan - Korea Economic Daily|New JN. 1 Covid variant gains ground in US ahead of holiday season - Financial Times"
1504,2023-12-23,Warren Buffett sold a whopping $7B worth of stock in Q3 — he even unloaded shares of 2 American 'dividend kings.' But here's why the Oracle of Omaha could be dead wrong - Yahoo Finance
1505,2023-12-24,The Vice President of Johnson Company calls for the killing and extermination of all residents in Gaza! - Watan
1506,2023-12-25,"Identification of highly selective SIK1/2 inhibitors that modulate innate immune activation and suppress intestinal inflammation - pnas.org|CORRECTING and REPLACING LegoChem Biosciences Announces License Agreement for LCB84 Trop2-Targeted ADC - Business Wire|LegoChem strikes historic $1.7B license deal with Janssen - The Korea JoongAng Daily|LegoChem Bio, Janssen sign $1.7 bn ADC licensing deal - Korea Economic Daily"
1507,2023-12-26,J&J leader spotlights neglected needs in maternal health - Drug Discovery & Development|Magazine roundup: Top 100 women in technology 2023 - Technology Magazine
1508,2023-12-27,"Johnson & Johnson CEO Discusses Branding and Leadership with Steve Adubato - New Jersey Business & Industry Association|11 Set-It-and-Forget-It Stocks to Buy According to Financial Media - Yahoo Finance|J&J jumps on ADC train, signs $1.7bn licensing deal with LegoChem - Pharmaceutical Technology|Ropes & Gray Represents LianBio in Licensing Agreement with Janssen Pharmaceuticals in China and Other Asian Markets - Ropes & Gray LLP|20 Most Expensive Drugs in the World - Yahoo Finance"
1509,2023-12-28,"11 Best Psychedelic Stocks to Buy in 2024 - Yahoo Finance|Judge certifies Johnson & Johnson shareholder class action over talc disclosures - Reuters.com|Markets News, Dec. 29, 2023: Stocks Fall to Cap Off Otherwise Sunny Year - Investopedia"
1510,2023-12-29,Paula Abdul accuses 'American Idol' producer of sexual assault - NPR
1511,2023-12-30,3 Beaten-Down Dow Jones Stocks That Dividend Investors Should Scoop Up in 2024 - The Motley Fool
1512,2023-12-31,Winning Secrets: Johnson & Johnson's 'Volunteering Leave' policy lets employees take up to 4 days per year - Philanthropy News Digest|Meet the 2024 Dogs of the Dow - The Motley Fool
1513,2024-01-01,Dr. Daphne Chan is helping to improve clinical trial diversity through the J&J VISIBLE study - Johnson & Johnson|Multiplexed multicolor antiviral assay amenable for high-throughput research - Nature.com|J&J 4Q Revenues Up 7% - Contract Pharma
1514,2024-01-02,Johnson & Johnson shareholders given green light for class action over talc cases - GlobalCosmeticsNews|(01/03/24) Top Picks 2024: Johnson & Johnson (JNJ) - Moneyshow.com|One backer of MDMA therapy sees 'exponential' growth upon FDA approval this year - MarketWatch
1515,2024-01-03,"AtriCure adds J&J veteran to its board - Mass Device|3 No-Brainer Stocks to Buy With $1,000 Right Now for the New Year - The Motley Fool"
1516,2024-01-04,"Johnson & Johnson Acquiring Mid Valley General Agency in Oregon - Insurance Journal|Illumina expands collaboration with Janssen to advance molecular residual disease cancer test - Illumina|Fierce Pharma Asia—Deal spree by AstraZeneca, J&J, Roche, Boehringer and more; Big Pharma’s China strategy - FiercePharma|J&J Limerck eye care unit revenues rise to €1.24bn - RTÉ News"
1517,2024-01-05,
1518,2024-01-06,
1519,2024-01-07,"Johnson & Johnson to Acquire Ambrx, Advancing Next Generation Antibody Drug Conjugates to Transform the Treatment of Cancer - Business Wire|Johnson & Johnson to Acquire Cancer-Treatment Developer Ambrx for $2 Billion - The Wall Street Journal|JPM24: Johnson & Johnson CEO says Tecvayli, Talvey and several other meds are set to trounce analyst estimates - FiercePharma|Johnson & Johnson Pays $2 Billion for Ambrx To Boost Its Cancer Drug Pipeline - Investopedia|J&J (JNJ) to Pay $700 Million to Settle States’ Talc Baby Power-Marketing Probe - Bloomberg"
1520,2024-01-08,"40 Under 40: Katie Buckley, Johnson & Johnson MedTech - MM+M Online|Novartis in advanced talks to buy Cytokinetics- source - Reuters|J&J to pay $700 mln to settle states' talc-marketing probe - Bloomberg News - Reuters|J&J beefs up ADC pipeline by acquiring Ambrx for $2B - Fierce Biotech"
1521,2024-01-09,JPM24: J&J’s Biosense Webster claims pulsed field ablation approval in Japan - Fierce Biotech|Sale of generic versions of cancer drug stops as Delhi HC prohibits patent infringement - The Times of India|St. Louis cancer drug startup's expansion plans include research pact with pharma giant - The Business Journals
1522,2024-01-10,"Ojas Eye Hospital to offer ELITA SILK, introducing cutting-edge vision correction in Mumbai - Hindustan Times|Novartis drops pursuit of Cytokinetics - source - Reuters.com|The biggest stories from the 2024 J.P. Morgan Healthcare Conference - Mass Device"
1523,2024-01-11,"JPMorgan's investor conference brings pharma firepower, but health services quiet - Axios|Amgen Emerges as Potential Cytokinetics Suitor as Novartis Pulls Away: Reports - BioSpace|2 Dow Stocks to Buy Hand Over Fist in 2024 and 1 to Avoid Like the Plague - The Motley Fool"
1524,2024-01-12,
1525,2024-01-13,VIDEO: J&J Vision company update showcases presbyopia-correcting IOL - Healio
1526,2024-01-14,CAR-T hype faces infrastructure reality check - FiercePharma
1527,2024-01-15,"This Week in Chancery Court: Johnson & Johnson, TransCanada - Bloomberg Law|LegoChem, riding ADC sugar rush, raises $411M from confectionery company - Fierce Biotech"
1528,2024-01-16,"J&J, AZ/Daiichi Sankyo cancer therapies lead Clarivate's annual rundown of notable new meds - FiercePharma|Johnson & Johnson manager wins discrimination case after being 'racially profiled' by boss who said she showed - Daily Mail|Menin inhibitors emerge as potential new treatment option for advanced acute leukemias - Healio"
1529,2024-01-17,"J&J Merger Undermined Surgical Robot Project, Auris Exec Says - Bloomberg Law|2024 Will Be a Good Year for the Pharma Industry: The Kiplinger Letter - Kiplinger's Personal Finance|Johnson's Baby Powder SWOT Analysis - MBA Skool"
1530,2024-01-18,"Johnson & Johnson names new Vision Care marketing lead for 4 regions - Marketing Interactive|Senators threaten to subpoena CEO testimony while J&J, Merck claim retaliation amid IRA legal fight - FiercePharma|Neutrogena class action alleges company falsely labels shampoo as containing no preservatives - Top Class Actions"
1531,2024-01-19,"Sanders threatens to subpoena J&J, Merck CEOs over drug prices - BioPharma Dive"
1532,2024-01-20,"Tesla, Netflix, AT&T, Lockheed Martin, Visa, and More Stocks to Watch This Week - Barron's|Nigerian Woman Wins Racial Profiling Case against US Pharmaceutical Firm - THISDAY Newspapers"
1533,2024-01-21,"Markets News, Jan. 22, 2024: Dow Passes 38,000; S&P 500 Adds to Record as Treasury Yields, Bitcoin Retreat - Investopedia|Johnson & Johnson’s bladder cancer drug Balversa granted full FDA approval - PMLiVE|J&J receives FDA’s full approval for BALVERSA - Pharmaceutical Technology|J&J's Balversa gets mixed approval in bladder cancer as FDA ratchets up scrutiny on subgroup data, patient survival - FiercePharma|3 bellwether companies to watch as medtech earnings season begins - MedTech Dive"
1534,2024-01-22,"Johnson & Johnson updates 2024 profit forecast after solid Q4 earnings - TheStreet|Johnson & Johnson reaches tentative deal to resolve talc baby powder litigation - CBS News|Johnson & Johnson MedTech reports 13% sales uptick in Q4, has positive ablation outlook - Mass Device|Johnson & Johnson posts Q4 earnings beat, $21.4B in revenue - Yahoo Finance"
1535,2024-01-23,Washington state reaches $149.5 million settlement with Johnson & Johnson over opioid crisis - PBS NewsHour|J&J profit edges past Street view after deals delay Stelara competition - Reuters.com|Genmab loses appeal in Darzalex royalties arbitration case against Johnson & Johnson - FiercePharma|2 Genius Safe Stocks to Buy for 2024 and Beyond - The Motley Fool|Johnson & Johnson still expects Carvykti to hit at least $5 bln peak sales -CFO - Reuters.com
1536,2024-01-24,"Johnson & Johnson Opioid Settlement - Washington State|Office of the Attorney General|Johnson & Johnson talc asbestos papers - U.S. Right to Know|Media reports: Johnson & Johnson reaches settlement to resolve talc baby powder investigations - PIRG|Washington state reaches a nearly $150 million settlement with Johnson & Johnson over opioid crisis - The Associated Press|Johnson & Johnson: Balance Growth Between MedTech And Medicine, Initiate With A 'Buy' - Seeking Alpha"
1537,2024-01-25,"Sanjay Murti Moves to Freshfields From Cravath - The Deal Pipeline|Growing IL-18 field looks to enhance cell therapies via decoy evasion - BioCentury|JNJ Stock: What to Consider Before Its Next Dividend Hike - Nasdaq|Merck, Johnson & Johnson CEOs agree to appear before Senate HELP - Roll Call|Brian Young Obituary (2024) - Sussex, NJ - Pinkel Funeral Home - Legacy.com"
1538,2024-01-26,Johnson & Johnson Faces a 1.03% Portfolio Impact in Eaton Vance Worldwide Health Sciences ... - Yahoo Finance|Better Growth Stock: UnitedHealth Group vs. Johnson & Johnson - The Motley Fool
1539,2024-01-27,"Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs - CNBC|Molecular determinants of ASIC1 modulation by divalent cations - Scientific Reports - Nature.com"
1540,2024-01-28,"What to watch for as Stryker, Boston Scientific and BD post earnings this week - MedTech Dive|J&J’s $100K gift helps Community FoodBank of NJ expand fleet - NJBIZ|Biggest Pharmaceutical Company in the World 2024, List of Top-10 - Adda247"
1541,2024-01-29,"Wall Street's Greatest Dividend Stock Just Made History Again, and 99% of Investors Probably Don't Realize It Exists - The Motley Fool|The 6 Best Comic Book Stores in Denver - 5280|The Denver Magazine|Cross-Border Impact Ventures announces over $90 million in commitments - Philanthropy News Digest"
1542,2024-01-30,"The pipeline and market for psoriasis drugs - Nature.com|Healthy Returns: J&J, Merck and Bristol Myers Squibb are in the hot seat - CNBC|FDA Hosts Public Psychedelics Discussion, Discloses Major Growth On Number Of New Psychiatric Drugs Filings Post-2000 - Benzinga|2024 Pharmaceutical Industry Mergers & Acquisitions Roundup - Contract Pharma"
1543,2024-01-31,Johnson & Johnson named a 2024 Fortune World’s Most Admired Company - Johnson & Johnson|US government sends initial offers for Medicare drug price cuts - Reuters.com|'Abusive Discovery Tactics'? Talc Plaintiffs Attack New J&J Subpoenas - Law.com
1544,2024-02-01,Bernie Sanders Has a Plan to Make Big Pharma’s Greedheads Squirm - The New Republic|10 surgical robotics companies you need to know - Mass Device|What is the pipeline for future medications for obesity? - International Journal of Obesity - Nature.com|Building health worker capacity to close the mental healthcare gap across Kenya - Johnson & Johnson
1545,2024-02-02,"Could we be on our way to eliminating cancer for good? - Johnson & Johnson|FDA sets date for high-profile CAR-T adcomm for Bristol's Abecma, J&J's Carvykti - FiercePharma"
1546,2024-02-03,nan
1547,2024-02-04,"The 7 Best Healthcare Stocks to Invest In for Big Gains in 2024 - InvestorPlace|J&J says top drug prospect works across autoimmune disorders - BioPharma Dive|J&J's immune disorder drug succeeds in mid and late-stage studies - Reuters.com|J&J's $6.5B autoimmune drug hits phase 3 goal, teeing up approval talks and keeping heat on argenx, UCB - Fierce Biotech|J&J Accused of Mismanaging Its Employees’ Drug Benefits - The Wall Street Journal"
1548,2024-02-05,"J&J's Biosense Webster puts forward pulsed field ablation data showing no afib after one year - Fierce Biotech|Pharmalittle: We’re reading about a lawsuit against J&J, Express Scripts dealings, and more - STAT|Johnson & Johnson employee sues over ‘massive overpayment’ for prescription meds - HR Dive"
1549,2024-02-06,Investigational targeted oral peptide JNJ-2113 demonstrated positive results in moderate-to-severe plaque psoriasis in Phase 2b study published in New England Journal of Medicine - PR Newswire|An Oral Interleukin-23–Receptor Antagonist Peptide for Plaque Psoriasis - nejm.org|J&J faces class action over employees' prescription drug costs - Reuters.com
1550,2024-02-07,"Johnson & Johnson (JNJ) DCF Valuation: Is The Stock Undervalued? - The Acquirer's Multiple|Kenvue’s stock slides 5.8% as J&J spinoff’s revenue and guidance fall short of expectations - MarketWatch|J&J, Merck and Bristol Myers CEOs defend high drug prices in Senate hearing, as Biden tries to cut costs - CNBC|Under Bernie Sanders’s Glare, Pharmaceutical Chiefs Defend Their Prices - The New York Times"
1551,2024-02-08,Biomedical scientist Robert Langer receives the 2023 Dr. Paul Janssen Award for Biomedical Research - Johnson & Johnson|Senators ask CEOs why their drugs cost so much more in the U.S. - NPR
1552,2024-02-09,Power Morcellator Lawsuit - Lawsuit Information Center Blog|Johnson & Johnson Case Signals Employee Drug Price Suits to Come - Bloomberg Law|Pharmaceutical Company CEOs Testify on Prescription Drug Prices - C-SPAN|Layoffs in medtech: These companies recently reduced their workforce - Mass Device
1553,2024-02-10,Don't Race Out To Buy Johnson & Johnson (NYSE:JNJ) Just Because It's Going Ex-Dividend - Yahoo Finance
1554,2024-02-11,The battle over prescription drug prices is heating up - Fast Company|HTuO Biosciences Joins Johnson & Johnson Innovation - JLABS - Business Wire|Is There An Opportunity With Johnson & Johnson's (NYSE:JNJ) 43% Undervaluation? - Simply Wall St|Senate Hearing Challenges Pharma CEOs on Drug Pricing - TechTarget
1555,2024-02-12,J&J expands Ethicon manufacturing operations in Manatí - The San Juan Daily Star|3 Dow Stocks You Can Confidently Buy Now and Hold Forever - The Motley Fool|Johnson & Johnson named a 2024 Fortune World’s Most Admired Company - Johnson & Johnson
1556,2024-02-13,"Senate Report Exposes Big Pharma's Profiteering at Americans’ Expense - TechTarget|Johnson & Johnson’s Pursuit of Asbestos Bankruptcy Continues - Mesothelioma.com|J&J Faces Talc Trial Over Anesthesiologist’s Ovarian Cancer Death, Watch Online via CVN - CVN News"
1557,2024-02-14,"UPDATED: Eicos Sciences' Aurlumyn scores first FDA approval to treat severe frostbite - FiercePharma|Manufacturing presence on the island expands - The Weekly Journal|Alvotech settles with J&J to launch Stelara biosimilar in Europe, Canada - Reuters.com"
1558,2024-02-15,"What is cardiac ablation? - Johnson & Johnson|Johnson & Johnson launches new intraocular lens in EMEA - Mass Device|J&J consumer health spinoff Kenvue telegraphs 100-plus layoffs in California, New Jersey - FiercePharma|Alvotech Reaches Settlement with J&J Over Stelara Biosimilar - BioSpace"
1559,2024-02-16,Steady Eddies: 3 Blue-Chip Stocks to Buy for the Long Haul - InvestorPlace
1560,2024-02-17,"If You Invested $10,000 in Johnson & Johnson Stock in 2004, This Is How Much You Would Have Today - The Motley Fool"
1561,2024-02-18,"MYGroup works with J&J on medical plastic recycling - Recycling Today|Gene Therapies In Ophthalmology Clinical Trial Pipeline - GlobeNewswire|Sisk enjoying a surge in growth, with projects across Europe - Irish Examiner"
1562,2024-02-19,Bi-weekly dose of Johnson & Johnson's blood cancer therapy gets US FDA approval - Reuters.com|Lilly Edges Out J&J to Top 20 BioPharma Market Cap List for 2023 - BioSpace
1563,2024-02-20,"Job Cuts At Kenvue - Beauty Packaging|Novo, Novartis, BMS and J&J win judge's blessing to combine arguments in upcoming IRA hearing - FiercePharma|Beasley Allen's Andy Birchfield Faces Evidentiary Hearing on Disqualification - Law.com"
1564,2024-02-21,"Johnson & Johnson Escapes Neutrogena Sunscreen Suit, for Now - Bloomberg Law|Sales of Johnson & Johnson 2006-2023 by region - Statista|Brand value of Johnson & Johnson's cosmetic brands worldwide from 2017 to 2019 - Statista|Revenue of Johnson & Johnson's pharmaceuticals segment worldwide from 2012 to 2024, by product category* - Statista|Do you know what heart failure is? (Hint: It’s probably not what you think) - Johnson & Johnson"
1565,2024-02-22,5 Best Buy-the-Dip Stocks To Buy Right Now - Insider Monkey|J&J secures EMA backing for earlier CAR-T use in multiple myeloma - BioPharma Dive|13 Best Dow Jones Dividend Stocks According to Analysts - Yahoo Finance
1566,2024-02-23,"7 Defensive Stocks for a Steady Return on Investment - U.S News & World Report Money|25 Easiest and Best Paying Jobs of 2024 - Yahoo Finance|Travere's Filspari, J&J's Carvykti win support from CHMP in blitz of positive recommendations - FiercePharma"
1567,2024-02-24,UPDATE: J&J to shut down massive Bay Area R&D facility less than 18 months after opening it - Fierce Biotech|J&J to shut Peninsula facility it opened less than 2 years ago but open another - The Business Journals
1568,2024-02-25,"Daily Digest: Cisco layoffs hit Bay Area offices; Fire shutters Target - San Francisco Business Times - The Business Journals|EU Panel Backs J&J, Legend’s Carvykti for Second-Line Multiple Myeloma - BioSpace|Obituary information for Richard M. Hyman, Jr. - Chapman Funerals & Cremations"
1569,2024-02-26,Positive Outlook For J&J’s Multiple Myeloma Portfolio Following Latest Regulatory Developments - Fitch Solutions|Nipocalimab: J&J's approach to IgG modulation in rare diseases - Drug Discovery & Development|Should You Pick Johnson & Johnson Stock At $160? - Forbes|Johnson & Johnson MedTech begins direct operations in Saudi Arabia - Arab News
1570,2024-02-27,"As historic MDMA decision nears, even J.P. Morgan eyes psychedelic investments - Fierce Biotech|Cyprus Mines and Ex-J&J Talc Supplier Imerys Create $862M Trust - Asbestos.com|What is an orphan drug? - Johnson & Johnson|3 health advocates; 1 program that empowers and connects patients - Johnson & Johnson"
1571,2024-02-28,"Johnson & Johnson drug benefits suit ‘absolutely’ a wake-up call for employers, exec says - HR Dive|J&J’s pulsed field ablation system secures European approval - MedTech Dive|With J&J settlement, Biocon Biologics gets a license to challenge Stelara in the US - FiercePharma"
1572,2024-02-29,"Biocon Biologics settles with Janssen Bmab 1200, a proposed Stelara biosimilar - The Pharma Letter|Pharmaceutical Giants Expand Research and Manufacturing Capabilities, Fueling 2024 Innovation and Growth - geneonline|J&J secures European afib approval for Varipulse pulsed field ablation system - Fierce Biotech|FDA approves J&J's combination therapy for a type of lung cancer - Reuters.com"
1573,2024-03-01,"Judge upholds Medicare drug price negotiation program, but more lawsuits are being considered in other courts - CNN|CM Revanth assures to hand over land to JNJMACHS, promises house sites to all journalists - Deccan Chronicle"
1574,2024-03-02,CM Revanth Reddy Promises Land Allocation to Eligible Journalists - ap7am
1575,2024-03-03,"With Takeda out of the picture, J&J’s Rybrevant moves into first line in lung cancer subtype - FiercePharma|Johnson & Johnson’s Rybrevant granted FDA approval for lung cancer indications - PMLiVE|J&J Wins Full FDA Approval for Rybrevant, Chemo Combo in NSCLC - BioSpace|Markets News, Mar. 4, 2024: Stocks Slump as Bitcoin Approaches $68K; Gold Closes at Record - Investopedia|As Medicare price negotiations roll on, drugmakers counter HHS' initial offers - FiercePharma"
1576,2024-03-04,Latest J&J talc trial ends with hung jury - Reuters.com|VIDEO: Early results ‘superb’ with new PureSee IOL - Healio|5 Best Pharma Dividend Stocks To Buy in 2024 - Insider Monkey
1577,2024-03-05,"Cardin, Kaine Statement on the Importance of Peru Respecting Judicial Independence - Senate Foreign Relations Committee|Lawsuit exposes hidden factors driving up prescription drug costs - Association of Health Care Journalists|Canon Korea to sell J&J MedTech's joint implant in Korea - KBR"
1578,2024-03-06,"Art Curation Raises Awareness About Prostate Cancer in Nigeria - THISDAY Newspapers|J&J’s growing rare disease focus brings a potential multi-use treatment to the table - PharmaVoice|J&J Completes $2 Billion Ambrx Acquisition, Boosts Pipeline for Next-Gen ADCs - Pharmaceutical Technology Magazine|After withdrawal, GSK touts another Blenrep combo win as analysts build blockbuster case for the myeloma ADC - FiercePharma|Cancer-causing chemical found in Clinique, Clearasil acne treatments - Free Malaysia Today"
1579,2024-03-07,"A Complete List of Johnson & Johnson Brands - Thomas Insights|Big Pharma's R&D ROI: Merck, Pfizer, J&J, AbbVie strategies - Drug Discovery & Development|Cancer-causing benzene found in acne products: Independent lab - NewsNation Now"
1580,2024-03-08,Inaugural AACR Oncology Industry Partnering Event Aims to Help Scientists Turn Research Into Treatments - American Association for Cancer Research (AACR)|Ex-gov’s wife seeks more awareness in tackling cancer - Punch Newspapers|Meet 3 leaders who are breaking new ground for women in healthcare - Johnson & Johnson|Johnson & Johnson acquires Ambrx Biopharma for $2bn - Pharmaceutical Technology
1581,2024-03-09,"New data shows JNJ-2113, the first and only investigational targeted oral peptide, maintained skin clearance in moderate-to-severe plaque psoriasis through one year - PR Newswire|Plaque psoriasis patients treated with JNJ-2113 maintain skin clearance up to 1 year - Healio|Anti-IL-17, Anti-IL-23 Rxs Show Sustained Psoriasis Control - Medscape"
1582,2024-03-10,J&J’s growing rare disease focus brings a potential multi-use treatment to the table - BioPharma Dive|Johnson & Johnson submits supplemental Biologics License Application to U.S. FDA seeking approval of TREMFYA® (guselkumab) for the treatment of adults with moderately to severely active ulcerative colitis - PR Newswire|Legend CEO offers preview of high-stakes FDA adcomm for J&J-partnered Carvykti - FiercePharma|J&J Gets Phase II Win for First Targeted Oral Peptide in Plaque Psoriasis - BioSpace
1583,2024-03-11,J&J and Protagonist’s JNJ-2113 shown to maintain skin clearance in plaque psoriasis - PMLiVE|Dr Imran Khan Addresses Teclistamab’s Groundbreaking Impact and Ongoing Promise - AJMC.com Managed Markets Network|3 Dividend Kings of Healthcare Stocks to Buy Hand Over Fist in March - The Motley Fool
1584,2024-03-12,"J&J reveal long-term data for novel oral peptide JNJ-2113 - European Pharmaceutical Review|Heard at SXSW: How Slack, Johnson & Johnson, and Greenhouse think about HR and AI - HR Brew|Johnson & Johnson Shuts Down California R&D Outpost, Implements Layoffs - The Healthcare Technology Report.|Pharmacy benefit design: Johnson & Johnson lawsuit ushers in new 'duty of prudence' standard - BenefitsPro"
1585,2024-03-13,Johnson & Johnson class action alleges benzoyl peroxide acne products contain benzene - Top Class Actions|J&J's John Reed takes home $20M-plus payday in his first year helming pharma R&D team - Fierce Biotech|Human Rights Watch condemns Congress’ decision to oust members of Peru’s National Board of Justice - Peru Reports
1586,2024-03-14,"Dr Laura Ferris Discusses Safety, Efficacy of JNJ-2113 in Patients With Plaque Psoriasis - AJMC.com Managed Markets Network|Viatris generic hypertension drug does not violate J&J patents, US court says - Reuters.com|Skillman Consumer Healthcare Company to Relocate HQ, Layoffs - The Montgomery News|UPDATED: Despite early death concerns, FDA advisers back J&J and Legend's Carvykti and BMS' Abecma for earlier myeloma - FiercePharma|J&J, Novo support Asgard’s push to make ‘in vivo’ cell therapies - BioPharma Dive"
1587,2024-03-15,"FDA panel backs broader use of J&J, Bristol Myers cell therapies for myeloma - BioPharma Dive|Johnson & Johnson Stock Is Great. Here's Why You Shouldn't Buy It. - Yahoo Finance|Johnson & Johnson Stock Is Great. Here's Why You Shouldn't Buy It. - sharewise|Asgard Gets $32M Series A Backing from J&J, Novo and Boehringer - BioSpace"
1588,2024-03-16,
1589,2024-03-17,"Johnson & Johnson MedTech Works With NVIDIA to Broaden AI’s Reach in Surgery - NVIDIA Blog | Cutting, meet edge: J&J MedTech taps Nvidia for surgery AI partnership - Fierce Biotech | Nvidia and Johnson & Johnson to develop new AI applications for surgery - CNBC | J&J Medtech, Nvidia partner to bring AI to the operating room - MedTech Dive | Johnson & Johnson MedTech partners with Nvidia on AI in surgery - Mass Device"
1590,2024-03-18,Will Johnson & Johnson Stock Rebound To Its Pre-Inflation Shock Highs Of $185? - Forbes|Johnson & Johnson consumer arm reviews global creative account - CampaignLive|JNJ-2113 Shows Promising Response Rates Compared With Competitor Oral Therapies for Psoriasis - AJMC.com Managed Markets Network
1591,2024-03-19,"Johnson & Johnson & NVIDIA aim to boost AI use in surgery - IT Brief Asia|Idorsia's Tryvio crosses FDA finish line, offering new mechanism to treat hypertension - FiercePharma|Johnson & Johnson, Pfizer, Eli Lilly and other big pharmas are backing this San Diego biotech with $175M - The San Diego Union-Tribune|News from NVIDIA GPU Technology Conference, GTC 2024: CEO Introduces Blackwell Artificial Intelligence (AI) Processor, Announces Alliances with GE Healthcare, J&J MedTech - Imaging Technology News"
1592,2024-03-20,J&J sues former employee for allegedly taking thousands of documents to a new job at Pfizer - STAT|Top 10: Companies for Diversity & Inclusion - Sustainability Magazine|Berrynarbor pub venture turns seafood dream into reality - North Devon Gazette
1593,2024-03-21,"Capstan Secures $175M Oversubscribed Series B with Backing from J&J, Bayer and BMS - BioSpace|J&J's Abiomed sees serious Impella recall linked to heart perforations, 49 deaths - Fierce Biotech|Gaining An Edge: 5 AI-Powered Strategies For Stock Market Success - Forbes|Acne cream class action lawsuit filed over Benzene in Clean and Clear, Neutrogena - CNBCTV18|NVIDIA, Johnson & Johnson Medtech partner to integrate AI into surgery - Mobihealth News"
1594,2024-03-22,Top 5 Consumer Staples Stocks for Stability - Securities.io|(PDF) A comprehensive analysis of Johnson and Johnson's quarterly earnings per share (1960-1980) using R Studio. - ResearchGate|New family-run restaurant opens in beautiful part of Devon - Devon Live|Johnson & Johnson Mission Statement|Vision|Core Values|Strategy (2024 Analysis) - Business Strategy Hub
1595,2024-03-23,Antitrust Lawsuits on Increasing Biosimilar Accessibility - The Center for Biosimilars
1596,2024-03-24,Nvidia's AI Revolution Is Transforming Healthcare with Johnson & Johnson and GE Healthcare Partnerships - Benzinga|J&J’s Biosense Webster submits Varipulse pulsed field ablation system for FDA approval - Mass Device|Abiomed Impella ‘Instruction for Use’ Recall Linked to 49 Deaths - MD+DI|Biosense Webster takes key step toward FDA approval for Varipulse PFA system - Cardiovascular Business
1597,2024-03-25,US pharma giant Johnson & Johnson to move into Maidenhead's Tempo building - Maidenhead Advertiser|Shockwave Medical is reportedly a J&J acquisition target - Mass Device|J&J files for FDA approval of Varipulse pulsed field ablation platform - MedTech Dive|Johnson & Johnson’s Opsynvi granted FDA approval in pulmonary arterial hypertension - PMLiVE
1598,2024-03-26,Exclusive|Johnson & Johnson Considers Deal for Shockwave Medical - The Wall Street Journal|Shockwave Medical shares rise on report of Johnson & Johnson acquisition talks - MarketWatch|Johnson & Johnson named to Fortune's 2024 America's Most Innovative Companies list - Johnson & Johnson
1599,2024-03-27,"Johnson & Johnson is suing a former Philly-area employee, saying he took trade secrets to Pfizer - The Philadelphia Inquirer|Report: Johnson & Johnson once again considering deal to acquire Shockwave Medical - Cardiovascular Business|FDA approves new drugs for pulmonary arterial hypertension from Johnson & Johnson, Merck - Cardiovascular Business|J&J can contest evidence linking its talc to cancer, US judge rules - Reuters.com|J&J in talks to buy Shockwave Medical: WSJ - MedTech Dive"
1600,2024-03-28,"Johnson & Johnson gets a new opportunity to contest science in talc litigation - FiercePharma|Johnson & Johnson signs lease at Tempo in Maidenhead - Property Week|J&J to Pay $75 Million to Settle $6 Billion Baby Powder Suit (2) - Bloomberg Law|J&J, Legend expand manufacturing deal with Novartis to include commercial production of Carvykti - FiercePharma|What Companies Does Johnson & Johnson Own? - The Motley Fool"
1601,2024-03-29,New warnings about heart pumps linked to 49 deaths - CNN|Promoting 'Comfortable Diversity' Can Impact Firms' Bottom Lines - Law.com|US regulator issues highest alert for heart pump linked to 49 deaths - BBC.com|FDA issues alert on heart pump associated with 49 deaths - The Washington Post
1602,2024-03-30,
1603,2024-03-31,"Local apparel company creates first NCAA Final Four T-shirts for the University of Alabama - Alabama's News Leader | HELIX hits another homer: J&J to take space at life science center - ROI-NJ.com | Teva, Viatris win new chance to challenge J&J schizophrenia drug patent - Reuters | Korea leverages JLABS global network to enhance growth of biotech and medtech startups - BSA bureau | Another J&J Talc Trial Opens in Florida: 'This Fundamentally Is a Case About Science' - Law.com"
1604,2024-04-01,Sarasota jury hears opening statements in wrongful death trial against Johnson & Johnson - Sarasota Herald-Tribune|Integra LifeSciences completes acquisition of J&J’s Acclarent - Mass Device|Johnson & Johnson Begins Another Florida Cosmetic Talc Trial - Watch Gavel-to-Gavel via CVN - CVN News
1605,2024-04-02,Evaluation of an enhanced monofocal intraocular lens - Ophthalmology Times Europe|J&J doubles down on health equity with 100-plus partnerships and renewed local health initiatives - FiercePharma
1606,2024-04-03,Forever Chemicals Detected in Popular Bandage Brands — Which Brands Are PFAS-Free? - Green Matters|FDA announces new recall of neurovascular catheters built by Johnson & Johnson subsidiary - Cardiovascular Business|VISTA checkpoint inhibition by pH-selective antibody SNS-101 with optimized safety and pharmacokinetic profiles enhances PD-1 response - Nature.com|Stock Bull Run Powers Ahead After Blockbuster Jobs: Markets Wrap - Bloomberg
1607,2024-04-04,Johnson & Johnson boosts heart device business with $12.5 billion Shockwave Medical deal - CNBC|Johnson & Johnson to Acquire Shockwave Medical - Business Wire|SWAV Stock Alert: Shockwave Medical Lands Big Buyer in Johnson & Johnson - InvestorPlace|Johnson & Johnson to buy Shockwave in $13.1B deal - Yahoo Money|Johnson & Johnson to Acquire Shockwave Medical for $13.1B - MD+DI
1608,2024-04-05,Johnson & Johnson to acquire Shockwave Medical - Vascular News|Johnson & Johnson to buy Shockwave Medical in $13.1 billion deal to further combat heart disease - USA TODAY|Johnson & Johnson to acquire Shockwave Medical for $13.1B - Cardiovascular Business|Johnson & Johnson adds Shockwave Medical to its cardiovascular collection with $13.1B deal - Fierce Biotech
1609,2024-04-06,Johnson & Johnson to acquire Shockwave Medical - Today's Medical Developments|FDA Approves Cilta-Cel for Earlier Treatment of RRMM - AJMC.com Managed Markets Network|Ticker: Apple slashes jobs in Silicon Valley; J&J makes $13B deal for Shockwave - Boston Herald|‘I’m WARNING y’all now’: ‘Forever chemicals’ in Johnson & Johnson Band-Aids found to cause cancer through open wounds - The Daily Dot
1610,2024-04-07,"ACC: Study shows J&J's Abiomed pump reduces deaths after widowmaker heart attacks - Fierce Biotech|Johnson & Johnson to expand cardiovascular capabilities with $13.1bn Shockwave acquisition - PMLiVE|Abiomed reports positive Impella CP results in treating cardiogenic shock - Mass Device|Kenvue Revamps Cyber Tools After Spinoff From J&J - The Wall Street Journal|With wider approval, J&J and Legend's Carvykti quickly leaps ahead of BMS' rival myeloma CAR-T - FiercePharma"
1611,2024-04-08,Johnson & Johnson Acquires Cardiovascular Medical Device Company Shockwave Medical - HospiMedica|J&J to buy Shockwave for $13B in medical device play - Crain's New York Business
1612,2024-04-09,VIDEO: Johnson & Johnson Vision prepares for Tecnis Odyssey prelaunch in US - Healio|Healthy Returns: J&J cell therapy gains new edge over Bristol Myers rival - CNBC|Does Johnson & Johnson's Latest Acquisition Make It a No-Brainer Buy? - The Motley Fool|Advancing health for communities of color from the ground up - Johnson & Johnson|Nigeria recalls J&J children's cough syrup over toxic substance - Reuters.com
1613,2024-04-10,Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for April 2024 - InvestorPlace|Johnson & Johnson Lawsuit Alleges Band-Aids Contain Toxic Forever Chemicals - ClassAction.org|What’s Next For Johnson & Johnson Stock After A 6% Decline In A Month? - Forbes|NAFDAC Recalls Johnson & Johnson’s Benylin Paediatrics Cough Syrup - Business Post Nigeria
1614,2024-04-11,"Why Is Rallybio (RLYB) Stock Up 93% Today? - InvestorPlace|Johnson & Johnson Faces Class Action After PFAS, Bandages Report - Bloomberg Law|Kenya becomes the second African country after Nigeria to recall J&J children's cough syrup over safety concerns - Business Insider Africa|Kenya recalls J&J children's cough syrup over suspected toxicity - Reuters.com"
1615,2024-04-12,Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet - Benzinga|South Africa recalls J&J's cough syrup sold in six African nations after suspected toxicity - Reuters.com|Gov. DeWine visits COVID-19 vaccine clinic at Heritage Hall - The New Political|News|Neutrogena To Shut Los Angeles Headquarters as Operations Move to New Jersey - CoStar Group|Kenya recalls Johnson & Johnson children's cough syrup over suspected toxicity - The Citizen
1616,2024-04-13,"The 3 Best Stocks to Buy to Survive the Coming S&P 500 Crash - InvestorPlace|How long will the S&P 500 slide last? - TheStreet|Earnings week ahead: BAC, JNJ, TSM, UNH, ABT, SLB, UAL, PG, NFLX and more - Seeking Alpha"
1617,2024-04-14,The top 20 pharma companies by 2023 revenue - FiercePharma|Wall Street Breakfast Podcast: Samsung Overtakes Apple As Top Smartphone Maker - Seeking Alpha|JNJ: JNJ Earnings Forecast - Is Pharmaceutical Industry Set for Shake-up? - StockNews.com
1618,2024-04-15,"Here’s What To Expect From Johnson & Johnson’s Q1 - Forbes|Kenvue, Johnson & Johnson engage NAFDAC on recall of children’s cough syrup in Nigeria - Nairametrics|Johnson & Johnson's profit beats as sales fall slightly short of estimates - MarketWatch|Stocks on the move: UnitedHealth and Johnson & Johnson - CNBC|Johnson & Johnson Earnings: Solid Growth to Start the Year, but We Expect That to Slow by Midyear - Morningstar"
1619,2024-04-16,"J&J's medical device sales fall short, cancer drugs seen growing - Reuters.com|Johnson & Johnson Stock Falls After Earnings Beat. Talc Issues Loom. - Barron's|‘We think in decades’: J&J’s $30B spending spree may not be over - MedTech Dive|Johnson & Johnson cough syrup recall: Wetin we know - BBC.com"
1620,2024-04-17,Johnson & Johnson Reports First Quarter 2024 Financial Results - Vision Monday|Challenges in combating arboviral infections - Nature.com|J&J wins trial over Florida woman who claimed its baby powder caused her cancer - Reuters.com|How Johnson & Johnson is investing in innovation for patients and the NHS - The Telegraph|Nurse Leaders Named Fellows in Nursing Innovation - ChristianaCare News
1621,2024-04-18,"Pharmalittle: We're reading about plans for generic Wegovy, cough syrup warnings, and more - STAT|J&J, Other Q1 Financials Beg the Question: What Does It Mean to Miss Expectations? - BioSpace|Sports Medicine Market Global Forecast 2024-2030, Featuring Key Players Zimmer Biomet, Medtronic, Smith & Nephew, Stryker, Novartis, Johnson & Johnson, Conmed and Surgalign Holdings. - OrthoSpineNews|Chutes & Ladders—Recursion makes big executive splash, nabs J&J's chief data science officer - Fierce Biotech|Building climate-resilient health clinics - Johnson & Johnson"
1622,2024-04-19,"Analyst updates Johnson & Johnson stock price target after earnings - TheStreet|J&J wins trial over Florida woman who claimed its baby powder caused her cancer - ETHealthWorld|J&J’s AI head jumps to Recursion; Doug Williams resigns as Sana’s R&D chief - Endpoints News|AbbVie tops, J&J drops as physicians rank immunology players - FiercePharma|WHO likely to issue wider alert on contaminated J&J cough syrup - Reuters.com"
1623,2024-04-20,"J&J, Kenvue Told to Pay $45 Million to Baby Powder User’s Family - Bloomberg|Medical device companies pay millions to NHS while pushing products, says study - The Guardian"
1624,2024-04-21,"Johnson & Johnson Innovative Medicine Nigeria - Punch Newspapers|J&J Fired Worker For Old Case Against New Boss, Suit Claims - Law360|Florida Jury Clears Johnson & Johnson In Latest Cosmetic Talc Trial - Watch Gavel-to-Gavel via CVN - CVN News|Efficacy and safety of aticaprant, a kappa receptor antagonist, adjunctive to oral SSRI/SNRI antidepressant in major depressive disorder: results of a phase 2 randomized, double-blind, placebo-controlled study - Nature.com|Johnson & Johnson To Pay Millions To Woman Who Blamed Baby Powder For Cancer - NDTV"
1625,2024-04-22,What is a gene mutation? - Johnson & Johnson|Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
1626,2024-04-23,"Inside J&J’s strategy to de-gender clinical trials - PharmaVoice|Resolving Workforce Skills Gaps with AI-Powered Insights|MIT Center for Information Systems Research - BRIAN HEGER|12 Conestoga High Students Win National Merit Scholarships - Patch|Maker of Tylenol, Band-Aids and Listerine holds groundbreaking for North Jersey global HQ - NorthJersey.com"
1627,2024-04-24,"Orphan drug market to reach $270B by 2028, led by J&J, Vertex and Roche: Evaluate - FiercePharma|Cidara regains rights to flu med after Janssen makes good on promise to divest - Fierce Biotech|Cidara buys back rights to flu therapy from J&J for $85m - Pharmaceutical Technology|3 Long-Term Stocks to Buy on the Dip: April 2024 - InvestorPlace|The Top 3 Small-Cap Stocks to Buy in April 2024 - InvestorPlace"
1628,2024-04-25,"Gilead latest as all PD-1 agonist boats lifted by rising tide - BioWorld Online|Kenvue hires Russell Dyer as chief corporate affairs officer - PR Week|J&J Spin-Off CISO on Maximizing Cybersecurity - Dark Reading|Judge Orders J&J To Pay $45 Million in Talc Ruling - Happi|Rheumatoid Arthritis Pipeline Assessment 2024: Clinical Trials, FDA, EMA, and PMDA Approvals, Therapies, Treatment Market, Growth Prospects, and Companies by DelveInsight - Barchart"
1629,2024-04-26,7 Stocks to Buy if Inflation Continues to Reign in 2024 - InvestorPlace
1630,2024-04-27,Better Dividend Stock: AbbVie or Johnson & Johnson? - The Motley Fool|Supplier Collaboration Key to Johnson & Johnson Climate Push - Supply Chain Digital
1631,2024-04-28,"J&J-Partnered Addex Fails Phase II Epilepsy Study, Mulls Future of Candidate - BioSpace|Weekly Recap: Renfrew Buys Beautycounter, Top Growing Skincare Brands, J&J’s Talc Lawsuit & More - Beauty Packaging|J&J, Bristol Myers lose challenges to US drug price negotiation program - Reuters.com|Johnson & Johnson and Spinoff Kenvue Ordered to Pay US$45 Million in Talc Cancer Case - GlobalCosmeticsNews"
1632,2024-04-29,"Why Is Addex Therapeutics Stock Nosediving On Monday? - Addex Therapeutics (NASDAQ:ADXN) - Benzinga|Bristol Myers, Johnson & Johnson plot appeal after US judge dismisses IRA lawsuits - FiercePharma|Judge tosses Medicare drug negotiation challenges from Bristol Myers Squibb, Johnson & Johnson - The Hill|Johnson & Johnson, Kenvue Hit With $45 Million Talc Judgment - DrugWatch.com"
1633,2024-04-30,"Johnson & Johnson to pay $6.5 billion to resolve nearly all talc ovarian cancer lawsuits in U.S. - CNBC|5 things we now know about bladder cancer - Johnson & Johnson|Health Minister, Johnson & Johnson explore collaborative opportunities at Qatar Goals 2024 - Daily News Egypt|Johnson & Johnson Has a New Plan to Settle Talc Bankruptcy - Barron's|Johnson & Johnson’s latest gambit to solve its massive talcum powder asbestos issue: A $6.5 billion settlement, paid out over 25 years - Fortune"
1634,2024-05-01,Johnson & Johnson Proposes $6.48 Billion Settlement To Resolve Talc Lawsuits - DrugWatch.com|Johnson & Johnson proposes $6.5bn settlement of talc cancer lawsuits - The Guardian|Johnson & Johnson offers to pay $6.5 billion to settle talc ovarian cancer lawsuits - CBS News|Johnson & Johnson Launches $6.48B Bankruptcy Plan to Resolve Talc Lawsuits - Law.com
1635,2024-05-02,"Janssen to adopt Johnson & Johnson brand in UK - Medical Dialogues|Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims - Yahoo Finance|“I couldn’t speak, walk or sit.” Inside a rare autoimmune disease that attacks the muscles - Johnson & Johnson|The Robotic Surgeon Will See You Now - Investor's Business Daily"
1636,2024-05-03,Pharma R&D spend and performance: an inconsistent relationship - Drug Discovery & Development|Thousands Believe Covid Vaccines Harmed Them. Is Anyone Listening? - The New York Times|J&J To Acquire Shockwave Medical For $13.1B - Contract Pharma|TAR-200 Monotherapy Has 82.8% Complete Response Rate in BCG-Unresponsive HR-NMIBC - AJMC.com Managed Markets Network
1637,2024-05-04,Pharma giant adds Israel to list of Middle East markets after omission raises questions - Fox Business
1638,2024-05-05,J&J’s ‘Pretzel’ Drug-Device Combo Scores in Mid-Stage Bladder Cancer Study - BioSpace|Janssen-Cilag seeks European approval for guselkumab in ulcerative colitis and Crohn’s disease treatment - News-Medical.Net|Portfolios for dividend investors to consider - The Globe and Mail
1639,2024-05-06,"Kenvue maps out hundreds of layoffs as service pact with J&J winds down - FiercePharma|Tylenol maker Kenvue to cut 4% jobs, beats quarterly profit estimates - Reuters.com|Time To Buy Johnson & Johnson? One Analyst Sees The Stock's Price Gaining Over 40% - Yahoo Finance|2024 game changers - Irvine Standard"
1640,2024-05-07,J&J's Biosense Webster brings AI to its heart-mapping Carto 3 system - Fierce Biotech|Johnson & Johnson shares positive results for TAR-200 in high-risk bladder cancer - PMLiVE|Shockwave Medical Investor Challenges $13B Deal With J&J - Law360
1641,2024-05-08,"Biotech Breakthroughs: 3 Stocks on the Verge of Revolutionizing Medicine - InvestorPlace|Johnson and Johnson baby powder class action - The Australian Women's Weekly|After Jury Returns $45M Verdict Against Johnson & Johnson, Dean Omar Opens New Talc Trial in Oregon - Law.com|How robots are helping personalize knee replacement surgery - Johnson & Johnson"
1642,2024-05-09,"Three BiTEs set to disrupt r/r multiple myeloma space with $9 billion sales by 2030 - The Pharma Letter|Tale of misleading advertising! From Patanjali, Cadbury, and Nestle to Johnson & Johnson - The Financial Express|What Is the Dividend Payout for Johnson & Johnson Stock? - The Motley Fool|REPORT: PhRMA Company R&D Spending Pales in Comparison to Other Priorities Like Lobbying and Investor Giveaways - Accountable.US"
1643,2024-05-10,Johnson & Johnson Sues Plaintiffs' Talc Experts Accused of 'Widespread Deception' - Law.com|J&J's Megadyne division pulls pediatric electrosurgery pad from market following patient burn recall - Fierce Biotech
1644,2024-05-11,Forget Johnson & Johnson: Buy This Better Healthcare Stock Instead - The Motley Fool|Top 5 Blue-Chip Stocks Riding High Amid Market Surge - Analytics Insight
1645,2024-05-12,Johnson & Johnson Is Officially Getting Out of Kenvue (KVUE) Stock - InvestorPlace|J&J to exit spinoff Kenvue with latest stake sale - Reuters.com|Johnson & Johnson looks to offload remaining Kenvue stake in $3.75B deal - FiercePharma|Johnson & Johnson is selling off its stake in the maker of Tylenol and Band-Aids - Quartzy|Is Johnson & Johnson Stock A Better Pick Over Merck? - Trefis
1646,2024-05-13,Johnson & Johnson is selling its remaining Kenvue shares - MarketWatch|Kenvue Announces Launch of Secondary Offering - Business Wire|J&J’s $13 billion bid for Shockwave gets help from Wall Street - MarketWatch
1647,2024-05-14,"Roxana Botea, Johnson & Johnson Romania: speaker at Innovate Health 2024 - Business Review|Kenvue Announces Pricing of Secondary Offering - Business Wire|Is Johnson & Johnson Stock A Better Pick Over Merck? - Forbes|Johnson & Johnson Settles With States for $700 Million - Mesothelioma.com|Kenvue appoints global creative agencies - Campaign US"
1648,2024-05-15,"Rare Blood Clots From J&J, Astra Covid Shots Linked to Genetics - Bloomberg|Analysis of pharmaceutical R&D ranks Novo Nordisk and Johnson & Johnson above their peers - STAT|J&J Joins Chase for Hot Immunology Target With $850M Proteologix Acquisition - MedCity News|J&J hooks Proteologix for $850M cash, reeling in a roster of early bispecifics - Fierce Biotech|Rare but deadly blood clots tied to Johnson & Johnson and AstraZeneca Covid-19 vaccines: scientists report to journal|Today News - Mint"
1649,2024-05-16,"Johnson & Johnson Agrees To Acquire Proteologix - Contract Pharma|Johnson & Johnson to Acquire Proteologix, Inc. to Lead in Atopic Dermatitis Treatment - Business Wire"
1650,2024-05-17,J&J (JNJ) to Boost Dermatology Portfolio With New Acquisition - Yahoo Finance|Johnson & Johnson brings in billions from remaining Kenvue stake - Mass Device|J&J expands dermatology portfolio with $850m Proteologix acquisition - Pharmaceutical Technology|Very rare COVID vaccine-related blood clots share genes with condition linked to common cold - Fierce Biotech|Biosense Webster presents data backing Varipulse pulsed field ablation - Mass Device
1651,2024-05-18,"Study links talc to ovarian cancer, with implications for J&J lawsuits - NBC News|Johnson & Johnson settlement shows the new stakes in litigation finance - Financial Times|CNS-Focused Rapport Therapeutics Preps IPO to Back Phase 2-Ready Epilepsy Drug - MedCity News"
1652,2024-05-19,"J&J MedTech and Hutom to co-promote AI-based surgical navigation platform - KBR|Third Rock, J&J neuroscience spinout Rapport is first biotech to outline summer IPO plans - Fierce Biotech|J&J posts latest Varipulse data while awaiting FDA review - MedTech Dive"
1653,2024-05-20,"Johnson & Johnson plans $850M Proteologix acquisition - NJBIZ|Johnson & Johnson 1Q Results - Contract Pharma|J&J study shows 25% of pulsed field ablation procedures performed with zero X-ray guidance - Fierce Biotech|UPDATED: As Stelara nears patent cliff, J&J fortifies Tremfya for upcoming IBD showdown - FiercePharma|Meet a nurse who leads clinical trials to find innovative cancer therapies - Johnson & Johnson"
1654,2024-05-21,"New NIH findings on talc use and ovarian cancer pose challenge to J&J's high-stakes defense - FiercePharma|Johnson & Johnson Talc Bankruptcies Abused System, Suit Says (1) - Bloomberg Law|Talc Plaintiffs File Class Action Over Johnson & Johnson's Alleged 'Fraudulent Transfers' - Law.com"
1655,2024-05-22,J&J faces allegations it used 'fraudulent maneuvers' to avoid compensating talc plaintiffs - FiercePharma|J&J medical technology sales by franchise 2021-2023 - Statista|Talcum Powder Lawsuit Update - Forbes
1656,2024-05-23,"Warning signs: Are you working with a self-serving PBM? - BenefitsPro|ASCO: J&J's radioligand spurs responses, but 4 deaths mar early results - Fierce Biotech|Johnson & Johnson (JNJ) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance Australia|Johnson & Johnson's Robust Portfolio and Pipeline Set Up Steady Long-Term Growth - Morningstar|ASCO24: J&J Reports Four Patient Deaths in Early-Stage Prostate Cancer Trial - BioSpace"
1657,2024-05-24,"3 Dow Stocks to Buy on the Dip: May 2024 - InvestorPlace|Why Top-Rated Medtech RxSight Has 20/20 Vision — And Is Seeing 50% Growth - Investor's Business Daily|If I Had To Retire With 10 Dividend Aristocrats, It Would Be These - Seeking Alpha"
1658,2024-05-25,
1659,2024-05-26,"Johnson & Johnson (NYSE:JNJ) Shares Down 1.8% - MarketBeat | 5 Magnificent Stocks Being Bought for Warren Buffett's $646 Million ""Secret"" Portfolio - The Motley Fool | Who Will the Next “Big Pharma” Players Be? - BioSpace"
1660,2024-05-27,Johnson & Johnson to Obtain Rights to a Clinical-Stage Bispecific Antibody to Address Distinct Patient Needs in Atopic Dermatitis - Business Wire|J&J Adds Another Bispecific Antibody for Atopic Dermatitis With $1.25B Acquisition - MedCity News|J&J’s Ethicon launches new surgical stapler - Mass Device|J&J acquires experimental skin disorder drug for $1.25 billion - Reuters.com|J&J scoops up another atopic dermatitis antibody in $1.25B Numab rights deal - Fierce Biotech
1661,2024-05-28,Johnson & Johnson (NYSE:JNJ) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future? - Yahoo Finance|Johnson & Johnson Pursues Global Rights to Numab Therapeutics’ AD-Targeting Bispecific Antibody in $1.25 Billion Acquisition - BioPharm International|J&J's drug eases depression and insomnia symptoms in late-stage study - Reuters.com
1662,2024-05-29,"Are You Looking for a High-Growth Dividend Stock? - Yahoo|Johnson & Johnson agrees to acquire Yellow Jersey Therapeutics - TechTarget|Johnson & Johnson Breach Could Be Linked to Cencora Breach - The Cyber Express|J&J Scores Phase III Victory in Major Depressive Disorder - BioSpace|Numab Therapeutics' spin-off, Yellow Jersey Therapeutics, gets acquired by Johnson & Johnson for USD 1.25 billion - Venturelab"
1663,2024-05-30,"J&J's (JNJ) Oral Pill Improves Depression & Insomnia Symptoms - Yahoo Finance|It’s official: Johnson & Johnson completes $13B Shockwave Medical acquisition - Cardiovascular Business|“I’m a scientist dedicated to bringing eye-health innovations to the world” - Johnson & Johnson|Johnson & Johnson launching ACUVUE OASYS MAX 1-Day Sphere and Multifocal contact lenses - Insight|ASCO: In surprise, J&J's injectable Rybrevant extends lung cancer patients' lives versus intravenous version - FiercePharma"
1664,2024-05-31,Johnson & Johnson: Market Will Regret The Overreaction (NYSE:JNJ) - Seeking Alpha|Johnson & Johnson Completes Acquisition of Shockwave Medical - Business Wire|Johnson & Johnson completes $13.1B acquisition of Shockwave Medical - NJBIZ
1665,2024-06-01,US lawmakers ask FBI for briefing on GenScript Biotech's links to China - Reuters.com|Development and deployment of a histopathology-based deep learning algorithm for patient prescreening in a clinical trial - Nature.com|Johnson & Johnson concludes acquisition of Shockwave Medical - Medical Dialogues|3 Magnificent Dividend Stocks to Buy and Hold Forever - Yahoo Finance
1666,2024-06-02,"J&J-backed Rapport Therapeutics seeks about $637 mln valuation in US IPO - ETHealthWorld|GSK hit with high-stakes setback in Zantac saga as judge allows tens of thousands of lawsuits to proceed - FiercePharma|J&J Must Pay $260 Million in Latest Talc Trial, Oregon Jury Says - U.S. News & World Report|Johnson & Johnson acquires Shockwave in $13.1bn deal - Yahoo Finance|Top 5 highest paid biopharma R&D executives in 2023 - Fierce Biotech"
1667,2024-06-03,US court jury directs J&J to pay $260 million to baby powder user - Business Standard|“Lung cancer wasn’t even on my radar. Then I was diagnosed.” - Johnson & Johnson|Beaverton woman awarded $260M from Johnson & Johnson after cancer diagnosis - KOIN.com|Oregon jury says Johnson & Johnson must pay $260M in mesothelioma talc case - FiercePharma
1668,2024-06-04,"Johnson & Johnson New Proposal for Talc Cancer Lawsuits - Mesothelioma Guide|4 things to know about Johnson & Johnson’s 2023 Health for Humanity Report - Johnson & Johnson|J&J must pay $260 million in latest talc trial, Oregon jury says - Reuters|The 3 Most Undervalued Dow Stocks to Buy in June 2024 - InvestorPlace"
1669,2024-06-05,"Is Johnson & Johnson A Good Quality Stock to Buy Now? - Insider Monkey|Beaverton woman awarded $260M from Johnson & Johnson following cancer diagnosis - Fox 12 Oregon|America’s Top 10 Most Valuable Companies, 1990 to 2024 - CEOWORLD magazine|Analysts predict myeloma market will hit $33B by 2030—and tip one company to take the lion's share - FiercePharma"
1670,2024-06-06,"Jury Awards $260 Million to Baby Powder User in Case Against Johnson & Johnson - DrugWatch.com|Is Johnson & Johnson (NYSE:JNJ) the Best Mega-Cap Dividend Aristocrat Stock? - Yahoo Finance|Up 400% In 3 Years, Eli Lilly Stock Just Keeps Giving - Forbes|J&J-backed Rapport Therapeutics valued at $636.8 mln in lukewarm debut - Reuters.com|Pharmalittle: We're reading about the aftermath of FDA vote on MDMA, rising pharma layoffs, and more - STAT"
1671,2024-06-07,DePuy Synthes Receives 510(k) FDA Clearance of the VELYS™ Robotic-Assisted Solution for Use in Unicompartmental Knee Arthroplasty Procedures - PR Newswire|Woman awarded $260M from Johnson & Johnson following cancer diagnosis - KMVT|Pharma’s R&D gamble: picking pipeline winners in a risky field - PharmaVoice
1672,2024-06-08,SunRISe-2 Trial: TAR-200 and Cetrelimab vs. Chemoradiotherapy for Muscle-Invasive Bladder Cancer - Stephen Williams - UroToday
1673,2024-06-09,"Pulsed field ablation to ‘cannibalize’ radiofrequency, cryo: Needham - MedTech Dive|How companies can use AI to find and close skills gaps - MIT Sloan News|Colorado board declares second prescription drug to be unaffordable - The Sum & Substance|Oregon Jury Awards $260 Million in Case Against Johnson & Johnson - Lawyer Monthly Magazine|J&J wins expanded FDA clearance for knee surgery robot - MedTech Dive"
1674,2024-06-10,"New Hampshire joins $700M settlement against Johnson & Johnson - WMUR Manchester|Vermont to get $3 million from nationwide settlement with Johnson & Johnson over products that may have contained asbestos - VTDigger|Johnson & Johnson (JNJ) Stock Dips While Market Gains: Key Facts - Yahoo Finance|Johnson & Johnson reaches $700 million settlement in talc baby powder case - CBS News|Johnson & Johnson, 43 attorneys general reach $700M settlement over talc baby powder - NBC Washington"
1675,2024-06-11,Johnson & Johnson agrees to pay $700M to settle talcum lawsuit with dozens of states - UPI News|Indiana AG’s Office files lawsuit against Johnson & Johnson for deceptive marketing over Talc Powder - FOX 59 Indianapolis|Arizona to get $15.5M in Johnson & Johnson settlement over talc baby powder - The Arizona Republic
1676,2024-06-12,The J&J lawsuit should be a wakeup call to the PBM industry — and to companies everywhere - STAT|New York gets $44 million from Johnson & Johnson for baby powder - NEWS10 ABC|Johnson & Johnson reaches $700 million talc settlement with U.S. states - NBC News|Johnson & Johnson reaches $700 million talc settlement with US govt - The Times of India|Talc plaintiffs file for restraining order to block Johnson & Johnson's 3rd bankruptcy attempt - FiercePharma
1677,2024-06-13,Johnson & Johnson Reaches $700M Settlement With 42 States Over Talc Product Marketing - Consumernotice.org|Alabama to get $13.5 million settlement in Johnson & Johnson baby powder lawsuit - 1819 News|MSFT: 3 Blue-Chip Stocks Offering Stability - StockNews.com|Xencor Regains CD20 x CD3 Bispecific T-Cell Engager - Business Wire
1678,2024-06-14,"Blue-Chip Jackpots: 3 Top-Notch Stocks at Bottom-Barrel Prices - InvestorPlace|Aldeyra Therapeutics concludes subject enrolment in dry eye disease trial - Clinical Trials Arena|Letitia James Celebrates $44 Million Win - Newsweek|JPMorgan's Ozempic bet, J&J's baby powder settlement, Moderna's COVID-flu vax: Pharma news round up - Quartzy|The 10 Best US Dividend Stocks - Morningstar"
1679,2024-06-15,
1680,2024-06-16,"Legend Biotech's Cancer Drug, 'The Most Attractive Product,' Set For Growth: Analyst - Markets Insider | J&J commits five-year investment in Italian medicine manufacturing - European Pharmaceutical Review | J&J's phase 2 Sjögren's data support FcRn strategy in the autoimmune disorder - Fierce Biotech | J&J’s DePuy Synthes orthopedics robot cleared for partial knee replacements - Fierce Biotech | Italy: Johnson & Johnson invests in Latina site to increase capacity - Investors in Healthcare"
1681,2024-06-17,Johnson & Johnson (JNJ) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance|Johnson & Johnson submits BLA to FDA for lung cancer treatment - Pharmaceutical Technology|Subcutaneous amivantamab Biologics License Application submitted to U.S. FDA for patients with EGFR-mutated non-small cell lung cancer - PR Newswire|Pharmaceutical Powerhouse: Johnson & Johnson is once again the world's most valuable and strongest pharma brand - Brand Finance
1682,2024-06-18,Discovery of JNJ-74856665: A Novel Isoquinolinone DHODH Inhibitor for the Treatment of AML - ACS Publications|Johnson & Johnson baby powder users want cancer monitoring even if it costs billions - The Straits Times|Pharmaceutical Powerhouse: Johnson & Johnson is once again the world’s most valuable and strongest pharma brand - WebWire|Johnsons & Johnsons Slammed With A New Class Action Suit For Talc Powder - Free Press Journal|Johnson & Johnson Settles With U.S. States for $700 Million - Mesothelioma Guide
1683,2024-06-19,"How Pfizer, Bristol Myers Squibb and Johnson & Johnson Are Confronting Patent Cliffs - BioSpace|Johnson & Johnson faces new class action lawsuit on behalf of talc users - Fox Business|Johnson & Johnson MedTech launches digital surgical ecosystem - Mass Device|Here's how much Wisconsin will receive from the $700 million Johnson & Johnson settlement - Milwaukee Journal Sentinel"
1684,2024-06-20,J&J (JNJ) Seeks Expanded Use of Tremfya for Crohn's Disease - Yahoo Finance|Johnson & Johnson seeks FDA approval for Tremfya for Crohn’s disease - Pharmaceutical Technology
1685,2024-06-21,"3 High-Yield Dividend Stocks Near Their 52-Week Lows to Buy and Hold - The Motley Fool|Menin inhibitors seek to debut as newest targeted therapy for leukaemia - Nature.com|Rochesterfest Vendors: Caribbean Delights, Cookies, and Fair Food Favorites - 106.9 KROC|Johnson & Johnson Completes Acquisition of Proteologix, Inc. - Business Wire"
1686,2024-06-22,Johnson & Johnson (NYSE:JNJ) Seems To Use Debt Quite Sensibly - Yahoo Finance|Johnson & Johnson Settles $700 Million Talc Product Investigation With 42 U.S. States - Live Law - Indian Legal News
1687,2024-06-23,Do Options Traders Know Something About Johnson & Johnson (JNJ) Stock We Don't? - Yahoo Finance|Johnson & Johnson invests in TECLens refractive technology startup - Healio|Johnson & Johnson (JNJ): What Made this Healthcare Giant Get a Positive Analyst Outlook in Q1? - Yahoo Finance|Johnson & Johnson Faces New Class Action Over Talc Products - GlobalCosmeticsNews
1688,2024-06-24,"Johnson & Johnson (JNJ) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance|After IBD wins, J&J's Tremfya misses the mark in giant cell arteritis - FiercePharma|Lawyers suing Johnson & Johnson in baby powder suits seek privileged attorney-client communications - ABA Journal"
1689,2024-06-25,10 Best Blue-Chip Stocks to Buy for 2024|Investing - U.S News & World Report Money|Innovation Made Real: How Johnson & Johnson Innovation – JLABS Singapore Helps Promising Healthcare Startups Gain Ground in Singapore - CapitaLand|Getting in front of cancer - Johnson & Johnson
1690,2024-06-26,"Johnson & Johnson on Balancing People, Planet & Profit - Sustainability Magazine|How Much Each State Will Get From J&J Talc Settlement - DrugWatch.com|11 Best Johnson & Johnson’s Baby Care Products In 2024 - MomJunction|Patient Education is Key — Head of Hematology at Johnson & Johnson On Getting Multiple Myeloma Patients Access to Good Information & Care - SurvivorNet"
1691,2024-06-27,"10 Top Dividend Stocks for 2024 - Morningstar|Johnson & Johnson Foundation - Girl Scouts|Johnson & Johnson's (NYSE:JNJ) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? - Yahoo Finance|Appeals Court Rejects Neutrogena, Aveeno Sunscreen Lawsuit Settlement - AboutLawsuits.com"
1692,2024-06-28,Supreme Court opioid case makes it harder to shield wealth in bankruptcy - The Washington Post|Johnson & Johnson Beats Bid to Block Third Talc Unit Bankruptcy - Bloomberg Law|J&J Offers $6.48 Billion to Settle Ovarian Cancer Talcum Powder Lawsuits - LawyersandSettlements.com|Nipocalimab pivotal Phase 3 trial demonstrates longest sustained disease control in FcRn class for broadest population of myasthenia gravis patients - PR Newswire|4 Cheap Stocks to Buy in July - The Motley Fool
1693,2024-06-29,Cancer victims lose bid to block proposed J&J talc bankruptcy - Reuters.com|Treasure Hunt: 3 Small-Cap Stocks Wall Street Hasn’t Discovered Yet - InvestorPlace
1694,2024-06-30,"J&J unwraps pivotal data on $6.5B autoimmune asset as it prepares to crash argenx and UCB's party - Fierce Biotech|Scientist defeats J&J lawsuit over cancer research - Reuters.com|Talc claimants denied in effort to block Johnson & Johnson's latest Texas two-step bankruptcy - FiercePharma|After Gilead and J&J lawsuits, distributor Safe Chain sees its owners charged in criminal indictment - FiercePharma|Quantum Computing for Pharma with Johnson & Johnson - The Quantum Insider"
1695,2024-07-01,"Court Rules Against Johnson & Johnson In Talcum Powder Cancer Study Case - Benzinga|Johnson & Johnson stock rises Monday, still underperforms market - MarketWatch|3 Magnificent Stocks Retirees Can Buy and Hold Forever - The Motley Fool|Johnson & Johnson reports positive phase 3 results in myasthenia gravis - BioPharma-Reporter.com"
1696,2024-07-02,"Johnson & Johnson: A Lot Of Moving Parts, But Perhaps Finally Lurching In The Right Direction - Seeking Alpha|Johnson & Johnson Acquires Ambrx Biopharma - Contract Pharma|Johnson & Johnson's Cell Therapy Carvykti Shows Better Survival Rate In Pretreated Blood Cancer Patients - Yahoo Finance|Johnson & Johnson gains FDA and EC approvals for TB treatment - Pharmaceutical Technology"
1697,2024-07-03,"Finding Hope with Clinical Trials: Q&A with Nick Slack, Chairman and CEO of START Center for Cancer Research - Applied Clinical Trials Online|Lloyd Doggett from Texas's 37th district reinvests in Home Depot, IBM, Johnson & Johnson, and PPG Industries - Investing.com|COVID-19 on the rise again - wvua23.com|Johnson & Johnson reports data from Phase III multiple myeloma treatment trial - Clinical Trials Arena"
1698,2024-07-04,"J&J's Patent for Paediatric TB Drug Rejected, Move Hailed as 'Significant Victory' for Children - The Wire|Johnson & Johnson stock rises Friday, still underperforms market - MarketWatch|Pharmalittle: We're reading about Ozempic and an eye condition, a failed Roche cancer drug trial, and more - STAT|Commission decides not to escalate Johnson & Johnson case to the Tribunal - Creamer Media's Engineering News"
1699,2024-07-05,"Lifesaving TB drug: SA's competition watchdog drops case into J&J after price cuts - News24|Here’s why Eli Lilly, Pfizer and J&J are in San Diego looking for the next big drug - The San Diego Union-Tribune|Another class action claims Band-Aid products contain PFAS - Top Class Actions"
1700,2024-07-06,7 Safe Haven Stocks to Buy Before the Next Market Correction - InvestorPlace
1701,2024-07-07,"The Talc tragedy: Inside the Johnson & Johnson lawsuit saga - The Economic Times|J&J's tuberculosis med Sirturo lands full US, EU approvals after more than a decade on the market - FiercePharma|J&J, Arcutis back educational video series about how skin conditions affect people of color - FiercePharma|Johnson & Johnson: Remaining A Buy Despite Remaining Risks (NYSE:JNJ) - Seeking Alpha"
1702,2024-07-08,Johnson & Johnson Faces MedTech Challenges But Is 'On Track' To Meet 2024 Guidance: Goldman Sachs - Markets Insider|Johnson & Johnson (JNJ): One of the Best Blue Chip Dividend Stocks Right Now According to Hedge Funds? - Insider Monkey|Emergent to receive $50M from J&J to settle Covid-19 vaccine contract dispute - The Business Journals|South Africa and J&J reach a deal to widen access to a key tuberculosis treatment - STAT
1703,2024-07-09,Emergent BioSolutions And Johnson & Johnson Resolve Claims Over COVID-19 Vaccine Manufacturing - Benzinga|Johnson & Johnson pays $50M to resolve its ugly divorce with Emergent BioSolutions - FiercePharma|Relief in South Africa after J&J reversal allows key tuberculosis drug production at lower prices - The Associated Press|Johnson & Johnson (JNJ) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance
1704,2024-07-10,TD Bank adds retired Johnson & Johnson executive to its Community Advisory Board - TBBW|JNJ should continue higher at least to complete a pullback - FXStreet|Johnson & Johnson closes $1.25B Yellow Jersey acquisition - NJBIZ|Multiple Novel Oral Agents Show Promise in Psoriasis - Physician's Weekly
1705,2024-07-11,Johnson & Johnson wraps up $1.2bn acquisition of Yellow Jersey Therapeutics - World Pharmaceutical Frontiers|No “killer acquisition” – FCO allows acquisition of Shockwave Medical by Johnson & Johnson - Cleary Antitrust Watch|Johnson & Johnson expands further with purchase of additional land for Cork site - Irish Examiner
1706,2024-07-12,"3 Essential Stocks for Building a Recession-Proof Portfolio - InvestorPlace|Johnson & Johnson secures additional land for expansion in Cork - EchoLive.ie|Johnson & Johnson stock rises Friday, still underperforms market - MarketWatch|J&J limits use of Megadyne electrodes due to burn risk - MedTech Dive|6 Most Undervalued Stocks To Buy In August 2024 - Forbes"
1707,2024-07-13,"Earnings week ahead: BAC, GS, JNJ, TSM, UNH, ABT, UAL, NFLX, AXP and more (NYSE:BAC) - Seeking Alpha|2 Healthcare Stocks to Buy Hand Over Fist This Month - The Motley Fool|What To Expect in the Markets This Week - Investopedia|The battle over J&J’s bankruptcy plan to end talc lawsuits - News24|3 High-Yield Dividend Stocks That Still Look Like Bargains - The Motley Fool"
1708,2024-07-14,Johnson & Johnson Stock (NYSE:JNJ): The Best Buying Opportunity in Over a Decade? - TipRanks|J&J’s CAR-T partner Legend Biotech reportedly receives buyout offer - FiercePharma|Johnson & Johnson's (NYSE:JNJ) 6.0% CAGR outpaced the company's earnings growth over the same five-year period - Yahoo Finance
1709,2024-07-15,Johnson & Johnson: Bullish Charts Signal Strong Setup Before Q2 Earnings - Benzinga|3 Reasons Johnson & Johnson (NYSE:JNJ) Is an Attractive Dividend Growth Stock - TipRanks|MedTech To Drive Johnson & Johnson’s Q2? - Forbes|Johnson & Johnson Q2 Earnings Preview: Can New Drugs Lift Sagging Stock? - Markets Insider
1710,2024-07-16,Johnson & Johnson Q2 profit beats expectations as forecast cut on M&A costs - Business Standard|J&J keeps growth projections afloat as it braces for IRA price negotiation impact - FiercePharma|This Medical Giant's Stock Rebounds: A 15% Upside Is the Minimum - MarketBeat|Johnson & Johnson boosts full-year outlook on strong Q2 sales numbers - MM+M Online
1711,2024-07-17,"3 High Yield Healthcare Giants With Consistent Dividend Growth: Johnson & Johnson, Merck, And Quest Diagnostics - Yahoo Finance|Johnson & Johnson (JNJ) Q2 2024 Earnings Call Transcript - The Motley Fool|Johnson & Johnson tops Wall Street’s Q2 expectations, lowers EPS guidance - Mass Device"
1712,2024-07-18,"Pharma Stock Roundup: JNJ, NVS Q2 Earnings, RHHBY's Positive Obesity Pill Data - Yahoo Finance|Johnson & Johnson Reports Sales Growth of 4.3 Percent in Second Quarter and Updates 2024 Guidance - Vision Monday|Johnson & Johnson Cancer Lawsuit - Action News 5|Is Johnson & Johnson a Buy Now? - The Motley Fool"
1713,2024-07-19,"Johnson & Johnson and Legend Biotech’s Carvykti shows improved survival in treatment-experienced multiple myeloma patients - 2 Minute Medicine|Pan-serotype dengue virus inhibitor JNJ-A07 targets NS4A-2K-NS4B interaction with NS2B/NS3 and blocks replication organelle formation - Nature.com|Dividend Roundup: Goldman Sachs, Johnson & Johnson, Qualcomm, Caterpillar, and more - Seeking Alpha|Yuhan’s new lung cancer drug set for global market with Johnson & Johnson deal - The Korea JoongAng Daily"
1714,2024-07-20,Johnson & Johnson Secures Additional Land for Cork Manufacturing Site - TheCork.ie|What a List of the Best-Performing Stocks of the Past Century Tells Us - Investopedia
1715,2024-07-21,Johnson & Johnson Faces Legal Hurdle In Talc Lawsuit Battle - Benzinga|J&J’s Carvykti to make meteoric rise in multiple myeloma - Clinical Trials Arena|J&J seeks expanded approval for antidepressant Spravato - BioPharma Dive|3. Johnson & Johnson - Contract Pharma|Should You Pick Johnson & Johnson Stock At $155 After Q2 Beat? - Forbes
1716,2024-07-22,Johnson & Johnson submits sNDA for SPRAVATO to treat depression - Pharmaceutical Technology|14 NBA Teams Hit With Music-Use Copyright Infringement Claims by Johnson & Johnson Firm - Law.com|Johnson & Johnson MedTech Unveils Polyphonic Digital Ecosystem for Enhanced Surgical Collaboration - The Healthcare Technology Report.|J&J Allies With Mass-Tort Specialists to Seal $8 Billion Talc Settlement - The Wall Street Journal|Johnson & Johnson Nears Settlement in Talc Dispute - Consumernotice.org
1717,2024-07-23,"Protagonist Therapeutics reveals new obesity program, BTIG keeps buy rating - Investing.com|J&J vets burst into biotech with $165M Third Arc series A - Fierce Biotech|Johnson & Johnson Strengthens Position In Italy With €580M Investment - Contract Pharma|New Jersey judge blocks JnJ move to disqualify law firm from talc cases - GlobalCosmeticsNews|Biotech led by J&J veterans launches with $165 million for cancer, autoimmune therapies - STAT"
1718,2024-07-24,Johnson & Johnson Vision produces disappointing results - Jacksonville Daily Record|J&J Loses Latest Legal Bid to Revive Talc Bankruptcy Strategy - Bloomberg|Sandoz launches biosimilar Pyzchiva across Europe - The Pharma Letter|J&J talc bankruptcy plan appeal denied (NYSE:JNJ) - Seeking Alpha
1719,2024-07-25,"J&J’s Third Try At 'Texas Two-Step' To Handle Talc Claims - Finimize|Johnson & Johnson stock rises Friday, still underperforms market - MarketWatch|AC Immune’s ACI-35.030 (now “JNJ-2056”) Granted FDA Fast Track Designation for Alzheimer’s Disease - Yahoo Finance|J&J's Texas two-step bankruptcy maneuver shut down again by appeals court - FiercePharma"
1720,2024-07-26,"Congress considers bill to toss Texas Two-Step bankruptcy strategy - NJBIZ|Could Johnson & Johnson's Troubles With Talc Lawsuits Finally Be Coming to an End? - The Motley Fool|FINAL DEADLINE: Ovarian Cancer Victims Have Until 5pm ET Today to Vote on Approximately $8 Billion J&J Talc Compensation Plan – Company Announcement - FT.com - Financial Times|With J&J pushing a 3rd talc bankruptcy, court affirms earlier loss - Reuters.com"
1721,2024-07-27,3 High-Yielding Dividend Aristocrats to Buy Now - TheStreet|'Never going to be the same': How Nvidia is trying to revolutionize healthcare - Yahoo Finance
1722,2024-07-28,Johnson & Johnson looks to expand FDA approval for Spravato anti-depressant - World Aerosols|Sriram Sundararajan receives the ASME Johnson & Johnson Medal - Iowa State University College of Engineering News|J&J spin-off Kenvue's Rs 120 crore regional media mandate up for grabs - BestMediaInfo|Johnson & Johnson’s Rybrevant recommended by CHMP for pre-treated advanced NSCLC - PMLiVE
1723,2024-07-29,"Johnson & Johnson to Participate in the 2024 Wells Fargo Healthcare Conference - Business Wire|JNJ-77242113, a highly potent, selective peptide targeting the IL-23 receptor, provides robust IL-23 pathway inhibition upon oral dosing in rats and humans - Nature.com|Q3’s Rising Stars: 3 Dow Stocks for Your Must-Watch List - InvestorPlace|Unlearn Presents Studies on AI-powered Clinical Trials with AbbVie and Johnson & Johnson Innovative Medicine at the Alzheimer's Association International Conference 2024 - Business Wire"
1724,2024-07-30,"Our partnerships for a lasting impact - Johnson & Johnson|FDA approves Johnson & Johnson’s multiple myeloma treatment - Pharmaceutical Technology|Bristol Myers, Johnson & Johnson, AbbVie, AstraZeneca Expect Minimal Impact From Upcoming Medicare Price Negotiations - AstraZeneca (NASDAQ:AZN), Johnson & Johnson (NYSE:JNJ), Bristol-Myers Squibb (NYSE:BMY) - Benzinga"
1725,2024-07-31,"FDA, Health Canada team up to raise awareness of J&J’s Megadyne recall - MedTech Dive|Johnson & Johnson’s Darzalex Faspro regimen approved by FDA for multiple myeloma - PMLiVE|Johnson & Johnson Escapes Class Action Over Gelcap Marketing - Bloomberg Law|JNJ Stock Gains 10% Through July, Earnings Impress - AskTraders"
1726,2024-08-01,J&J's DePuy Synthes nets clearance for Velys spine surgery robot - Fierce Biotech|Forget Johnson & Johnson: Another Healthcare Giant Is a Much Better Bet for Growth - The Motley Fool|J&J’s DePuy Synthes launches Velys surgical robot for spine - Mass Device|Johnson & Johnson secures deal for Strickland General Agency - Insurance Business
1727,2024-08-02,Prediction: 2 Stocks That Will Be Worth More Than Johnson & Johnson 10 Years From Now - The Motley Fool|DePuy Synthes Launches its First Active Spine Robotics and Navigation Platform - PR Newswire|U.S. Appeals Court Affirms Rejection of Johnson & Johnson's Second Talcum Powder Bankruptcy Filing - AboutLawsuits.com
1728,2024-08-03,Invest $50K in Johnson & Johnson to Become a Dividend Millionaire in 10 Years? - Yahoo Finance|Prediction: 2 Stocks That Will Be Worth More Than Johnson & Johnson 10 Years From Now - sharewise|3 Under-The-Radar Healthcare Stocks to Buy for Outsized Returns - InvestorPlace|The Best Stocks to Buy for Your RRSP in November 2024 - Stocktrades.ca
1729,2024-08-04,37% Of This Johnson & Johnson Insider's Holdings Were Sold - Simply Wall St|3 Defensive Stocks Weathering the Market Storm - MarketBeat|Montgomery County biotech firm led by J&J alums emerges from stealth mode with $165M - The Business Journals|Johnson & Johnson’s MedTech announce orthopaedics receives 501K clearance from FDA for spinal robotics and navigation platform - Pharmafile|The Market's Excessive Recession Fears - Yahoo Finance
1730,2024-08-05,Is Wall Street Bullish Or Bearish On Johnson & Johnson Stock? - Barchart|JNJ: 3 Top Stocks for Dividend Reinvestment Plans (DRIPs) - StockNews.com|South Carolina Jury Hears Openings In Latest Johnson & Johnson Talc Powder Trial - CVN News
1731,2024-08-06,Is It Time to Buy These Overlooked Dividend Stocks? - Nasdaq|FDA expands labeling for Linx reflux management system from J&J’s Ethicon - Mass Device|The 3 Best Dividend Aristocrats to Buy for Sustainable Income: August 2024 - InvestorPlace
1732,2024-08-07,"Paul Harris' Past Picks: Bank of America, TD Bank, and Johnson & Johnson - BNN Bloomberg|Johnson & Johnson talc baby powder asbestos: key facts - U.S. Right to Know|JNJ: 3 Must-Buy Healthcare Stocks for Defensive Investing - StockNews.com|J&J’s DePuy Synthes launches new plating system - Mass Device"
1733,2024-08-08,"New Johnson & Johnson Baby Powder Trial Underway in South Carolina - DrugWatch.com|Top 15 Johnson and Johnson Competitors and Alternatives - Business Strategy Hub|Johnson & Johnson’s Nipocalimab Shows Promising Results in Preventing Severe Hemolytic Disease of the Fetus and Newborn - Femtech Insider|Johnson & Johnson stock rises Friday, still underperforms market - MarketWatch"
1734,2024-08-09,How Much Will Sunscreen Recall Lawsuits Be Worth? - Lawsuit Information Center Blog|Gilead exits J&J royalty deal for liver drug ahead of potential FDA nod - Seeking Alpha|Medicare paid substantially more for J&J's Stelara when it was covered under Part D than under Part B - STAT
1735,2024-08-10,Johnson & Johnson (JNJ): An Undervalued Dividend King With Strong Financials - Markets Insider
1736,2024-08-11,Johnson & Johnson stock outperforms competitors despite losses on the day - MarketWatch|J&J Gets Plaintiff Backing for $6.5 Billion Baby Powder Accord - Bloomberg|Johnson & Johnson MedTech Employees Volunteer for Beach Cleanup in Newport Beach - Newport Beach Independent Newspaper|J&J makes headway in settling talc baby powder litigation: reports (NYSE:JNJ) - Seeking Alpha
1737,2024-08-12,"Johnson & Johnson’s new robotic surgical system to rival Intuitive Surgical’s da Vinci - Yahoo Finance|Pulsed field ablation catheters take shape at Medtronic, Boston Scientific, Abbott and J&J's Biosense Webster - Medical Design & Outsourcing|J&J has enough support from claimants for $6.5-billion talc settlement, Bloomberg reports - Reuters.com|J&J Moves Closer to Resolving Baby Powder Lawsuits, 75% of Plaintiffs Support $6.5B Settlement - Yahoo Finance"
1738,2024-08-13,Johnson & Johnson Wins Critical Support from Plaintiffs for $6.5B Settlement - TipRanks|Johnson & Johnson under investigation in South Africa over 'excessive' drug prices - Africanews English|JNJ: 3 Bargain Healthcare Stocks to Buy for Long-Term Gains - StockNews.com|Johnson & Johnson Wins Bankruptcy Vote: What's Next for Victims - Mesothelioma.com
1739,2024-08-14,"7 Dependable Dividend Stocks for Long-Term Income - InvestorPlace|J&J and Roche are the strongest companies in the biopharma industry, says S&P Global - FiercePharma|J&J Pursues Global Resolution for Talc Product Lawsuits - Value the Markets|Prediction: Johnson & Johnson's Dividend Payouts Will Increase in 2025 - 24/7 Wall St."
1740,2024-08-15,"Dean Omar Scores 3rd Talc Verdict With $63.4M Against Johnson & Johnson - Law.com|J&J nearing talc settlement disclosure, sources say - FBC News|SC man who said Johnson & Johnson baby powder gave him cancer awarded $63M by jury - The Post and Courier"
1741,2024-08-16,"Johnson & Johnson stock rises Friday, still underperforms market - MarketWatch|Baltimore reaches $152.5 million settlement with Cardinal Health over opioid crisis, $242.5 million in total recoveries - CBS News|Talc Suit Updates: J&J Secures Votes for $6.5 B Deal, Loses Bankruptcy Attempt #3; Avon Files for Bankruptcy - Cosmetics & Toiletries|J&J Eyes Texas as Venue for Next Round of Baby Powder Fight - Claims Journal"
1742,2024-08-17,"Johnson & Johnson (JNJ) Is on Track for a Record-Setting 2024 - TipRanks|J&J, Roche come out on top in S&P ratings of strongest pharma companies (NYSE:JNJ) - Seeking Alpha|Glenn R. Mattes Obituary 2024 - Goldsteins Funeral|2 Dow Jones Dividend Stocks With Above-Average Yields to Buy Now and Hold for at Least a Decade - The Motley Fool|Johnson & Johnson SWOT 2024|SWOT Analysis of Johnson & Johnson - Business Strategy Hub"
1743,2024-08-18,Latest J&J Baby Powder Lawsuit Ends in Big Win for Plaintiff - DrugWatch.com|OS Therapies Accepted Into Johnson & Johnson Innovation - JLABS - Yahoo Finance
1744,2024-08-19,Johnson & Johnson to buy heart failure implant company V-Wave for up to $1.7B - Fierce Biotech|Johnson & Johnson CEO pay doubled in 2023; Former J&J MedTech leader's comp also climbed - Medical Design & Outsourcing|Johnson & Johnson (JNJ) to acquire V-Wave in deal worth up to $1.7bn - StreetInsider.com|37% Of This Johnson & Johnson Insider's Holdings Were Sold - Yahoo Finance|JNJ Shows Interest in OSTX Antibody Drug Conjugate Platform Tech - Insider Financial
1745,2024-08-20,"J&J to Pay as Much as $1.7 Billion for Heart-Tech Firm V-Wave - Bloomberg|Johnson & Johnson Gets FDA Approval for Treatment, Makes Acquisition of Up to $1.7 Billion - Barron's|Johnson & Johnson (JNJ) Outperforms Broader Market: What You Need to Know - Yahoo Finance|J&J (JNJ) Gets FDA Nod for Chemotherapy-Free Lung Cancer Therapy - Yahoo Finance|Johnson & Johnson (JNJ) Announces RYBREVANT plus LAZCLUZE approved in the U.S. - StreetInsider.com"
1746,2024-08-21,Johnson & Johnson: Don’t Bet Against Double Compounding (NYSE:JNJ) - Seeking Alpha|Johnson & Johnson Buys Israeli MedTech Firm For Up To $1.7B - NoCamels - Israeli Innovation News|Johnson & Johnson to buy Israeli-based V-Wave for up to $1.7bn - Jewish News|Johnson & Johnson Acquires Cardiovascular Specialist V-Wave - HospiMedica
1747,2024-08-22,Meet two brothers who are revolutionizing the way scientists develop treatments for cancer - Johnson & Johnson|We Think Johnson & Johnson (NYSE:JNJ) Can Stay On Top Of Its Debt - Simply Wall St|HRSA tells Johnson & Johnson its plan for 340B drug rebates is not allowed - Healthcare Finance News|Jury awards $63M in cancer patient’s J&J talc trial - Top Class Actions
1748,2024-08-23,Investors in Johnson & Johnson (NYSE:JNJ) have seen notable returns of 46% over the past five years - Yahoo Finance|UOG nursing student awarded Johnson & Johnson scholarship - The Guam Daily Post
1749,2024-08-24,J&J in talks with holdouts to $6.5 billion talc settlement - ETLegalworld|3 of the Best Long-Term Stocks to Buy Now and Hold Forever - 24/7 Wall St.|Is Johnson & Johnson (JNJ) The Best Among The S&P 500 Dividend Aristocrats According to Hedge Funds? - Yahoo Finance
1750,2024-08-25,Johnson & Johnson to Appoint Kristen Mulholland as Chief Human Resources Officer - citybiz|Is Johnson & Johnson Stock a Buy? - The Motley Fool|Johnson & Johnson Aims New Policy For Hospital Payments Under 340B Drug Discount Program Related To Its Flagship Blood Thinner And Arthritis Drugs - Benzinga|Johnson & Johnson stock underperforms Monday when compared to competitors despite daily gains - MarketWatch|Johnson & Johnson Taps New Chief Human Resources Officer - Contract Pharma
1751,2024-08-26,"Johnson & Johnson appoints Michaela Hagenhofer as Irish GM - Business Plus|Johnson & Johnson (JNJ) Stock Dips While Market Gains: Key Facts - Yahoo Finance|J&J, HRSA at Loggerheads Over 340B Drug Pricing for Stelara and Xarelto - BioSpace|Johnson & Johnson in talks with holdouts over $6.5B talc settlement - NJBIZ"
1752,2024-08-27,Johnson & Johnson’s longtime HR leader to retire - NJBIZ|How High Can This Healthcare Stock Soar With Nvidia's Help? - Barchart|JNJ Stock A Winner Right Now? - Forbes
1753,2024-08-28,'Good Faith' Bankruptcy Filings Get Fresh Look Ahead of J&J Move - Bloomberg Law|Johnson & Johnson MedTech signs collaboration agreement to build awareness about heart health in Egypt - Ahram Online|WMT: 3 Inflation-Beating Stocks for Your Portfolio - StockNews.com|LifeNet launches newest bone allograft gel with Johnson & Johnson - Medical Device Network
1754,2024-08-29,New and notable appointments at companies across Ireland. - Business & Finance|Johnson & Johnson seeks first approval of nipocalimab to treat broadest population living with antibody positive generalized myasthenia gravis - PR Newswire|JNJ Apparel celebrates 20 years of business in Tuscaloosa - wvua23.com|JNJ Seeks First FDA Nod for Autoimmune Disease Drug Nipocalimab - Yahoo Finance|Hospitals seek fines against Johnson & Johnson in 340B battle - Modern Healthcare
1755,2024-08-30,"A wrap for the first cohort of the Nurse Innovation Fellowship Program - Penn Today|Johnson & Johnson-Spin Off Kenvue Wins Lawsuit Over Pain Killer Tylenol 'Rapid Release' Gelcaps - Benzinga|Johnson & Johnson's (NYSE:JNJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects? - Yahoo Finance|Drop Johnson & Johnson, Pick These Steady Eddie Stocks? - Forbes|Must-have stocks for passive income in 2025 - Finbold - Finance in Bold"
1756,2024-08-31,Is Johnson & Johnson the Best Dividend Stock for You? - The Motley Fool|Johnson & Johnson To Acquire Ambrx Biopharma In $2B Deal - Contract Pharma|ChatGPT Stock Advice: 10 Recent Stock Recommendations - Insider Monkey
1757,2024-09-01,"Johnson & Johnson picks Onco360 as pharmacy partner for LAZCLUZE - Pharmaceutical Technology|AHA wants J&J to face monetary penalties in 340B plan - Healthcare Finance News|ChatGPT-4o builds ideal $1,000 stock portfolio for Q4 2024 - Finbold - Finance in Bold|Johnson & Johnson (JNJ): A Good 52-Week High Stock to Buy According to Short Sellers - Yahoo Finance"
1758,2024-09-02,"Paul Harris' Past Picks: TD Bank, Stryker, and Johnson & Johnson. - BNN Bloomberg|AHA urges HRSA to block J&J’s illegal imposition of 340B rebate model - American Hospital Association|Johnson & Johnson (JNJ) Increases Despite Market Slip: Here's What You Need to Know - Yahoo Finance|Hospitals protest Johnson & Johnson’s planned changes to 340B drug discounts - Chief Healthcare Executive|Johnson & Johnson (JNJ): Among ChatGPT’s Recent Stock Recommendations - Insider Monkey"
1759,2024-09-03,J&J talc powder settlement backed by key attorney: report (NYSE:JNJ) - Seeking Alpha|Report: Judge says Johnson & Johnson must pay Auris shareholders $1B in damages - Mass Device|Johnson & Johnson Sweetens Talc Settlement Deal by $1.1B - TipRanks|How Johnson & Johnson is fighting counterfeit medical products - Johnson & Johnson
1760,2024-09-04,"Court Orders Johnson & Johnson To Compensate Auris Health Shareholders $1B - Benzinga|With $1.1B pot sweetener, Johnson & Johnson gets one step closer in Texas two-step talc plan: Reuters - FiercePharma|Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results - Business Wire|Johnson & Johnson Must Pay $1B in Damages for Surgical Robotics Contract Breaches, Fraud - Law.com|Johnson & Johnson Raises Talc Settlement Offer to $9B, Moves Closer to Settlement Victory - Benzinga"
1761,2024-09-05,"J&J ordered to pay $1B over fallout from Auris robotic surgery deal - Fierce Biotech|Final Trades: Dell Technologies, CoStar Group, Johnson & Johnson and PayPal Holdings - CNBC|Is Johnson & Johnson Underperforming The S&P 500? - Barchart|Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know - Yahoo Finance"
1762,2024-09-06,"Johnson & Johnson reportedly adds $1.1B to proposed talc settlement - NJBIZ|Johnson & Johnson, Flex to Keynote at MEDevice Silicon Valley - MD+DI|What J&J’s Now $9 Billion Settlement Offer Means for Talcum Powder Lawsuits - DrugWatch.com|J&J’s Talcum Powder Settlement is Moving Closer to Reality - Consumernotice.org"
1763,2024-09-07,Johnson & Johnson (JNJ): A Magic Formula Stock You Should Pay Attention To - Insider Monkey|Top 3 recession-proof stocks to buy as US monthly jobs data disappoints again - TradingView|J&J bolsters Rybrevant-Lazcluze's case against AZ's Tagrisso with survival analysis - FiercePharma|Telangana CM advises journalist community to strive to enhance dignity of their profession - The Hindu
1764,2024-09-08,"Johnson & Johnson Increases Talcum Powder Settlement Offer by $1.1B: Reuters - AboutLawsuits.com|5 Stocks to Watch: Apple's Launch Week Showdown - Money Morning|Johnson & Johnson to Acquire V-Wave Ltd. for $600 Million, Expanding Cardiovascular Portfolio - The Healthcare Technology Report.|Johnson & Johnson (JNJ) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance"
1765,2024-09-09,"J&J MedTech updates brand identity, renames five businesses - Mass Device|Johnson & Johnson stock outperforms competitors on strong trading day - MarketWatch|Protagonist Therapeutics' Two Investigational Candidates Target Over $10B Market, Bullish Analyst Opines - Yahoo Finance|Johnson & Johnson told to pay ₹35 lakh each as compensation to hip implant victims - The Economic Times"
1766,2024-09-10,Johnson & Johnson Announces Board Director Retirement and Succession - TipRanks|Johnson & Johnson reports data from Phase II NSCLC treatment trial - Clinical Trials Arena|Production music firm APM sues pharma giant Johnson & Johnson - Music Ally|Metals in Tampons: FDA Initiates New Safety Measures and Testing - Benzinga|Sony Music-Universal Music JV Hits Johnson & Johnson With Copyright Lawsuit Over Unlicensed Music Use Covering 80 Videos - Johnson & Johnson (NYSE:JNJ) - Benzinga
1767,2024-09-11,"J&J CFO Sees Value in Tech Partnerships - Marketscreener.com|LifeNet, J&J MedTech Introduce New Bone Allograft - https://ryortho.com/|Johnson & Johnson Announces Rebate Model for Certain 340B Drugs; HRSA Pushes Back - Manatt, Phelps & Phillips, LLP"
1768,2024-09-12,Johnson & Johnson: A Strategic MedTech Shift For This Dividend King (NYSE:JNJ) - Seeking Alpha|Connecticut’s First J&J Cosmetic Talc Trial Gets Underway - Watch Online via CVN - CVN News|FDA approves Johnson & Johnson’s TREMFYA for ulcerative colitis - Pharmaceutical Technology|FDA Grants Label Expansion to J&J's Tremfya in Ulcerative Colitis - Yahoo Finance|Johnson & Johnson’s IL-23 inhibitor Tremfya granted FDA approval for ulcerative colitis - PMLiVE
1769,2024-09-13,"J&J leads H1 healthcare deals as Big Pharma dealmaking returns: report - Seeking Alpha|Johnson & Johnson - Sustainability Magazine|SpectraWAVE raises $50M for FDA-cleared intravascular imaging technology - Cardiovascular Business|Johnson & Johnson stock rises Friday, still underperforms market - MarketWatch|From HYBE’s mystery acquisition to the copyright lawsuit against Johnson & Johnson… it’s MBW’s Weekly Round-Up - Music Business Worldwide"
1770,2024-09-14,"Is Johnson & Johnson (JNJ) the Best Blue Chip Stock To Invest In According to Short Sellers? - Insider Monkey|Discovery and In Vivo Exploration of 1,3,4-Oxadiazole and α-Fluoroacrylate Containing IL-17 Inhibitors - ACS Publications"
1771,2024-09-15,Johnson & Johnson settles with Baltimore as opioid trial was set to start - Fox Baltimore|Johnson & Johnson (JNJ) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance|Baltimore settles opioid lawsuit with Johnson & Johnson ahead of trial against drug companies - The Baltimore Banner|J&J’s Shockwave adds enhanced catheter to U.S. IVL portfolio - Mass Device|(JNJ) Investment Analysis and Advice - Stock Traders Daily
1772,2024-09-16,"Baltimore settles with Johnson & Johnson over opioids - WBAL TV Baltimore|Edwards Lifesciences gains amid takeover speculation - Seeking Alpha|Then and Now – NextEra Energy - My Own Advisor|Johnson & Johnson Trends After Authorities Revealed They Seized 1,000 Bottles Of Baby Oil When Raiding Diddy's Homes - TheJasmineBrand"
1773,2024-09-17,J&J threatened with sanctions over plan to rebate 340B drugs - Healthcare Dive|Top 10 biotech and pharmaceutical companies based on market cap 2024 - Statista|Meet a health worker empowered to serve her community through a unique model of care - Johnson & Johnson|Top biotech and pharma companies by net income 2024 ranking - Statista|Johnson & Johnson (JNJ) Faces Legal Challenges While Advancing MedTech Innovations for Growth - Yahoo Finance
1774,2024-09-18,Johnson & Johnson obtains FDA OK for new indication for Tremfya - Drug Store News|HRSA orders J&J to drop controversial 340B rebate model - Modern Healthcare|Pharma Stocks: 5 Biggest Companies in 2024 - Investing News Network|HRSA Threatens J&J With Sanctions Over Planned 340B Rebate Scheme - BioSpace|HRSA warns Johnson & Johnson of consequences of 340B rebates - Healthcare Finance News
1775,2024-09-19,"J&J Unit Seeks Chapter 11 For Third Time Over Baby Powder (2) - Bloomberg Law|J&J unit files for bankruptcy to advance $10 billion talc settlement - Reuters.com|First Multi-District Litigation Ovarian Cancer Trial Against J & J Scheduled for December 3, 2024 - Mesothelioma.net Blog|Johnson & Johnson (NYSE:JNJ) Sees Robust Q2 Sales Growth and Strategic FDA Approvals, But Faces MedTech Challenges - Simply Wall St|J&J subsidiary files for bankruptcy to advance $8 billion talc settlement - CNN"
1776,2024-09-20,Johnson & Johnson Subsidiary Files for Bankruptcy to Settle Talc Claims - TipRanks|Johnson & Johnson's Rybrevant Scores Third FDA-Approval Of 2024 For Certain Type Of Inoperable Lung Cancer In Pretreated Patients - Benzinga|Johnson & Johnson Files Third Talc Bankruptcy in Texas - Law.com|J&J tries bankruptcy again for talc cases - Axios|Is Johnson & Johnson Stock a Buy? - sharewise
1777,2024-09-21,"Johnson & Johnson Files Third Bankruptcy Case, in an attempt to End Talc Lawsuits - Eurasia Business News|Johnson & Johnson Unit seeks Chapter 11 bankruptcy for third time over baby powder lawsuits - Deccan Herald|“The Space of Potential Molecules is Gigantic” — Says Head of Computer-aided Drug Design at Johnson & Johnson - The Quantum Insider|Is Johnson & Johnson (JNJ) the Best Future Stock For The Long-Term? - Insider Monkey"
1778,2024-09-22,"J&J talc opponents decry bankruptcy as ""deja vu all over again"" - Reuters.com|J&J Subsidiary Files for Bankruptcy Again - Asbestos.com|Multi Axis Arthroscopy Market Company Share, Major Competitors, Regional Segments, Strategies, And Forecast... - WhaTech|Top Three Questions on Johnson & Johnson’s Third Talc Bankruptcy - The Wall Street Journal|Johnson & Johnson Adds $1.75 Billion to Cancer Lawsuit Bankruptcy Proposal - Mesothelioma Guide"
1779,2024-09-23,Judge rejects cancer patient’s $260M J&J talc verdict - Top Class Actions|Johnson & Johnson stock outperforms competitors despite losses on the day - MarketWatch|Johnson & Johnson Marks 50 Years In Singapore With Range Of Events - BERNAMA|Cerenovus and Biosense Webster among brands newly incorporated into Johnson & Johnson MedTech - NeuroNews International|Johnson & Johnson’s Third Bankruptcy Venue to Be Determined by Houston Judge - The Wall Street Journal
1780,2024-09-24,Vulnerability Reporting Program - Johnson & Johnson|Faulty hip replacement device: Johnson & Johnson to pay Rs 35L - DTNEXT|J&J Spurs DOJ Venue Fight Over Third Bankruptcy Filing in Texas - Bloomberg Law|J&J lawsuit bankruptcy move causes ruffles|Dippy Singh|CDR Article - CDR Magazine|Advancing a community health co-creation strategy to achieve universal health coverage in Africa - Johnson & Johnson
1781,2024-09-25,"What Factors Will Determine if J&J’s Third Talc Settlement Attempt Succeeds? - Consumernotice.org|J&J to shutter cardiovascular, metabolic drug unit: report (NYSE:JNJ) - Seeking Alpha|Novavax taps J&J, Merck alum Ruxandra Draghia-Akli as new R&D head - Bizwomen - The Business Journals|Is Johnson & Johnson (JNJ) the Best Stock To Buy Right Now According To Billionaire Cliff Asness? - Yahoo Finance|Johnson & Johnson (JNJ): A Good Holding Company Stock to Buy Now - Insider Monkey"
1782,2024-09-26,New myeloma treatment shows promising results in study - Investing.com India|Research & development - Johnson & Johnson|Leading where medicine is going - Johnson & Johnson|Exclusive: J&J folds cardiovascular and metabolic drug unit - Endpoints News
1783,2024-09-27,"Fierce Pharma Asia—Daiichi, AZ's ADC setback; Fosun, Kite JV's separation; Yuhan's busy week - FiercePharma|J&J releases encouraging data on Talvey combination therapies (NYSE:JNJ) - Seeking Alpha|HRSA issues final warning to J&J to cease implementation of its 340B proposed rebate program - American Hospital Association|Johnson & Johnson (JNJ) reports TALVEY and DARZALEX FASPRO based combination shows deep and durable responses in patients with relapsed or refractory multiple myeloma - StreetInsider.com|Pharma Stock Roundup: JNJ's 3rd Talc-Related Bankruptcy Filing & More - Yahoo Finance"
1784,2024-09-28,Who Are Pfizer's (PFE) Main Competitors? - Investopedia|Acadia replaces outgoing CEO with BMS exec - The Pharma Letter|NewEdge Advisors LLC Increases Stock Position in Johnson & Johnson (NYSE:JNJ) - MarketBeat|Johnson & Johnson announces updated results from Phase 1b RedirecTT-1 study - Yahoo Finance|2 Excellent Dividend Stocks to Buy With Less Than $200 - The Motley Fool
1785,2024-09-29,"Johnson & Johnson (JNJ) Rolls Out New TECNIS Odyssey Next-Generation Intraocular Lens Offering Cataract Patients Precise Vision at Every Distance in Any Lighting - StreetInsider.com|Johnson & Johnson Submits Application to FDA for Multiple Myeloma Treatment - MarketWatch|Johnson & Johnson stock rises Monday, still underperforms market - MarketWatch|Johnson & Johnson eyes $1B, 420-job expansion in Wilson, sources say - WRAL News|Johnson & Johnson Rolls Out New TECNIS Odyssey Next-Generation Intraocular Lens Offering Cataract Patients Precise Vision at Every Distance in Any Lighting - PR Newswire"
1786,2024-09-30,"Cooper announces $2 Billion Johnson & Johnson plant for Wilson - WITN|J&J to invest over $2 billion for new manufacturing facility in North Carolina - Reuters.com|Johnson & Johnson to pour $2B into North Carolina biologics plant, add 420 jobs - FiercePharma|Johnson & Johnson to invest over $2 billion in new facility in Wilson - CBS17.com"
1787,2024-10-01,"Johnson & Johnson Announces $2B Investment in North Carolina Biologics Plant - Zenopa|Johnson & Johnson plans $2B North Carolina plant (NYSE:JNJ) - Seeking Alpha|Johnson & Johnson (NYSE:JNJ) is a favorite amongst institutional investors who own 73% - Yahoo Finance|J&J to Invest $2B in North Carolina Manufacturing Facility, Create 420 Jobs - BioSpace|Johnson & Johnson plans 420-worker plant in Eastern NC, as area gets another biotech boost - Yahoo Canada Finance"
1788,2024-10-02,Johnson & Johnson - MHA - Michigan Health & Hospital Association|Activist sues over sale of Johnson & Johnson baby powder in Kenya - KahawaTungu|Johnson & Johnson Sets a $2 Billion Anchor in Wilson County with a New Pharmaceutical Campus - Hoodline|Johnson & Johnson Announces Collaborative Effort with USAID to Strengthen the Health Workforce Across Latin America and the Caribbean - Johnson & Johnson
1789,2024-10-03,Johnson & Johnson Ends Phase 2 Study For Dengue Antiviral Amid R&D Reprioritization - Benzinga|Big pharma companies lay off hundreds amid tepid sales and legal battles - Crain's New York Business|2 Smart Income Stocks to Buy Right Now - The Motley Fool|Bringing orthopaedic surgical care closer to home for Malawi’s rural population - Johnson & Johnson|Johnson & Johnson plans $2B North Carolina plant - Manufacturing Dive
1790,2024-10-04,3 Dividend Kings You’ve Never Heard Of - TheStreet|J&J drops phase 2 dengue candidate as part of ongoing move away from vaccines - Fierce Biotech|Johnson & Johnson to Participate in the Guggenheim Global Healthcare Conference - Yahoo Finance|J&J discontinues dengue drug study after changes in R&D portfolio - Reuters.com|J&J discontinues dengue drug study - PharmaLive
1791,2024-10-05,"Is Johnson & Johnson (JNJ) the Best Stock to Buy According to Billionaire Ray Dalio? - Insider Monkey|J&J Backs Down From 340B Rebates, But Maintains They’re ‘Legally Permissible’ Per Statute - MedCity News|EU: Johnson and Johnson vaccine has possible link to blood clotting - Telegrafi"
1792,2024-10-06,"Should JNJ Stock Be in Your Portfolio Ahead of Q3 Earnings? - Zacks Investment Research|Darren Sissons' Past Picks: British American Tobacco PLC,Canadian Natural Resources, and Johnson & Johnson - BNN Bloomberg|Johnson & Johnson Scraps Phase II Study on Antiviral for Dengue Virus - Yahoo Finance|Chicago Appeals Court Upholds $45 Million Mesothelioma Verdict - Mesothelioma.net Blog|How The Hospital Industrial Complex Robs Poor Patients - Forbes"
1793,2024-10-07,J&J drops antiviral for the prevention of dengue - The Pharma Letter|Johnson & Johnson submits new Monarch surgical robot software for FDA clearance - Mass Device|Johnson & Johnson Ends Bladder Cancer Study But Still Backs TAR-200 - MarketWatch|J&J Wins OK For $505M Deal With Bankrupt Talc Miners - Law360|Is Johnson & Johnson (JNJ) the Best Cheap Stock to Buy According to Billionaire Ray Dalio? - Yahoo Finance
1794,2024-10-08,J&J’s Court-Shopping Strategy Pits New Jersey Home Against Texas - Bloomberg|J&J to discontinue SunRISe-2 study of TAR-200 - The Pharma Letter|Genomic surveillance reveals a dengue 2 virus epidemic lineage with a marked decrease in sensitivity to Mosnodenvir - Nature.com|What To Expect When Johnson & Johnson Reports Q3 Earnings Next Week? - Benzinga
1795,2024-10-09,Johnson & Johnson 2024: Above-market growth continues - PharmaLive|J&J takes over heart failure treatment company V-Wave - Medical Device Network|Johnson & Johnson MedTech Launches VOLT™ Plating System - PR Newswire|Johnson & Johnson (JNJ) Stock Moves -0.09%: What You Should Know - Yahoo Finance|JnJ completes acquisition of V Wave - Medical Dialogues
1796,2024-10-10,"Stifel maintains Johnson & Johnson shares at Hold rating - Investing.com|Wells Fargo sustains stock target, equal weight on JNJ amid EPS concerns - Investing.com|Retirees: Focus on Dividend Growth With These 3 Stocks - 24/7 Wall St.|Johnson & Johnson launches VOLT plating system - Mass Device|J&J talc bankruptcy stays in Texas, boosting settlement odds - Texarkana Gazette"
1797,2024-10-11,"What Trends Will Drive Johnson & Johnson's Q3 Results? - Forbes|Stocks Extend Weekly Win Streaks to 5 - Schaeffers Research|J&J’s Court-Shopping Win Highlights Irresistible Bankruptcy Tool - Yahoo Finance|Sumitomo Life launches 1st eye insurance for contact lens users - Kyodo News Plus|J&J Talc bankruptcy stays in Texas, boosting settlement odds - Daily Maverick"
1798,2024-10-12,"Earnings week ahead: BAC, GS, JNJ, TSM, UNH, ABT, UAL, NFLX, PG, AXP and more - Seeking Alpha|Medical Device Technologies Market to See Huge Demand by 2030:Medtronic, Johnson & Johnson - Newstrail|Wall Street Breakfast: The Week Ahead - Seeking Alpha|Johnson & Johnson (JNJ-N) Quote - Press Release - The Globe and Mail|What You Need To Know Ahead of Johnson & Johnson's Earnings - Investopedia"
1799,2024-10-13,Johnson & Johnson receives updated NICE recommendation for Tecvayli in multiple myeloma - PMLiVE|What To Expect in the Markets This Week - Yahoo Finance|Will Earnings Season Trigger a Stronger Rotation Into Smaller Stocks? - TheStreet|Johnson & Johnson (JNJ) Q3 Pre-Earnings: Here’s What to Expect - TipRanks
1800,2024-10-14,"J&J lifts profit and sales forecasts, beats Wall Street expectations - PharmaLive|Johnson & Johnson's Q3 Earnings: Revenue And EPS Beat On Strong Cancer Drug Sales, Revises Annual Outlook To Reflect V-Wave Acquisition - Yahoo Finance|Johnson and Johnson Earnings Beat Estimates - Barron's|Johnson & Johnson Reports Q3 2024 Results - Business Wire|J&J Stock Leapfrogs 50-Day Line After Health Care Titan Raises Sales Outlook - Investor's Business Daily"
1801,2024-10-15,"Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2024 - Business Wire|J&J must pay $15 million to man who says its talc caused his cancer, jury finds - Reuters|Johnson & Johnson's Baby Talcum Powder: Cancer Claims and Legal Battles - Bizz Buzz|Johnson & Johnson Earnings: Both Segments See Solid Q3 Growth - Morningstar|Are JNJ’s mergers and acquisitions weighing down company’s performance? - MSN"
1802,2024-10-16,"Citigroup Raises Johnson & Johnson (NYSE:JNJ) Price Target to $185.00 - MarketBeat|Johnson & Johnson Stock: Setting the Stage for 2025 Highs - Johnson & Johnson (NYSE:JNJ), Kenvue (NYSE:KVUE) - Benzinga|Johnson & Johnson Beats Wall Street Estimates. Is It Time to Buy, Sell, or Hold? - Yahoo Finance|Johnson & Johnson's MedTech Challenges Loom Amid Chinese Market Pressures And Orthopedics Overhaul, Analysts Say - Benzinga|Vontobel Holding Ltd. Sells 44,928 Shares of Johnson & Johnson (NYSE:JNJ) - MarketBeat"
1803,2024-10-17,"Johnson & Johnson Q3 Earnings Review: Nicely Poised For Steady Growth (Upgrade) (JNJ) - Seeking Alpha|Tyra raised to buy by BofA ahead of TYRA-300 data readout (NASDAQ:TYRA) - Seeking Alpha|Johnson & Johnson (NYSE:JNJ) Trading Down 0.2% - Here's Why - MarketBeat|Johnson & Johnson expands treatment options for inflammatory diseases - European Pharmaceutical Manufacturer|Neutrogena makeup remover towelettes falsely advertised as plant-based, class action claims - Top Class Actions"
1804,2024-10-18,"Is Johnson & Johnson (NYSE:JNJ) a Worthwhile Dividend Stock? - TipRanks|BofA Upgrades Tyra Biosciences As Investors Focus On Preclinical Data Amid High Benchmarks Set By Johnson & Johnson's Drug - Yahoo Finance|Johnson & Johnson (JNJ): Growth Prospects Enhanced by Key Acquisitions and Approvals - Insider Monkey|Johnson & Johnson stock rises Friday, still underperforms market - MarketWatch|J&J Talc Settlement Holdouts Accuse Company of Buying Votes - Insurance Journal"
1805,2024-10-19,"Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever - The Motley Fool|Tylenol, Listerine Maker Kenvue Under Activist Spotlight With Starboard Value Stake — Overhaul Ahead For The Johnson & Johnson Spinoff? - Benzinga|Capital Investment Advisors LLC Grows Stock Position in Johnson & Johnson (NYSE:JNJ) - MarketBeat|All It Takes Is $2,500 Invested in Each of These 3 High-Yield Dow Dividend Stocks to Help Generate Over $300 in Passive Income Per Year - The Motley Fool|Starboard Value takes stake in JNJ spin-off Kenvue- WSJ - Investing.com"
1806,2024-10-20,"Arlington Partners LLC Purchases 5,334 Shares of Johnson & Johnson (NYSE:JNJ) - MarketBeat|Best Stocks To Buy If Trump Or Harris Wins In 2024 - Forbes|Activist investor Starboard sets its sights on J&J spinout Kenvue: WSJ - FiercePharma|How Did New York Jets Owner Woody Johnson Build His $384.03 Billion Fortune? - Total Pro Sports|Tylenol Maker Kenvue Stock Surges on Report Starboard Takes 'Sizable Stake' - Investopedia"
1807,2024-10-21,"Pharmalittle: We're reading about a probe of Pfizer and Lilly telehealth, pharma exec donations, and more - STAT|Raleigh Capital Management Inc. Boosts Position in Johnson & Johnson (NYSE:JNJ) - MarketBeat|J&J’s Ketamine-Derived Drug Is Taking Off - The Wall Street Journal|The 'Texas two-step' is back as J&J tries to shed talc lawsuits for a third time - Yahoo Finance"
1808,2024-10-22,"Speculate on Walgreens Boots, Etsy, and More - Baystreet.ca|Activist Investor Starboard Takes Aim at J&J Spinoff Kenvue on Heels of $1B Stake in Pfizer - BioSpace|Johnson & Johnson (NYSE:JNJ) Stock Price Up 0% - What's Next? - MarketBeat|Johnson & Johnson's (NYSE:JNJ) investors will be pleased with their favorable 45% return over the last five years - Yahoo Finance|Johnson & Johnson receives $15M verdict in mesothelioma lawsuit - Top Class Actions"
1809,2024-10-23,Johnson & Johnson's SWOT analysis: pipeline potential drives stock outlook - Investing.com|Johnson & Johnson Investing $2B to Build Pharma Factory in North Carolina - Yahoo Finance|DOJ Files Motion to Halt J&J Talc Settlement - DrugWatch.com|Once grand Queen St centre a ghost town but owners push ahead with development dream - New Zealand Herald|Johnson & Johnson (NYSE:JNJ) is Leo Wealth LLC's Largest Position - MarketBeat
1810,2024-10-24,"J&J to Open $2B Pharmaceutical Plant in North Carolina - AdvancedManufacturing.org|J&J’s Asish Xavier on biotech’s rebound in a volatile era - BioPharma Dive|Johnson & Johnson (JNJ): Legal Challenges Over Talc Products Impact Dow Performance - Yahoo Finance|J&J, Eli Lilly pad immunology profiles with trial readouts in new patient groups - FiercePharma"
1811,2024-10-25,DOJ Calls J&J Talcum Powder Cancer Lawsuit Bankruptcy Filing “Textbook Example of Bad Faith” - AboutLawsuits.com|Alzheimer’s disease: driving advancements with precision medicine - Drug Target Review|Johnson & Johnson's Blockbuster Drug Tremfya Clears Plaque Psoriasis With Lesions Covering Body's Smaller Areas - Yahoo Finance|Is Kenvue Stock a Buy Now? - MSN
1812,2024-10-26,Johnson & Johnson Gets CDSCO Panel Nod to Study anti-cancer drug Amivantamab - Medical Dialogues|Johnson & Johnson Continues To Deny Justice To Victims Of Talc Powder - The Ring of Fire Network|Johnson & Johnson (NYSE:JNJ) Shares Acquired by Moody Lynn & Lieberson LLC - MarketBeat|Johnson & Johnson (NYSE:JNJ) Shares Acquired by Capital Management Associates Inc - MarketBeat|How activist Starboard may help boost value in Kenvue's skin and beauty business - NBC DFW
1813,2024-10-27,"Johnson & Johnson's Tremfya Seeks Expanded Use Approval After It Shares Encouraging Late-Stage Study Data In Crohn's Disease - Yahoo Finance|AbbVie inks $1.4B Aliada buyout, landing ex-J&J Alzheimer's drug to leap the blood-brain barrier - Fierce Biotech|TREMFYA shows promise in Crohn's disease treatment - Investing.com|This Johnson & Johnson Insider Reduced Their Stake By 37% - Yahoo Finance|AbbVie to acquire a J&J-backed brain drugmaker for $1.4B - BioPharma Dive"
1814,2024-10-28,"News|Dietary supplement supplier signs lease at former Johnson & Johnson campus - CoStar Group|Respiratory Syncytial Virus Pipeline 2024: Clinical Trials Assessment, FDA Approvals, Therapies, and Key Companies Involved by DelveInsight|GSK, MedImmune, ReViral, Pfizer, Sanofi, BioComo, Merck - The Globe and Mail|Johnson & Johnson’s $8.2 billion talc bankruptcy deal faces legal challenges in January trial - Vartha Bharati"
1815,2024-10-29,"Johnson & Johnson (NYSE:JNJ) Shares Up 0.2% - What's Next? - MarketBeat|J&J’s $8.2 Billion Talc Settlement Faces January Court Test - Insurance Journal|Impella ECP Pivotal Study Demonstrates Safety, Efficacy for Use in High-Risk PCI - BioSpace|Johnson & Johnson (NYSE:JNJ) Stock Holdings Lifted by FCG Investment Co - MarketBeat|7 of the Best Long-Term Stocks to Buy|Investing - U.S News & World Report Money"
1816,2024-10-30,"Fortitude Family Office LLC Purchases 6,518 Shares of Johnson & Johnson (NYSE:JNJ) - MarketBeat|Top Stock Reports for Amazon.com, Johnson & Johnson and Boston Scientific - Yahoo Finance|Johnson & Johnson (NYSE:JNJ) Trading Down 0.2% - What's Next? - MarketBeat|Department of Justice Intervenes in J&J Talc Bankruptcy - Mesothelioma.net Blog|Judge to Decide J&J’s $8.2B Talc Settlement Offer in 2025 - Asbestos.com"
1817,2024-10-31,"Robert Scott Wilson & Paul Telfer to Hit the Runway! - Soap Opera News|Hand And Body Lotion Market to Witness Stunning Growth with Johnson & Johnson, Procter & Gamble, Unilever - Newstrail|J&J Medtech CIO Larry Jones resigns - MedTech Dive|Johnson & Johnson, 42 attorneys general reach $700M settlement over talc baby powder - MSN"
1818,2024-11-01,"US government moves to block J&J talc bankruptcy resolution - Chemistry World|Buy 3 November Dogs Of The Dow & Watch 7 More - Seeking Alpha|10 Best Blue Chip Stocks Of 2024 - Forbes|Johnson & Johnson stock rises Friday, still underperforms market - MarketWatch"
1819,2024-11-02,"Johnson & Johnson (NYSE:JNJ) Shares Sold by New York State Common Retirement Fund - MarketBeat|STAAR Surgical Third Quarter 2024 Earnings: Beats Expectations - Simply Wall St|Johnson & Johnson MedTech concludes enrolment for OMNY-AF trial pilot phase - MSN|Hitachi Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Simply Wall St|Janssen-Cilag seeks European approval for guselkumab in ulcerative colitis and Crohn’s disease treatment - MSN"
1820,2024-11-03,"Lmcg Investments LLC Purchases 21,471 Shares of Johnson & Johnson (NYSE:JNJ) - MarketBeat|7 Alzheimer’s and Parkinson’s Programs Discarded in 2024 - BioSpace"
1821,2024-11-04,Is Johnson & Johnson (JNJ) the Best Pharma Stock to Buy Right Now? - Yahoo Finance|10 Best Pharma Stocks To Buy Right Now - Insider Monkey|Johnson & Johnson backs UM spinout in $65M funding round - Crain's Detroit Business|10 Best Pharma Stocks To Buy Right Now - Insider Monkey|Johnson & Johnson (JNJ) Tops Q3 Earnings and Revenue Estimates - MSN
1822,2024-11-05,"Gulf International Bank UK Ltd Sells 8,378 Shares of Johnson & Johnson (NYSE:JNJ) - MarketBeat|This Popular Hygiene Product May Cause Cancer, New Lawsuit Alleges - Parade Magazine|Lawyers increase talc ad spending after J&J's $9 billion settlement offer - Reuters.com|J&J's $9 Billion Offer Spurs Wave Of Talc Claims Ads - Finimize|Johnson & Johnson (NYSE:JNJ) Trading Down 0.2% - Time to Sell? - MarketBeat"
1823,2024-11-06,"JNJ: 3 Healthcare Stocks for Long-Term Stability and Growth - StockNews.com|Johnson & Johnson’s Balversa granted MHRA approval in bladder cancer - PMLiVE|Johnson & Johnson (NYSE:JNJ) Shares Acquired by Crestwood Advisors Group LLC - MarketBeat|Stoneridge Investment Partners LLC Has $1.30 Million Position in Johnson & Johnson (NYSE:JNJ) - MarketBeat|Yacktman Asset Management LP Sells 93,440 Shares of Johnson & Johnson (NYSE:JNJ) - MarketBeat"
1824,2024-11-07,"Solvay Third Quarter 2024 Earnings: Misses Expectations - Simply Wall St|Protagonist Reports Third Quarter 2024 Financial Results and Provides Corporate Update - Joplin Globe|FDA Greenlights J&J's Varipulse Device for Safer Atrial Fibrilla - GuruFocus.com|QUS: Mixing Value, Quality And Volatility For An Average Outcome (NYSEARCA:QUS) - Seeking Alpha|Novo Nordisk Third Quarter 2024 Earnings: EPS Beats Expectations - Simply Wall St"
1825,2024-11-08,"Johnson & Johnson stock underperforms Friday when compared to competitors - MarketWatch|Bridgewater Advisors Inc. Boosts Stake in Johnson & Johnson (NYSE:JNJ) - MarketBeat|J&J angles Darzalex for first move into early-stage myeloma with trial win, FDA filing - FiercePharma|Why Johnson & Johnson (JNJ)’s Legal Issues Could Wrap Up Quickly - Yahoo Finance UK|Hour 2 - Johnson & Johnson|FOX Sports Radio|The Ben Maller Show - Fox Sports Radio"
1826,2024-11-09,"Johnson & Johnson (NYSE:JNJ) Shares Sold by Stiles Financial Services Inc - MarketBeat|AEGON ASSET MANAGEMENT UK Plc Sells 12,224 Shares of Johnson & Johnson (NYSE:JNJ) - MarketBeat|Philip James Wealth Mangement LLC Raises Stake in Johnson & Johnson (NYSE:JNJ) - MarketBeat|Easterly Investment Partners LLC Boosts Stock Holdings in Johnson & Johnson (NYSE:JNJ) - MarketBeat|Ethereum Surpasses Johnson & Johnson In Global Market Capitalization - Binance"
1827,2024-11-10,"Verdence Capital Advisors LLC Buys 8,480 Shares of Johnson & Johnson (NYSE:JNJ) - MarketBeat|JnJ seeks approval from USFDA, EMA for DARZALEX FASPRO as subcutaneous monotherapy for high-risk... - Medical Dialogues|Nordwand Advisors LLC Has $123.66 Million Stock Holdings in Johnson & Johnson (NYSE:JNJ) - MarketBeat|Natura &Co Holding Third Quarter 2024 Earnings: Misses Expectations - Simply Wall St|US FDA approves Johnson & Johnson's device for heart condition - MSN"
